1 00:00:07,203 --> 00:00:09,706 I'M MARY GLENSHAW, 2 00:00:09,706 --> 00:00:10,973 DESIGNATESSED FEDERAL OFFICIAL 3 00:00:10,973 --> 00:00:12,675 EXECUTIVE SECRETARY OF OFFICE OF 4 00:00:12,675 --> 00:00:14,377 AIDS RESEARCH ADVISORY COUNCIL. 5 00:00:14,377 --> 00:00:15,745 WELCOME, THANK YOU FOR JOIN 6 00:00:15,745 --> 00:00:16,479 ARING US TODAY. 7 00:00:16,479 --> 00:00:18,548 AS A BRIEF REMINDER OUR COUNCIL 8 00:00:18,548 --> 00:00:20,550 IS GOVERNED BY PROVISIONS OF THE 9 00:00:20,550 --> 00:00:22,318 FEDERAL ADVISORY COMMITTEE ACT 10 00:00:22,318 --> 00:00:24,420 AS AMENDED WHICH SETS FORTH 11 00:00:24,420 --> 00:00:25,988 STANDARDS FOR THE FORMATION AND 12 00:00:25,988 --> 00:00:28,524 USE OF ADVISORY COMMITTEES. 13 00:00:28,524 --> 00:00:31,594 AS SUCH MY ROLE IS TO BE PREPARE 14 00:00:31,594 --> 00:00:33,596 AGENDAS MEETINGS, ATTEND AND 15 00:00:33,596 --> 00:00:34,731 APPROVE ALL COUNCIL AND 16 00:00:34,731 --> 00:00:36,833 SUBCOMMITTEE MEETINGS. 17 00:00:36,833 --> 00:00:38,835 I WILL ADJOURN ANY MEETING WHEN 18 00:00:38,835 --> 00:00:40,536 DETERMINED TO BE IN PUBLIC 19 00:00:40,536 --> 00:00:41,871 INTEREST AND CHAIR MEETINGS WHEN 20 00:00:41,871 --> 00:00:44,841 DIRECTED BY THE NIH OR THE OAR 21 00:00:44,841 --> 00:00:45,208 DIRECTOR. 22 00:00:45,208 --> 00:00:48,311 PLEASE ALSO WELCOME MS. BURK WHO 23 00:00:48,311 --> 00:00:50,313 WILL FULFILL THESE DUTIES IN THE 24 00:00:50,313 --> 00:00:51,881 EVENT I'M ABSENT. 25 00:00:51,881 --> 00:00:56,152 AS IN PREVIOUS MEETINGS GENERAL 26 00:00:56,152 --> 00:00:59,188 GUIDELINES FOR TODAY KINDLY STAY 27 00:00:59,188 --> 00:01:00,890 T MUTED UNLESS SPEAKING. 28 00:01:00,890 --> 00:01:02,959 KEEP YOUR CAMERA ON MOST OF THE 29 00:01:02,959 --> 00:01:03,626 MEETING. 30 00:01:03,626 --> 00:01:05,094 FEEL FREE TO HIDE MOMENTARILY 31 00:01:05,094 --> 00:01:06,696 AND RETURN AS NEEDED. 32 00:01:06,696 --> 00:01:08,364 WHEN YOU LIKE TO PARTICIPATE IN 33 00:01:08,364 --> 00:01:09,665 DISCUSSION WE ASK THAT YOU 34 00:01:09,665 --> 00:01:11,534 PHYSICALLY RAISE YOUR HAND OR 35 00:01:11,534 --> 00:01:14,170 USE THE ZOOM RAISE HAND FEATURE. 36 00:01:14,170 --> 00:01:15,805 FROM TOLBERT AND I WILL NOTE 37 00:01:15,805 --> 00:01:17,573 THOSE WHO WANT TO SPEAK AND CALL 38 00:01:17,573 --> 00:01:20,243 IN TURN SO WE CAN AVOID SPEAKING 39 00:01:20,243 --> 00:01:21,611 OVER EACH OTHER. 40 00:01:21,611 --> 00:01:23,846 PLEASE BE AWARE THAT YOU WILL 41 00:01:23,846 --> 00:01:25,948 NEED TO LOWER YOUR ZOOM HAND 42 00:01:25,948 --> 00:01:26,949 FEATURE ONCE YOU MADE YOUR 43 00:01:26,949 --> 00:01:29,852 REMARKS. 44 00:01:29,852 --> 00:01:32,488 FEEL FREE TO USE THE CHAT, 45 00:01:32,488 --> 00:01:35,258 KINDLY KEEP MESSAGES TO 46 00:01:35,258 --> 00:01:37,193 LOGISTICS ISSUES AND IF YOU HAVE 47 00:01:37,193 --> 00:01:39,429 ANY ISSUES OR CONCERNS, PLEASE 48 00:01:39,429 --> 00:01:43,399 SEND ME OR MELISSA A TEXT. 49 00:01:43,399 --> 00:01:44,734 OUR PHONE NUMBERS ARE IN THE 50 00:01:44,734 --> 00:01:45,768 EMAIL. 51 00:01:45,768 --> 00:01:47,403 SO NOW REMINDER ABOUT OUR 52 00:01:47,403 --> 00:01:48,504 POLICIES REGARDING CONFLICT OF 53 00:01:48,504 --> 00:01:50,807 INTEREST. 54 00:01:50,807 --> 00:01:51,808 COUNCIL MEMBERS MAY NOT 55 00:01:51,808 --> 00:01:53,376 PARTICIPATE IN REVIEWER 56 00:01:53,376 --> 00:01:54,911 DISCUSSION OF SPECIFIC PROGRAM 57 00:01:54,911 --> 00:01:56,913 OR PROJECT FOR WHICH THEY HAVE A 58 00:01:56,913 --> 00:01:58,281 REAL OR APPARENT CONFLICT OF 59 00:01:58,281 --> 00:01:58,848 INTEREST. 60 00:01:58,848 --> 00:02:00,316 IF A PROGRAM OR PROJECT IS 61 00:02:00,316 --> 00:02:01,451 DISCUSSED THAT PREVENTS A 62 00:02:01,451 --> 00:02:04,353 CONFLICT TO YOU, YOU MUST EXCUSE 63 00:02:04,353 --> 00:02:04,987 YOURSELF FROM NEATING. 64 00:02:04,987 --> 00:02:06,622 TO DO THIS SIGNAL ME AND WE WILL 65 00:02:06,622 --> 00:02:09,158 REMOVE YOU TO A SEPARATE MEETING 66 00:02:09,158 --> 00:02:11,127 SPACE IN ZOOM AND THEN RETURN 67 00:02:11,127 --> 00:02:13,529 YOU AFTER THAT PORTION IS OVER. 68 00:02:13,529 --> 00:02:16,499 AFTER THE MEETING, KINDLY 69 00:02:16,499 --> 00:02:17,834 ELECTRONICALLY SIGN THE CONFLICT 70 00:02:17,834 --> 00:02:19,302 OF INTEREST FORM WE WILL MAIL TO 71 00:02:19,302 --> 00:02:20,436 YOU LATER TODAY. 72 00:02:20,436 --> 00:02:23,239 AND SEND IT BACK TO ME TO VERIFY 73 00:02:23,239 --> 00:02:25,208 THAT NOTHING POSTED A CONFLICT 74 00:02:25,208 --> 00:02:25,808 FOR YOU. 75 00:02:25,808 --> 00:02:27,043 ARE THERE ANY QUESTIONS 76 00:02:27,043 --> 00:02:28,578 REGARDING POTENTIAL CONFLICT OF 77 00:02:28,578 --> 00:02:29,812 INTEREST WITH REGARD TO TODAY'S 78 00:02:29,812 --> 00:02:32,849 AGENDA? 79 00:02:32,849 --> 00:02:35,451 ALL RIGHT. 80 00:02:35,451 --> 00:02:37,920 HEARING NONE, TODAY'S MEETING IS 81 00:02:37,920 --> 00:02:38,821 OPEN TO GENERAL PUBLIC AND 82 00:02:38,821 --> 00:02:39,989 CURRENTLY BEING RECORDED AN 83 00:02:39,989 --> 00:02:43,626 VIDEOCAST LIVE. 84 00:02:43,626 --> 00:02:47,330 NOW TO DR. TOLBERT. 85 00:02:47,330 --> 00:02:49,131 >> GOOD AFTERNOON, EVERYONE. 86 00:02:49,131 --> 00:02:50,766 THE 60TH MEETING OF OFFICE OF 87 00:02:50,766 --> 00:02:52,101 AIDS RESEARCH ADVISORY COUNCIL 88 00:02:52,101 --> 00:02:53,135 IS NOW IN SESSION. 89 00:02:53,135 --> 00:02:55,371 I WOULD LIKE TO WELCOME THE 90 00:02:55,371 --> 00:02:56,906 COUNCIL MEMBERS AND INVITED 91 00:02:56,906 --> 00:02:57,907 SPEAKERS NIH COLLEAGUES AND 92 00:02:57,907 --> 00:02:58,908 GUESTS LISTENING IN. 93 00:02:58,908 --> 00:03:00,343 WE WILL START TODAY WITH THE 94 00:03:00,343 --> 00:03:02,478 ROLE CALL OF ALL PERSONS 95 00:03:02,478 --> 00:03:02,879 ATTENDING. 96 00:03:02,879 --> 00:03:06,582 COLLEAGUES WHEN I CALL YOUR NAME 97 00:03:06,582 --> 00:03:07,183 PLEASE STATE YOUR POSITION AND 98 00:03:07,183 --> 00:03:09,218 INSTITUTIONAL AFFILIATION. 99 00:03:09,218 --> 00:03:11,888 WE WILL START WITH OUR OARAC 100 00:03:11,888 --> 00:03:15,458 VOTING MEMBERS, DR. (INAUDIBLE). 101 00:03:15,458 --> 00:03:15,925 >> PRESENT. 102 00:03:15,925 --> 00:03:17,693 I AM PROFESSOR AND CHAIR OF THE 103 00:03:17,693 --> 00:03:19,662 DEPARTMENT OF COMMUNITY HEALTH 104 00:03:19,662 --> 00:03:21,430 AND PREVENTIVE MEDICINE 105 00:03:21,430 --> 00:03:25,201 MOREHOUSE SCHOOL OF MEDICINE. 106 00:03:25,201 --> 00:03:29,872 >> DR. MARGARET L BRENDOU. 107 00:03:29,872 --> 00:03:31,741 >> GOOD AFTERNOON, I'M PROFESSOR 108 00:03:31,741 --> 00:03:33,109 OF MANAGEMENT SCIENCE AND EDGE 109 00:03:33,109 --> 00:03:36,078 NEARING AT STANFORD UNIVERSITY 110 00:03:36,078 --> 00:03:44,554 AND PROFESSOR HEALTH POLICY. 111 00:03:44,554 --> 00:03:46,322 >> I'M PROFESSOR INTERNAL 112 00:03:46,322 --> 00:03:48,925 MEDICINE MICROBIOLOGY 113 00:03:48,925 --> 00:03:49,926 IMMUNOLOGY, UNIVERSITY OF 114 00:03:49,926 --> 00:03:52,328 MICHIGAN ALSO DIRECTOR OF MSTP 115 00:03:52,328 --> 00:03:55,565 ASSOCIATE DEAN OF PHI SINCE 116 00:03:55,565 --> 00:03:56,766 SCIENTIST EDUCATION AND 117 00:03:56,766 --> 00:03:57,433 TRAINING. 118 00:03:57,433 --> 00:03:58,501 >> DR. HEIDI. 119 00:03:58,501 --> 00:04:03,005 >> I'M HERE, I'M PROFESSOR OF 120 00:04:03,005 --> 00:04:04,473 MEDICINE INFECTIOUS DISEASE 121 00:04:04,473 --> 00:04:06,842 UNIVERSITY OF WASHINGTON 122 00:04:06,842 --> 00:04:11,180 >> THANK YOU. 123 00:04:11,180 --> 00:04:15,184 DR. MEHTA. 124 00:04:15,184 --> 00:04:18,187 >> SHRUTI MEHTA. 125 00:04:18,187 --> 00:04:19,589 DEPARTMENT OF EPIDEMIOLOGY. 126 00:04:19,589 --> 00:04:20,723 >> IS DR. MILLER WITH US TODAY? 127 00:04:20,723 --> 00:04:24,293 THE NOT YET. 128 00:04:24,293 --> 00:04:26,429 DR. JOHN SLEASMAN. 129 00:04:26,429 --> 00:04:30,933 >> I'M JOHN SLEASMAN, PROFESSOR 130 00:04:30,933 --> 00:04:32,802 ALLERGY IMMUNOLOGY DUKE 131 00:04:32,802 --> 00:04:33,302 UNIVERSITY SCOLD OF MED. 132 00:04:33,302 --> 00:04:34,837 >> THANK YOU. 133 00:04:34,837 --> 00:04:40,476 DR. IVY TURNBULL. 134 00:04:40,476 --> 00:04:42,478 DR. TURNBULL IS NOT WITH US. 135 00:04:42,478 --> 00:04:42,979 >> HE IS. 136 00:04:42,979 --> 00:04:44,180 >> I'M SORRY. 137 00:04:44,180 --> 00:04:47,416 >> HE IS HERE. 138 00:04:47,416 --> 00:04:48,751 MAYBE AN AUDIO ISSUE. 139 00:04:48,751 --> 00:04:52,455 >> MY CAMERA DOESN'T WORK. 140 00:04:52,455 --> 00:04:55,524 IT'S THE HOST STOPPED VIDEO. 141 00:04:55,524 --> 00:04:57,727 BUT I'M DEPUTY EXECUTIVE 142 00:04:57,727 --> 00:05:00,563 DIRECTOR AIDS ALLIANCE FOR WOMEN 143 00:05:00,563 --> 00:05:02,698 INFANTS CHILDREN AND FAMILIES IN 144 00:05:02,698 --> 00:05:03,199 WASHINGTON D.C. 145 00:05:03,199 --> 00:05:06,268 >> THANK YOU. 146 00:05:06,268 --> 00:05:09,572 YOU ARE AUDIO WAS MUFFLED BUT I 147 00:05:09,572 --> 00:05:11,107 THINK WE WERE ABLE TO HEAR YOUR 148 00:05:11,107 --> 00:05:11,607 INTRO. 149 00:05:11,607 --> 00:05:14,577 SO NEXT I WILL MOVE TO THE OARAC 150 00:05:14,577 --> 00:05:15,044 EX-OFFICIOS. 151 00:05:15,044 --> 00:05:18,881 DR. VICTORIA DAVY 152 00:05:18,881 --> 00:05:20,583 >> ASSOCIATE DIRECTOR FOR 153 00:05:20,583 --> 00:05:22,685 RESEARCH AND DEVELOPMENT OF THE 154 00:05:22,685 --> 00:05:24,220 DEPARTMENT OF VETERANS AFFAIRS. 155 00:05:24,220 --> 00:05:26,622 AND OF COURSE THE VA EX-OFFICIO. 156 00:05:26,622 --> 00:05:27,990 THANK YOU. 157 00:05:27,990 --> 00:05:29,825 >> THANK YOU. 158 00:05:29,825 --> 00:05:37,900 DR. DIFFENBACH WHO WILL JOIN 159 00:05:37,900 --> 00:05:39,168 LATER. 160 00:05:39,168 --> 00:05:41,637 DR. 161 00:05:41,637 --> 00:05:45,708 >> DR. ROHAN HAZRA DIRECTOR 162 00:05:45,708 --> 00:05:48,844 DIVISION OF EXTRAMURAL RESEARCH 163 00:05:48,844 --> 00:05:49,378 NICHD. 164 00:05:49,378 --> 00:05:51,814 >> REAR ADMIRAL JOHN HERMAN. 165 00:05:51,814 --> 00:05:54,583 >> DIRECTOR OF NATIONAL CENTER 166 00:05:54,583 --> 00:05:59,121 FOR HIV VIRAL HEPATITIS, STD AT 167 00:05:59,121 --> 00:05:59,655 CDC. 168 00:05:59,655 --> 00:06:01,424 >> WE WILL MOVE TO ADVISORY 169 00:06:01,424 --> 00:06:06,696 COUNCIL REPRESENTATIVES. 170 00:06:06,696 --> 00:06:11,967 DR. FRANCIS OZMAN. 171 00:06:11,967 --> 00:06:15,271 >> FRANCIS OSMAN, PROFESSOR 172 00:06:15,271 --> 00:06:16,605 EMERITUS NEUROSURGERY. 173 00:06:16,605 --> 00:06:18,708 THE CO-DIRECTOR OF THE BRAIN 174 00:06:18,708 --> 00:06:21,911 TUMOR RESEARCH PROGRAM AT DUKE 175 00:06:21,911 --> 00:06:22,311 UNIVERSITY. 176 00:06:22,311 --> 00:06:24,747 >> THANK YOU. 177 00:06:24,747 --> 00:06:30,553 DR. BOB Y YARCHOAN. 178 00:06:30,553 --> 00:06:34,156 >> I'M REPRESENTING THE NATIONAL 179 00:06:34,156 --> 00:06:36,225 CANCER ADVISORY BOARD. 180 00:06:36,225 --> 00:06:39,995 >> THANK YOU, DR. OSMAN. 181 00:06:39,995 --> 00:06:41,130 IS DR. BOB YARCHOAN WITH US 182 00:06:41,130 --> 00:06:43,432 TODAY? 183 00:06:43,432 --> 00:06:45,167 >> MAYBE JOINING LATER. 184 00:06:45,167 --> 00:06:49,004 >> THANK YOU, DR. MONICA DUNDEE. 185 00:06:49,004 --> 00:06:52,174 >> MY NAME IS MONICA DUNDEE, 186 00:06:52,174 --> 00:06:54,276 PROFESSOR OF MEDICINE INFECTIOUS 187 00:06:54,276 --> 00:06:56,779 DISEASE AT UCSF AND I'M 188 00:06:56,779 --> 00:07:00,649 REPRESENTING THE NIAID ADVISORY 189 00:07:00,649 --> 00:07:03,219 COUNCIL, ARAC TODAY. 190 00:07:03,219 --> 00:07:04,286 ON OARAC. 191 00:07:04,286 --> 00:07:07,556 >> DR. MARGUERITA LIGHTFOOT. 192 00:07:07,556 --> 00:07:09,692 >> HI EVERYONE. 193 00:07:09,692 --> 00:07:10,793 MARGUERITA LIGHTFOOT ASSOCIATE 194 00:07:10,793 --> 00:07:15,231 DEAN FOR RESEARCH AT THE OHSU 195 00:07:15,231 --> 00:07:16,565 PSU SCHOOL OF PUBLIC HEALTH 196 00:07:16,565 --> 00:07:18,300 REPRESENTING NIMH COUNCIL. 197 00:07:18,300 --> 00:07:20,336 >> THANK YOU. 198 00:07:20,336 --> 00:07:23,739 DR. REDONNA CHANDLER. 199 00:07:23,739 --> 00:07:24,473 >> GOOD MORNING. 200 00:07:24,473 --> 00:07:27,877 MY NAME IS REDONNA CHANDLER, 201 00:07:27,877 --> 00:07:29,111 DIRECTOR OF THE RESEARCH PROGRAM 202 00:07:29,111 --> 00:07:30,813 AT NIDA. 203 00:07:30,813 --> 00:07:31,514 >> THANK YOU. 204 00:07:31,514 --> 00:07:34,717 SO NOW TO OUR OAR LEADERSHIP 205 00:07:34,717 --> 00:07:41,123 SPEAKERS DR. MAUREEN GOODENOW. 206 00:07:41,123 --> 00:07:41,557 >> HERE. 207 00:07:41,557 --> 00:07:43,325 >> I'M SORRY. 208 00:07:43,325 --> 00:07:44,560 THANK YOU DR. GLENSHAW. 209 00:07:44,560 --> 00:07:48,531 >> I'M HERE AS WELL. 210 00:07:48,531 --> 00:07:55,104 >> DR. LEO BERTI. 211 00:07:55,104 --> 00:07:57,006 >> HE WILL BE JOINING LATER: 212 00:07:57,006 --> 00:08:01,043 >> AND MS. CORETTA BURK. 213 00:08:01,043 --> 00:08:02,011 >> I'M HERE. 214 00:08:02,011 --> 00:08:02,745 THANK YOU. 215 00:08:02,745 --> 00:08:04,413 >> THANK YOU. 216 00:08:04,413 --> 00:08:06,515 SO LASTLY OUR INVITED SPEAKERS 217 00:08:06,515 --> 00:08:08,484 AND GUESTS LISTED IN ORDER OF 218 00:08:08,484 --> 00:08:09,485 APPEARANCE SOME SPEAKERS MAY 219 00:08:09,485 --> 00:08:10,853 JOIN THE MEETING LATER BUT WE 220 00:08:10,853 --> 00:08:14,023 WILL GO AHEAD AND AT LEAST 221 00:08:14,023 --> 00:08:15,157 ACKNOWLEDGE THEM ON THE ROLL 222 00:08:15,157 --> 00:08:15,858 CALL. 223 00:08:15,858 --> 00:08:17,526 SO FIRST WE HAVE DR. SUSAN 224 00:08:17,526 --> 00:08:20,429 GREGURICK. 225 00:08:20,429 --> 00:08:22,131 WHO WILL JOIN LATER. 226 00:08:22,131 --> 00:08:23,833 >> I BELIEVE THEY ARE ALL 227 00:08:23,833 --> 00:08:25,334 JOINING LATER. 228 00:08:25,334 --> 00:08:27,036 >> GREAT. 229 00:08:27,036 --> 00:08:29,104 ROLL CALL. 230 00:08:29,104 --> 00:08:30,372 MS. KAY HAYES, DR. LAURA 231 00:08:30,372 --> 00:08:30,906 CHEEVER. 232 00:08:30,906 --> 00:08:35,611 REAR ADMIRAL JONATHAN MERMIN. 233 00:08:35,611 --> 00:08:36,545 MR. JIN PARK. 234 00:08:36,545 --> 00:08:40,082 DR. HENRY MASUR. 235 00:08:40,082 --> 00:08:43,519 SO WE ALSO NOTE REGRETS FROM DR. 236 00:08:43,519 --> 00:08:49,558 JOENA SACSHA COLONEL JULIE ACHE 237 00:08:49,558 --> 00:08:52,728 AND DOCTORED RICARDO RIVERA. 238 00:08:52,728 --> 00:08:53,829 SO IS WILL ANYONE THAT I DID NOT 239 00:08:53,829 --> 00:09:00,970 CALL? 240 00:09:00,970 --> 00:09:03,873 >> DR. ROBERT YARCHOAN WAS 241 00:09:03,873 --> 00:09:04,440 SUPPOSED TO BE ON. 242 00:09:04,440 --> 00:09:05,908 NOT SURE IF LAST MINUTE HE 243 00:09:05,908 --> 00:09:08,444 HASN'T TOLD ME HE'S NOT COMING 244 00:09:08,444 --> 00:09:11,780 ON, HEAD OF HIV CANCER RESEARCH 245 00:09:11,780 --> 00:09:12,915 OF THE NCI. 246 00:09:12,915 --> 00:09:15,017 MAUREEN. 247 00:09:15,017 --> 00:09:16,151 WAS ANY CHANGE IN HIS JOINING 248 00:09:16,151 --> 00:09:17,219 US? 249 00:09:17,219 --> 00:09:18,888 >> NO, I UNDERSTAND THAT HE WILL 250 00:09:18,888 --> 00:09:19,655 BE JOINING US. 251 00:09:19,655 --> 00:09:24,760 >> OKAY SO HE SHOULD BE ON THE 252 00:09:24,760 --> 00:09:28,831 -- SO WE CAN ACKNOWLEDGE HIM 253 00:09:28,831 --> 00:09:30,733 LATER WHEN HE JOINS. 254 00:09:30,733 --> 00:09:32,234 BUT THANK YOU FOR THAT. 255 00:09:32,234 --> 00:09:33,335 SO OUR FIRST ORDER OF BUSINESS 256 00:09:33,335 --> 00:09:37,006 IS TO APPROVE MINUTE THE FED 20, 257 00:09:37,006 --> 00:09:39,074 22 OARAC MEETING YOU SHOULD HAVE 258 00:09:39,074 --> 00:09:40,276 RECEIVED THESE MINUTES 259 00:09:40,276 --> 00:09:41,510 ELECTRONICALLY IN THE BRIEFING 260 00:09:41,510 --> 00:09:42,878 BOOK. 261 00:09:42,878 --> 00:09:43,846 ANY ADDITIONS OR CORRECTIONS TO 262 00:09:43,846 --> 00:09:48,317 THE MINUTES? 263 00:09:48,317 --> 00:09:49,852 IF NOT IS THERE A MOTION TO 264 00:09:49,852 --> 00:09:51,320 ACCEPT THE MINUTES AS THEY 265 00:09:51,320 --> 00:09:57,192 STAND. 266 00:09:57,192 --> 00:10:05,100 (INDISCERNIBLE) 267 00:10:05,100 --> 00:10:06,468 >> IS THERE A SECOND TO THE 268 00:10:06,468 --> 00:10:09,405 MOTION TO ACCEPT THE MINUTES? 269 00:10:09,405 --> 00:10:11,307 >> I WILL SECOND THAT. 270 00:10:11,307 --> 00:10:12,007 >> THANK YOU. 271 00:10:12,007 --> 00:10:13,542 THE MOTION IS PASSED AND MINUTES 272 00:10:13,542 --> 00:10:14,910 ARE APPROVED. 273 00:10:14,910 --> 00:10:16,912 SO THANK YOU, EVERYONE LET ME 274 00:10:16,912 --> 00:10:19,782 PROVIDE A BRIEF OVERVIEW OF 275 00:10:19,782 --> 00:10:21,383 TODAY'S AGENDA FROM THE OAR 276 00:10:21,383 --> 00:10:22,651 DIRECTOR. 277 00:10:22,651 --> 00:10:23,953 A PRESENTATION FROM DIRECTOR OF 278 00:10:23,953 --> 00:10:25,621 OFFICE OF DATA SCIENCE 279 00:10:25,621 --> 00:10:27,656 STRATEGIES. 280 00:10:27,656 --> 00:10:29,358 AND UPDATE ON PRESENTATION FROM 281 00:10:29,358 --> 00:10:32,695 HHS INCLUDING THE CDC AND HRSA. 282 00:10:32,695 --> 00:10:34,363 UPDATES FROM THE OARAC HIV 283 00:10:34,363 --> 00:10:36,699 CLINICAL GUIDELINES WORKING 284 00:10:36,699 --> 00:10:39,034 GROUPS. 285 00:10:39,034 --> 00:10:41,136 AN UPDATES -- THE AGENDA ALSO 286 00:10:41,136 --> 00:10:42,905 INCLUDES TIME FOR REGISTERED 287 00:10:42,905 --> 00:10:44,673 PUBLIC COMMENTS, ANYONE 288 00:10:44,673 --> 00:10:46,008 LISTENING IN TODAY WHO WISHES TO 289 00:10:46,008 --> 00:10:48,410 MAKE A PUBLIC COMMENT SHOULD 290 00:10:48,410 --> 00:10:52,247 EMAIL DR. GLENSHAW AT OARAC 291 00:10:52,247 --> 00:10:55,851 INFO@NIH.GOV, OARACINFO AT 292 00:10:55,851 --> 00:10:57,386 NIH.GOV WITH YOUR NAME 293 00:10:57,386 --> 00:10:59,788 AFFILIATION QUESTION OR COMMENT. 294 00:10:59,788 --> 00:11:01,890 PLEASE VISIT THE OAR WEBSITE OR 295 00:11:01,890 --> 00:11:03,492 THE FEDERAL REGISTER NOTICE FOR 296 00:11:03,492 --> 00:11:05,761 MORE DETAILS. 297 00:11:05,761 --> 00:11:08,597 SO COLLEAGUES AS REMINDER PER 298 00:11:08,597 --> 00:11:10,966 OUR CHARTER AND LEGISLATION THE 299 00:11:10,966 --> 00:11:13,769 OARAC ADVISES THE OAR DIRECTOR O 300 00:11:13,769 --> 00:11:15,971 ON BROAD MATTERS RELATING TO HIV 301 00:11:15,971 --> 00:11:17,539 RESEARCH POLICIES PRIORITIES AN 302 00:11:17,539 --> 00:11:18,640 STRATEGIC PLANNING INCLUDING 303 00:11:18,640 --> 00:11:21,543 REVIEW OF THE NIH HIV AIDS 304 00:11:21,543 --> 00:11:22,077 PROGRAM. 305 00:11:22,077 --> 00:11:24,246 SO WE LOOK FORWARD TO PROVIDING 306 00:11:24,246 --> 00:11:25,848 OUR INPUT. 307 00:11:25,848 --> 00:11:27,549 WE WILL NOW HEAR FROM DR. 308 00:11:27,549 --> 00:11:29,852 GOODENOW, DIRECTOR OF THE OFFICE 309 00:11:29,852 --> 00:11:31,954 OF AIDS RESEARCH, DR. GOODENOW 310 00:11:31,954 --> 00:11:37,059 PASS OVER TO YOU. 311 00:11:37,059 --> 00:11:39,628 >> THANK YOU BRAN BLANTON. 312 00:11:39,628 --> 00:11:40,362 GOOD DAY, EVERYONE. 313 00:11:40,362 --> 00:11:49,671 LET ME JUST GET MY -- OKAY. 314 00:11:49,671 --> 00:11:51,640 WELCOME TO ALL, THIS IS THE 60TH 315 00:11:51,640 --> 00:11:54,109 MEETING OF THE OARAC. 316 00:11:54,109 --> 00:11:55,544 AND TIME TO REFLECT ON ALL THE 317 00:11:55,544 --> 00:11:56,045 WORK WE HAVE BEEN DOING 318 00:11:56,045 --> 00:11:57,279 TOGETHER. 319 00:11:57,279 --> 00:11:58,380 FROM IT IS OAR IS EXTREMELY 320 00:11:58,380 --> 00:12:00,682 GRATEFUL TO OUR ADVISORY BOARD 321 00:12:00,682 --> 00:12:03,419 FOR PROVIDING GUIDANCE TO HELP 322 00:12:03,419 --> 00:12:06,522 DEFINE POLICIES AND RESEARCH 323 00:12:06,522 --> 00:12:08,824 STRATEGIES TO THE NIH AGENDA. 324 00:12:08,824 --> 00:12:11,126 WE ARE PARTICULARLY INDEBTED TO 325 00:12:11,126 --> 00:12:13,896 CURRENT PAST OARAC MEMBERS WHO 326 00:12:13,896 --> 00:12:15,097 GENEROUSLY PROVIDED TIME AND 327 00:12:15,097 --> 00:12:18,500 EXPERTISE TO SUPPORT THE NIH OAR 328 00:12:18,500 --> 00:12:22,738 MISSION AS LEGISLATED IN 1988. 329 00:12:22,738 --> 00:12:25,174 AS YOU KNOW JUNE IS PRIDE MONTH 330 00:12:25,174 --> 00:12:27,176 AND IN FOUR DAYS WE WILL BE 331 00:12:27,176 --> 00:12:28,077 OBSERVING NATIONAL HIV TESTING 332 00:12:28,077 --> 00:12:29,711 DAY. 333 00:12:29,711 --> 00:12:31,680 NIH OAR HAS BEEN ACTIVELY 334 00:12:31,680 --> 00:12:33,148 WORKING WITH OUR PARTNERS TO 335 00:12:33,148 --> 00:12:35,250 PROMOTE AND AMPLIFY ACTIVITIES 336 00:12:35,250 --> 00:12:38,754 RELATED TO THESE IMPORTANT 337 00:12:38,754 --> 00:12:39,154 EVENTS. 338 00:12:39,154 --> 00:12:42,591 I'M GOING TO START WITH A FEW 339 00:12:42,591 --> 00:12:43,892 BRIEF UPDATES. 340 00:12:43,892 --> 00:12:48,063 YOU HAVE ALREADY MET DR. IVY 341 00:12:48,063 --> 00:12:50,332 TURN BULL LAST OCTOBER AS AD HOC 342 00:12:50,332 --> 00:12:52,534 OARAC MEMBER AND I'M PLEASED TO 343 00:12:52,534 --> 00:12:53,836 ANNOUNCE THAT AS OF TODAY'S 344 00:12:53,836 --> 00:12:55,971 MEETING SHE JOINS OARAC AS 345 00:12:55,971 --> 00:12:56,538 VOTING MEMBER. 346 00:12:56,538 --> 00:12:58,707 AS DEPUTY EXECUTIVE DIRECTOR OF 347 00:12:58,707 --> 00:13:01,243 THE AIDS ALLIANCE FOR WOMEN 348 00:13:01,243 --> 00:13:03,445 INFANTS CHILDREN YOUTH AND 349 00:13:03,445 --> 00:13:05,180 FAMILIES, DR. TURN BULL 350 00:13:05,180 --> 00:13:07,950 ADVOCATES FOR PUBLIC POLICIES 351 00:13:07,950 --> 00:13:11,787 BENEFIT THESE CONSTITUENTS AND 352 00:13:11,787 --> 00:13:12,454 CONSTITUENCIES AND MORE 353 00:13:12,454 --> 00:13:14,123 INFORMATION IS INCLUDED IN BIO 354 00:13:14,123 --> 00:13:16,725 WHICH APPEARS IN REGION 355 00:13:16,725 --> 00:13:18,093 MATERIALS. 356 00:13:18,093 --> 00:13:18,427 WELCOME, IVY. 357 00:13:18,427 --> 00:13:20,295 THANK YOU FOR YOUR 358 00:13:20,295 --> 00:13:21,163 PARTICIPATION, WE LOOK FORWARD 359 00:13:21,163 --> 00:13:26,135 TO YOUR CONTRIBUTIONS. 360 00:13:26,135 --> 00:13:29,338 NIH OAR RECENTLY RESTRUCTURED 361 00:13:29,338 --> 00:13:30,906 COMMUNICATIONS AND SCIENCE 362 00:13:30,906 --> 00:13:33,976 POLICY INTO A NEW POLICY 363 00:13:33,976 --> 00:13:36,712 LEGISLATION COMMUNICATIONS AND 364 00:13:36,712 --> 00:13:38,347 ENGAGEMENT PLACE TEAM. 365 00:13:38,347 --> 00:13:43,185 WHICH IS LED NOW BY OARC POLICY 366 00:13:43,185 --> 00:13:44,419 ADVISORY DR. (INAUDIBLE). 367 00:13:44,419 --> 00:13:46,855 DR. LYNN JOINED NIH OAR IN MAY 368 00:13:46,855 --> 00:13:49,558 FROM PREVIOUS POSITION AT NICHD. 369 00:13:49,558 --> 00:13:52,494 WHERE SHE WAS THE LEAD HEALTH 370 00:13:52,494 --> 00:13:53,629 SCIENCE POLICY ANALYST FOR THE 371 00:13:53,629 --> 00:13:55,831 SCIENCE POLICY AND PLANNING 372 00:13:55,831 --> 00:13:58,700 BRANCH OFFICE OF SCIENCE POLICY 373 00:13:58,700 --> 00:14:00,169 PROGRAM ANALYSIS. 374 00:14:00,169 --> 00:14:03,138 EACH OF THE TEAMS, THE FIVE 375 00:14:03,138 --> 00:14:06,341 TEAMS SHOWN ON THE SLIDE WORK 376 00:14:06,341 --> 00:14:08,844 ACROSS THE OAR, THE OFFICE TO 377 00:14:08,844 --> 00:14:11,413 FULFILL THE OAR MISSION. 378 00:14:11,413 --> 00:14:14,683 THE TEAM LEADS FORM THE OAR 379 00:14:14,683 --> 00:14:15,951 DIRECTORS MANAGEMENT ADVISORY 380 00:14:15,951 --> 00:14:16,418 TEAM. 381 00:14:16,418 --> 00:14:18,287 A TERRIFIC GROUP OF PARTNERS WHO 382 00:14:18,287 --> 00:14:20,822 ARE ESSENTIAL TO OAR TO ACHIEVE 383 00:14:20,822 --> 00:14:21,323 ITS MISSION. 384 00:14:21,323 --> 00:14:23,659 I WOULD LIKE TO TAKE THIS 385 00:14:23,659 --> 00:14:24,893 OPPORTUNITY TO THANK THEM ALL, I 386 00:14:24,893 --> 00:14:27,029 APPRECIATE THE WORK YOU AND YOUR 387 00:14:27,029 --> 00:14:31,400 TEAMS DO FOR NIH OAR. 388 00:14:31,400 --> 00:14:34,803 SO THE REST OF MY REPORT, IT 389 00:14:34,803 --> 00:14:36,705 WILL BE INCLUDE -- IT WILL 390 00:14:36,705 --> 00:14:39,374 INCLUDE AN UPDATE ON THE NIH 391 00:14:39,374 --> 00:14:41,577 RESEARCH BUDGET, DESCRIPTION OF 392 00:14:41,577 --> 00:14:43,045 INTERAGENCY COLLABORATIONS 393 00:14:43,045 --> 00:14:44,713 BETWEEN THE NIH OAR AND OUR 394 00:14:44,713 --> 00:14:46,949 PARTNERS ACROSS THE FEDERAL 395 00:14:46,949 --> 00:14:47,616 GOVERNMENT. 396 00:14:47,616 --> 00:14:49,885 UPDATES ON ACTIVITIES PROMOTING 397 00:14:49,885 --> 00:14:51,553 KEY OAR SCIENTIFIC WORK FORCE 398 00:14:51,553 --> 00:14:54,423 PRIORITIES. 399 00:14:54,423 --> 00:14:57,859 SO LET'S START WITH AN OVERVIEW 400 00:14:57,859 --> 00:15:01,563 OF THE NIH HIV RESEARCH BUDGET. 401 00:15:01,563 --> 00:15:03,432 FROM HISTORICAL PERSPECTIVE 402 00:15:03,432 --> 00:15:05,434 AFTER SIGNIFICANT BUDGET 403 00:15:05,434 --> 00:15:06,902 INCREASES, FOR THE HIV PROGRAM 404 00:15:06,902 --> 00:15:11,306 INTO THE EARLY 2000s, NIH HIV 405 00:15:11,306 --> 00:15:13,575 FUNDING WAS FLAT DURING FISCAL 406 00:15:13,575 --> 00:15:16,011 YEARS 2014 TO 2018. 407 00:15:16,011 --> 00:15:18,814 WHICH REPRESENTED BY THE FIRST 408 00:15:18,814 --> 00:15:21,583 FIVE BARS ON THE GRAPH ON THE 409 00:15:21,583 --> 00:15:22,851 SLIDE. 410 00:15:22,851 --> 00:15:26,622 FROM 2019 TO 2021 THERE WERE NEW 411 00:15:26,622 --> 00:15:29,925 FUNDS TOTALLY ABOUT $87 MILLION 412 00:15:29,925 --> 00:15:31,960 WHICH RAISED THE ANNUAL BUDGET 413 00:15:31,960 --> 00:15:36,098 TO JUST OVER 2 BILLION IN FY 21. 414 00:15:36,098 --> 00:15:40,302 IF FY 2022 FAR MOST THE RIGHT 415 00:15:40,302 --> 00:15:42,304 BAR ON THE FAR MOST RIGHT OF THE 416 00:15:42,304 --> 00:15:43,305 SLIDE, THE CONGRESSIONAL 417 00:15:43,305 --> 00:15:45,173 ALLOCATION TO THE OAR INCLUDED 418 00:15:45,173 --> 00:15:48,744 AN INCREASE OF MORE THAN $100 419 00:15:48,744 --> 00:15:50,245 MILLION FOR NIH HIV AIDS 420 00:15:50,245 --> 00:15:54,449 RESEARCH WHICH IS 3.4% OVER THE 421 00:15:54,449 --> 00:15:56,385 FY 2021 LEVEL AND ACTIVE LEVEL. 422 00:15:56,385 --> 00:15:59,154 THIS IS THE LARGEST INCREASE FOR 423 00:15:59,154 --> 00:16:02,991 HIV RESEARCH SINCE FY 2014 424 00:16:02,991 --> 00:16:05,661 REPRESENTS 13.4% OF THE 425 00:16:05,661 --> 00:16:07,763 ESTIMATED $775 MILLION REQUESTED 426 00:16:07,763 --> 00:16:12,968 IN THE FY 2022 PROFESSIONAL 427 00:16:12,968 --> 00:16:16,338 JUDGMENT BUDGET. 428 00:16:16,338 --> 00:16:17,339 THE INCREASED FUNDS SUPPORT 429 00:16:17,339 --> 00:16:18,907 FOCUSED INVESTMENTS IN AREAS 430 00:16:18,907 --> 00:16:22,077 ALIGNED WITH THE GOALS OF THE 431 00:16:22,077 --> 00:16:23,211 NIH STRATEGIC PLAN FOR HIV AND 432 00:16:23,211 --> 00:16:25,113 HIV RELATED RESEARCH. 433 00:16:25,113 --> 00:16:27,783 THE OBJECTIVES OF THE NATIONAL 434 00:16:27,783 --> 00:16:30,419 HIV AIDS STRATEGY INCLUDING THE 435 00:16:30,419 --> 00:16:32,487 ENDING THE HIV EPIDEMIC 436 00:16:32,487 --> 00:16:34,356 INITIATIVE AND THE AREAS 437 00:16:34,356 --> 00:16:36,825 EMPHASIZED IN THE FY 2022 438 00:16:36,825 --> 00:16:40,629 PROFESSIONAL JUDGMENT BUDGETS. 439 00:16:40,629 --> 00:16:43,065 AS A REMINDER EACH YEAR THE NIH 440 00:16:43,065 --> 00:16:47,769 OAR PREPARES A PROPROFESSIONAL 441 00:16:47,769 --> 00:16:50,672 BUDGET OR PJ, AS REQUIRED BY NIH 442 00:16:50,672 --> 00:16:52,674 REVITALIZATION ACT OF 1993. 443 00:16:52,674 --> 00:16:54,543 THE LEGISLATION AND I QUOTE, 444 00:16:54,543 --> 00:16:57,079 MANDATES A COMPREHENSIVE PLAN 445 00:16:57,079 --> 00:16:58,080 THROUGH CONDUCT AND SUPPORT OF 446 00:16:58,080 --> 00:17:02,617 ALL AIDS ACTIVITIES WITH NIH AND 447 00:17:02,617 --> 00:17:03,819 REQUIRES IN A FULL FUNDING 448 00:17:03,819 --> 00:17:06,788 BUDGET FOR CARRYING OUT THE PLAN 449 00:17:06,788 --> 00:17:09,491 REWE SUBMITTED TO THE PRESIDENT. 450 00:17:09,491 --> 00:17:11,026 DEVELOPMENT PROVIDES THE OFFICE 451 00:17:11,026 --> 00:17:13,228 OF AN ANNUAL OPPORTUNITY TO 452 00:17:13,228 --> 00:17:15,330 PRESENT AN ASPIRATIONAL BUDGET 453 00:17:15,330 --> 00:17:17,132 THAT HIGHLIGHTS AREAS THAT 454 00:17:17,132 --> 00:17:19,668 BENEFIT FROM ADDITIONAL 455 00:17:19,668 --> 00:17:20,035 INVESTMENT. 456 00:17:20,035 --> 00:17:22,471 THESE HIGHLIGHTED AREAS IDENTIFY 457 00:17:22,471 --> 00:17:23,905 EACH YEAR THROUGH ENGAGEMENTS 458 00:17:23,905 --> 00:17:25,540 WITH NIH ICOs, THE INSTITUTE 459 00:17:25,540 --> 00:17:27,008 CENTERS AND OFFICES. 460 00:17:27,008 --> 00:17:29,111 FEDERAL PARTNERS, AND HIV 461 00:17:29,111 --> 00:17:33,749 COMMUNITY LEADERS. 462 00:17:33,749 --> 00:17:36,985 E RELEASED THIS MONOTO CONGRESS 463 00:17:36,985 --> 00:17:43,492 AND PRESIDENT, THE FY 20223 464 00:17:43,492 --> 00:17:44,159 ESTIMATES $639 MILLION IN 465 00:17:44,159 --> 00:17:45,927 ADDITIONAL FUNDS, A 20% INCREASE 466 00:17:45,927 --> 00:17:49,998 IN HIV RESEARCH INVESTMENT OVER 467 00:17:49,998 --> 00:17:51,066 FY 2022. 468 00:17:51,066 --> 00:17:54,102 THE ESTIMATED FUNDING WOULD 469 00:17:54,102 --> 00:17:56,171 EXPAND THE NIH INVESTMENTS TO 470 00:17:56,171 --> 00:18:00,041 CATALYZE KEY AREAS KEY RESEARCH 471 00:18:00,041 --> 00:18:01,710 AREAS SUCH AS IN NO SPECIFIC 472 00:18:01,710 --> 00:18:04,479 ORDER EXPAND BASIC RESEARCH IN 473 00:18:04,479 --> 00:18:05,914 BIOMEDICAL BEHAVIORAL SOCIAL 474 00:18:05,914 --> 00:18:07,582 SCIENCES, ADDRESS HIV 475 00:18:07,582 --> 00:18:11,486 CO-OCCURRING CONDITIONS, DEVELOP 476 00:18:11,486 --> 00:18:12,120 TRAININGS FORMATIVE TECHNOLOGIES 477 00:18:12,120 --> 00:18:14,089 METHODOLOGIES AND IMPLEMENTATION 478 00:18:14,089 --> 00:18:15,624 APPROACHES, AND ENHANCE 479 00:18:15,624 --> 00:18:17,058 DIVERSITY AND STRENGTHEN 480 00:18:17,058 --> 00:18:18,427 CAPACITY OF THE HIV RESEARCH 481 00:18:18,427 --> 00:18:20,562 WORK FORCE. 482 00:18:20,562 --> 00:18:22,764 THE PJ WAS PROVIDED TO COUNCIL 483 00:18:22,764 --> 00:18:25,200 MEMBERS IN ADVANCE OF TODAY'S 484 00:18:25,200 --> 00:18:26,301 MEETING AND IS AVAILABLE TO 485 00:18:26,301 --> 00:18:29,304 PUBLIC ON OAR WEBSITE. 486 00:18:29,304 --> 00:18:31,373 AS WELL THERE IS NEW BLOG POST 487 00:18:31,373 --> 00:18:34,743 THAT INCLUDES INFORMATION ON THE 488 00:18:34,743 --> 00:18:38,680 FY 22 PJ AND FY 2022 BUDGET 489 00:18:38,680 --> 00:18:43,952 INCREASE. 490 00:18:43,952 --> 00:18:47,055 SO MOVING ON WHILE COORDINATING 491 00:18:47,055 --> 00:18:50,225 HIV RESEARCH ACROSS THE NIH, THE 492 00:18:50,225 --> 00:18:52,794 NIH OAR ALSO PARTNERS ACROSS THE 493 00:18:52,794 --> 00:18:54,262 FEDERAL GOVERNMENT AS OUTLINED 494 00:18:54,262 --> 00:18:59,334 IN THE OAR LEGISLATION. 495 00:18:59,334 --> 00:19:02,637 NIH IS ONE OF THE 11 OPERATING 496 00:19:02,637 --> 00:19:03,772 DIVISIONS IN DEPARTMENT OF 497 00:19:03,772 --> 00:19:06,675 HEALTH AND HUMAN SERVICES. 498 00:19:06,675 --> 00:19:09,010 THE OAR IS LOCATED WITHIN THE 499 00:19:09,010 --> 00:19:10,879 NIH OFFICE OF DIRECTOR AND IS 500 00:19:10,879 --> 00:19:14,516 THE SECOND OLDEST OF THE 14 NIH 501 00:19:14,516 --> 00:19:15,584 COORDINATING PLANNING AND 502 00:19:15,584 --> 00:19:18,753 STRATEGIC INITIATIVE OFFICES. 503 00:19:18,753 --> 00:19:20,956 THE DIRECTOR FROM ONE OF THE 504 00:19:20,956 --> 00:19:22,057 OFFICES, DATA SCIENCE STRATEGY 505 00:19:22,057 --> 00:19:24,759 IS PRESENTING LATER TODAY TO THE 506 00:19:24,759 --> 00:19:26,828 OARAC. 507 00:19:26,828 --> 00:19:28,597 TWO ADDITIONAL OFFICES TRIBAL 508 00:19:28,597 --> 00:19:30,665 HEALTH RESEARCH AND OFFICE OF 509 00:19:30,665 --> 00:19:32,467 RESEARCH FOR WOMEN'S HEALTH ARE 510 00:19:32,467 --> 00:19:33,101 REFERENCESSED IN MY PRESENTATION 511 00:19:33,101 --> 00:19:34,035 TODAY. 512 00:19:34,035 --> 00:19:35,070 -- REFERENCED IN MY PRESENTATION 513 00:19:35,070 --> 00:19:37,939 TODAY. 514 00:19:37,939 --> 00:19:38,740 COMMUNICATION AND COLLABORATION 515 00:19:38,740 --> 00:19:41,843 WITH OTHER FEDERAL AGENCIES ARE 516 00:19:41,843 --> 00:19:43,478 CRUCIAL TO ESTABLISH EFFECTIVE 517 00:19:43,478 --> 00:19:45,146 STRATEGIES FOR HIV PREVENTION 518 00:19:45,146 --> 00:19:48,650 TREATMENT AND CARE ACROSS THE 519 00:19:48,650 --> 00:19:49,784 NATIONAL AND GLOBAL COMMUNITIES. 520 00:19:49,784 --> 00:19:51,887 THESE COLLABORATIONS PLAY A KEY 521 00:19:51,887 --> 00:19:54,589 ROLE TO MAXIMIZE THE RETURN ON 522 00:19:54,589 --> 00:19:56,992 PUBLIC INVESTMENT AND FACILITATE 523 00:19:56,992 --> 00:19:59,027 A WHOLE GOVERN AGENDA TO END THE 524 00:19:59,027 --> 00:20:01,596 HIV PANDEMIC. 525 00:20:01,596 --> 00:20:04,032 GLOBALLY AND IN THE UNITED 526 00:20:04,032 --> 00:20:04,466 STATES. 527 00:20:04,466 --> 00:20:06,034 ONE WAY ACROSS AGENCY 528 00:20:06,034 --> 00:20:08,270 COMMUNICATION OCCURS IS THROUGH 529 00:20:08,270 --> 00:20:08,637 OARAC. 530 00:20:08,637 --> 00:20:10,739 AS YOU HEARD TODAY ADDITION TO 531 00:20:10,739 --> 00:20:13,542 VOTING MEMBERS, OARAC INCLUDES 532 00:20:13,542 --> 00:20:14,676 EX-OFFICIO MEMBERS REPRESENTING 533 00:20:14,676 --> 00:20:17,078 HEALTH AND HUMAN SERVICES, CDC, 534 00:20:17,078 --> 00:20:19,548 VETERANS ADMINISTRATION AND 535 00:20:19,548 --> 00:20:20,749 DEPARTMENT OF DEFENSE. 536 00:20:20,749 --> 00:20:22,651 WITH OTHER EX-OFFICIO MEMBERS 537 00:20:22,651 --> 00:20:25,420 REPRESENTING THE NIH OFFICE OF 538 00:20:25,420 --> 00:20:26,755 DIRECTOR, AND THE INSTITUTE AND 539 00:20:26,755 --> 00:20:28,924 CENTERS WITH THE LARGEST 540 00:20:28,924 --> 00:20:33,628 PROPORTION OF NIH HIV FUNDING. 541 00:20:33,628 --> 00:20:38,333 FROM LINKAGES ACROSS FEDERAL 542 00:20:38,333 --> 00:20:40,101 AGENCIES ARE FACILITATED BY 543 00:20:40,101 --> 00:20:41,736 INTERACTIVE NETWORK OF ADVISORY 544 00:20:41,736 --> 00:20:43,171 BOARDS AND PARTNERSHIPS THAT 545 00:20:43,171 --> 00:20:45,006 PROVIDE CRITICAL INFORMATION AND 546 00:20:45,006 --> 00:20:49,077 EXPERT ADVICE TO OAR THAT CAN 547 00:20:49,077 --> 00:20:50,445 INFORM THE NIH HIV RESEARCH 548 00:20:50,445 --> 00:20:50,879 ENTERPRISE. 549 00:20:50,879 --> 00:20:54,149 WE MENTIONED OARAC IN ADDITION 550 00:20:54,149 --> 00:20:58,820 THERE IS ILLUSTRATED ON THE 551 00:20:58,820 --> 00:21:01,256 SLIDE IN BLUE SYMBOL LOWER 552 00:21:01,256 --> 00:21:07,529 MIDDLE PART OF THE SLIDE, THE 553 00:21:07,529 --> 00:21:09,931 NAC, NIH HIV AIDS EXECUTIVE 554 00:21:09,931 --> 00:21:11,266 COMMITTEE COMPRISED OF 555 00:21:11,266 --> 00:21:12,367 REPRESENTATIVES FROM ACROSS THE 556 00:21:12,367 --> 00:21:15,136 NIH AND IS THE OAR ADVISORY 557 00:21:15,136 --> 00:21:17,072 COORDINATING COMMITTEE FOR ALL 558 00:21:17,072 --> 00:21:19,741 NIH HIV RESEARCH EFFORTS. 559 00:21:19,741 --> 00:21:23,912 IN ADDITION THERE IS THE CHA, 560 00:21:23,912 --> 00:21:27,749 HHS CDC HRSA ADVISORY COMMITTEE 561 00:21:27,749 --> 00:21:30,185 ON HIV, VIRAL HEPATITIS AND STD 562 00:21:30,185 --> 00:21:32,487 PREVENTION AND TREATMENT. 563 00:21:32,487 --> 00:21:34,990 AND YOU WILL BE HEARING MORE 564 00:21:34,990 --> 00:21:36,891 ABOUT THIS FROM CDC AND HRSA 565 00:21:36,891 --> 00:21:37,692 TODAY. 566 00:21:37,692 --> 00:21:40,128 AND AS WELL THERE IS THE 567 00:21:40,128 --> 00:21:41,496 PRESIDENTIAL ADVISORY COUNCIL ON 568 00:21:41,496 --> 00:21:43,064 HIV AIDS. 569 00:21:43,064 --> 00:21:45,300 THAT ADVISES THE WHITE HOUSE 570 00:21:45,300 --> 00:21:47,035 THROUGH THE HHS ASSISTANT 571 00:21:47,035 --> 00:21:48,570 SECRETARY OF HEALTH AND HHS 572 00:21:48,570 --> 00:21:53,375 SECRETARY. 573 00:21:53,375 --> 00:21:55,210 CHOCK SIMILAR TO OARAC ALSO 574 00:21:55,210 --> 00:21:56,745 INCLUDE EX-OFFICIO AND FEDERAL 575 00:21:56,745 --> 00:21:58,713 STAFF AS WELL AS COMMUNITY 576 00:21:58,713 --> 00:21:59,714 ACADEMIC AND PRIVATE SECTOR 577 00:21:59,714 --> 00:22:02,083 PARTNERS. 578 00:22:02,083 --> 00:22:03,652 JUST TO POINT OUT THAT THE 579 00:22:03,652 --> 00:22:05,320 ADVISORY GROUPS INCLUDED IN THIS 580 00:22:05,320 --> 00:22:07,589 SLIDE ARE NOT EXHAUSTIVE. 581 00:22:07,589 --> 00:22:09,557 FOR EXAMPLE PEPFAR IN THE UPPER 582 00:22:09,557 --> 00:22:12,293 RIGHT SIDE OF THE SLIDE HAS A 583 00:22:12,293 --> 00:22:13,495 SCIENTIFIC ADVISORY BOARD THAT 584 00:22:13,495 --> 00:22:15,897 ALSO INCLUDES SUBJECT MATTER 585 00:22:15,897 --> 00:22:17,966 EXPERTS CIVIL SOCIETY FEDERAL 586 00:22:17,966 --> 00:22:20,402 PARTNERS HHS AGENCIES. 587 00:22:20,402 --> 00:22:22,704 THE IMPORTANT POINT IS SHARED 588 00:22:22,704 --> 00:22:24,272 MEMBERSHIP BY FEDERAL AGENCIES 589 00:22:24,272 --> 00:22:27,375 ON DIFFERENT ADVISORY BOARDS 590 00:22:27,375 --> 00:22:28,910 PROMOTES FLUID COMMUNICATION AND 591 00:22:28,910 --> 00:22:30,278 UNDERSTANDING OF THE PERSPECTIVE 592 00:22:30,278 --> 00:22:32,914 OF EACH AGENCY'S ROLE IN SHAPING 593 00:22:32,914 --> 00:22:34,215 HIV AIDS POLICIES ACROSS THE 594 00:22:34,215 --> 00:22:37,052 GOVERNMENT. 595 00:22:37,052 --> 00:22:38,687 THE GUIDANCE OAR RECEIVES 596 00:22:38,687 --> 00:22:41,122 DIRECTLY FROM ITS OWN COUNCIL 597 00:22:41,122 --> 00:22:43,558 OARAC AND INDIRECTLY FROM OTHER 598 00:22:43,558 --> 00:22:45,226 ADVISORY COUNCILS CONTRIBUTES TO 599 00:22:45,226 --> 00:22:47,862 THE DEVELOPMENT OF THE NIH HIV 600 00:22:47,862 --> 00:22:50,165 RESEARCH AGENDA AND THE BUDGET 601 00:22:50,165 --> 00:22:51,099 REQUEST PRESENTED TO CONGRESS 602 00:22:51,099 --> 00:22:53,735 AND TO THE WHITE HOUSE. 603 00:22:53,735 --> 00:22:55,270 SO NOW IN THE FOLLOWING SLIDES I 604 00:22:55,270 --> 00:22:56,938 WILL DESCRIBE SPECIFIC 605 00:22:56,938 --> 00:22:58,673 ENGAGEMENTS BETWEEN VARIOUS 606 00:22:58,673 --> 00:22:59,574 FEDERAL PARTNERS INVOLVED IN 607 00:22:59,574 --> 00:23:01,209 NATIONAL AND INTERNATIONAL 608 00:23:01,209 --> 00:23:03,144 EFFORTS TO END THE HIV EPIDEMIC. 609 00:23:03,144 --> 00:23:07,549 FROIN ADDITION THE OARAC AGENDA 610 00:23:07,549 --> 00:23:09,317 TODAY INCLUDES SEVERAL OF OUR 611 00:23:09,317 --> 00:23:11,886 NIH OAR FEDERAL PARTNERS AS I 612 00:23:11,886 --> 00:23:13,755 MENTIONED, WE WILL DISCUSS 613 00:23:13,755 --> 00:23:16,057 RELATIONSHIPS AND SYNERGIES THAT 614 00:23:16,057 --> 00:23:18,159 MAKE MULTI-FACETED FEDERAL HIV 615 00:23:18,159 --> 00:23:20,929 RESPONSE UNIQUE, EFFECTIVE AND 616 00:23:20,929 --> 00:23:26,234 WELL ANNOUNCED. 617 00:23:26,234 --> 00:23:27,769 SO INCLUDED IN SOME OF THE 618 00:23:27,769 --> 00:23:30,438 IMPORTANT INTERAGENCY 619 00:23:30,438 --> 00:23:32,941 ACTIVITIES, LAST YEAR THE OAR 620 00:23:32,941 --> 00:23:35,176 COORDINATED THE NIH INPUT TO 621 00:23:35,176 --> 00:23:38,246 UPDATE NATIONAL HIV AIDS 622 00:23:38,246 --> 00:23:42,083 STRATEGY THIS YEAR OAR CONVENED 623 00:23:42,083 --> 00:23:44,219 PARTNERS FROM 19 NIH INSTITUTE 624 00:23:44,219 --> 00:23:46,321 CENTERS AND OFFICES AND SHARED 625 00:23:46,321 --> 00:23:49,524 THE NAIC IN HOUSE WORKING GROUP 626 00:23:49,524 --> 00:23:52,260 TO CATALOG IMPLEMENTATION 627 00:23:52,260 --> 00:23:54,462 ACTIONS THAT SPAN BASIC CLINICAL 628 00:23:54,462 --> 00:23:57,132 SOCIAL BEHAVIORAL AND 629 00:23:57,132 --> 00:23:58,233 IMPLEMENTATION RESEARCH. 630 00:23:58,233 --> 00:23:59,768 THESE ACTIVITIES ADDRESSED 631 00:23:59,768 --> 00:24:02,837 FOCUSED AREAS OF HIV WORK FORCE 632 00:24:02,837 --> 00:24:04,472 EXPANSION AND DIVERSIFICATION 633 00:24:04,472 --> 00:24:07,041 AND STIGMA AND DISPARITIES 634 00:24:07,041 --> 00:24:08,810 REDUCTION AMONG ALL IN HOUSE 635 00:24:08,810 --> 00:24:10,512 PRIORITY POPULATIONS. 636 00:24:10,512 --> 00:24:12,380 NIH OAR WILL CONTINUE TO 637 00:24:12,380 --> 00:24:16,851 COORDINATE MONITOR AND REPORT ON 638 00:24:16,851 --> 00:24:18,987 NIH WIDE HOUSE ACTIVITIES WITHIN 639 00:24:18,987 --> 00:24:20,355 HIV LEADERSHIP AND OTHER 640 00:24:20,355 --> 00:24:20,622 PARTNERS. 641 00:24:20,622 --> 00:24:24,325 THE OAR IS CURRENTLY PROVIDING 642 00:24:24,325 --> 00:24:26,227 STAFF SUPPORT TO OFFICE OF THE 643 00:24:26,227 --> 00:24:27,896 WHITE HOUSE OFFICE OF NATIONAL 644 00:24:27,896 --> 00:24:31,966 HIV AIDS POLICY, IS WORKING WITH 645 00:24:31,966 --> 00:24:33,802 NIAID NIMH IN COLLABORATION WITH 646 00:24:33,802 --> 00:24:37,872 THE CDC, HRSA AND SAMHSA ON 647 00:24:37,872 --> 00:24:40,308 AGENCY ONAC WORKING GROUP TO 648 00:24:40,308 --> 00:24:41,843 DEVELOP QUALITY OF LIFE 649 00:24:41,843 --> 00:24:43,645 INDICATORS, FOR THE NATIONAL HIV 650 00:24:43,645 --> 00:24:48,183 AIDS STRATEGY. 651 00:24:48,183 --> 00:24:49,751 LAST MONTH NIH ATTENDED AN 652 00:24:49,751 --> 00:24:51,452 OPERATIONAL LEADERSHIP TEAM 653 00:24:51,452 --> 00:24:56,057 RETREAT HOSTED BY THE ONAC 654 00:24:56,057 --> 00:24:58,293 DIRECTOR HAROLD PHILLIPS. 655 00:24:58,293 --> 00:24:59,828 DISCUSSIONS ON STATUS NEUTRAL 656 00:24:59,828 --> 00:25:02,163 AND APPROACH IMPLICATIONS FOR 657 00:25:02,163 --> 00:25:04,599 THE HIV EPIDEMIC AND THE 658 00:25:04,599 --> 00:25:05,533 NATIONAL HIVE AIDS STRATEGY, AS 659 00:25:05,533 --> 00:25:08,036 WELL AS PLANNING START OF PHASE 660 00:25:08,036 --> 00:25:11,306 2 IN 2026. 661 00:25:11,306 --> 00:25:14,642 THE FIRST THREE YEARS OF THE NIH 662 00:25:14,642 --> 00:25:16,211 EHE FUNDING ARE SUMMARIZED ON 663 00:25:16,211 --> 00:25:17,745 RIGHT SIDE OF THE SLIDE. 664 00:25:17,745 --> 00:25:22,550 WHILE THE DIRECT EH FUNDING HAS 665 00:25:22,550 --> 00:25:25,887 BEEN FOCUSED TO THE CFAR 666 00:25:25,887 --> 00:25:27,355 PROGRAMS, NIH ALSO LEVERAGES 667 00:25:27,355 --> 00:25:29,557 BASED HIV FUNDING TO SUPPORT AND 668 00:25:29,557 --> 00:25:32,060 EXPAND EFFORTS TO MEET EHE 669 00:25:32,060 --> 00:25:33,728 OBJECTIVES, BUT ALSO ADVANCE THE 670 00:25:33,728 --> 00:25:40,835 NIH HIV RESEARCH MISSION. 671 00:25:40,835 --> 00:25:42,670 LAST MONTH KAY HAYES WAS 672 00:25:42,670 --> 00:25:44,105 APPOINTED DEPUTY ASSISTANT 673 00:25:44,105 --> 00:25:45,273 SECRETARY FOR INFECTIOUS 674 00:25:45,273 --> 00:25:46,708 DISEASES AND THE DIRECTOR OF THE 675 00:25:46,708 --> 00:25:49,711 OFFICE OF INFECTIOUS DISEASE AND 676 00:25:49,711 --> 00:25:51,946 HIV AIDS POLICY. 677 00:25:51,946 --> 00:25:55,350 WITH THE SHORTER OIDP ACRONYM. 678 00:25:55,350 --> 00:25:57,986 WE LOOK FORWARD TO HEARING MORE 679 00:25:57,986 --> 00:25:59,120 FROM HER LATER IN TODAY'S 680 00:25:59,120 --> 00:26:01,756 PROGRAM, IN HER ROLE AS DEPUTY 681 00:26:01,756 --> 00:26:03,091 ASSISTANT SECRETARY KAY SERVES 682 00:26:03,091 --> 00:26:05,727 AS EXECUTIVE DIRECTOR OF THE 683 00:26:05,727 --> 00:26:09,097 PRESIDENTIAL ADVISORY COUNCIL ON 684 00:26:09,097 --> 00:26:11,132 HIV AIDS. 685 00:26:11,132 --> 00:26:14,769 OAR INTERACTIONS HAVE INCLUDED 686 00:26:14,769 --> 00:26:17,772 IN MARCH PARTICIPATED IN THE 687 00:26:17,772 --> 00:26:19,607 73RD MEETING AS THE NIH EXUPPISH 688 00:26:19,607 --> 00:26:21,609 OWE MEMBER. 689 00:26:21,609 --> 00:26:22,644 -- EX-OFFICIO MEMBER. 690 00:26:22,644 --> 00:26:24,579 AT THE RECENT PLANNING SESSION 691 00:26:24,579 --> 00:26:29,384 OAR DEPUTY DIREC DIRECTOR AND TE 692 00:26:29,384 --> 00:26:31,586 DADES DIRECTOR BRIEFED ABOUT 693 00:26:31,586 --> 00:26:33,755 PLANNED HIV PREVENTION CARE REAM 694 00:26:33,755 --> 00:26:35,523 AND CURE RESEARCH. 695 00:26:35,523 --> 00:26:37,725 IN MAY I REPRESENTED THE NIH OAR 696 00:26:37,725 --> 00:26:40,361 AT MOLECULAR HIV CLUSTER 697 00:26:40,361 --> 00:26:41,162 DETECTION AND RESPONSE WORK 698 00:26:41,162 --> 00:26:43,398 GROUP. 699 00:26:43,398 --> 00:26:44,632 SUGGESTIONS FOR HIV CLUSTER 700 00:26:44,632 --> 00:26:46,501 DETECTION POLICIES AND PRACTICES 701 00:26:46,501 --> 00:26:48,736 WERE SUBMITTED TO THE PACHA 702 00:26:48,736 --> 00:26:53,041 STIGMA AND DISTE DISPARITIES 703 00:26:53,041 --> 00:26:54,342 SUBCOMMITTEE FOR CONSIDERATION 704 00:26:54,342 --> 00:26:55,476 ADVISING THE PRESIDENT VIA HHS 705 00:26:55,476 --> 00:26:58,346 AND OFFICE OF NATIONAL HIV AIDS 706 00:26:58,346 --> 00:27:01,549 POLICY. 707 00:27:01,549 --> 00:27:05,086 THE NIH OAR IS CDC HRSA ADVISORY 708 00:27:05,086 --> 00:27:07,622 COMMITTEE IS MENTIONED, AND WE 709 00:27:07,622 --> 00:27:12,160 WILL HEAR MORE ABOUT THIS FROM 710 00:27:12,160 --> 00:27:14,996 RARE ADMIRAL JOHN MERMIN AND 711 00:27:14,996 --> 00:27:20,368 FROM DR. (INAUDIBLE). 712 00:27:20,368 --> 00:27:23,671 EARLIER THIS MONTH AMBASSADOR AT 713 00:27:23,671 --> 00:27:24,539 LARGE DR. JOHN (INAUDIBLE) 714 00:27:24,539 --> 00:27:26,541 OFFICIALLY ASSUMED HIS NEW ROLE 715 00:27:26,541 --> 00:27:28,843 AS U.S. GLOBAL AIDS COORDINATOR 716 00:27:28,843 --> 00:27:31,045 AND SPECIAL REPETITIVE FOR -- 717 00:27:31,045 --> 00:27:33,348 REPRESENTATIVE FOR GLOBAL HEALTH 718 00:27:33,348 --> 00:27:35,149 DIPLOMACY STATE DEPARTMENT. 719 00:27:35,149 --> 00:27:37,151 HE'S THE FIFTH PERSON TO HOLD 720 00:27:37,151 --> 00:27:38,886 THIS POSITION, SINCE U.S. 721 00:27:38,886 --> 00:27:40,321 PRESIDENT EMERGENCY PLAN FOR 722 00:27:40,321 --> 00:27:42,557 AIDS RELIEF PEPFAR DOESOR WAS 723 00:27:42,557 --> 00:27:44,025 CREATED IN 2003 UNDER THE 724 00:27:44,025 --> 00:27:45,893 PRESIDENT BUSH. 725 00:27:45,893 --> 00:27:47,795 NIH OAR WILL CONTINUE TO WORK 726 00:27:47,795 --> 00:27:49,897 WITH PEPFAR LEADERSHIP TO 727 00:27:49,897 --> 00:27:50,999 ACCELERATE PROGRESS ON THE 728 00:27:50,999 --> 00:27:52,367 GLOBAL HIV RESPONSE. 729 00:27:52,367 --> 00:27:54,268 AND LATER TODAY WE WILL REVEAL 730 00:27:54,268 --> 00:27:57,238 MORE ABOUT PEPFAR FROM JIN PARK, 731 00:27:57,238 --> 00:27:58,606 DIRECTOR OF THE OFFICE WITHIN 732 00:27:58,606 --> 00:28:00,141 THE HHS OFFICE OF GLOBAL 733 00:28:00,141 --> 00:28:04,879 AFFAIRS. 734 00:28:04,879 --> 00:28:07,115 THE NIH HIV RESEARCH PORTFOLIO 735 00:28:07,115 --> 00:28:09,550 IS TRULY GLOBAL. 736 00:28:09,550 --> 00:28:11,819 INTERNATIONAL HIV RESEARCH 737 00:28:11,819 --> 00:28:14,222 REPRESENTS APPROXIMATELY 20% OF 738 00:28:14,222 --> 00:28:15,790 THE TOTAL ANNUAL NIH HIV 739 00:28:15,790 --> 00:28:17,925 RESEARCH FUNDING. 740 00:28:17,925 --> 00:28:24,098 IN FY 2021, THAT MEANT OVER $600 741 00:28:24,098 --> 00:28:26,467 MILLION WAS INVESTED IN MORE 742 00:28:26,467 --> 00:28:28,669 THAN 1100 HIV RESEARCH PROJECTS 743 00:28:28,669 --> 00:28:30,838 OR RESEARCH GRANTS IN 95 744 00:28:30,838 --> 00:28:31,539 COUNTRIES OUTSIDE THE UNITED 745 00:28:31,539 --> 00:28:33,708 STATES. 746 00:28:33,708 --> 00:28:35,476 THIS INTERNATIONAL RESEARCH 747 00:28:35,476 --> 00:28:37,011 PORTFOLIO FOCUSES ON HIV 748 00:28:37,011 --> 00:28:40,648 PRIORITY AREAS RELEVANT FOR BOTH 749 00:28:40,648 --> 00:28:41,582 HOST NATION AND THE UNITED 750 00:28:41,582 --> 00:28:42,750 STATES. 751 00:28:42,750 --> 00:28:45,887 INCLUDING MULTI-NATIONAL HIV 752 00:28:45,887 --> 00:28:47,121 CLINICAL TRIAL NETWORKS, 753 00:28:47,121 --> 00:28:48,890 INITIATIVES FOCUSED ON 754 00:28:48,890 --> 00:28:50,224 IMPLEMENTATION SCIENCE, AND 755 00:28:50,224 --> 00:28:54,962 TRAINING AND CAPACITY BUILDING 756 00:28:54,962 --> 00:28:55,763 EFFORTS. 757 00:28:55,763 --> 00:28:57,031 BIDIRECTIONAL LESSONS LEARNED 758 00:28:57,031 --> 00:28:59,267 FROM THE EFFORTS WILL PROVIDE 759 00:28:59,267 --> 00:29:03,304 VALID MODELS OF REAL LIFE 760 00:29:03,304 --> 00:29:05,006 IMPLEMENTATION TO SUPPORT 761 00:29:05,006 --> 00:29:05,673 DOMESTICALLY. 762 00:29:05,673 --> 00:29:08,943 SIMILAR TO HOW NIH OAR LEVERAGES 763 00:29:08,943 --> 00:29:10,945 DOMESTIC FUNDS, NIH PEPFAR 764 00:29:10,945 --> 00:29:13,347 EXPANDS INTERNATIONAL 765 00:29:13,347 --> 00:29:14,615 COLLABORATION TO LEVERAGE AND 766 00:29:14,615 --> 00:29:18,352 BUILD UPON NETWORKS AND 767 00:29:18,352 --> 00:29:19,053 INFRASTRUCTURE, CLINICAL 768 00:29:19,053 --> 00:29:21,155 PRACTICE GUIDELINES FOR HIV AIDS 769 00:29:21,155 --> 00:29:23,257 PREPARED BY THE OARAC WORKING 770 00:29:23,257 --> 00:29:26,594 GROUPS, ENHANCE HEALTH WORK 771 00:29:26,594 --> 00:29:28,362 FORCE AND IMPLEMENT ADVANCE 772 00:29:28,362 --> 00:29:29,397 DIAGNOSISSIC AND CLINICAL 773 00:29:29,397 --> 00:29:33,201 MONITORING TECHNOLOGIES. 774 00:29:33,201 --> 00:29:34,902 DIAGNOSTIC AND CLINICAL 775 00:29:34,902 --> 00:29:35,470 MONITORING TECHNOLOGIES. 776 00:29:35,470 --> 00:29:38,873 AS I TURN TO UPDATES ON KEY NIH 777 00:29:38,873 --> 00:29:41,943 OAR SCIENTIFIC WORK FORCE 778 00:29:41,943 --> 00:29:44,579 PRIORITIES, LISTENING SESSIONS 779 00:29:44,579 --> 00:29:45,480 HAVE CONTINUED DURING THE TRAVEL 780 00:29:45,480 --> 00:29:46,581 RESTRICTIONS DUE TO THE COVID 781 00:29:46,581 --> 00:29:48,983 PANDEMIC. 782 00:29:48,983 --> 00:29:50,585 VIRTUAL ENGAGEMENTS HAVE BEEN 783 00:29:50,585 --> 00:29:52,687 EFFECTIVE IN THE ABSENCE OF IN 784 00:29:52,687 --> 00:29:53,955 PERSON MEETINGS. 785 00:29:53,955 --> 00:29:55,423 AND A REPORT SUMMARIZING 786 00:29:55,423 --> 00:29:57,391 FINDINGS FROM THE VIRTUAL 787 00:29:57,391 --> 00:29:58,493 LISTENING SESSIONS THROUGH JULY 788 00:29:58,493 --> 00:30:00,728 OF LAST YEAR IS NOW AVAILABLE ON 789 00:30:00,728 --> 00:30:04,398 OAR WEBSITE. 790 00:30:04,398 --> 00:30:06,734 RECENTLY IN MAY THE NIH OAR 791 00:30:06,734 --> 00:30:08,269 PARTICIPATED IN TWO VIRTUAL 792 00:30:08,269 --> 00:30:11,606 LISTENING SESSIONS, IN TEXAS. 793 00:30:11,606 --> 00:30:14,041 THE SESSIONS WERE HOSTED BY THE 794 00:30:14,041 --> 00:30:15,243 TEXAS DEVELOPMENTAL CENTER FOR 795 00:30:15,243 --> 00:30:17,445 AIDS RESEARCH, THE DC FAR AND 796 00:30:17,445 --> 00:30:20,047 THE HOUSTON HEALTH DEPARTMENT. 797 00:30:20,047 --> 00:30:21,949 AND INCLUDED RESEARCHERS 798 00:30:21,949 --> 00:30:23,217 CLINICIANS, ADVOCATES AND 799 00:30:23,217 --> 00:30:25,620 COMMUNITY MEMBERS. 800 00:30:25,620 --> 00:30:27,722 WE HEARD LOCAL CONCERNS ABOUT 801 00:30:27,722 --> 00:30:29,590 SPECIFIC ISSUES INCLUDING HIGH 802 00:30:29,590 --> 00:30:31,893 INCIDENCE OF SUBSTANCE USE 803 00:30:31,893 --> 00:30:34,095 BEYOND OPIOID AND PEOPLE WITH 804 00:30:34,095 --> 00:30:34,862 HIV. 805 00:30:34,862 --> 00:30:37,431 DIFFICULTIES ACCESSING LONG 806 00:30:37,431 --> 00:30:40,434 ACTING HIV MEDICATION, NEED TO 807 00:30:40,434 --> 00:30:43,804 ADDRESS HIGHLY PREVALENT LOCAL 808 00:30:43,804 --> 00:30:45,873 CO-MORBIDITIES SUCH AS OBESITY, 809 00:30:45,873 --> 00:30:47,508 LACK CLINICAL GUIDANCE ABOUT HIV 810 00:30:47,508 --> 00:30:51,045 MEDICATION AND NEED TO CONTINUE 811 00:30:51,045 --> 00:30:51,612 ADDRESSING INTERSECTIONAL 812 00:30:51,612 --> 00:30:54,382 STIGMA. 813 00:30:54,382 --> 00:30:56,050 ALSO IN MAY THE NIH OAR WAS 814 00:30:56,050 --> 00:31:00,121 INVITED TO HOST A LISTENING 815 00:31:00,121 --> 00:31:02,356 SESSION AT NATIONAL -- ANNUAL 816 00:31:02,356 --> 00:31:04,325 MEETING OF NATIONAL COUNCIL OF 817 00:31:04,325 --> 00:31:05,193 URBAN INDIAN HEALTH. 818 00:31:05,193 --> 00:31:08,729 THE NATIONAL -- NIH TRIBAL 819 00:31:08,729 --> 00:31:10,598 HEALTH RESEARCH OFFICE DIRECTOR 820 00:31:10,598 --> 00:31:11,899 DR. DAVID WILSON SERVED AS 821 00:31:11,899 --> 00:31:12,500 MODERATOR. 822 00:31:12,500 --> 00:31:14,602 THIS WAS THE FIRST OAR LISTENING 823 00:31:14,602 --> 00:31:17,038 SESSION FOCUSED SPECIFICALLY ON 824 00:31:17,038 --> 00:31:18,873 NATIVE AMERICAN POPULATIONS. 825 00:31:18,873 --> 00:31:20,208 IN THIS COMMUNITY SETTING WE 826 00:31:20,208 --> 00:31:22,843 LEARNED THE CRITICAL VALUE OF 827 00:31:22,843 --> 00:31:24,645 PROVIDING HIV CLINICAL 828 00:31:24,645 --> 00:31:26,180 INTERVENTION WITHIN A CULTURAL 829 00:31:26,180 --> 00:31:27,715 CONTEXT THAT INCORPORATES 830 00:31:27,715 --> 00:31:30,351 SPIRITUAL PRACTICES, AND FAMILY 831 00:31:30,351 --> 00:31:40,828 DYNAMICS INTO HIV TREATMENT. 832 00:31:41,829 --> 00:31:44,532 IN APRIL THE HIV NIH AIDS FOCUS 833 00:31:44,532 --> 00:31:47,702 GROUP TO USED ON EARLY CAREER 834 00:31:47,702 --> 00:31:49,904 INVESTIGATORS CONVENED A 835 00:31:49,904 --> 00:31:51,472 WORKSHOP WITH GRADUATE STUDENTS, 836 00:31:51,472 --> 00:31:53,207 EARLY CAREER INVESTIGATORS AND 837 00:31:53,207 --> 00:31:56,877 SEASONED MANAGERS. 838 00:31:56,877 --> 00:31:57,979 APPROXIMATELY 150 PARTICIPANTS 839 00:31:57,979 --> 00:31:58,980 ATTENDED. 840 00:31:58,980 --> 00:32:00,147 AMONG OTHER GOALS OF THE 841 00:32:00,147 --> 00:32:02,883 WORKSHOP INTENDED TO STIMULATE 842 00:32:02,883 --> 00:32:03,884 SCIENTIFIC EXCHANGE NETWORKING 843 00:32:03,884 --> 00:32:06,187 AND COLLABORATION AMONG THE NEXT 844 00:32:06,187 --> 00:32:08,723 GENERATION OF INVESTIGATORS. 845 00:32:08,723 --> 00:32:09,724 AND INCREASE FAMILIARITY ABOUT 846 00:32:09,724 --> 00:32:11,259 THE NIH REVIEW AND FUNDING 847 00:32:11,259 --> 00:32:12,960 PROCESSES. 848 00:32:12,960 --> 00:32:15,129 THE WORKSHOP INCLUDED A MOCK 849 00:32:15,129 --> 00:32:17,665 REVIEW SESSION AND WAS AN 850 00:32:17,665 --> 00:32:19,433 OPPORTUNITY TO DEMYSTIFY THE 851 00:32:19,433 --> 00:32:22,970 SCIENTIFIC REVIEW PROCESS FOR 852 00:32:22,970 --> 00:32:23,671 INVESTIGATORS. 853 00:32:23,671 --> 00:32:25,973 NEXT STEPS INCLUDE DEVELOPMENT 854 00:32:25,973 --> 00:32:27,842 OF FOLLOW-ON WORKSHOP FOR HIV 855 00:32:27,842 --> 00:32:30,544 EARLY CAREER INVESTIGATORS 856 00:32:30,544 --> 00:32:32,046 INFORMED BY PARTICIPANT 857 00:32:32,046 --> 00:32:34,015 FEEDBACK, ENHANCE AND UPDATED 858 00:32:34,015 --> 00:32:35,783 WEB CONTENT FOR RESOURCES FOR 859 00:32:35,783 --> 00:32:38,486 HIV EARLY CAREER INVESTIGATORS. 860 00:32:38,486 --> 00:32:41,122 INCREASE NETWORKING 861 00:32:41,122 --> 00:32:42,990 OPPORTUNITIES PARTICULARLY IN 862 00:32:42,990 --> 00:32:45,893 PERSON MEETINGS MAY INCREASE AND 863 00:32:45,893 --> 00:32:47,561 DEVELOPMENT OF SUSTAINABILITY 864 00:32:47,561 --> 00:32:50,798 PLAN FOR DIVERSE HIV RESEARCH 865 00:32:50,798 --> 00:32:55,703 WORK FORCE. 866 00:32:55,703 --> 00:32:57,805 THE NIH JUST ANNOUNCED THE 867 00:32:57,805 --> 00:33:00,541 APPOINTMENT OF MR. KEVIN 868 00:33:00,541 --> 00:33:02,209 WILLIAMS AS NEW DIRECTOR OF THE 869 00:33:02,209 --> 00:33:03,778 NIH OFFICE OF EQUITY DIVERSITY 870 00:33:03,778 --> 00:33:06,580 AND INCLUSION. 871 00:33:06,580 --> 00:33:09,383 AS YOU MAY KNOW NIH LAUNCHED A 872 00:33:09,383 --> 00:33:10,718 GRANT PROGRAM AIMED AT CLOSING 873 00:33:10,718 --> 00:33:12,520 THE GAP IN FUNDING RATES BETWEEN 874 00:33:12,520 --> 00:33:15,056 BLACK AND WHITE INVESTIGATORS 875 00:33:15,056 --> 00:33:18,025 AND WE WILL HEAR MORE ABOUT THIS 876 00:33:18,025 --> 00:33:19,760 PROGRAM LATER THIS AFTERNOON. 877 00:33:19,760 --> 00:33:21,996 THE OAR WORK FORCE ACTIVITIES 878 00:33:21,996 --> 00:33:23,564 WITH THE EARLY CAREER 879 00:33:23,564 --> 00:33:25,032 INVESTIGATORS ARE ALIGNED WITH 880 00:33:25,032 --> 00:33:28,035 THE GOALS OF THE NIH UNITE 881 00:33:28,035 --> 00:33:28,703 MISSION. 882 00:33:28,703 --> 00:33:31,038 WITH THE FIRST NIH WIDE 883 00:33:31,038 --> 00:33:32,707 STRATEGIC PLAN FOR DIVERSITY 884 00:33:32,707 --> 00:33:33,374 EQUITY INCLUSION AND 885 00:33:33,374 --> 00:33:35,509 ACCESSIBILITY. 886 00:33:35,509 --> 00:33:37,812 THIS PLAN IS BEING FINALIZED AND 887 00:33:37,812 --> 00:33:39,280 INCLUDES STRATEGIES TO 888 00:33:39,280 --> 00:33:41,916 STRENGTHEN THE CAREERS OF WOMEN 889 00:33:41,916 --> 00:33:43,417 IN THE HIV RESEARCH WORK FORCE 890 00:33:43,417 --> 00:33:48,255 AS WELL. 891 00:33:48,255 --> 00:33:53,461 WITHIN THIS CONTEXT THE NIH OAR 892 00:33:53,461 --> 00:33:54,595 REPRESENTATION IN NIH STUDIES 893 00:33:54,595 --> 00:33:57,898 INCLUDING WORK FORCE RESEARCH 894 00:33:57,898 --> 00:33:58,766 GAPS AND OPPORTUNITIES AT THE 895 00:33:58,766 --> 00:34:00,868 WOMEN'S RESEARCH INITIATIVE ON 896 00:34:00,868 --> 00:34:02,203 HIV AIDS HOSTED BY THE WELL 897 00:34:02,203 --> 00:34:04,271 PROJECT LAST MONTHS. 898 00:34:04,271 --> 00:34:06,907 THE WOMEN RESEARCH INITIATIVE 899 00:34:06,907 --> 00:34:08,909 BRINGS TOGETHER LEADERS IN HIV 900 00:34:08,909 --> 00:34:11,579 TO IDENTIFY KEY OPPORTUNITIES TO 901 00:34:11,579 --> 00:34:13,481 ACCELERATE THE UNDERSTANDING OF 902 00:34:13,481 --> 00:34:15,850 HIV DISEASE IN WOMEN. 903 00:34:15,850 --> 00:34:19,353 NIH OAR PARTICIPATED IN THE 904 00:34:19,353 --> 00:34:22,590 ADVISORY CABINET OF THE NIH 905 00:34:22,590 --> 00:34:23,758 MATERNAL MORBIDITY AND MORTALITY 906 00:34:23,758 --> 00:34:25,226 TASK FORCE. 907 00:34:25,226 --> 00:34:28,329 TO DISCUSS THE IMPROVE 908 00:34:28,329 --> 00:34:28,896 INITIATIVE. 909 00:34:28,896 --> 00:34:32,199 THIS ACTIVITY IS LED BY DR. 910 00:34:32,199 --> 00:34:34,268 DIANA BY YANKEE, DIRECTOR OF 911 00:34:34,268 --> 00:34:36,504 EUNICE -- BIANCI, NATIONAL 912 00:34:36,504 --> 00:34:38,172 INSTITUTE OF CHILD HEALTH AND 913 00:34:38,172 --> 00:34:38,572 HUMAN DEVELOPMENT. 914 00:34:38,572 --> 00:34:40,775 DR. JANINE CLAYTON, NIH 915 00:34:40,775 --> 00:34:43,344 ASSOCIATE DIRECTOR FOR RESEARCH 916 00:34:43,344 --> 00:34:45,413 ON WOMEN HELP AND DIRECTOR OF 917 00:34:45,413 --> 00:34:47,014 THE NIH OFFICE OF RESEARCH ON 918 00:34:47,014 --> 00:34:49,116 WOMEN'S HEALTH. 919 00:34:49,116 --> 00:34:51,752 AND DR. COURTNEY ACLIN ACTING 920 00:34:51,752 --> 00:34:55,089 NIH ASSOCIATE DEPUTY DIRECTOR. 921 00:34:55,089 --> 00:34:56,824 IN 2022 CONGRESS APPROVED THE 922 00:34:56,824 --> 00:34:59,226 PRESIDENT REQUEST FOR $30 923 00:34:59,226 --> 00:35:02,596 MILLION TO ENHANCE THIS PROGRAM. 924 00:35:02,596 --> 00:35:06,700 SO THE TASK FORCE CABINET AND 925 00:35:06,700 --> 00:35:09,570 HAVE BEEN DEVELOPING INNOVATIVE 926 00:35:09,570 --> 00:35:13,407 INITIATIVE OPPORTUNITIES TO 927 00:35:13,407 --> 00:35:15,075 ACCELERATE PROGRESS FOR THE 928 00:35:15,075 --> 00:35:16,544 HEALTH OF PREGNANT WOMEN -- 929 00:35:16,544 --> 00:35:21,115 PREGNANT PEOPLE WITH HIV. 930 00:35:21,115 --> 00:35:22,750 ROHAN, I THINK YOU ARE ON THE 931 00:35:22,750 --> 00:35:23,250 CALL. 932 00:35:23,250 --> 00:35:24,785 I DON'T KNOW IF THERE IS 933 00:35:24,785 --> 00:35:27,488 ANYTHING ADDITIONAL TO ADD TO 934 00:35:27,488 --> 00:35:28,656 THIS DISCUSSION SECTION, THAT 935 00:35:28,656 --> 00:35:32,426 WOULD BE GREAT. 936 00:35:32,426 --> 00:35:34,995 HIV AND AGING CONTINUES AS A 937 00:35:34,995 --> 00:35:37,431 HIGH PRIORITY ACTIVITY FOR THE 938 00:35:37,431 --> 00:35:38,933 NIH HIV RESEARCH PORTFOLIO. 939 00:35:38,933 --> 00:35:41,469 THE OAR WAS INVITED TO PRESENT 940 00:35:41,469 --> 00:35:45,773 AT RECENT FEDERAL AIDS POLICY 941 00:35:45,773 --> 00:35:48,008 PARTNERSHIP MEETING ON THE NIH 942 00:35:48,008 --> 00:35:50,044 HIV AGING RESEARCH LANDSCAPE. 943 00:35:50,044 --> 00:35:51,979 THAT IS A NATIONAL ADVOCACY 944 00:35:51,979 --> 00:35:54,949 COALITION OF MORE THAN 120 LOCAL 945 00:35:54,949 --> 00:35:56,717 REGIONAL AND NATIONAL 946 00:35:56,717 --> 00:35:58,853 ORGANIZATIONS FOCUSED ON FUNDING 947 00:35:58,853 --> 00:36:01,088 LEGISLATION AND POLICY TO END 948 00:36:01,088 --> 00:36:02,890 THE HIV EPIDEMIC. 949 00:36:02,890 --> 00:36:05,893 ONE ITEM DISCUSSED WAS NIH OAR 950 00:36:05,893 --> 00:36:07,328 FUNDING OF SEVERAL SUPPLEMENTS 951 00:36:07,328 --> 00:36:09,930 THROUGH NOTICE OF SPECIAL 952 00:36:09,930 --> 00:36:11,832 INTEREST, THAT IS INDICATED ON 953 00:36:11,832 --> 00:36:14,134 THE SLIDE ISSUED EARLIER THIS 954 00:36:14,134 --> 00:36:16,136 YEAR IN ONGOING COLLABORATION 955 00:36:16,136 --> 00:36:18,172 FOR NATIONAL INSTITUTE ON AGING, 956 00:36:18,172 --> 00:36:23,344 THE NOCI EXPANDS CURRENT NIH 957 00:36:23,344 --> 00:36:25,546 AGING RESEARCH MORE GENERAL NIH 958 00:36:25,546 --> 00:36:28,048 HIV RESEARCH TO INCLUDE HIV 959 00:36:28,048 --> 00:36:29,350 OBJECTIVES AND EXPLORE HEALTH 960 00:36:29,350 --> 00:36:31,352 OUTCOMES OF PEOPLE WITH HIV 961 00:36:31,352 --> 00:36:34,054 THROUGHOUT THE LIFE SPAN. 962 00:36:34,054 --> 00:36:38,325 I MET WITH THE NATIONAL 963 00:36:38,325 --> 00:36:39,994 INSTITUTE FOR AGING DIRECTOR DR. 964 00:36:39,994 --> 00:36:42,396 RICHARD HODES TO REVIEW NIH AND 965 00:36:42,396 --> 00:36:44,198 AGING UPCOMING RESEARCH 966 00:36:44,198 --> 00:36:45,866 PRIORITIES AND EXPAND THE 967 00:36:45,866 --> 00:36:47,868 ACTIVITIES MOVING FORWARDS. 968 00:36:47,868 --> 00:36:48,936 -- MOVING FORWARD. 969 00:36:48,936 --> 00:36:52,606 SINCE THE LAST OARAC SEVERAL NIH 970 00:36:52,606 --> 00:36:53,707 WORKSHOPS DISCUSSED THE PROGRESS 971 00:36:53,707 --> 00:36:55,476 AND FUTURE DIRECTIONS OF HIV AND 972 00:36:55,476 --> 00:36:57,811 AGING RESEARCH INCLUDING THE 973 00:36:57,811 --> 00:37:00,981 PATHOGENESIS OF AGE RELATED HIV 974 00:37:00,981 --> 00:37:03,150 NEURODEGENERATION WORKSHOP AND 975 00:37:03,150 --> 00:37:05,452 THE NIH INTRAMURAL NEURAL HIV 976 00:37:05,452 --> 00:37:12,660 RESEARCH WORKSHOP FOR 2022. 977 00:37:12,660 --> 00:37:16,397 AT THE UPCOMING AIDS 2022 978 00:37:16,397 --> 00:37:17,531 CONFERENCE NEXT MONTH OAR 979 00:37:17,531 --> 00:37:19,300 TOGETHER WITH MEMBER OF NIH 980 00:37:19,300 --> 00:37:21,835 INSTITUTES AND CENTERS, WILL 981 00:37:21,835 --> 00:37:23,704 LEAD ACTIVELY PARTICIPATE IN 982 00:37:23,704 --> 00:37:25,606 WORKSHOPS SYMPOSIA PRESENTATIONS 983 00:37:25,606 --> 00:37:28,576 AND OTHER ACTIVITIES. 984 00:37:28,576 --> 00:37:31,245 SPECIFICALLY NIH OAR WILL LEAD 985 00:37:31,245 --> 00:37:32,713 SESSIONS ON GLOBAL DOMESTIC 986 00:37:32,713 --> 00:37:34,481 BIDIRECTIONAL LESSONS LEARNED. 987 00:37:34,481 --> 00:37:37,785 THE NIH OAR NIMH LAUNCH OF 988 00:37:37,785 --> 00:37:39,753 SPECIAL ISSUE IN THE AMERICAN 989 00:37:39,753 --> 00:37:42,089 JOURNAL OF PUBLIC HEALTH 990 00:37:42,089 --> 00:37:44,858 FOCUSING ON HIV RELATED 991 00:37:44,858 --> 00:37:45,759 INTERSECTIONAL STIGMA AND 992 00:37:45,759 --> 00:37:47,294 DISCRIMINATION TO IMPROVE 993 00:37:47,294 --> 00:37:48,228 OUTCOMES AND INFORM PUBLIC 994 00:37:48,228 --> 00:37:49,930 HEALTH. 995 00:37:49,930 --> 00:37:52,666 AND A SATELLITE SESSION ON 996 00:37:52,666 --> 00:37:54,234 IMPLEMENTATION SCIENCE AS 997 00:37:54,234 --> 00:37:57,671 RELATED TO THE EHE INITIATIVE. 998 00:37:57,671 --> 00:38:00,207 THERE ARE ALSO NUMBER OF OTHER 999 00:38:00,207 --> 00:38:04,378 NIH SESSIONS THAT COUPLE TO NOTE 1000 00:38:04,378 --> 00:38:08,449 AS WORKSHOP ADVANCING HIV HEALTH 1001 00:38:08,449 --> 00:38:09,149 COMMUNICATION SCIENCE SPONSORED 1002 00:38:09,149 --> 00:38:11,885 BY THE NATIONAL INSTITUTE OF 1003 00:38:11,885 --> 00:38:13,120 MENTAL HEALTH DIVISION OF AIDS 1004 00:38:13,120 --> 00:38:14,822 RESEARCH, A SESSION ON THE USE 1005 00:38:14,822 --> 00:38:17,458 OF BEHAVIORAL ECONOMICS AND 1006 00:38:17,458 --> 00:38:19,660 CONDITIONAL INCENTIVES IN NIH 1007 00:38:19,660 --> 00:38:21,662 TREATMENT AND PREVENTION. 1008 00:38:21,662 --> 00:38:22,896 SPONSORED BY FOGARTY 1009 00:38:22,896 --> 00:38:24,598 INTERNATIONAL CENTER AND NIMH. 1010 00:38:24,598 --> 00:38:27,134 AND A SESSION FOCUSED ON RECENT 1011 00:38:27,134 --> 00:38:30,304 EVIDENCE OPTIMAL METHODS TO 1012 00:38:30,304 --> 00:38:32,373 EVALUATE NEURAL DEVELOPMENTAL 1013 00:38:32,373 --> 00:38:36,210 OUTCOMES IN HIV. 1014 00:38:36,210 --> 00:38:43,283 SO HOPE THAT MANY OF YOU WILL BE 1015 00:38:43,283 --> 00:38:44,118 PARTICIPATING. 1016 00:38:44,118 --> 00:38:48,922 PERHAPS WE WILL GET TO 1017 00:38:48,922 --> 00:38:49,523 (INAUDIBLE). 1018 00:38:49,523 --> 00:38:50,557 SHORTLY AFTER I FINISH MY 1019 00:38:50,557 --> 00:38:52,826 REMARKS WE WILL HEAR FROM DR. 1020 00:38:52,826 --> 00:38:54,728 SUSAN GREGURICK WHO IS DIRECTOR 1021 00:38:54,728 --> 00:38:57,164 OF THE NIH OFFICE OF DATA 1022 00:38:57,164 --> 00:38:59,733 SCIENCE STRATEGY ODSS. 1023 00:38:59,733 --> 00:39:02,603 THIS OFFICE PROVIDES LEADERSHIP 1024 00:39:02,603 --> 00:39:05,039 AND COORDINATION AT BROAD RANGE 1025 00:39:05,039 --> 00:39:06,440 OF NIH WIDE DATA SCIENCE 1026 00:39:06,440 --> 00:39:08,976 ACTIVITIES TO REALIZE THE AGENCY 1027 00:39:08,976 --> 00:39:12,279 VISION FOR MODERNIZED INTEGRATED 1028 00:39:12,279 --> 00:39:15,382 BIOMEDICAL DATA ECOSYSTEM. 1029 00:39:15,382 --> 00:39:16,850 ACHIEVING THIS WILL MAXIMIZE 1030 00:39:16,850 --> 00:39:18,585 VALUE OF DATA GENERATED THROUGH 1031 00:39:18,585 --> 00:39:22,189 NIH FUNDED RESEARCH AND EXPAND 1032 00:39:22,189 --> 00:39:24,324 ACCESS TO DATA SETS THAT MAY 1033 00:39:24,324 --> 00:39:27,127 INFORM HIV RESEARCH. 1034 00:39:27,127 --> 00:39:29,196 DR. GREGURICK WILL DISCUSS DATA 1035 00:39:29,196 --> 00:39:32,399 SHARING PRACTICES, DATA 1036 00:39:32,399 --> 00:39:33,967 TRIANGULATION, ACCESSIBILITY AND 1037 00:39:33,967 --> 00:39:35,436 TRANSPARENCY, THESE ARE TOPICS 1038 00:39:35,436 --> 00:39:38,138 FOR CURRENT AND FUTURE 1039 00:39:38,138 --> 00:39:39,606 COLLABORATIONS THAT WILL YIELD 1040 00:39:39,606 --> 00:39:40,407 BENEFITS WITHIN THE NIH 1041 00:39:40,407 --> 00:39:41,809 COMMUNITY AND BEYOND WITH THE 1042 00:39:41,809 --> 00:39:48,415 EXTRAMURAL RESEARCH COMMUNITY. 1043 00:39:48,415 --> 00:39:53,587 SO I THINK THIS THE REST OF THE 1044 00:39:53,587 --> 00:39:55,155 DAY, BLANTON HAS OUTLINED THIS 1045 00:39:55,155 --> 00:39:57,024 FOR YOU, IT IS IN YOUR PROGRAM 1046 00:39:57,024 --> 00:39:59,560 SO I FOR SAKE OF TIME MOVE 1047 00:39:59,560 --> 00:40:00,961 FORWARD. 1048 00:40:00,961 --> 00:40:05,532 JUST TO REMIND YOU THAT NEXT 1049 00:40:05,532 --> 00:40:05,966 OARAC. 1050 00:40:05,966 --> 00:40:09,403 IS THURSDAY, THE 27TH. 1051 00:40:09,403 --> 00:40:12,039 AND WE MEMBERSHIP ABOUT 1052 00:40:12,039 --> 00:40:13,741 CONFERENCES FOR HYBRID VERSUS 1053 00:40:13,741 --> 00:40:15,409 ALL VIRTUAL MEETING. 1054 00:40:15,409 --> 00:40:18,912 SO PLEASE MAKE SURE THAT YOU USE 1055 00:40:18,912 --> 00:40:19,546 SURVEY, SHOULD TAKE ABOUT A 1056 00:40:19,546 --> 00:40:24,351 MINUTE. 1057 00:40:24,351 --> 00:40:25,819 THERE ARE MANY WAYS TO STAY 1058 00:40:25,819 --> 00:40:28,355 CONNECTED WITH OAR IN OUR 1059 00:40:28,355 --> 00:40:30,657 ACTIVITIES, PLEASE VISIT OUR 1060 00:40:30,657 --> 00:40:31,792 WEBSITE, JOIN OUR LIST AND 1061 00:40:31,792 --> 00:40:34,027 FOLLOW US ON SOCIAL MEDIA. 1062 00:40:34,027 --> 00:40:36,897 THANK YOU FOR YOUR ATTENTION AND 1063 00:40:36,897 --> 00:40:40,667 I THINK THERE'S TIME FOR US TO 1064 00:40:40,667 --> 00:40:42,469 HAVE SOME CONVERSATION. 1065 00:40:42,469 --> 00:40:44,104 BLANTON, BLACK TO YOU. 1066 00:40:44,104 --> 00:40:45,472 -- BACK TO YOU. 1067 00:40:45,472 --> 00:40:48,675 >> THANK YOU, DR. GOODENOW FOR A 1068 00:40:48,675 --> 00:40:49,710 VERY EXCELLENT REPORT. 1069 00:40:49,710 --> 00:40:51,044 SO COLLEAGUES I WANT TO OPEN UP 1070 00:40:51,044 --> 00:40:53,914 NOW FOR DISCUSSION AND REMIND 1071 00:40:53,914 --> 00:40:56,683 YOU TO PLEASE RAISE YOUR HANDS. 1072 00:40:56,683 --> 00:41:07,161 AND WE WILL ACKNOWLEDGE YOU. 1073 00:41:10,230 --> 00:41:11,398 >> I HAD A QUICK QUESTION ABOUT 1074 00:41:11,398 --> 00:41:13,267 THE LISTENING SESSION. 1075 00:41:13,267 --> 00:41:16,970 HOW (INAUDIBLE)? 1076 00:41:16,970 --> 00:41:24,077 >> AM I -- GOOD QUESTION. 1077 00:41:24,077 --> 00:41:26,380 LISTENING SESSIONS ARE SET UP 1078 00:41:26,380 --> 00:41:31,118 PLEASE REALLY MIXTURE OF LOTS OF 1079 00:41:31,118 --> 00:41:33,520 TIMES PEOPLE INVITE US TO COME 1080 00:41:33,520 --> 00:41:34,421 AND HAVE LISTENING SESSIONS WITH 1081 00:41:34,421 --> 00:41:36,356 THEM. 1082 00:41:36,356 --> 00:41:38,091 SOMETIMES DURING OTHER TYPES OF 1083 00:41:38,091 --> 00:41:39,092 INTERACTIONS IT WILL BECOME 1084 00:41:39,092 --> 00:41:42,095 CLEAR THIS IS A GOOD 1085 00:41:42,095 --> 00:41:43,163 OPPORTUNITY. 1086 00:41:43,163 --> 00:41:47,434 SOMETIMES WE USE LISTENING 1087 00:41:47,434 --> 00:41:50,270 SESSIONS AS SIDE BAR ACTIVITIES 1088 00:41:50,270 --> 00:41:52,472 OR ACTIVITIES ON THE MARGINS OF 1089 00:41:52,472 --> 00:41:53,707 MEETINGS THAT WE MIGHT BE 1090 00:41:53,707 --> 00:41:54,208 ATTENDING. 1091 00:41:54,208 --> 00:41:57,377 WE WILL PROBABLY DO SOME TYPE OF 1092 00:41:57,377 --> 00:41:59,613 LISTENING SESSION OR SITE VISIT 1093 00:41:59,613 --> 00:42:00,781 IN MONTREAL. 1094 00:42:00,781 --> 00:42:05,419 UPCOMING MEETING IN OCTOBER OF 1095 00:42:05,419 --> 00:42:08,989 THE USCHA HELD IN PUERTO RICO 1096 00:42:08,989 --> 00:42:10,657 AND WE WILL BE ADDING ON SOME 1097 00:42:10,657 --> 00:42:13,093 SITE VISITS AND LISTENING 1098 00:42:13,093 --> 00:42:15,429 SESSIONS IN PUERTO RICO 1099 00:42:15,429 --> 00:42:17,698 PARTICULARLY BECAUSE THE NIH OAR 1100 00:42:17,698 --> 00:42:21,668 INVESTED A LARGE AMOUNT OF 1101 00:42:21,668 --> 00:42:23,570 MONEY, CONSTRUCTION MONEY IN 1102 00:42:23,570 --> 00:42:25,739 2017 AFTER HURRICANE MARIE 1103 00:42:25,739 --> 00:42:28,275 DESTROYED THE NON -HUMAN PRIMATE 1104 00:42:28,275 --> 00:42:30,177 CENTER IN PUERTO RICO. 1105 00:42:30,177 --> 00:42:31,745 SO THEY HAVE BEEN REBUILDING, 1106 00:42:31,745 --> 00:42:33,981 THEY ARE EXCITED ABOUT US BEING 1107 00:42:33,981 --> 00:42:34,348 THERE. 1108 00:42:34,348 --> 00:42:35,515 TO LOOK AND SEE WHAT THEY HAVE 1109 00:42:35,515 --> 00:42:36,383 BEEN DOING. 1110 00:42:36,383 --> 00:42:38,185 SO IT IS A VARIETY OF WAYS AND 1111 00:42:38,185 --> 00:42:43,223 WE ARE OPEN TO ANYONE WANTING A 1112 00:42:43,223 --> 00:42:43,857 CONVERSATION ABOUT IT. 1113 00:42:43,857 --> 00:42:44,825 THE LISTENING SESSIONS 1114 00:42:44,825 --> 00:42:47,461 THEMSELVES WHEN THEY ARE HELD 1115 00:42:47,461 --> 00:42:48,495 ONE OF THE THINGS WE HAVE BEEN 1116 00:42:48,495 --> 00:42:51,031 ABLE TO CAPITALIZE ON AND TO 1117 00:42:51,031 --> 00:42:56,403 MAINTAIN IS THE IDEA OF HAVING 1118 00:42:56,403 --> 00:42:57,537 RELATIVELY SMALL GROUPS AND 1119 00:42:57,537 --> 00:43:02,142 LISTENING SESSIONS ARE USUALLY 1120 00:43:02,142 --> 00:43:04,011 ADVERTISING AND OPEN TO PEOPLE 1121 00:43:04,011 --> 00:43:07,648 IN THE AREA, THEY DECIDE WHO IS 1122 00:43:07,648 --> 00:43:09,416 GOING TO BE INCLUDED IF IT IS A 1123 00:43:09,416 --> 00:43:10,450 COMMUNITY GROUP THEY DECIDE WHO 1124 00:43:10,450 --> 00:43:11,718 IS GOING TO BE INCLUDED. 1125 00:43:11,718 --> 00:43:17,658 BUT THEY ACTUALLY WE ARE SORT OF 1126 00:43:17,658 --> 00:43:20,027 CONCERNED ABOUT LOSING A LOT OF 1127 00:43:20,027 --> 00:43:21,361 INTIMACY AND CONVERSATIONAL 1128 00:43:21,361 --> 00:43:24,431 ASPECTS OF THESE ENGAGEMENTS 1129 00:43:24,431 --> 00:43:26,733 THAT OCCUR IN PERSON, THEY ARE 1130 00:43:26,733 --> 00:43:30,270 VERY EFFECTIVE IN THE VIRTUAL 1131 00:43:30,270 --> 00:43:32,706 SPACE PARTLY BECAUSE ABLE TO 1132 00:43:32,706 --> 00:43:35,642 KEEP THE SIZE OF EACH ENCOUNTER 1133 00:43:35,642 --> 00:43:37,177 USUALLY NO BIGGER THAN YOU CAN 1134 00:43:37,177 --> 00:43:38,745 GET PICTURES ON THE SCREEN AT 1135 00:43:38,745 --> 00:43:41,014 THE SAME TIME. 1136 00:43:41,014 --> 00:43:45,452 SO IT IS -- WE HAVE BEEN 1137 00:43:45,452 --> 00:43:47,554 MODIFYING ADAPTING EVERYONE'S 1138 00:43:47,554 --> 00:43:48,188 EXPERIENCE. 1139 00:43:48,188 --> 00:43:49,823 DOES THAT HELP? 1140 00:43:49,823 --> 00:43:55,529 >> THANK YOU. 1141 00:43:55,529 --> 00:44:01,068 >> DR. ALI-OSMAN. 1142 00:44:01,068 --> 00:44:02,202 >> GREAT PRESENTATION. 1143 00:44:02,202 --> 00:44:04,938 WONDERING EXTENT TO WHICH OFFICE 1144 00:44:04,938 --> 00:44:08,208 -- NIH OFFICE OF AIDS RESEARCH 1145 00:44:08,208 --> 00:44:08,942 COORDINATES RELATED ACTIVITY 1146 00:44:08,942 --> 00:44:14,681 ACROSS THE INSTITUTES, AND TO 1147 00:44:14,681 --> 00:44:17,584 LEVERAGE EACH OTHER, SO ON. 1148 00:44:17,584 --> 00:44:19,486 A LITTLE BIT ENLIGHTENMENT ON 1149 00:44:19,486 --> 00:44:21,321 THAT. 1150 00:44:21,321 --> 00:44:23,256 >> THAT IS A REALLY GOOD 1151 00:44:23,256 --> 00:44:24,691 QUESTION BECAUSE IT IS AN 1152 00:44:24,691 --> 00:44:28,228 IMPORTANT ASPECT OF THE OAR 1153 00:44:28,228 --> 00:44:29,896 ACTIVITIES AND NOT ONLY 1154 00:44:29,896 --> 00:44:31,098 ACTIVITIES THAT HAVE DEVELOPED 1155 00:44:31,098 --> 00:44:32,566 BUT ACTIVITIES THAT ARE MANDATED 1156 00:44:32,566 --> 00:44:34,267 IN THE LEGISLATION. 1157 00:44:34,267 --> 00:44:36,036 WHEN OFFICE OF AIDS RESEARCH WAS 1158 00:44:36,036 --> 00:44:38,672 SET UP, WHICH WAS VERY EARLY IN 1159 00:44:38,672 --> 00:44:41,008 THE DAYS OF THE PANDEMIC, I 1160 00:44:41,008 --> 00:44:44,544 THINK THERE WAS NIH FUNDING TO 1161 00:44:44,544 --> 00:44:47,581 NIH RESEARCH EVEN BEFORE THERE 1162 00:44:47,581 --> 00:44:49,783 WAS AN OFFICIAL CONGRESSIONALLY 1163 00:44:49,783 --> 00:44:51,585 DESIGNATED OFFICE. 1164 00:44:51,585 --> 00:44:54,021 BUT IN ALL THIS IS GOING ON IN 1165 00:44:54,021 --> 00:44:57,057 EARLY '80s, AND BY THE TIME 1166 00:44:57,057 --> 00:45:04,498 THE ACTUAL LEGISLATION MID 1167 00:45:04,498 --> 00:45:05,766 1980s, IT WAS VERY CLEAR TO 1168 00:45:05,766 --> 00:45:07,401 THE LEADERSHIP AND THE 1169 00:45:07,401 --> 00:45:09,669 PRINCIPLES AT THAT TIME THE WAY 1170 00:45:09,669 --> 00:45:12,506 FOR THIS TO FUNCTION WAS TO BE 1171 00:45:12,506 --> 00:45:15,008 AT LEVEL SO THEY -- SO THE 1172 00:45:15,008 --> 00:45:16,610 ACTIVITIES COULD BE COORDINATED 1173 00:45:16,610 --> 00:45:18,779 AND WOULDN'T DEPEND ANY ONE 1174 00:45:18,779 --> 00:45:22,816 INSTITUTE OR CENTER. 1175 00:45:22,816 --> 00:45:25,352 THEN OVER TIME THE OFFICE MODEL 1176 00:45:25,352 --> 00:45:29,856 HAS REALLY EXPANDED TO OTHER 1177 00:45:29,856 --> 00:45:30,957 SUBJECT MATTER AREAS THAT WE 1178 00:45:30,957 --> 00:45:34,061 JUST TALKED ABOUT, TRIBAL HEALTH 1179 00:45:34,061 --> 00:45:35,962 RESEARCH WOMEN HEALTH RESEARCH 1180 00:45:35,962 --> 00:45:37,030 SEXUAL AND GENDER MINORITY 1181 00:45:37,030 --> 00:45:38,732 RESEARCH, SO THERE IS NOW A 1182 00:45:38,732 --> 00:45:42,135 CADRE OF OFFICES INVOLVED IN 1183 00:45:42,135 --> 00:45:44,671 COORDINATING ACROSS THE NIH 1184 00:45:44,671 --> 00:45:48,742 DIFFERENT ASPECTS OF THE NIH 1185 00:45:48,742 --> 00:45:53,447 RESEARCH PORTFOLIO THAT CAN BE 1186 00:45:53,447 --> 00:45:55,115 ASSIGNED NOT WITHIN THE SCOPE OF 1187 00:45:55,115 --> 00:45:57,150 THE WORK OF ANY ONE INSTITUTE OR 1188 00:45:57,150 --> 00:45:59,019 CENTER. 1189 00:45:59,019 --> 00:46:01,555 SO THE WAY WE DO THAT IS USING 1190 00:46:01,555 --> 00:46:04,558 -- WE HAVE SIMILAR METHODOLOGIES 1191 00:46:04,558 --> 00:46:06,460 WE APPLY IN PARTICULAR SOME THAT 1192 00:46:06,460 --> 00:46:08,562 I MENTION TODAY, WE HAVE THE 1193 00:46:08,562 --> 00:46:10,764 OARAC, WE ALSO HAVE INTERNAL 1194 00:46:10,764 --> 00:46:12,299 COORDINATING COMMISSION -- 1195 00:46:12,299 --> 00:46:13,533 COMMITTEE, EXECUTIVE COMMITTEE 1196 00:46:13,533 --> 00:46:15,969 WHICH HAS REPRESENTATIVES OF 1197 00:46:15,969 --> 00:46:17,404 EACH OF THE INSTITUTES CENTERS 1198 00:46:17,404 --> 00:46:20,740 AND OFFICES THAT ARE 1199 00:46:20,740 --> 00:46:22,075 PARTICIPATING IN THE AGENDA. 1200 00:46:22,075 --> 00:46:24,878 IN THE HIV AGENDA. 1201 00:46:24,878 --> 00:46:25,946 FUNDING FOR IT. 1202 00:46:25,946 --> 00:46:29,382 SO THAT EVERYONE HAS AN 1203 00:46:29,382 --> 00:46:31,818 OPPORTUNITY TO INPUT AND THEN IT 1204 00:46:31,818 --> 00:46:33,887 IS OUR JOB TO TRIANGULATE ALL 1205 00:46:33,887 --> 00:46:37,757 THE INFORMATION THAT WE GET FROM 1206 00:46:37,757 --> 00:46:41,828 OUR INTERNAL FOLKS, FEDERAL 1207 00:46:41,828 --> 00:46:43,463 COLLEAGUES AND PARTNERS FROM THE 1208 00:46:43,463 --> 00:46:44,798 EXTRAMURAL COMMUNITY, FROM THE 1209 00:46:44,798 --> 00:46:47,033 COMMUNITY AND ADVOCATES. 1210 00:46:47,033 --> 00:46:53,840 AND COME UP WITH A WAY TO KEEP 1211 00:46:53,840 --> 00:46:56,910 THE AGENDA MOVING FORWARD AND 1212 00:46:56,910 --> 00:46:58,578 KEEP IT NIMBLE AND AGILE IN THE 1213 00:46:58,578 --> 00:47:01,982 WAY THAT IT REALLY NEEDS TO BE 1214 00:47:01,982 --> 00:47:03,183 FOR FIELD MOVING VERY FAST, IF 1215 00:47:03,183 --> 00:47:03,917 YOU THINK ABOUT IT. 1216 00:47:03,917 --> 00:47:06,553 WE HAVE COME A LONG WAY IN 40 1217 00:47:06,553 --> 00:47:09,022 YEARS. 1218 00:47:09,022 --> 00:47:13,426 THERE'S REALLY CHANGE IS ALMOST 1219 00:47:13,426 --> 00:47:15,729 -- IS A GIVEN IN THE WAY THAT WE 1220 00:47:15,729 --> 00:47:16,863 FUNCTION, WE WERE STILL DOING 1221 00:47:16,863 --> 00:47:18,465 EVERYTHING THE WAY IT WAS DONE 1222 00:47:18,465 --> 00:47:19,633 40 YEARS AGO ALL THE UNDERSTOOD 1223 00:47:19,633 --> 00:47:21,201 FUNDING WAS GOING TO THE SAME 1224 00:47:21,201 --> 00:47:24,404 TOPICS IT WENT TO YEARS AGO, 1225 00:47:24,404 --> 00:47:25,539 THAT I DON'T THINK WOULD BE 1226 00:47:25,539 --> 00:47:29,176 VIEWED BEING SUCCESSFUL PROGRAM. 1227 00:47:29,176 --> 00:47:31,244 SO THE BALANCING COMES IN AND 1228 00:47:31,244 --> 00:47:35,348 WHERE WE USE ADVICE AND IS HOW 1229 00:47:35,348 --> 00:47:38,285 DO YOU BALANCE THE NEEDS WITH 1230 00:47:38,285 --> 00:47:40,020 THE RESOURCES. 1231 00:47:40,020 --> 00:47:42,756 AND KEEP RESOURCES FLUID TO BE 1232 00:47:42,756 --> 00:47:46,526 ABLE TO ACCOMMODATE NEW NEEDS, 1233 00:47:46,526 --> 00:47:48,695 WHEN THERE IS NEW MONEY THAT 1234 00:47:48,695 --> 00:47:50,797 EASIER THAN WHEN WHETHER IS NOT 1235 00:47:50,797 --> 00:47:52,632 BEFORE MY PREDECESSORS AND WE 1236 00:47:52,632 --> 00:47:54,901 HAVE CONTINUED SOME OF THESE 1237 00:47:54,901 --> 00:47:56,169 PRACTICES, DIFFERENT WAYS THAT 1238 00:47:56,169 --> 00:47:58,572 IT IS POSSIBLE TO KEEP MONEY 1239 00:47:58,572 --> 00:48:00,473 MOVING THROUGH THE PORTFOLIO TO 1240 00:48:00,473 --> 00:48:03,143 ACCOMMODATE A LOT OF NEW AREAS 1241 00:48:03,143 --> 00:48:09,616 THAT REALLY NEED ATTENTION NOW. 1242 00:48:09,616 --> 00:48:11,218 >> THANK YOU. 1243 00:48:11,218 --> 00:48:14,287 MAUREEN, I WOULD LIKE TO ASK A 1244 00:48:14,287 --> 00:48:16,189 FOLLOW-UP QUESTION TO THAT, BUT 1245 00:48:16,189 --> 00:48:17,857 FIRST I WANT TO CONGRATULATE YOU 1246 00:48:17,857 --> 00:48:21,394 ON INCREASING IN THE 1247 00:48:21,394 --> 00:48:22,529 CONGRESSIONAL BUDGET AND ALSO 1248 00:48:22,529 --> 00:48:25,498 RESEARCH PRIORITY AREAS THAT ARE 1249 00:48:25,498 --> 00:48:26,199 HIGHLIGHTED. 1250 00:48:26,199 --> 00:48:28,635 MY FOLLOW-UP, I MAY HAVE MISSED 1251 00:48:28,635 --> 00:48:32,272 THIS, I NOTICE THAT SOME ICs 1252 00:48:32,272 --> 00:48:36,009 WERE MISSING IN YOUR SLIDE IN 1253 00:48:36,009 --> 00:48:37,544 TERMS OF INTRAAGENCY 1254 00:48:37,544 --> 00:48:40,113 COLLABORATION AND PARTNERSHIPS. 1255 00:48:40,113 --> 00:48:43,016 I WAS -- IF I'M CORRECT ON THAT, 1256 00:48:43,016 --> 00:48:45,685 I MAY HAVE MISSED -- MAY HAVE 1257 00:48:45,685 --> 00:48:47,120 NOT SEEN THAT CORRECTLY BUT IF 1258 00:48:47,120 --> 00:48:49,122 THAT IS TRUE, THAT SOME ICs 1259 00:48:49,122 --> 00:48:52,259 ARE NOT LISTED AND INVOLVE CAN 1260 00:48:52,259 --> 00:48:55,695 YOU ENLIGHTEN US ON THE 1261 00:48:55,695 --> 00:48:58,098 MECHANISMS AND STRATEGIES TO 1262 00:48:58,098 --> 00:49:01,801 GARNER THOSE PARTNERSHIPS? 1263 00:49:01,801 --> 00:49:03,903 >> SO FIRST THE ONES THAT I 1264 00:49:03,903 --> 00:49:05,672 MENTION TODAY ARE JUST A SMALL 1265 00:49:05,672 --> 00:49:07,474 NUMBER OF EXAMPLES THAT OCCURRED 1266 00:49:07,474 --> 00:49:09,643 IN THE LAST THREE MONTHS BECAUSE 1267 00:49:09,643 --> 00:49:12,112 WE -- THERE IS UNFORTUNATELY WE 1268 00:49:12,112 --> 00:49:14,080 TOOK SOME SLIDES OUT BUT I'M 1269 00:49:14,080 --> 00:49:16,950 SORRY WE DO NOW BECAUSE IT WAS 1270 00:49:16,950 --> 00:49:18,918 BASED ON TIMES, I THINK I CAME 1271 00:49:18,918 --> 00:49:21,054 IN JUST ON TIME SO WE HAD TO GET 1272 00:49:21,054 --> 00:49:22,289 TWO SLIDES OUT OF THERE. 1273 00:49:22,289 --> 00:49:24,357 THERE IS OUT OF THE 27 1274 00:49:24,357 --> 00:49:30,630 INSTITUTES AND CENTERS, I THINK 1275 00:49:30,630 --> 00:49:32,098 THAT THE NUMBER OF INSTITUTES 1276 00:49:32,098 --> 00:49:36,069 AND CENTERS WHO HAVE HIV 1277 00:49:36,069 --> 00:49:37,971 PROGRAMS AND RECEIVED PART OF 1278 00:49:37,971 --> 00:49:39,639 THE HIV ALLOCATION IS SOMETHING 1279 00:49:39,639 --> 00:49:41,508 LIKE 20. 1280 00:49:41,508 --> 00:49:43,510 OF THE INSTITUTES AND CENTERS. 1281 00:49:43,510 --> 00:49:47,447 AND OUT OF THE OFFICES, THE 14 1282 00:49:47,447 --> 00:49:48,682 OFFICES THERE IS 8 THAT ARE 1283 00:49:48,682 --> 00:49:51,318 REALLY DOING PROGRAMMATIC WORK 1284 00:49:51,318 --> 00:49:53,887 AND VIRTUALLY ALL OF THEM ARE 1285 00:49:53,887 --> 00:49:55,388 INVOLVED IN THE NIH PROGRAM SO 1286 00:49:55,388 --> 00:50:03,697 IT IS INCREDIBLY INTERACTIVE. 1287 00:50:03,697 --> 00:50:04,064 WIDESPREAD. 1288 00:50:04,064 --> 00:50:06,933 AND THEN THE DEPTH OF THE 1289 00:50:06,933 --> 00:50:08,935 INVESTMENT, THE DEPTH AND 1290 00:50:08,935 --> 00:50:10,970 INSTITUTE CENTER OFFICE LEVEL, 1291 00:50:10,970 --> 00:50:13,840 TO WHICH THEY ARE INVOLVED, IS 1292 00:50:13,840 --> 00:50:15,408 VARIABLE TOO, DEPENDING. 1293 00:50:15,408 --> 00:50:19,145 AND AGAIN, THERE'S INSTITUTES 1294 00:50:19,145 --> 00:50:21,815 THAT RECEIVE TRADITIONALLY MORE 1295 00:50:21,815 --> 00:50:24,184 MONEY AND IN SOME CASES IT IS A 1296 00:50:24,184 --> 00:50:25,285 LARGE PROPORTION OF THEIR 1297 00:50:25,285 --> 00:50:25,919 BUDGET. 1298 00:50:25,919 --> 00:50:30,857 FOR EXAMPLE NIAID RECEIVES ABOUT 1299 00:50:30,857 --> 00:50:32,726 TALKING VERY ROUGH NUMBERS, 1300 00:50:32,726 --> 00:50:35,228 SOMETHING LIKE 60% OF HIV 1301 00:50:35,228 --> 00:50:36,429 ALLOCATION. 1302 00:50:36,429 --> 00:50:41,000 THAT'S OVER -- THAT IS SOMEWHERE 1303 00:50:41,000 --> 00:50:42,569 LIKE 33, 35% OF BUDGET SO VERY 1304 00:50:42,569 --> 00:50:46,840 BIG COMMITMENT WITHIN THEIR IC 1305 00:50:46,840 --> 00:50:47,574 OBVIOUSLY HIV. 1306 00:50:47,574 --> 00:50:48,875 THE FOGARTY INSTITUTE HAS 1307 00:50:48,875 --> 00:50:50,110 SMALLER BUDGET, ABOUT 25 1308 00:50:50,110 --> 00:50:54,481 MILLION, BUT THEY ALSO HAVE A 1309 00:50:54,481 --> 00:50:56,950 LARGE PROPORTION, 30% OR MORE, 1310 00:50:56,950 --> 00:50:59,219 THEIR BUDGET IS ALSO HIV. 1311 00:50:59,219 --> 00:51:02,122 FROM THE HIV PORTFOLIO. 1312 00:51:02,122 --> 00:51:04,991 I THINK THE IMPORTANT PIECE IS 1313 00:51:04,991 --> 00:51:08,528 HOW THE -- HOW THESE FLUCTUATE 1314 00:51:08,528 --> 00:51:10,330 OVER TIME AND THE OVERALL 1315 00:51:10,330 --> 00:51:13,066 ENTERPRISE AND RESEARCH GOALS, 1316 00:51:13,066 --> 00:51:14,968 NEED NEW INPUT AND NEW AREAS 1317 00:51:14,968 --> 00:51:20,073 THAT WE ARE ABLE TO EXPAND FOR 1318 00:51:20,073 --> 00:51:23,676 EXAMPLE IN ASIA NOW, IN NURSING 1319 00:51:23,676 --> 00:51:26,980 RESEARCH, IN BIOTECHNOLOGY, 1320 00:51:26,980 --> 00:51:29,215 AREAS THAT ARE REALLY BECOMING 1321 00:51:29,215 --> 00:51:31,651 MORE AND MORE IMPORTANT FOR THE 1322 00:51:31,651 --> 00:51:34,087 PORTFOLIO TO BE ABLE TO ACHIEVE 1323 00:51:34,087 --> 00:51:35,321 THE GOALS OF THE NEXT NOT ONLY 1324 00:51:35,321 --> 00:51:36,489 THROUGH THE CURRENT STRATEGIC 1325 00:51:36,489 --> 00:51:37,424 PLAN BUT GOING FORWARDS. 1326 00:51:37,424 --> 00:51:40,493 AS WELL. 1327 00:51:40,493 --> 00:51:45,165 >> THANK YOU. 1328 00:51:45,165 --> 00:51:46,332 ARE THERE OTHER QUESTIONS OR 1329 00:51:46,332 --> 00:51:52,238 COMMENTS? 1330 00:51:52,238 --> 00:51:54,240 IF NONE I THINK WE CAN MOVE 1331 00:51:54,240 --> 00:51:55,975 AHEAD WITH THE SCHEDULE, THANK 1332 00:51:55,975 --> 00:51:57,444 YOU AGAIN, DR. GOODENOW FOR THE 1333 00:51:57,444 --> 00:52:01,247 REPORT. 1334 00:52:01,247 --> 00:52:03,883 AND I BELIEVE OUR FIRST SPEAKER 1335 00:52:03,883 --> 00:52:08,321 IS AVAILABLE WITH US, AND AS DR. 1336 00:52:08,321 --> 00:52:09,989 GOODENOW MENTIONED WE WILL HEAR 1337 00:52:09,989 --> 00:52:14,294 NEXT FROM DR. SUSAN GREGURICK. 1338 00:52:14,294 --> 00:52:16,729 SO I WILL MOVE AHEAD AN 1339 00:52:16,729 --> 00:52:18,631 INTRODUCE DR. GREGURICK. 1340 00:52:18,631 --> 00:52:21,167 DR. GREGURICK WAS APPOINTED 1341 00:52:21,167 --> 00:52:22,368 ASSOCIATE DIRECTOR FOR DATA 1342 00:52:22,368 --> 00:52:24,604 SCIENCE AND DIRECTOR OF OF OF 1343 00:52:24,604 --> 00:52:25,839 OFFICE OF DATA SCIENCE STRATEGY 1344 00:52:25,839 --> 00:52:28,875 AT THE NIH IN 2019. 1345 00:52:28,875 --> 00:52:31,311 UNDER DR. GREGURICK'S 1346 00:52:31,311 --> 00:52:35,381 LEADERSHIP, THE ODSSS LEADS 1347 00:52:35,381 --> 00:52:36,416 IMPLEMENTATION OF THE NIH 1348 00:52:36,416 --> 00:52:38,418 STRATEGIC PLAN FOR DATA SCIENCE 1349 00:52:38,418 --> 00:52:41,821 THROUGH SCIENTIFIC TECHNICAL AND 1350 00:52:41,821 --> 00:52:42,622 OPERATIONAL COLLABORATION WITH 1351 00:52:42,622 --> 00:52:44,290 THE INSTITUTES CENTERS AND 1352 00:52:44,290 --> 00:52:47,060 OFFICES THAT COMPRISE NIH. 1353 00:52:47,060 --> 00:52:51,331 DR. GREGURICK RECEIVED A 2020 1354 00:52:51,331 --> 00:52:52,765 LEADERSHIP BIOLOGY CONTROL 1355 00:52:52,765 --> 00:52:54,868 SCIENCES AWARD -- BIOLOGICAL 1356 00:52:54,868 --> 00:52:56,102 SCIENCES AWARD, CONGRATULATIONS 1357 00:52:56,102 --> 00:52:57,070 FOR HER WORK IN THIS ROLE. 1358 00:52:57,070 --> 00:52:58,671 SO WITH THAT, WE ARE DI LIGHTED 1359 00:52:58,671 --> 00:53:00,773 TO HAVE YOU JOIN US TODAY, DR. 1360 00:53:00,773 --> 00:53:02,308 GREGURICK, PASS IT OVER TO YOU. 1361 00:53:02,308 --> 00:53:03,810 >> THANK YOU SO MUCH. 1362 00:53:03,810 --> 00:53:04,811 IT IS A PLEASURE TO BE HERE 1363 00:53:04,811 --> 00:53:06,112 TODAY. 1364 00:53:06,112 --> 00:53:07,447 I'M LOOKING FORWARD TO OUR 1365 00:53:07,447 --> 00:53:09,115 DISCUSSIONS AND I HOPE THAT WHAT 1366 00:53:09,115 --> 00:53:10,783 I SHOW YOU WHICH IS ESSENTIALLY 1367 00:53:10,783 --> 00:53:14,087 GOING TO BE A LITTLE BIT OF 1368 00:53:14,087 --> 00:53:14,754 REVERE AND REVIEW ALL THE THINGS 1369 00:53:14,754 --> 00:53:17,290 THAT WE HAVE DONE OVER THE PAST 1370 00:53:17,290 --> 00:53:19,726 ONE TO TWO YEARS SUPPORTED BY 1371 00:53:19,726 --> 00:53:23,363 THE OFFICE OF DATA SCIENCE 1372 00:53:23,363 --> 00:53:25,231 STRATEGY AND OUR WORK IN OUR 1373 00:53:25,231 --> 00:53:26,132 OFFICE. 1374 00:53:26,132 --> 00:53:28,968 SO THE NEXT SLIDE. 1375 00:53:28,968 --> 00:53:31,170 IT IS A LITTLE HIGHLIGHT OF 1376 00:53:31,170 --> 00:53:33,373 NORTH STAR FOR DATA SCIENCE NIH, 1377 00:53:33,373 --> 00:53:38,111 THE STRATEGIC PLAN FOR DATA 1378 00:53:38,111 --> 00:53:39,812 SCIENCE, THESE ARE THE GOALS OF 1379 00:53:39,812 --> 00:53:41,414 THE STREAM PLAN TO SUPPORT 1380 00:53:41,414 --> 00:53:44,284 INFRASTRUCTURE AND ARCHITECTURE 1381 00:53:44,284 --> 00:53:45,451 FOR DATA SIEGES, LEVERAGING 1382 00:53:45,451 --> 00:53:47,887 TOOLS AND TECHNOLOGY AND 1383 00:53:47,887 --> 00:53:49,455 SERVICES ENHANCING BIOMEDICAL 1384 00:53:49,455 --> 00:53:50,557 DATA SCIENCE RESEARCH WORK 1385 00:53:50,557 --> 00:53:51,190 FORCE. 1386 00:53:51,190 --> 00:53:53,493 ENABLING RESEARCHERS TO SHARE 1387 00:53:53,493 --> 00:53:57,130 DATA TO ACCESS DATA AND TO 1388 00:53:57,130 --> 00:53:58,498 CREATE INTEROPERABILITY BETWEEN 1389 00:53:58,498 --> 00:54:00,333 DATA AND RESOURCES, ENSURING AT 1390 00:54:00,333 --> 00:54:02,669 THE SAME TIME THE SECURITY AND 1391 00:54:02,669 --> 00:54:04,871 CONFIDENTIALITY OF PATIENT AND 1392 00:54:04,871 --> 00:54:05,972 PARTICIPANT DATA AND ALSO 1393 00:54:05,972 --> 00:54:08,341 IMPROVING OUR ABILITY TO CAPTURE 1394 00:54:08,341 --> 00:54:10,076 CURE RATE VALIDATE AND STORE 1395 00:54:10,076 --> 00:54:11,844 ANALYZE NOT JUST CLINICAL DATA 1396 00:54:11,844 --> 00:54:14,480 BUT ALL DATA AND FINALLY PROMOTE 1397 00:54:14,480 --> 00:54:16,049 DEVELOPMENT AND REFINEMENT OF 1398 00:54:16,049 --> 00:54:18,151 DATA STANDARDS INCLUDING DATA 1399 00:54:18,151 --> 00:54:20,353 VOCABULARY, DATA MODEL AND 1400 00:54:20,353 --> 00:54:20,987 ONTOLOGIES. 1401 00:54:20,987 --> 00:54:23,656 SO NEXT SLIDE. 1402 00:54:23,656 --> 00:54:24,791 A BROAD VISION. 1403 00:54:24,791 --> 00:54:26,125 OUR OFFICE SITS WITHIN THE 1404 00:54:26,125 --> 00:54:30,096 OFFICE OF DPKPSI. 1405 00:54:30,096 --> 00:54:32,098 OUR GOAL IS TO PROVIDE 1406 00:54:32,098 --> 00:54:33,132 LEADERSHIP COORDINATION ON 1407 00:54:33,132 --> 00:54:35,134 STRATEGIC PLAN ACROSS NIH TO 1408 00:54:35,134 --> 00:54:37,503 IMPLEMENT AND DEVELOP OUR VISION 1409 00:54:37,503 --> 00:54:38,938 PROOUR MODERNIZE INTEGRATED 1410 00:54:38,938 --> 00:54:40,740 BIOMEDICAL DATA ECOSYSTEM AND AT 1411 00:54:40,740 --> 00:54:44,344 THE SAME TIME ENHANCING THE 1412 00:54:44,344 --> 00:54:47,180 TALENTED STRONG DETERSIONS WORK 1413 00:54:47,180 --> 00:54:48,081 FORCE AND BUILD STRATEGIC 1414 00:54:48,081 --> 00:54:49,549 PARTNERSHIP NOT JUST WITH NIH 1415 00:54:49,549 --> 00:54:50,950 BUT OTHER FEDERAL AGENCIES 1416 00:54:50,950 --> 00:54:53,252 NON-PROFITS AND INTERNATIONAL 1417 00:54:53,252 --> 00:54:54,120 PARTNERSHIPS. 1418 00:54:54,120 --> 00:54:55,054 NEXT SLIDE IS ANOTHER WAY TO 1419 00:54:55,054 --> 00:54:56,923 LOOK AT THE STRATEGIC PLAN BUT 1420 00:54:56,923 --> 00:54:59,659 NOW IN TERMS OF -- INSTEAD OF 1421 00:54:59,659 --> 00:55:02,929 LOFTY GOALS BUT IN TERMS OF 1422 00:55:02,929 --> 00:55:04,063 APPLICATION OF WHAT WE ARE GOING 1423 00:55:04,063 --> 00:55:05,698 TO DO, I CAN'T TALK ABOUT ALL 1424 00:55:05,698 --> 00:55:07,400 THE THINGS WE DOING SO I 1425 00:55:07,400 --> 00:55:11,037 SELECTED A FEW HIGHLIGHTS THAT I 1426 00:55:11,037 --> 00:55:11,871 THOUGHT WOULD BE OF INTEREST TO 1427 00:55:11,871 --> 00:55:16,743 THIS GROUP. 1428 00:55:16,743 --> 00:55:18,177 IT TAKES A VILLAGE TO DO THE 1429 00:55:18,177 --> 00:55:19,445 WORK WE WILL TALK ABOUT. 1430 00:55:19,445 --> 00:55:23,383 WE WORK WITH ALMOST 200 NIH 1431 00:55:23,383 --> 00:55:24,517 STAFF FROM 23 INSTITUTES CENTERS 1432 00:55:24,517 --> 00:55:26,619 AND OFFICES AND ALL THESE 1433 00:55:26,619 --> 00:55:28,321 CONTRIBUTE IN VARIOUS WAYS 1434 00:55:28,321 --> 00:55:29,756 SOMETIMES LEADING AND SOMETIMES 1435 00:55:29,756 --> 00:55:30,990 PARTICIPATING IN THE ACTIVITIES 1436 00:55:30,990 --> 00:55:34,560 THAT WE TALK ABOUT. 1437 00:55:34,560 --> 00:55:38,631 BUT TO START NEXT SLIDE, I NEED 1438 00:55:38,631 --> 00:55:41,401 TO TALK ABOUT AND GROUND US IN 1439 00:55:41,401 --> 00:55:43,136 NIH FINAL POLICY FOR DATA 1440 00:55:43,136 --> 00:55:45,471 MANAGEMENT AND DATA SHARING. 1441 00:55:45,471 --> 00:55:48,341 I'M SURE YOU FAMILIAR WITH DATA 1442 00:55:48,341 --> 00:55:49,742 POLICY, IT GOES INTO EFFECT LESS 1443 00:55:49,742 --> 00:55:52,178 THAN A YEAR FROM NOW, JANUARY 1444 00:55:52,178 --> 00:55:53,246 25, 2023. 1445 00:55:53,246 --> 00:55:55,081 REQUIRING NIH APPLICANTS TO 1446 00:55:55,081 --> 00:55:57,917 PROSPECT TVLY PLAN FOR HOW DATA 1447 00:55:57,917 --> 00:56:00,620 WILL BE SHARED AND STORED 1448 00:56:00,620 --> 00:56:01,754 SUBMISSION OF DATA MANAGEMENT 1449 00:56:01,754 --> 00:56:02,989 AND SHARING PLAN AT THE TIME OF 1450 00:56:02,989 --> 00:56:04,157 APPLICATION. 1451 00:56:04,157 --> 00:56:07,126 YOU ARE GOING TO OUTLINE HOW 1452 00:56:07,126 --> 00:56:08,928 SCIENTIFIC DATA AND ANY METADATA 1453 00:56:08,928 --> 00:56:11,264 OR STANDARDS WILL BE MANAGED AND 1454 00:56:11,264 --> 00:56:13,399 SHARE AND TAKEN INTO ACCOUNT POO 1455 00:56:13,399 --> 00:56:15,401 TENIAL RESTRICTIONS OR 1456 00:56:15,401 --> 00:56:16,769 LIMITATIONS TO SHARE OF DATA. 1457 00:56:16,769 --> 00:56:18,771 THE PLAN WILL BE PART OF YOUR 1458 00:56:18,771 --> 00:56:20,206 BUDGET JUSTIFICATION AND YOUR 1459 00:56:20,206 --> 00:56:21,474 APPLICATION. 1460 00:56:21,474 --> 00:56:23,342 WE WILL BE SUBMITING A PDF WITH 1461 00:56:23,342 --> 00:56:24,777 GRANT APPLICATION, WE RECOMMEND 1462 00:56:24,777 --> 00:56:28,781 YOUR PLAN BE NO MORE THAN TWO 1463 00:56:28,781 --> 00:56:29,949 BEIGES IN LENGTH AND WILL BE -- 1464 00:56:29,949 --> 00:56:31,984 PAGES IN LEG AND EXPLORE THE USE 1465 00:56:31,984 --> 00:56:33,553 OF STRUCTURED FORMS -- 1466 00:56:33,553 --> 00:56:35,021 STRUCTURED PDF FORMS TO COLLECT 1467 00:56:35,021 --> 00:56:36,789 THE INFORMATION IN THE FUTURE 1468 00:56:36,789 --> 00:56:38,558 BUT AT THIS PARTICULAR TIME I 1469 00:56:38,558 --> 00:56:41,094 DON'T BELIEVE STRUCTURE FORMSES 1470 00:56:41,094 --> 00:56:41,794 ARE POSSIBLE. 1471 00:56:41,794 --> 00:56:44,063 THIS POLICY APPLIES TO ALL 1472 00:56:44,063 --> 00:56:46,733 FUNDED RESEARCH, CONDUCTED AT 1473 00:56:46,733 --> 00:56:48,835 NIH THAT DOES GENERATE 1474 00:56:48,835 --> 00:56:50,403 SCIENTIFIC DATA INCLUDES 1475 00:56:50,403 --> 00:56:51,704 EXTRAMURAL GRANTS, CONTRACTS, 1476 00:56:51,704 --> 00:56:53,306 AND INTRAMURAL RESEARCH PROJECTS 1477 00:56:53,306 --> 00:56:55,641 AS WELL. 1478 00:56:55,641 --> 00:56:56,843 IT DOES NOT INCLUDE ACTIVITIES 1479 00:56:56,843 --> 00:56:59,846 THAT DO NOT GENERATE DATA WHICH 1480 00:56:59,846 --> 00:57:01,214 INCLUDES TRAINING INFRASTRUCTURE 1481 00:57:01,214 --> 00:57:02,315 DEVELOPMENT OR NON-RESEARCH 1482 00:57:02,315 --> 00:57:03,816 ACTIVITIES. 1483 00:57:03,816 --> 00:57:07,053 NOT ONLY FEW SLIDES FROM DR. 1484 00:57:07,053 --> 00:57:09,322 LAWYER NEXT SLIDE JUST QUICKLY 1485 00:57:09,322 --> 00:57:10,523 HIGHLIGHT WHAT ARE SOME OF THE 1486 00:57:10,523 --> 00:57:14,861 KEY PARAMETERS. 1487 00:57:14,861 --> 00:57:16,229 OFFICE OF NIH SUPPORTED 1488 00:57:16,229 --> 00:57:17,663 RESEARCH, GENERATING SCIENTIFIC 1489 00:57:17,663 --> 00:57:20,967 DATA, THIS IS RECORDED FACTUAL 1490 00:57:20,967 --> 00:57:23,569 MATERIALS, THAT WILL BE OF 1491 00:57:23,569 --> 00:57:24,804 SUFFICIENT QUALITY AND ABLE 1492 00:57:24,804 --> 00:57:30,109 REPLICATE RESEARCH FINDING. 1493 00:57:30,109 --> 00:57:32,445 NOTE BOOKS OR CASE REPORTS. 1494 00:57:32,445 --> 00:57:34,347 WHEN SHOULD YOU SHARE YOUR DATA, 1495 00:57:34,347 --> 00:57:35,848 CERTAINLY AS SOON AS REASONABLE 1496 00:57:35,848 --> 00:57:38,751 BUT NO LATER THAN PUBLICATION OR 1497 00:57:38,751 --> 00:57:42,321 END OF YOUR AWARD. 1498 00:57:42,321 --> 00:57:43,723 NEXT SLIDE IS HIGHLIGHT WHAT 1499 00:57:43,723 --> 00:57:46,959 SOME ELEMENTS COULD BE FOR YOUR 1500 00:57:46,959 --> 00:57:47,927 DATA MANAGEMENT SHARING PLAN 1501 00:57:47,927 --> 00:57:50,096 INCLUDING THE DATA TYPES THAT 1502 00:57:50,096 --> 00:57:51,197 YOU INTEND TO PRESERVE AND 1503 00:57:51,197 --> 00:57:51,864 SHARE. 1504 00:57:51,864 --> 00:57:53,666 THE RELATED TOOLS AND SOFTWARE 1505 00:57:53,666 --> 00:57:56,135 CODE NEEDED TO GENERATE AND 1506 00:57:56,135 --> 00:57:58,738 IMPLEMENT THE DATA AND ANY 1507 00:57:58,738 --> 00:57:59,972 NECESSARY STANDARDS, INCLUDING 1508 00:57:59,972 --> 00:58:02,942 MOST IMPORTANT METADATA, THE 1509 00:58:02,942 --> 00:58:04,043 PRESERVATION PLAN HOW DATA WILL 1510 00:58:04,043 --> 00:58:06,846 BE ACCESSED AND TIMELINESS OF 1511 00:58:06,846 --> 00:58:11,250 THAT DATA, AS WELL AS ANY 1512 00:58:11,250 --> 00:58:12,785 REDISTRIBUTION CONSIDERATIONS 1513 00:58:12,785 --> 00:58:14,620 PARTICULARLY FACTORS THAT IMPACT 1514 00:58:14,620 --> 00:58:18,724 ACCESS AND OF COURSE OVERALL 1515 00:58:18,724 --> 00:58:21,060 POOL MANAGE DATA IN THE LAB. 1516 00:58:21,060 --> 00:58:22,595 APPLICANTS WILL BE SUBMITTING 1517 00:58:22,595 --> 00:58:26,332 THIS AS PDF WITH GRANT 1518 00:58:26,332 --> 00:58:27,400 APPLICATION COMPLIANCE WITH DATA 1519 00:58:27,400 --> 00:58:28,434 MANAGEMENT SHARING PLAN IS 1520 00:58:28,434 --> 00:58:31,437 APPROVED BY FUNDING INSTITUTE OR 1521 00:58:31,437 --> 00:58:34,473 CENTER THAT MANAGES THE AWARD. 1522 00:58:34,473 --> 00:58:39,378 THE NEXT SLIDE, THERE IS A LOT 1523 00:58:39,378 --> 00:58:41,347 OF INFORMATION MORE INFORMATION 1524 00:58:41,347 --> 00:58:43,349 BEING EVERY DAY TO OFFICE OF 1525 00:58:43,349 --> 00:58:47,687 EXTRAMURAL RESEARCH SHARING THAT 1526 00:58:47,687 --> 00:58:49,555 NIH.GOV WEBSITE I ENCOURAGE YOU 1527 00:58:49,555 --> 00:58:51,691 TO REVIEW THIS WEBSITE, PRETTY 1528 00:58:51,691 --> 00:58:53,326 MUCH ON REGULAR BASIS, THERE IS 1529 00:58:53,326 --> 00:58:55,127 GOING TO BE A NUMBER OF WEBINARS 1530 00:58:55,127 --> 00:58:58,497 COMING OUT, I KNOW FOR SURE A 1531 00:58:58,497 --> 00:59:00,533 WEBINAR AUGUST 11, THAT WILL 1532 00:59:00,533 --> 00:59:01,367 HELP COMMUNITY UNDERSTAND 1533 00:59:01,367 --> 00:59:03,069 PREPARE FOR THIS POLICY. 1534 00:59:03,069 --> 00:59:05,171 THESE WEBINARS LAB REPORTED, IF 1535 00:59:05,171 --> 00:59:08,774 YOU CAN'T MAKE IT ON AUGUST 11 1536 00:59:08,774 --> 00:59:09,942 THERE LAB REPORTED VIEWING OF 1537 00:59:09,942 --> 00:59:12,144 THAT WEBINAR. 1538 00:59:12,144 --> 00:59:14,380 YOU WILL SEE MORE INFORMATION 1539 00:59:14,380 --> 00:59:18,384 RELEASED ON NIH DATA SHARING 1540 00:59:18,384 --> 00:59:23,089 WEBSITE INCLUDING AN OVERVIEW OF 1541 00:59:23,089 --> 00:59:25,424 THE POLICY, SOME POINTS ON 1542 00:59:25,424 --> 00:59:26,325 CONSIDERATION FOR BUDGETING FOR 1543 00:59:26,325 --> 00:59:28,294 DATA MANAGEMENT AND SHARING 1544 00:59:28,294 --> 00:59:29,195 COSTS, THERE WILL BE GUIDE 1545 00:59:29,195 --> 00:59:31,864 NOTICES ON THE IMPLEMENTATION 1546 00:59:31,864 --> 00:59:33,165 AND IN PARTICULAR PROTECTING 1547 00:59:33,165 --> 00:59:35,067 PRIVACY WHEN SHARING HUMAN 1548 00:59:35,067 --> 00:59:36,936 RELATED PARTICIPANT DATA, AND 1549 00:59:36,936 --> 00:59:39,472 SOME RESPONSIBLE DATA MANAGEMENT 1550 00:59:39,472 --> 00:59:41,340 AND SHARING CONCEPTS WHEN 1551 00:59:41,340 --> 00:59:43,743 CONSIDERING AMERICAN INDIAN 1552 00:59:43,743 --> 00:59:45,044 ALASKA NATIVE PARTICIPANT DATA. 1553 00:59:45,044 --> 00:59:47,580 SO I HOPE YOU WILL CONTINUE TO 1554 00:59:47,580 --> 00:59:49,215 MONITOR THIS WEBSITE, THESE ARE 1555 00:59:49,215 --> 00:59:52,151 VERY IMPACTFUL AND CULTURE 1556 00:59:52,151 --> 00:59:52,852 CHANGING ACTIVITIES IN DATA 1557 00:59:52,852 --> 00:59:55,855 MANAGEMENT DATA SHARING. 1558 00:59:55,855 --> 00:59:58,190 THE NEXT SLIDE WILL HIGHLIGHT 1559 00:59:58,190 --> 01:00:00,960 WHAT WE MY OFFICE IN PARTICULAR 1560 01:00:00,960 --> 01:00:03,796 AND ACROSS NIH CAN DO O TO 1561 01:00:03,796 --> 01:00:05,031 SUPPORT DATA MANAGEMENT AND DATA 1562 01:00:05,031 --> 01:00:06,098 SHARING. 1563 01:00:06,098 --> 01:00:08,434 THAT IS THE POLICY IN LITTLE 1564 01:00:08,434 --> 01:00:12,438 MORE ON IMPLEMENTATION. 1565 01:00:12,438 --> 01:00:14,206 SO I THINK WE ALL RECOGNIZE THAT 1566 01:00:14,206 --> 01:00:18,311 THERE IS NOT GOING TO BE ONE 1567 01:00:18,311 --> 01:00:20,346 SIZE FITS ALL SOLUTION TO 1568 01:00:20,346 --> 01:00:21,414 SHARING DATA. 1569 01:00:21,414 --> 01:00:23,482 RESEARCHERS ACROSS BIOMEDICAL 1570 01:00:23,482 --> 01:00:24,917 ENTERPRISE HAVE DIFFERENT 1571 01:00:24,917 --> 01:00:27,253 EXPECTATIONS AND DIFFERENT 1572 01:00:27,253 --> 01:00:28,254 EXPERIENCES AND THEIR NEEDS FOR 1573 01:00:28,254 --> 01:00:32,258 DATA SHARING. 1574 01:00:32,258 --> 01:00:34,060 NIH INVESTIGATORS CAN SHARE DATA 1575 01:00:34,060 --> 01:00:36,329 AS PART OF THEIR SUPPLEMENTAL 1576 01:00:36,329 --> 01:00:38,097 MATERIAL ASSOCIATED WITH THE 1577 01:00:38,097 --> 01:00:39,865 PUBLICATIONS AND THIS IS SHARED 1578 01:00:39,865 --> 01:00:42,001 VIA PUBMED CENTRAL, ON THE FAR 1579 01:00:42,001 --> 01:00:46,205 LEFT-HAND SIDE OF THE SLIDE. 1580 01:00:46,205 --> 01:00:47,707 PUBMED CENTRAL DATA ASSOCIATED 1581 01:00:47,707 --> 01:00:49,842 WITH PUBLICATIONS IS SHARED 1582 01:00:49,842 --> 01:00:51,377 THROUGH OUR STRIDES PARTNERSHIP 1583 01:00:51,377 --> 01:00:54,246 WITH THE AWS OPEN DATA 1584 01:00:54,246 --> 01:00:55,948 SPONSORSHIP PROGRAMMING, YOU CAN 1585 01:00:55,948 --> 01:00:58,451 FIND THAT DATA THERE AND USE IT. 1586 01:00:58,451 --> 01:01:00,152 INVESTIGATORS CAN ALSO SHARE 1587 01:01:00,152 --> 01:01:01,587 DATA AND OTHER MATERIALS FROM 1588 01:01:01,587 --> 01:01:04,023 THE RESEARCH IN A NUMBER OF 1589 01:01:04,023 --> 01:01:05,791 GENERAL REPOSITORIES SHOWN IN 1590 01:01:05,791 --> 01:01:07,326 CENTER OF THE SLIDE, TALK IN A 1591 01:01:07,326 --> 01:01:09,962 MOMENT ABOUT OUR WORK TO ENHANCE 1592 01:01:09,962 --> 01:01:12,431 DATA SHARING THROUGH GENERALIST 1593 01:01:12,431 --> 01:01:13,632 REPOSITORIES. 1594 01:01:13,632 --> 01:01:15,668 FINALLY, RESEARCHERS CAN PARTNER 1595 01:01:15,668 --> 01:01:17,436 WITH US AND OUR STRIDES PROGRAM, 1596 01:01:17,436 --> 01:01:19,872 THAT IS A PARTNERSHIP AWS GOOGLE 1597 01:01:19,872 --> 01:01:22,942 MICROSOFT ENSURE, DATA CAN BE 1598 01:01:22,942 --> 01:01:24,710 STORED AND MADE ACCESSIBLE ON 1599 01:01:24,710 --> 01:01:25,544 THE STRIDES PLATFORM. 1600 01:01:25,544 --> 01:01:28,748 I WILL TELL YOU A LITTLE LATER 1601 01:01:28,748 --> 01:01:30,950 HOW MUCH DATA NIH IS STORING AND 1602 01:01:30,950 --> 01:01:32,218 SHARING ON OUR THREE CLOUD 1603 01:01:32,218 --> 01:01:34,720 SERVICE PROVIDERS, IT IS 1604 01:01:34,720 --> 01:01:35,388 STAGGERING. 1605 01:01:35,388 --> 01:01:37,690 THIS IS A WELL SUITED PLATFORM. 1606 01:01:37,690 --> 01:01:40,126 WHEN YOU HAVE VERY, VERY LARGE 1607 01:01:40,126 --> 01:01:40,726 DATA SETS. 1608 01:01:40,726 --> 01:01:43,929 THE NEXT SLIDE. 1609 01:01:43,929 --> 01:01:47,433 TALKS ABOUT MAKING DATA MORE 1610 01:01:47,433 --> 01:01:49,535 FAIR FINDABLE ACCESSIBLE AND 1611 01:01:49,535 --> 01:01:51,237 INTEROPERABLE AND REUSABLE AND 1612 01:01:51,237 --> 01:01:52,605 AI READY. 1613 01:01:52,605 --> 01:01:53,773 ENHANCING DATA TO BE FAIR IS 1614 01:01:53,773 --> 01:01:55,674 OFTEN A BIT OF CHALLENGE, 1615 01:01:55,674 --> 01:01:58,444 REQUIRES ENGAGEMENT AND FEEDBACK 1616 01:01:58,444 --> 01:01:59,545 FROM APPLICATION. 1617 01:01:59,545 --> 01:02:03,082 GOING BEYOND FAIR DATA, MAKING 1618 01:02:03,082 --> 01:02:05,184 DATA AI READY, REQUIRES 1619 01:02:05,184 --> 01:02:05,885 REPRESENTATION OF INFORMATION 1620 01:02:05,885 --> 01:02:09,221 METADATA. 1621 01:02:09,221 --> 01:02:11,090 UNDERSTANDING PERSISTENCE OF 1622 01:02:11,090 --> 01:02:13,025 NOISE, UNDERSTANDING UNCERTAINTY 1623 01:02:13,025 --> 01:02:15,895 OF LABELS AND AM OF DATA SO DATA 1624 01:02:15,895 --> 01:02:18,397 TOXICITY AND IMPACT OF 1625 01:02:18,397 --> 01:02:19,065 COMPUTATIONAL MODEL PERFORMANCE. 1626 01:02:19,065 --> 01:02:20,499 WE HAVE RUN A NUMBER OF 1627 01:02:20,499 --> 01:02:22,168 SUPPLEMENTAL PROGRAMS TO BRING 1628 01:02:22,168 --> 01:02:24,670 NIH RESEARCHERS TOGETHER WITH 1629 01:02:24,670 --> 01:02:25,671 RESEARCHERS AND ARTIFICIAL 1630 01:02:25,671 --> 01:02:28,007 INTELLIGENCE MACHINE LEARNING, 1631 01:02:28,007 --> 01:02:30,776 AND DATA SCIENCE TO MAKE NIH 1632 01:02:30,776 --> 01:02:32,111 SUPPORTED DATA FAIR READY SO YOU 1633 01:02:32,111 --> 01:02:33,245 CAN SEE STATISTICS ON THE RIGHT 1634 01:02:33,245 --> 01:02:34,780 HAND SIDE IN TERMS OF NUMBER OF 1635 01:02:34,780 --> 01:02:36,682 AWARDS MADE, THIS PAST YEAR, WE 1636 01:02:36,682 --> 01:02:38,884 WILL BE AWARDING MORE PROGRAMS 1637 01:02:38,884 --> 01:02:41,120 IN FY 22, THIS SUMMER. 1638 01:02:41,120 --> 01:02:42,655 AND I JUST WANT TO HIGHLIGHT ON 1639 01:02:42,655 --> 01:02:46,659 THE NEXT SLIDE, A SNAP SHOT HOW 1640 01:02:46,659 --> 01:02:47,893 RESEARCHERS ARE MAKING DATA MORE 1641 01:02:47,893 --> 01:02:49,428 AI READY SO YOU CAN SEE WHERE 1642 01:02:49,428 --> 01:02:52,965 THE COMMUNITY IS. 1643 01:02:52,965 --> 01:02:54,200 I WOULD LIKE TO CALL A 1644 01:02:54,200 --> 01:03:03,542 PARTICULAR RESEARCHERS DR. MARIA 1645 01:03:03,542 --> 01:03:06,412 VASQUEZ, WORKING FOR ELECTRONIC 1646 01:03:06,412 --> 01:03:07,613 HEALTH DATA FROM HOSPITALS THAT 1647 01:03:07,613 --> 01:03:08,714 ARE SOCIALLY ECONOMICALLY 1648 01:03:08,714 --> 01:03:10,049 DIVERSE POPULATIONS TO USE DATA 1649 01:03:10,049 --> 01:03:12,051 IN MACHINE LEARNING ALGORITHMS 1650 01:03:12,051 --> 01:03:13,586 AND HER GOAL IS TO BETTER 1651 01:03:13,586 --> 01:03:14,820 PREDICT AND UNDERSTAND WHO IS AT 1652 01:03:14,820 --> 01:03:17,456 RISK FOR DEVELOPING SEPSIS THAT 1653 01:03:17,456 --> 01:03:19,658 WOULD BE CAUSED BY MULTI-DRUG 1654 01:03:19,658 --> 01:03:20,926 RESISTANCE MICROBES. 1655 01:03:20,926 --> 01:03:23,896 THAT'S HER INTEREST IS DRUG 1656 01:03:23,896 --> 01:03:25,397 RESISTANCE MICROBES. 1657 01:03:25,397 --> 01:03:26,398 ELECTRONIC HEALTHCARE DATA IS 1658 01:03:26,398 --> 01:03:28,134 TRICKY TO WORK WITH BUT IN 1659 01:03:28,134 --> 01:03:29,535 PARTICULAR FOR UNDER-REPRESENTED 1660 01:03:29,535 --> 01:03:31,270 POPULATIONS IT IS NOTORIOUSLY 1661 01:03:31,270 --> 01:03:32,738 CHALLENGING BECAUSE DATA IS 1662 01:03:32,738 --> 01:03:33,873 SPARSE, THERE IS FAIRLY 1663 01:03:33,873 --> 01:03:37,176 INCONSISTENT METADATA, WITH 1664 01:03:37,176 --> 01:03:38,210 ELECTRONIC HEALTHCARE RECORDS, 1665 01:03:38,210 --> 01:03:40,513 IN FACT THERE IS A LOT OF 1666 01:03:40,513 --> 01:03:42,181 LITERATURE SITING TO THE FACT 1667 01:03:42,181 --> 01:03:44,383 THAT THE DESCRIPTORS INCLUDING 1668 01:03:44,383 --> 01:03:46,919 RACE AND ETHNICITY ARE OFTEN 1669 01:03:46,919 --> 01:03:49,321 MISREPRESENTED IN THE EHR DATA 1670 01:03:49,321 --> 01:03:51,190 FOR UNDER-REPRESENTED 1671 01:03:51,190 --> 01:03:51,991 POPULATIONS SO WORK IS 1672 01:03:51,991 --> 01:03:52,925 IMPACTFUL. 1673 01:03:52,925 --> 01:03:59,331 THE NEXT SLIDE. 1674 01:03:59,331 --> 01:04:00,766 MAKING DATA AI READY BUT IT 1675 01:04:00,766 --> 01:04:02,034 NEEDS TO GO SOMEWHERE. 1676 01:04:02,034 --> 01:04:03,369 WE HAVE BEEN ENHANCING A NUMBER 1677 01:04:03,369 --> 01:04:06,672 OF YEARS, NIH SUPPORTED 1678 01:04:06,672 --> 01:04:09,074 REPOSITORIES TO ALIGN WITH THE 1679 01:04:09,074 --> 01:04:12,378 OSTP DESIRE CHARACTERISTICS FOR 1680 01:04:12,378 --> 01:04:14,113 REPOSITORY THAT INCLUDE 1681 01:04:14,113 --> 01:04:14,914 TRANSPARENCY OF FUNCTION 1682 01:04:14,914 --> 01:04:16,148 RESPONSIBILITY OF DATA 1683 01:04:16,148 --> 01:04:18,350 STEWARDSHIP, USER FOCUSED AND 1684 01:04:18,350 --> 01:04:19,885 COMMUNITY FOCUSED DRIVEN 1685 01:04:19,885 --> 01:04:22,421 CAPABILITIES, SUSTAINABILITY, 1686 01:04:22,421 --> 01:04:25,057 ALIGNMENT AND ATTENTION TO 1687 01:04:25,057 --> 01:04:25,991 TECHNOLOGIES, AND TRUST. 1688 01:04:25,991 --> 01:04:28,260 SO TODAY WE HAVE SUPPORTED 17 1689 01:04:28,260 --> 01:04:29,962 AWARDS AND YOU CAN SEE THEM ON 1690 01:04:29,962 --> 01:04:31,830 THE LEFT-HAND SIDE, I HOPE SOME 1691 01:04:31,830 --> 01:04:33,499 OF THESE ARE FAMILIAR WITH YOU 1692 01:04:33,499 --> 01:04:35,601 AND MANY OF THESE DATA 1693 01:04:35,601 --> 01:04:36,602 REPOSITORIES ARE BECOMING MUCH 1694 01:04:36,602 --> 01:04:41,240 MORE ALIGNED WITH THE OSTTP 1695 01:04:41,240 --> 01:04:41,907 CHARACTERISTICS ARE EXCELLENT 1696 01:04:41,907 --> 01:04:44,176 PLACES TO CONSIDER SHARING DATA. 1697 01:04:44,176 --> 01:04:47,846 NEXT SLIDE. 1698 01:04:47,846 --> 01:04:51,383 WE ALSO HAVE NUMBER OF PROGRAMS 1699 01:04:51,383 --> 01:04:55,020 THAT SUPPORT DATA REPOSITORY AND 1700 01:04:55,020 --> 01:04:56,055 KNOWLEDGE BASES. 1701 01:04:56,055 --> 01:04:58,958 DATA REPOSITORY AND KNOWLEDGE 1702 01:04:58,958 --> 01:05:01,961 BASES ARE THEMSELVES RESOURCES 1703 01:05:01,961 --> 01:05:03,395 AND TYPICALLY THEY HAVE BEEN 1704 01:05:03,395 --> 01:05:05,497 SUPPORTED BY RO1 TYPE GRANTS OR 1705 01:05:05,497 --> 01:05:06,765 OTHER TYPE OF GRANTS. 1706 01:05:06,765 --> 01:05:08,534 SO THIS PROGRAM SUPPORTS THE 1707 01:05:08,534 --> 01:05:10,869 DATA REPOSITORIES AND KNOWLEDGE 1708 01:05:10,869 --> 01:05:12,972 BASE AS BIOMEDICAL DATA 1709 01:05:12,972 --> 01:05:14,974 RESOURCES WITH THEIR OWN FUNDING 1710 01:05:14,974 --> 01:05:16,642 MECHANISM AND A SPECIAL EMPHASIS 1711 01:05:16,642 --> 01:05:18,510 PANEL THAT IS OVERSEEN BY THE 1712 01:05:18,510 --> 01:05:21,981 CENTER FOR SCIENTIFIC REVIEW. 1713 01:05:21,981 --> 01:05:23,549 THIS PROGRAM REQUIRES THAT NIH 1714 01:05:23,549 --> 01:05:25,317 DATA REPOSITORY AND KNOWLEDGE 1715 01:05:25,317 --> 01:05:30,889 BASE APPLICANTS SUPPORT A 1716 01:05:30,889 --> 01:05:32,625 PARTICULAR NIH IC MISSION AND 1717 01:05:32,625 --> 01:05:33,292 SUPPORT DATA MANAGEMENT AND 1718 01:05:33,292 --> 01:05:34,426 SHARING WITH DEMONSTRATED 1719 01:05:34,426 --> 01:05:35,628 SCIENTIFIC IMPACT WITHIN THE 1720 01:05:35,628 --> 01:05:37,196 COMMUNITY. 1721 01:05:37,196 --> 01:05:38,330 APPLICANTS NEED TO ADDRESS THE 1722 01:05:38,330 --> 01:05:42,268 QUALITY OF THE DATA SERVICES AS 1723 01:05:42,268 --> 01:05:43,836 WELL AS METHODS TO INCREASE 1724 01:05:43,836 --> 01:05:44,737 EFFICIENCY OF OPERATION. 1725 01:05:44,737 --> 01:05:49,041 SUCH AS FOR EXAMPLE, AUTOMATED 1726 01:05:49,041 --> 01:05:51,543 CAPABILITY FOR CURATION, QUALITY 1727 01:05:51,543 --> 01:05:53,445 ASSURANCE AND QUALITY CONTROL OR 1728 01:05:53,445 --> 01:05:56,548 ALSO CONSIDER LEVERAGING STRIDES 1729 01:05:56,548 --> 01:05:58,417 IN OUR CLOUD INFRASTRUCTURE. 1730 01:05:58,417 --> 01:06:01,153 APPLICANTS NEED TO ENGAGE WITH 1731 01:06:01,153 --> 01:06:04,723 SCIENTIFIC COMMUNITY AND WITH 1732 01:06:04,723 --> 01:06:05,357 THE SCIENCE JOURNALS THAT ALIGN 1733 01:06:05,357 --> 01:06:06,125 WITH FOCUS. 1734 01:06:06,125 --> 01:06:07,793 WE DO WANT COMMUNITY JOURNAL 1735 01:06:07,793 --> 01:06:08,560 ENGAGEMENT WITH THESE 1736 01:06:08,560 --> 01:06:09,061 APPLICATIONS. 1737 01:06:09,061 --> 01:06:11,597 AS WELL AS ESTABLISHING THE 1738 01:06:11,597 --> 01:06:12,631 TRANSPARENCY OF GOVERNANCE. 1739 01:06:12,631 --> 01:06:14,533 WE ARE ENCOURAGING GOOD DATA 1740 01:06:14,533 --> 01:06:15,968 MANAGEMENT PRACTICES AND DATA 1741 01:06:15,968 --> 01:06:18,070 LIFE CYCLE PRACTICES. 1742 01:06:18,070 --> 01:06:20,673 AS WELL AS NEW THIS YEAR 1743 01:06:20,673 --> 01:06:22,107 DEVELOPING METRICS THAT CAN BE 1744 01:06:22,107 --> 01:06:24,343 SHARED OPENLY FOR USE AND 1745 01:06:24,343 --> 01:06:25,944 UTILITY OF DATA REPOSITORIES. 1746 01:06:25,944 --> 01:06:29,248 YOU CAN SEE JUST A FEW EXAMPLES 1747 01:06:29,248 --> 01:06:30,883 OF NUMBER OF APPLICATIONS THAT 1748 01:06:30,883 --> 01:06:32,518 WERE FUNDED THIS PAST YEAR. 1749 01:06:32,518 --> 01:06:34,286 AND I THINK PERHAPS MAYBE SOME 1750 01:06:34,286 --> 01:06:38,557 OF YOU MIGHT BE FAMILIAR WITH IC 1751 01:06:38,557 --> 01:06:39,458 TV. 1752 01:06:39,458 --> 01:06:42,528 THESE ARE FAIRLY WELL DEVELOPED 1753 01:06:42,528 --> 01:06:44,563 REPOSITORY AND KNOWLEDGE BASES. 1754 01:06:44,563 --> 01:06:45,664 THIS PROGRAM WILL CONTINUE FOR 1755 01:06:45,664 --> 01:06:48,233 THE NEXT THREE YEARS AND PERHAPS 1756 01:06:48,233 --> 01:06:50,202 SHIFT A LITTLE BIT TO ALSO 1757 01:06:50,202 --> 01:06:52,104 INCLUDE NOT JUST WELL 1758 01:06:52,104 --> 01:06:54,106 ESTABLISHED DATA REPOSITORIES 1759 01:06:54,106 --> 01:06:56,542 AND KNOWLEDGE BASE BUT NEWLY 1760 01:06:56,542 --> 01:06:57,576 EMERGING DATA KNOWLEDGE BASES 1761 01:06:57,576 --> 01:07:01,747 AND REPOSITORIES. 1762 01:07:01,747 --> 01:07:03,749 NEXT SLIDE IN ADDITION TO ALL OF 1763 01:07:03,749 --> 01:07:06,051 THOSE GREAT DOMAIN SPECIFIC 1764 01:07:06,051 --> 01:07:08,153 REPOSITORY, WE DO ENCOURAGE YOU 1765 01:07:08,153 --> 01:07:10,923 TO EXPLORE DOMAIN SPECIFIC 1766 01:07:10,923 --> 01:07:12,024 REPOSITORIES AS A FIRST STANCE 1767 01:07:12,024 --> 01:07:13,392 FOR SHARING DATA. 1768 01:07:13,392 --> 01:07:15,694 THERE ARE NUMBER OF GENERAL 1769 01:07:15,694 --> 01:07:16,829 REPOSITORIES THAT OFFER 1770 01:07:16,829 --> 01:07:19,031 ADDITIONAL CAPABILITIES TO SHARE 1771 01:07:19,031 --> 01:07:20,999 DATA AND SCIENTIFIC DIGITAL 1772 01:07:20,999 --> 01:07:22,534 PRODUCTS THAT ARE A RESULT OF 1773 01:07:22,534 --> 01:07:23,836 THEIR RESEARCH. 1774 01:07:23,836 --> 01:07:26,038 WE JUST RECENTLY LAUNCHED THE 1775 01:07:26,038 --> 01:07:27,272 PROGRAM THIS YEAR, THE 1776 01:07:27,272 --> 01:07:29,675 GENERALIST REPOSITORY ECOSYSTEM 1777 01:07:29,675 --> 01:07:31,777 INITIATIVE TO SUPPORT A 1778 01:07:31,777 --> 01:07:32,978 COLLABORATION BETWEEN THE SIX 1779 01:07:32,978 --> 01:07:34,313 GENERALIST REPOSITORIES YOU SEE 1780 01:07:34,313 --> 01:07:36,081 LISTED ON THE BOTTOM OF THE 1781 01:07:36,081 --> 01:07:37,783 SLIDE AND AND I WILL NOTE WE ARE 1782 01:07:37,783 --> 01:07:39,885 WORKING WITH 7TH GENERALIST 1783 01:07:39,885 --> 01:07:40,753 REPOSITORY TO ADD TO OUR 1784 01:07:40,753 --> 01:07:42,721 PORTFOLIO. 1785 01:07:42,721 --> 01:07:43,489 WHAT ARE OUR GOALS? 1786 01:07:43,489 --> 01:07:45,591 WE WANTS TO MAKE EASIER FOR 1787 01:07:45,591 --> 01:07:48,460 RESEARCHERS TO SHARE DATA FUNDED 1788 01:07:48,460 --> 01:07:50,028 BY NIH AND COMPLY WITH OUR DATA 1789 01:07:50,028 --> 01:07:51,930 MANAGEMENT AND SHARING POLICY. 1790 01:07:51,930 --> 01:07:53,365 WE ALSO WANT TO MAKE IT EASIER 1791 01:07:53,365 --> 01:07:55,367 FOR RESEARCHERS TO FINDS NIH 1792 01:07:55,367 --> 01:07:56,835 SUPPORTED DATA ACROSS THESE 1793 01:07:56,835 --> 01:07:58,404 REPOSITORIES. 1794 01:07:58,404 --> 01:08:01,073 OF COURSE WE WANT TO ENHANCE 1795 01:08:01,073 --> 01:08:03,375 RIGOR AND REPRODUCIBILITY AND 1796 01:08:03,375 --> 01:08:04,476 DEVELOP SHARE SET OF CORE 1797 01:08:04,476 --> 01:08:05,878 METRICS ACROSS REPOSITORY. 1798 01:08:05,878 --> 01:08:07,312 THIS IS FOR US A REALLY 1799 01:08:07,312 --> 01:08:09,848 IMPORTANT KEY CONCEPT IS 1800 01:08:09,848 --> 01:08:11,150 AGREEING ON CORE METRICS THAT 1801 01:08:11,150 --> 01:08:13,152 ENHANCE THE USER AND USABILITY 1802 01:08:13,152 --> 01:08:16,722 OF THESE REPOSITORIES. 1803 01:08:16,722 --> 01:08:19,191 AS WELL AS CORE METADATA. 1804 01:08:19,191 --> 01:08:22,261 WE DO WANT TO ENHANCE 1805 01:08:22,261 --> 01:08:23,829 DISCOVERABILITY AND AGREE UPON 1806 01:08:23,829 --> 01:08:25,364 SET OF CORE METADATA THAT 1807 01:08:25,364 --> 01:08:27,566 DESCRIBES OUR DATA ACROSS SIX 1808 01:08:27,566 --> 01:08:29,001 REPOSITORIES, SO THEN WE CAN 1809 01:08:29,001 --> 01:08:30,502 ACTUALLY HELP RESEARCHERS FIND 1810 01:08:30,502 --> 01:08:31,737 THE DATA. 1811 01:08:31,737 --> 01:08:33,305 THEN WE WANTS TO ENCOURAGE A 1812 01:08:33,305 --> 01:08:36,308 SECONDARY REUSE OF DATA. 1813 01:08:36,308 --> 01:08:38,243 SUPER PLEASED TO BE WORKING WITH 1814 01:08:38,243 --> 01:08:40,746 EACH OF SIX NOW ADDING A 7TH 1815 01:08:40,746 --> 01:08:41,547 GENERALIST REPOSITORY. 1816 01:08:41,547 --> 01:08:42,648 I THINK THAT THE WORK THAT WE 1817 01:08:42,648 --> 01:08:44,316 ARE DOING HERE WILL IMPACT MANY 1818 01:08:44,316 --> 01:08:46,785 OF OUR DOMAIN SPECIFIC 1819 01:08:46,785 --> 01:08:47,386 REPOSITORIES. 1820 01:08:47,386 --> 01:08:48,620 WE ARE STARTING WITH OUR 1821 01:08:48,620 --> 01:08:50,389 GENERALIST REPOSITORIES AND SOME 1822 01:08:50,389 --> 01:08:54,259 OF THESE KEY CAPABILITIES. 1823 01:08:54,259 --> 01:08:56,895 THE NEXT SLIDE THIS IS A LITTLE 1824 01:08:56,895 --> 01:08:58,230 OUT OF THE BOX FOR DATA SHARING, 1825 01:08:58,230 --> 01:09:00,766 THIS IS A PARTNERSHIP WITH 1826 01:09:00,766 --> 01:09:01,366 FASEB. 1827 01:09:01,366 --> 01:09:03,001 THE FEDERATION OF AMERICAN 1828 01:09:03,001 --> 01:09:05,871 SOCIETIES FOR EXPERIMENTAL 1829 01:09:05,871 --> 01:09:07,306 BIOLOGY, WE ARE CREATING A NEW 1830 01:09:07,306 --> 01:09:09,308 DATA WORKS CHALLENGE. 1831 01:09:09,308 --> 01:09:11,210 THIS PRIZE FUELS CONCEPT OF DATA 1832 01:09:11,210 --> 01:09:13,946 SHARING AND REUSE, BY PROVIDING 1833 01:09:13,946 --> 01:09:15,714 AN ANNUAL CHALLENGE THAT 1834 01:09:15,714 --> 01:09:17,149 SHOWCASES BENEFITS OF RESEARCH 1835 01:09:17,149 --> 01:09:19,384 DATA MANAGEMENT AND SHARING, AND 1836 01:09:19,384 --> 01:09:20,652 REWARDING TEAMS WHO DEMONSTRATE 1837 01:09:20,652 --> 01:09:22,187 THE POWER OF DATA SHARING 1838 01:09:22,187 --> 01:09:24,857 THROUGH PRACTICES TO ADVANCE 1839 01:09:24,857 --> 01:09:27,626 SCIENTIFIC HEALTH AND DISCOVERY. 1840 01:09:27,626 --> 01:09:29,261 WE ARE SEEKING NEW INNOVATIVE 1841 01:09:29,261 --> 01:09:32,264 APPROACHES TO DATA SHARING. 1842 01:09:32,264 --> 01:09:36,001 WE ANTICIPATE 12 MONETARY PRIZES 1843 01:09:36,001 --> 01:09:37,903 FOR TOTAL CASH PRIZE PURSE OF 1844 01:09:37,903 --> 01:09:40,873 $500,000. 1845 01:09:40,873 --> 01:09:42,774 THE REGISTRATION CLOSES NEXT 1846 01:09:42,774 --> 01:09:45,410 WEEK ON JUNE 28, THIS IS A TEAM 1847 01:09:45,410 --> 01:09:47,312 PRIZE SO TEAMS COME TOGETHER, 1848 01:09:47,312 --> 01:09:49,381 THEY DESCRIBE HOW THEY 1849 01:09:49,381 --> 01:09:51,149 IMPACTFULLY SHARE OR REUSE DATA 1850 01:09:51,149 --> 01:09:56,989 SO IT IS A STORY BASE PRIZE THAT 1851 01:09:56,989 --> 01:09:58,957 IS -- WILL BE CLOSE ON JULY 19. 1852 01:09:58,957 --> 01:10:00,425 SO I HOPE THAT YOU WILL EXPLORE 1853 01:10:00,425 --> 01:10:02,294 THIS A LITTLE BIT MORE, IT IS A 1854 01:10:02,294 --> 01:10:04,162 FAIRLY OUT OF THE BOX KIND OF 1855 01:10:04,162 --> 01:10:06,899 DATA PRIZE BUT I THINK IT WILL 1856 01:10:06,899 --> 01:10:08,333 ENCOURAGE TO THINK ABOUT DATA 1857 01:10:08,333 --> 01:10:11,370 SHARING AND PERHAPS EVEN ENTICE 1858 01:10:11,370 --> 01:10:12,271 RESEARCHERS TO DEVELOP 1859 01:10:12,271 --> 01:10:14,039 REYEAHTIVE DATA MANAGEMENT 1860 01:10:14,039 --> 01:10:15,474 SHARING PLANS -- CREATIVE DATA 1861 01:10:15,474 --> 01:10:17,509 MANAGEMENT SHARING PLANS. 1862 01:10:17,509 --> 01:10:18,510 NEXT SLIDE THAT THERE ARE MANY 1863 01:10:18,510 --> 01:10:19,411 WAYS TO SHARE DATA. 1864 01:10:19,411 --> 01:10:21,179 YOU CAN SHARE DATA THROUGH 1865 01:10:21,179 --> 01:10:25,884 PUBMED CENTER, SUPPLEMENT TO 1866 01:10:25,884 --> 01:10:26,685 PUBLICATION. 1867 01:10:26,685 --> 01:10:29,888 SHARE DATA IN DOMAIN SPECIFIC 1868 01:10:29,888 --> 01:10:33,725 REPOSITORY OR THIRDLY, YOU CAN 1869 01:10:33,725 --> 01:10:35,427 SHARE DATA ON THE CLOUD. 1870 01:10:35,427 --> 01:10:38,597 SO WE HAVE PARTNERED WITH AWS 1871 01:10:38,597 --> 01:10:42,568 GOOGLE MICROSOFT AZURE THROUGH 1872 01:10:42,568 --> 01:10:44,503 HOUR STRIDES PROGRAM FORGOT WHAT 1873 01:10:44,503 --> 01:10:46,805 STRIDES STANDS FOR, IT IS LIKE 1874 01:10:46,805 --> 01:10:47,506 -- SHOOT. 1875 01:10:47,506 --> 01:10:49,441 TOTALLY FORGOTTEN. 1876 01:10:49,441 --> 01:10:50,943 SORRY ABOUT THAT. 1877 01:10:50,943 --> 01:10:53,545 TO PROVIDE DISCOUNTS ON CLOUD 1878 01:10:53,545 --> 01:10:54,646 STORAGE AND CLOUD COMPUTE 1879 01:10:54,646 --> 01:10:56,949 PROFESSIONAL SERVICES AND 1880 01:10:56,949 --> 01:10:59,051 TRAINING COLLABORATIVE 1881 01:10:59,051 --> 01:10:59,718 ENGAGEMENTS. 1882 01:10:59,718 --> 01:11:00,819 SO YOU CAN SEE SOME OF THE 1883 01:11:00,819 --> 01:11:01,920 STATISTICS ON THE RIGHT HAND 1884 01:11:01,920 --> 01:11:03,589 SIDE OF THE SLIDE IN TERMS OF 1885 01:11:03,589 --> 01:11:05,691 WHAT STRIDES HAS DONE SINCE 1886 01:11:05,691 --> 01:11:08,360 INCEPTION IN 2018. 1887 01:11:08,360 --> 01:11:11,463 THUS FAR TODAY WE HAVE 173 1888 01:11:11,463 --> 01:11:13,432 PEDABYTES OF DATA ACROSS THREE 1889 01:11:13,432 --> 01:11:15,467 CLOUD SERVICE PROVIDERS. 1890 01:11:15,467 --> 01:11:17,903 50 PEDABYTES GENOMIC DATA 1891 01:11:17,903 --> 01:11:20,072 SEQUENCES OF RATS, COWS BIRDS 1892 01:11:20,072 --> 01:11:22,207 CHICKENS AND HUMANS. 1893 01:11:22,207 --> 01:11:24,176 SO 173 PEDABYTES OF DATA IS 1894 01:11:24,176 --> 01:11:27,179 EQUIVALENT TO BASICALLY ALL THE 1895 01:11:27,179 --> 01:11:28,547 PRINTED MATERIAL EVER DONE, SO 1896 01:11:28,547 --> 01:11:30,249 IT IS IN VERY, VERY LARGE AMOUNT 1897 01:11:30,249 --> 01:11:32,918 OF DATA. 1898 01:11:32,918 --> 01:11:34,886 MANAGING -- THANK YOU SO MUCH, 1899 01:11:34,886 --> 01:11:35,087 ROHAN. 1900 01:11:35,087 --> 01:11:36,855 I CANNOT BELIEVE I FORGOT WHAT 1901 01:11:36,855 --> 01:11:37,856 IT STOOD FOR. 1902 01:11:37,856 --> 01:11:40,058 MANAGING SEARCHING STORING, THIS 1903 01:11:40,058 --> 01:11:42,561 AMOUNT OF DATA ACROSS DIFFICULT 1904 01:11:42,561 --> 01:11:43,762 WHICH YOU HAVE HAD PROVIDERS IS 1905 01:11:43,762 --> 01:11:46,231 REALLY NOT TRIVIAL AND PRODUCES 1906 01:11:46,231 --> 01:11:47,866 AN INTERESTING CHALLENGES ON 1907 01:11:47,866 --> 01:11:53,038 DATA AND COMPUTATIONAL SCIENCE. 1908 01:11:53,038 --> 01:11:54,940 WE ARE WORKING ON HOW THE USAGE 1909 01:11:54,940 --> 01:11:56,475 OF PEDABYTES SEQUENCE DATA TO 1910 01:11:56,475 --> 01:11:59,311 FUND PARTICULAR SEQUENCES 1911 01:11:59,311 --> 01:12:00,979 INTERESTED TO RESEARCH FOR 1912 01:12:00,979 --> 01:12:02,047 EVOLUTIONARY BIOLOGY. 1913 01:12:02,047 --> 01:12:04,016 SO REALLY COMPELLING AND NOT 1914 01:12:04,016 --> 01:12:14,259 EASY CHALLENGE. 1915 01:12:14,259 --> 01:12:15,794 IT WILL BE HARD FOR RESEARCH 1916 01:12:15,794 --> 01:12:18,263 GROUPS WE WORK WITH ACROSS NIH 1917 01:12:18,263 --> 01:12:20,032 AND FUND TO UTILIZE CLOUD FOR 1918 01:12:20,032 --> 01:12:20,632 DATA ANALYSIS. 1919 01:12:20,632 --> 01:12:21,933 IT IS NOT ALWAYS STRAIGHT 1920 01:12:21,933 --> 01:12:23,168 FORWARD AS ONE WOULD HOPE AND 1921 01:12:23,168 --> 01:12:27,272 THERE IS CERTAINLY CONCERNS BY 1922 01:12:27,272 --> 01:12:28,707 RESEARCHERS ABOUT COST OF CLOUD 1923 01:12:28,707 --> 01:12:31,443 COMPUTER, PERSISTENCE OF 1924 01:12:31,443 --> 01:12:32,678 CAPABILITIES AS GRANT CYCLES ARE 1925 01:12:32,678 --> 01:12:35,580 CYCLIC AND UTILITY, IS THE JUICE 1926 01:12:35,580 --> 01:12:37,916 WORTH THE SQUEEZE. 1927 01:12:37,916 --> 01:12:41,353 TO HELP ADDRESS ISSUES WE STOOD 1928 01:12:41,353 --> 01:12:43,555 UP CLOUD TO HELP RESEARCHERS 1929 01:12:43,555 --> 01:12:45,223 GAIN FAMILIARITY WITH CLOUD AND 1930 01:12:45,223 --> 01:12:47,125 SAND BOX LIKE APPROACH THAT 1931 01:12:47,125 --> 01:12:49,661 PROVIDES CLOUD CREDITS, ABOUT 1932 01:12:49,661 --> 01:12:51,630 $500 WHICH IS ENOUGH TO DO A 1933 01:12:51,630 --> 01:12:55,867 LARGE ANALYTIC PIPELINE TOOL. 1934 01:12:55,867 --> 01:12:57,035 AND PROVIDE TOOLS FOR 1935 01:12:57,035 --> 01:12:57,636 RESEARCHERS. 1936 01:12:57,636 --> 01:12:59,371 WHAT RESEARCHERS CAN DO IS THEY 1937 01:12:59,371 --> 01:13:02,708 CAN EXPERIMENT ON THE CLOUD WITH 1938 01:13:02,708 --> 01:13:04,443 SPECIFIC TASKS, SOME CANNED 1939 01:13:04,443 --> 01:13:05,711 APPLICATIONS YOU CAN BRING YOUR 1940 01:13:05,711 --> 01:13:07,279 OWN APPLICATION. 1941 01:13:07,279 --> 01:13:08,280 YOU CAN BUILD OUT PROOF OF 1942 01:13:08,280 --> 01:13:09,281 CONCEPT SOLUTIONS AND TEST THEM 1943 01:13:09,281 --> 01:13:11,416 IN A CLOUD IN A WAY THAT DOESN'T 1944 01:13:11,416 --> 01:13:14,553 COST MONEY SO IT IS A SAND BOX. 1945 01:13:14,553 --> 01:13:17,789 IF YOU ARE AN EXPERT DEVELOPER 1946 01:13:17,789 --> 01:13:21,193 YOU CAN BENCHMARK TOOLS WITH 1947 01:13:21,193 --> 01:13:22,994 CONFIGURATION, DIFFERENT CPUs, 1948 01:13:22,994 --> 01:13:25,797 CHIP ARCHITECTURES IN THE CLOUD 1949 01:13:25,797 --> 01:13:27,366 AND BENCH MARK COST AND 1950 01:13:27,366 --> 01:13:29,267 HOPEFULLY OPTIMIZE PARTICULAR 1951 01:13:29,267 --> 01:13:29,935 INFRASTRUCTURE ON YOUR 1952 01:13:29,935 --> 01:13:32,671 PARTICULAR CLOUD SERVICE 1953 01:13:32,671 --> 01:13:35,307 PROVIDER TO ADDRESS YOUR 1954 01:13:35,307 --> 01:13:37,676 ANALYTIC METHODS AN GOALS. 1955 01:13:37,676 --> 01:13:39,678 I THINK WE HAVE BEEN DOING A 1956 01:13:39,678 --> 01:13:41,046 RELEASE FROM INTRAMURAL RESEARCH 1957 01:13:41,046 --> 01:13:42,914 PROGRAM AND I THINK WE ARE ALSO 1958 01:13:42,914 --> 01:13:44,583 STARTING TO ENGAGE THE 1959 01:13:44,583 --> 01:13:48,420 EXTRAMURAL RESEARCH PROGRAM. 1960 01:13:48,420 --> 01:13:51,623 NEXT SLIDE IS SAID THAT IF DATA 1961 01:13:51,623 --> 01:13:53,392 IS THE NEW OIL AND SOFTWARE IS 1962 01:13:53,392 --> 01:13:54,893 REFINERY SO I WANT TO TELL YOU 1963 01:13:54,893 --> 01:13:57,028 SOME OF THE THINGS THAT WE ARE 1964 01:13:57,028 --> 01:13:59,131 DOING IN SOFTWARE ENHANCEMENT 1965 01:13:59,131 --> 01:14:01,032 STARTING WITH OUR PARTNERSHIP 1966 01:14:01,032 --> 01:14:02,334 WITH NSF. 1967 01:14:02,334 --> 01:14:04,903 WE HAVE A VERY LONG STANDING 1968 01:14:04,903 --> 01:14:06,638 PARTNERSHIP WITH THE COMPUTER 1969 01:14:06,638 --> 01:14:08,840 SCIENCE DIRECTOR NSF TO BRING 1970 01:14:08,840 --> 01:14:10,075 COMPUTER SCIENTISTS TOGETHER 1971 01:14:10,075 --> 01:14:15,981 WITH BIOMEDICAL RESEARCHERS TO 1972 01:14:15,981 --> 01:14:17,749 ACCELERATERY SEARCH IN AND 1973 01:14:17,749 --> 01:14:19,017 SUPPORT -- RESEARCH IN AND 1974 01:14:19,017 --> 01:14:20,519 SUPPORT CAPABILITIES FOR 1975 01:14:20,519 --> 01:14:20,919 MEDICINE. 1976 01:14:20,919 --> 01:14:22,788 I WILL SHOW YOU THE NEXT SLIDE 1977 01:14:22,788 --> 01:14:25,924 WHICH IS SOME STATISTICS. 1978 01:14:25,924 --> 01:14:27,559 ALL THE INSTITUTES AND CENTERS 1979 01:14:27,559 --> 01:14:29,461 PARTNER WITH US ON SMART 1980 01:14:29,461 --> 01:14:30,195 CONNECTED HEALTH AND HERE YOU 1981 01:14:30,195 --> 01:14:32,964 CAN SEE THE NUMBER OF AWARDS 1982 01:14:32,964 --> 01:14:34,866 ACROSS THE NIH IN TERMS OF THE 1983 01:14:34,866 --> 01:14:35,867 INSTITUTES THAT HAVE RECEIVED 1984 01:14:35,867 --> 01:14:38,837 THESE AWARDS AND IT IS NOT 1985 01:14:38,837 --> 01:14:41,940 SURPRISING THAT OUR INSTITUTE 1986 01:14:41,940 --> 01:14:44,709 NIBIB BIOMEDICAL ENGINEERING AND 1987 01:14:44,709 --> 01:14:46,478 IMAGING RECEIVED LARGEST NUMBER 1988 01:14:46,478 --> 01:14:48,146 BECAUSE THE PROGRAM STARTED OUT 1989 01:14:48,146 --> 01:14:50,348 AS A DEVICE FOCUSED PROGRAM 1990 01:14:50,348 --> 01:14:52,083 SMART CONNECTED DEVICES AND 1991 01:14:52,083 --> 01:14:54,252 EXTENDING NOW INTO DATA SCIENCE 1992 01:14:54,252 --> 01:14:56,388 AND ARTIFICIAL INTELLIGENCE SO 1993 01:14:56,388 --> 01:14:58,023 ONE MORE CLIP WILL SHOW YOU 1994 01:14:58,023 --> 01:15:00,792 DOMAIN SPECIFIC AREAS, SENSING 1995 01:15:00,792 --> 01:15:02,260 WEARABLES ROBOTICS IS A LONG 1996 01:15:02,260 --> 01:15:03,929 STANDING PART OF THIS PROGRAM. 1997 01:15:03,929 --> 01:15:06,364 LAST YEAR WE ADDED ARTIFICIAL 1998 01:15:06,364 --> 01:15:08,600 INTELLIGENCE IMAGING ELECTRONIC 1999 01:15:08,600 --> 01:15:11,002 HEALTHCARE AND EHR TYPE OF 2000 01:15:11,002 --> 01:15:11,636 APPLICATION. 2001 01:15:11,636 --> 01:15:13,672 THEN YOU CAN SEE IN THE LAST 2002 01:15:13,672 --> 01:15:15,006 COMPONENT HERE THE TYPES OF 2003 01:15:15,006 --> 01:15:16,441 DISEASES THAT PEOPLE ARE 2004 01:15:16,441 --> 01:15:18,109 INTERESTED IN RESEARCH, THIS IS 2005 01:15:18,109 --> 01:15:19,845 AN INVESTIGATOR INITIATED 2006 01:15:19,845 --> 01:15:21,513 PROGRAM, RESEARCHERS DO COME 2007 01:15:21,513 --> 01:15:24,583 INTO NSF, THIS IS AN NSF LED 2008 01:15:24,583 --> 01:15:29,855 PROGRAM APPLICATIONS ARE NSN AND 2009 01:15:29,855 --> 01:15:32,524 PANELS BUT NIH CSR APPLICATIONS 2010 01:15:32,524 --> 01:15:35,293 ARE PRESENT, APPLICATION FUND 2011 01:15:35,293 --> 01:15:37,095 FUNDED BY NSF OR NIH. 2012 01:15:37,095 --> 01:15:37,462 . 2013 01:15:37,462 --> 01:15:39,331 APPLICATIONS THAT COME TO NIH 2014 01:15:39,331 --> 01:15:40,999 ARE BROUGHT IN BY CSR. 2015 01:15:40,999 --> 01:15:42,534 YOU DON'T GO THROUGH ANOTHER 2016 01:15:42,534 --> 01:15:45,170 REVIEW, THE SUMMARY FROM NSF IS 2017 01:15:45,170 --> 01:15:48,006 PORTED TO CSR AND APPLICATIONS 2018 01:15:48,006 --> 01:15:49,241 ARE DIRECTLY FUNDED FROM 2019 01:15:49,241 --> 01:15:54,045 INSTITUTES THAT CO-FUNDED BY MY 2020 01:15:54,045 --> 01:15:56,548 OFFICE. 2021 01:15:56,548 --> 01:16:00,218 NEXT SLIDE IT IS HARD FOR 2022 01:16:00,218 --> 01:16:02,120 RESEARCHERS TO DEVELOP SOFTWARE 2023 01:16:02,120 --> 01:16:04,623 TO ADD IN THAT THIRDING FROM 2024 01:16:04,623 --> 01:16:06,858 ENHANCING SOFTWARE TOOLS, TO 2025 01:16:06,858 --> 01:16:08,627 REACH BROADER AUDIENCES TO ADAPT 2026 01:16:08,627 --> 01:16:10,528 TO NEW HIGH THROUGH PUT 2027 01:16:10,528 --> 01:16:12,497 COMPUTING ENVIRONMENTS LIKE 2028 01:16:12,497 --> 01:16:14,165 CLOUD OR BRING ON NEW SOFTWARE 2029 01:16:14,165 --> 01:16:16,134 ENGINEERS AS COLLABORATORS. 2030 01:16:16,134 --> 01:16:18,470 THIS IS A SUPPLEMENTAL PROGRAM 2031 01:16:18,470 --> 01:16:21,439 TO SUPPORT EXISTING NIH 2032 01:16:21,439 --> 01:16:24,342 RESEARCHERS TO ENHANCE SOFTWARE, 2033 01:16:24,342 --> 01:16:26,211 TO REALLY BRING IN THOSE 2034 01:16:26,211 --> 01:16:29,881 SOFTWARE ENGINEERS TO PORT 2035 01:16:29,881 --> 01:16:32,817 SOFTWARE TO LARGER AUDIENCE AND 2036 01:16:32,817 --> 01:16:34,619 EXPLORE CLOUD COMPUTING OR HIGH 2037 01:16:34,619 --> 01:16:39,557 PERFORMANCE COMPUTING. 2038 01:16:39,557 --> 01:16:40,425 NEXT ILLUSTRATES AWARDEES SO YOU 2039 01:16:40,425 --> 01:16:44,396 CAN SEE WHAT RESEARCHERS ARE 2040 01:16:44,396 --> 01:16:45,664 DOING WHO ARE SUPPLEMENTED TO 2041 01:16:45,664 --> 01:16:45,997 THIS PROGRAM. 2042 01:16:45,997 --> 01:16:49,134 I WANT TO HIGHLIGHT DR. CONNIE 2043 01:16:49,134 --> 01:16:56,341 SELUM PROFESSOR OF GLOBAL HEALTH 2044 01:16:56,341 --> 01:16:58,009 PROFESSOR MEDICINE ALLERGY 2045 01:16:58,009 --> 01:16:59,711 DISEASES, PROFESSOR EPIDEMIOLOGY 2046 01:16:59,711 --> 01:17:01,780 AND COLLABORATOR DR. JAMES 2047 01:17:01,780 --> 01:17:02,781 MULLINS, PROFESSOR OF 2048 01:17:02,781 --> 01:17:03,882 MICROBIOLOGY. 2049 01:17:03,882 --> 01:17:07,285 THIS PROGRAM SUPPLEMENTED THEIR 2050 01:17:07,285 --> 01:17:08,720 WORK ON THE LABORATORY 2051 01:17:08,720 --> 01:17:10,055 INFORMATION MANAGEMENT SYSTEM 2052 01:17:10,055 --> 01:17:13,458 CALLED BIOVERSE, A PLATFORM THAT 2053 01:17:13,458 --> 01:17:16,528 HELPS COLLECTS STORES, RETRIEVAL 2054 01:17:16,528 --> 01:17:18,196 ANALYSIS OF SAMPLES A LOT OF 2055 01:17:18,196 --> 01:17:20,899 GENOMICS SAMPLES IN BIO VERSE AS 2056 01:17:20,899 --> 01:17:26,404 WELL AS OTHER TYPES OF DATA SUCH 2057 01:17:26,404 --> 01:17:27,872 AS IMAGE AND CLINICAL DATA SO, 2058 01:17:27,872 --> 01:17:30,542 THIS IS TO ENHANCE USABILITY OF 2059 01:17:30,542 --> 01:17:31,676 BIOVERSE IN SOUTH AFRICA 2060 01:17:31,676 --> 01:17:33,111 PARTICULARLY AND ALSO INCLUDES 2061 01:17:33,111 --> 01:17:35,080 TRAINING ANED YOU REACH WITH 2062 01:17:35,080 --> 01:17:36,348 SOUTH AFTER CAN STUDENTS. 2063 01:17:36,348 --> 01:17:39,751 THIS IS A GOAL TO INCREASE 2064 01:17:39,751 --> 01:17:41,553 VISIBILITY, OF EXISTING NIH 2065 01:17:41,553 --> 01:17:45,724 SUPPORTED SOFTWARE. 2066 01:17:45,724 --> 01:17:46,124 NEXT SLIDE. 2067 01:17:46,124 --> 01:17:49,661 DO WANT TO TALK ABOUT CLINICAL 2068 01:17:49,661 --> 01:17:50,362 INTEROPERABILITY. 2069 01:17:50,362 --> 01:17:52,030 MOSTLY FOCUSING ON LEVERAGING 2070 01:17:52,030 --> 01:17:54,833 CAPABILITIES THAT ARE HAPPENING 2071 01:17:54,833 --> 01:17:57,268 IN THE HEALTH IT SECTOR, 2072 01:17:57,268 --> 01:17:58,470 PARTICULARLY FAST HEALTHCARE 2073 01:17:58,470 --> 01:17:59,371 INTEROPERABLE RESOURCES. 2074 01:17:59,371 --> 01:18:02,841 AND THE WORK OF THE COMMUNITY HL 2075 01:18:02,841 --> 01:18:03,408 7. 2076 01:18:03,408 --> 01:18:09,014 SO THE NEXT SLIDE. 2077 01:18:09,014 --> 01:18:12,283 FIRE INCREASES ESSENTIALLY ALLOW 2078 01:18:12,283 --> 01:18:14,853 HEALTH IT TO MAP DIFFERENT 2079 01:18:14,853 --> 01:18:15,954 ELECTRONIC HEALTHCARE RECORDS 2080 01:18:15,954 --> 01:18:18,757 ACROSS SYSTEMS. 2081 01:18:18,757 --> 01:18:21,493 SO YOU MIGHT BE I 2B 2, FIRE 2082 01:18:21,493 --> 01:18:24,462 ALLOWS YOU TO MAP THOSE 2083 01:18:24,462 --> 01:18:26,664 ELECTRONIC HEALTHCARE SYSTEMS. 2084 01:18:26,664 --> 01:18:29,167 IN TERMS OF RESEARCH, FIRE IS A 2085 01:18:29,167 --> 01:18:30,502 GOOD AT INTEROPERABILITY AND 2086 01:18:30,502 --> 01:18:32,871 DATA SHARING, IT ALLOWS UPS TO 2087 01:18:32,871 --> 01:18:35,173 TRANSLATE DIFFERENT RESEARCH 2088 01:18:35,173 --> 01:18:36,941 THAT CAN BE MAPPED INTO 2089 01:18:36,941 --> 01:18:40,145 ELECTRONIC HEALTHCARE SYSTEMS IT 2090 01:18:40,145 --> 01:18:43,214 ALSO ALLOWS US TO BUILD AND FIND 2091 01:18:43,214 --> 01:18:44,883 DATA MORE EASILY, SO GOING TO 2092 01:18:44,883 --> 01:18:46,418 SHOW YOU NEXT SLIDE SOME OF THE 2093 01:18:46,418 --> 01:18:50,188 WORK WE ARE DOING TO PROMOTE THE 2094 01:18:50,188 --> 01:18:52,557 USE OF FIRE FOR RESEARCH. 2095 01:18:52,557 --> 01:18:53,858 THIS IS B HAS BEEN ON OUR ROAD 2096 01:18:53,858 --> 01:18:55,060 MAP FOR A YEAR AND THERE IS A 2097 01:18:55,060 --> 01:18:57,262 NUMBER OF ICs WHO ARE 2098 01:18:57,262 --> 01:18:57,862 LEVERAGING FIRE. 2099 01:18:57,862 --> 01:19:02,200 FOR EXAMPLE, NIDDK DEVELOPED A 2100 01:19:02,200 --> 01:19:03,968 SMART ON FIRE APPLICATION SO 2101 01:19:03,968 --> 01:19:05,904 RESEARCHERS WHO ARE INTERESTED 2102 01:19:05,904 --> 01:19:09,607 IN US UNDERSTANDING PARTICIPANTS 2103 01:19:09,607 --> 01:19:13,578 WITH MULTIPLE CHRONIC DISEASES 2104 01:19:13,578 --> 01:19:15,480 CAN DOWNLOADS MODIFIABILITY TO 2105 01:19:15,480 --> 01:19:16,614 DO DATA DOWNLOADS. 2106 01:19:16,614 --> 01:19:18,716 A LARGE PROGRAM SUPPORTED BY 2107 01:19:18,716 --> 01:19:21,019 NHGRI IS FUNDING THE MAP IN A 2108 01:19:21,019 --> 01:19:22,220 PHENOTYPIC DATA FROM GENOMIC 2109 01:19:22,220 --> 01:19:23,755 SEQUENCES INTO THE FIRE BASE 2110 01:19:23,755 --> 01:19:24,289 SCHEMA. 2111 01:19:24,289 --> 01:19:25,623 SO THIS IS REALLY DIFFICULT, IT 2112 01:19:25,623 --> 01:19:29,194 IS HARD TO MAP PHENOTYPIC DATA 2113 01:19:29,194 --> 01:19:31,963 INTO FIRE SCHEMA THAT IS BASED 2114 01:19:31,963 --> 01:19:35,533 ON ELECTRONIC HEALTH STANDARDS. 2115 01:19:35,533 --> 01:19:37,068 EMERGE IN NUMBER OF OTHER 2116 01:19:37,068 --> 01:19:39,304 PROGRAMS ARE DOING THAT WORK AS 2117 01:19:39,304 --> 01:19:41,940 WELL AS THE OTHER PROGRAMS 2118 01:19:41,940 --> 01:19:43,408 CALLED PHENOPACKETS. 2119 01:19:43,408 --> 01:19:45,376 WE ARE ALSO DEVELOPING TOOLS 2120 01:19:45,376 --> 01:19:47,245 THROUGH MY OFFICE TO LEVERAGE 2121 01:19:47,245 --> 01:19:49,814 FIRE TO FIND AND BUILD COHORT OF 2122 01:19:49,814 --> 01:19:52,217 PATIENTS ACROSS MULTIPLE NIH 2123 01:19:52,217 --> 01:19:54,652 SUPPORTED PLATFORMS INCLUDING 2124 01:19:54,652 --> 01:19:56,621 THE KIDS FIRST PLATFORM CANCER 2125 01:19:56,621 --> 01:19:58,823 RESEARCH DATA COMMONS PLATFORM, 2126 01:19:58,823 --> 01:20:00,925 BIODATA CATALYST PLATFORM AND 2127 01:20:00,925 --> 01:20:02,594 WHEN WE CAN MAP PHENOTYPIC DATA 2128 01:20:02,594 --> 01:20:05,029 INTO FIRE WE WILL BE ABLE TO DO 2129 01:20:05,029 --> 01:20:07,799 THAT FOR THE G TEXT PLATFORM. 2130 01:20:07,799 --> 01:20:11,903 SO THE NEXT SLIDE. 2131 01:20:11,903 --> 01:20:13,805 IT IS NOT EASY FOR CLINICAL 2132 01:20:13,805 --> 01:20:16,040 RESEARCHERS TO PICK UP FIRE. 2133 01:20:16,040 --> 01:20:18,309 IT DOES REQUIRE TRAINING, SO WE 2134 01:20:18,309 --> 01:20:19,577 HAVE THIS PAST YEAR DONE A 2135 01:20:19,577 --> 01:20:21,346 NUMBER OF TRAINING SESSIONS 2136 01:20:21,346 --> 01:20:23,248 FOCUSING FIRST ON NIH INTRAMURAL 2137 01:20:23,248 --> 01:20:24,249 RESEARCHERS, WHO ARE INTERESTED 2138 01:20:24,249 --> 01:20:28,987 IN UTILIZING FIRE EITHER WITH R 2139 01:20:28,987 --> 01:20:30,855 OR PYTHON AND NOW DEVELOPING 2140 01:20:30,855 --> 01:20:33,424 TRAINING MATERIALS AND UTILIZING 2141 01:20:33,424 --> 01:20:36,694 CLOUD THAT I MENTIONED EARLIER 2142 01:20:36,694 --> 01:20:39,697 FOR CLINICAL RESEARCHERS START 2143 01:20:39,697 --> 01:20:42,567 WELCOME CSTR AND CTSA AWARDEES. 2144 01:20:42,567 --> 01:20:45,003 AND FINALLY, I HOPE THAT YOU 2145 01:20:45,003 --> 01:20:48,173 WILL CONTINUE WITH US, ON THE 2146 01:20:48,173 --> 01:20:49,641 NEXT SLIDE OUR JOURNEY IN DATA 2147 01:20:49,641 --> 01:20:51,075 SHARING DATA REUSE. 2148 01:20:51,075 --> 01:20:54,512 EACH MONTH WE HIGHLIGHT IN 2149 01:20:54,512 --> 01:20:56,681 DIFFERENT INSTITUTE NIH THEIR 2150 01:20:56,681 --> 01:20:58,249 PROGRAMS AND DATA SHOWING DATA 2151 01:20:58,249 --> 01:20:59,817 SCIENCE AND PARTICULARLY THEY 2152 01:20:59,817 --> 01:21:01,686 ARE FUNDED AWARDEES TO TELL US 2153 01:21:01,686 --> 01:21:03,688 ABOUT THEIR RESEARCH AND HOW 2154 01:21:03,688 --> 01:21:06,257 THEY ARE SHARING THEIR DATA, HOW 2155 01:21:06,257 --> 01:21:09,027 THEY REUSE DATA, WE HAVE AN 2156 01:21:09,027 --> 01:21:10,361 MAZING NUMBER OF -- AMAZING 2157 01:21:10,361 --> 01:21:12,063 NUMBER OF TALKS FOR THE PAST 2158 01:21:12,063 --> 01:21:15,266 YEAR AND A HALF FOR EXAMPLE, 2159 01:21:15,266 --> 01:21:18,369 LAST JUNE DR. ROSA ALFASAR 2160 01:21:18,369 --> 01:21:19,604 PROFESSOR COMMUNITY COLLEGE AND 2161 01:21:19,604 --> 01:21:23,708 SHE IS CREATING A GENOMICS DATA 2162 01:21:23,708 --> 01:21:25,076 SHARING PROGRAM AND RESOURCES 2163 01:21:25,076 --> 01:21:26,644 AIMED AT COMMUNITY COLLEGES. 2164 01:21:26,644 --> 01:21:29,180 SO THIS IS JUST -- SHE IS A 2165 01:21:29,180 --> 01:21:31,382 WONDERFUL SPEAKER, HER TALK IS 2166 01:21:31,382 --> 01:21:33,251 ARCHIVED ON THE SITE LISTED 2167 01:21:33,251 --> 01:21:34,619 BELOW AS WELL AS ALL THE OTHER 2168 01:21:34,619 --> 01:21:35,119 TALKS. 2169 01:21:35,119 --> 01:21:38,356 WE HAVE HAD OVER 680 2170 01:21:38,356 --> 01:21:40,058 PARTICIPANTS OVER THE COURSE OF 2171 01:21:40,058 --> 01:21:41,759 THE LAST YEAR. 2172 01:21:41,759 --> 01:21:43,661 TYPICALLY 60 TO 100 PARTICIPANTS 2173 01:21:43,661 --> 01:21:46,030 PER TALK INCLUDING INTERNATIONAL 2174 01:21:46,030 --> 01:21:46,698 PARTICIPANTS FROM ALL OVER THE 2175 01:21:46,698 --> 01:21:49,500 WORLD. 2176 01:21:49,500 --> 01:21:51,269 THE NEXT SLIDE IS LAST SLIDE, 2177 01:21:51,269 --> 01:21:53,238 THAT IS MY STORY, WE ARE WORKING 2178 01:21:53,238 --> 01:21:56,241 TO CREATE A MODERNIZE INTEGRATED 2179 01:21:56,241 --> 01:21:58,710 FAIR BIOMEDICAL DATA ECOSYSTEM 2180 01:21:58,710 --> 01:22:01,112 TO SUPPORT THE WORK THAT YOU ARE 2181 01:22:01,112 --> 01:22:04,415 DOING IN DATA AND SCIENCE TO 2182 01:22:04,415 --> 01:22:05,750 SUPPORT OUR POLICIES AN DATA 2183 01:22:05,750 --> 01:22:07,285 MANAGEMENT AND DATA SHARING. 2184 01:22:07,285 --> 01:22:12,690 WITH THAT, I AM HAPPY TO TAKE 2185 01:22:12,690 --> 01:22:13,358 QUESTIONS. 2186 01:22:13,358 --> 01:22:14,425 OR COMMENTS. 2187 01:22:14,425 --> 01:22:17,195 >> THANK YOU, DR. GREGURICK FOR 2188 01:22:17,195 --> 01:22:21,799 A VERY NICE PRESENTATION. 2189 01:22:21,799 --> 01:22:23,101 WE WILL OPEN UP FOR QUESTIONS 2190 01:22:23,101 --> 01:22:23,501 AND COMMENTS. 2191 01:22:23,501 --> 01:22:26,571 I WOULD LIKE TO JUST COMMENT 2192 01:22:26,571 --> 01:22:31,509 YOUR LAST SLIDE ABOUT DR. ROSA 2193 01:22:31,509 --> 01:22:33,945 ALTHAZAR IS A GREAT EXAM HOW 2194 01:22:33,945 --> 01:22:36,147 YOUR OFFICE CAN REACH A BROAD 2195 01:22:36,147 --> 01:22:37,682 AUDIENCE OF INDIVIDUALS SO HANKS 2196 01:22:37,682 --> 01:22:38,283 FOR SHARING THAT. 2197 01:22:38,283 --> 01:22:42,787 I WILL GO TO DR. SLEASMAN FIRST. 2198 01:22:42,787 --> 01:22:46,658 >> THANK YOU FOR GREAT 2199 01:22:46,658 --> 01:22:47,625 PRESENTATION. 2200 01:22:47,625 --> 01:22:48,493 GLAD THIS IS KIND OF GOES BACK 2201 01:22:48,493 --> 01:22:52,797 TO THE LAST SLIDE. 2202 01:22:52,797 --> 01:22:55,500 COMMUNITY COLLEGES, ONE OF MY 2203 01:22:55,500 --> 01:22:59,470 CONCERNS ABOUT LARGE SCALE DATA 2204 01:22:59,470 --> 01:23:04,709 MANAGEMENT AND IMPLICATIONS FOR 2205 01:23:04,709 --> 01:23:05,576 INVESTIGATORS, IS WE REQUIRE 2206 01:23:05,576 --> 01:23:08,146 INSTITUTIONAL RESOURCES TO 2207 01:23:08,146 --> 01:23:11,049 COMPLY WITH THE NEW GUIDELINES. 2208 01:23:11,049 --> 01:23:14,619 WE ALREADY KNOW THAT MUCH OF THE 2209 01:23:14,619 --> 01:23:16,421 NIH IS FALLING ON FEWER 2210 01:23:16,421 --> 01:23:20,124 INSTITUTIONS AND I WORRY ABOUT 2211 01:23:20,124 --> 01:23:21,592 PARTICULAR INSTITUTIONS DOING 2212 01:23:21,592 --> 01:23:27,198 RESEARCH AND SERVING UNDERSERVED 2213 01:23:27,198 --> 01:23:28,199 POPULATIONS PARTICULARLY HIV 2214 01:23:28,199 --> 01:23:31,069 EPIDEMIC IS HOW THESE RESOURCES 2215 01:23:31,069 --> 01:23:33,037 BE MADE AVAILABLE TO THOSE 2216 01:23:33,037 --> 01:23:36,140 INSTITUTIONS THAT INVOLVED IN 2217 01:23:36,140 --> 01:23:38,176 THE EPIDEMIC. 2218 01:23:38,176 --> 01:23:40,211 >> THAT IS SUCH A GREAT 2219 01:23:40,211 --> 01:23:40,945 QUESTION, SOMETHING THAT WE HAVE 2220 01:23:40,945 --> 01:23:48,019 BEEN TALKING ABOUT HERE AT NIH 2221 01:23:48,019 --> 01:23:50,822 IS PARTICULARLY WITH THE ADVENT 2222 01:23:50,822 --> 01:23:55,460 OF PARTNERING WITH THE CLOUD 2223 01:23:55,460 --> 01:23:56,594 INDUSTRIES DISPROPORTIONATE 2224 01:23:56,594 --> 01:23:58,062 AMOUNT OF FUNDING AVAILABLE AND 2225 01:23:58,062 --> 01:23:58,930 THE REQUIREMENT FOR USING THE 2226 01:23:58,930 --> 01:24:01,099 CLOUD SO THIS IS SOMETHING THAT 2227 01:24:01,099 --> 01:24:02,800 IS ON OUR RADAR. 2228 01:24:02,800 --> 01:24:04,569 IN TERMS OF DATA MANAGEMENT AND 2229 01:24:04,569 --> 01:24:08,039 DATA SHARING, I HOPE RESEARCHERS 2230 01:24:08,039 --> 01:24:11,476 WILL BE ENCOURAGED TO EXPLORE 2231 01:24:11,476 --> 01:24:12,777 EXISTING DATA REPOSITORIES AND 2232 01:24:12,777 --> 01:24:15,179 FOR THE HIV COMMUNITY THIS MAY 2233 01:24:15,179 --> 01:24:15,813 BE CERTAINLY SOMETHING TO 2234 01:24:15,813 --> 01:24:18,883 CONSIDER. 2235 01:24:18,883 --> 01:24:20,752 IF THERE ARE ADDITIONAL 2236 01:24:20,752 --> 01:24:21,953 REPOSITORIES NEEDED PARTICULARLY 2237 01:24:21,953 --> 01:24:25,890 FOR YOUR COMMUNITY. 2238 01:24:25,890 --> 01:24:27,525 WHAT IS AVAILABLE IN RESEARCH 2239 01:24:27,525 --> 01:24:28,559 COMMUNITY FOR SHARING DATA, 2240 01:24:28,559 --> 01:24:30,995 THERE IS ALWAYS THE GENERAL 2241 01:24:30,995 --> 01:24:32,463 REPOSITORIES THE SHARE DATA. 2242 01:24:32,463 --> 01:24:34,332 WHAT WOULD BE LESS IDEAL IS IF 2243 01:24:34,332 --> 01:24:36,634 RESEARCHERS ARE SANDING UP THEIR 2244 01:24:36,634 --> 01:24:39,370 OWN FTP SITE TO SHARE DATA THAT 2245 01:24:39,370 --> 01:24:41,172 MAKES HARD TO FIND ACCESS DATA 2246 01:24:41,172 --> 01:24:44,275 WHEN OTHER RESEARCHERSND WANT TO 2247 01:24:44,275 --> 01:24:46,043 FIND IT UNLESS YOU ARE LOOKING 2248 01:24:46,043 --> 01:24:48,713 FOR DATA THROUGH PUBLICATIONS IN 2249 01:24:48,713 --> 01:24:49,847 WHICH CASE YOU CAN SHARE THROUGH 2250 01:24:49,847 --> 01:24:50,648 PUBMED CENTRAL. 2251 01:24:50,648 --> 01:24:52,717 SO AS A FIRST PASS I WOULD 2252 01:24:52,717 --> 01:24:53,618 ABSOLUTELY LOOK AT WHAT IS 2253 01:24:53,618 --> 01:24:57,054 AVAILABLE IN THE COMMUNITY, AND 2254 01:24:57,054 --> 01:24:58,322 WITHIN AN INSTITUTION. 2255 01:24:58,322 --> 01:24:59,891 HOWEVER, THERE ARE INSTITUTIONS 2256 01:24:59,891 --> 01:25:02,260 UNIVERSITY OF CALIFORNIA AS 2257 01:25:02,260 --> 01:25:04,028 FAIRLY STRONG LIBRARY SYSTEM 2258 01:25:04,028 --> 01:25:06,864 THAT DOES HAVE DATA QUITE DATA 2259 01:25:06,864 --> 01:25:07,799 SHARING CAPABILITIES FOR 2260 01:25:07,799 --> 01:25:11,335 RESEARCHERS. 2261 01:25:11,335 --> 01:25:13,204 I HOPE THAT ADDRESSES YOUR 2262 01:25:13,204 --> 01:25:15,907 QUESTION TO SOME EXTENT. 2263 01:25:15,907 --> 01:25:18,976 >> WORRIED ABOUT UNDERSERVED 2264 01:25:18,976 --> 01:25:22,480 UNDER-REPRESENTED POPULATION. 2265 01:25:22,480 --> 01:25:25,349 >> I'M ABSOLUTELY WORKING VERY 2266 01:25:25,349 --> 01:25:26,918 HARD WITH OUR INSTITUTES 2267 01:25:26,918 --> 01:25:28,119 PARTICULARLY THE INSTITUTE 2268 01:25:28,119 --> 01:25:29,687 MINORITY HEALTH AND HEALTH 2269 01:25:29,687 --> 01:25:33,024 DISPARITIES AND NIGMS HOW WE CAN 2270 01:25:33,024 --> 01:25:35,893 ENABLE GREATER DATA 2271 01:25:35,893 --> 01:25:37,228 CAPABILITIES. 2272 01:25:37,228 --> 01:25:39,363 IN MINORITY SERVING AND 2273 01:25:39,363 --> 01:25:40,531 UNDERREPRESENTED INSTITUTIONS. 2274 01:25:40,531 --> 01:25:47,038 THIS IS ON OUR RADAR ABSOLUTELY. 2275 01:25:47,038 --> 01:25:49,774 >> ARE THERE OTHER QUESTIONS 2276 01:25:49,774 --> 01:25:53,444 THIS TIME? 2277 01:25:53,444 --> 01:25:56,214 >> I WANTED TO ADD ON TO THE 2278 01:25:56,214 --> 01:25:58,549 COMMENT THAT JOHN MADE. 2279 01:25:58,549 --> 01:26:02,820 NICHD WE HAVE A LONG STANDING 2280 01:26:02,820 --> 01:26:04,489 POPULATION DYNAMICS RESEARCH 2281 01:26:04,489 --> 01:26:07,124 DATA PROGRAM, SEVERAL DECADES 2282 01:26:07,124 --> 01:26:07,792 OLD. 2283 01:26:07,792 --> 01:26:08,893 DIRECTLY TO ADDRESS JOHN'S 2284 01:26:08,893 --> 01:26:12,129 COMMENT IN THE MOST RECENT CYCLE 2285 01:26:12,129 --> 01:26:14,765 OF THAT, WE EXPLICITLY REQUIRED 2286 01:26:14,765 --> 01:26:17,802 THESE CENTERS NEED TO COME IN 2287 01:26:17,802 --> 01:26:20,905 WITH A NEWLY ESTABLISHED 2288 01:26:20,905 --> 01:26:21,873 RELATIONSHIP WITH MINORITY 2289 01:26:21,873 --> 01:26:24,208 SERVING OR MULTIPLE MINORITY 2290 01:26:24,208 --> 01:26:25,243 SERVING INSTITUTIONS. 2291 01:26:25,243 --> 01:26:26,477 SOME EXACTLY THAT IS TAKING 2292 01:26:26,477 --> 01:26:27,812 THESE ORGANIZATIONS THAT DO A 2293 01:26:27,812 --> 01:26:31,582 VERY GOOD JOB OF MANAGING DATA 2294 01:26:31,582 --> 01:26:33,784 AND UTILIZING FURTHER FUNDING 2295 01:26:33,784 --> 01:26:37,288 ONE OF THE REQUIREMENTS IS THAT 2296 01:26:37,288 --> 01:26:39,490 THEY HELP BUILD CAPACITY LESS 2297 01:26:39,490 --> 01:26:40,791 WELL FUNDED INSTITUTIONS. 2298 01:26:40,791 --> 01:26:42,994 SO WE ARE -- WE JUST STARTED IT 2299 01:26:42,994 --> 01:26:44,862 SO HAVEN'T SEEN YET RESULTS OF 2300 01:26:44,862 --> 01:26:47,832 IT BUT OBVIOUSLY HOPEFUL THAT 2301 01:26:47,832 --> 01:26:49,700 THAT WILL GO IN SMALL WAY TO 2302 01:26:49,700 --> 01:26:54,572 HELP ADDRESS THE CONCERNS. 2303 01:26:54,572 --> 01:26:56,574 >> THANK YOU, ROHAN. 2304 01:26:56,574 --> 01:27:00,444 THAT IS EXCELLENT. 2305 01:27:00,444 --> 01:27:01,078 MARGARET. 2306 01:27:01,078 --> 01:27:03,648 >> I WAS LOOKING FOR MY RAISED 2307 01:27:03,648 --> 01:27:04,048 HAND COUP FIND IT. 2308 01:27:04,048 --> 01:27:06,817 THANK YOU FOR A SUPER 2309 01:27:06,817 --> 01:27:07,652 INTERESTING PRESENTATION. 2310 01:27:07,652 --> 01:27:08,786 WHAT DO YOU THINK FUTURE HOLDS? 2311 01:27:08,786 --> 01:27:12,957 WE ARE GRAPPLING WITH YOU HAD ON 2312 01:27:12,957 --> 01:27:15,593 YOUR SLIDE PEDABYTES OF DATA AND 2313 01:27:15,593 --> 01:27:17,395 ALL KINDS OF THINGS. 2314 01:27:17,395 --> 01:27:18,062 WHAT DO YOU THINK HAVE YOU 2315 01:27:18,062 --> 01:27:19,697 THOUGHT TO WHAT WE ARE GOING 2316 01:27:19,697 --> 01:27:20,131 TOWARD? 2317 01:27:20,131 --> 01:27:21,432 I REALIZE WE HAVE MASSIVE 2318 01:27:21,432 --> 01:27:22,967 AMOUNTS OF DATA AND LOT OF IT IS 2319 01:27:22,967 --> 01:27:25,202 NIH FUNDED RESEARCH. 2320 01:27:25,202 --> 01:27:26,971 WE WANT THIS DATA PUBLICLY 2321 01:27:26,971 --> 01:27:28,205 ACCESSIBLE BY OTHER RESEARCHERS 2322 01:27:28,205 --> 01:27:30,575 AND OTHER PEOPLE. 2323 01:27:30,575 --> 01:27:33,411 WHAT DO YOU THINK IS GOING TO 2324 01:27:33,411 --> 01:27:35,146 HAPPEN IF YOU COULD HAZARD A 2325 01:27:35,146 --> 01:27:35,646 GUESS? 2326 01:27:35,646 --> 01:27:38,616 I REALIZE MAYBE THIS IS 2327 01:27:38,616 --> 01:27:38,916 UNANSWERABLE 2328 01:27:38,916 --> 01:27:43,354 >> LET ME GIVE IT A SHOT AND SEE 2329 01:27:43,354 --> 01:27:45,022 WHAT RESONATES. 2330 01:27:45,022 --> 01:27:46,991 I THINK WHEN I FIRST STARTED OUT 2331 01:27:46,991 --> 01:27:48,659 IN DATA SCIENCE THERE WAS THE 2332 01:27:48,659 --> 01:27:51,395 CONCEPT YOU PROBABLY WILL BE 2333 01:27:51,395 --> 01:27:54,165 FAMILIAR CREATING THE DATA, 2334 01:27:54,165 --> 01:27:56,133 ESSENTIALLY A VERY LARGE AMOUNT 2335 01:27:56,133 --> 01:27:57,668 OF DATA STORED PRIMARILY IN THE 2336 01:27:57,668 --> 01:28:00,004 CLOUD BECAUSE THIS IS HUGE 2337 01:28:00,004 --> 01:28:01,806 AMOUNTS OF DATA. 2338 01:28:01,806 --> 01:28:04,308 AND RESEARCHERS SORT OF PUT THE 2339 01:28:04,308 --> 01:28:05,509 DATA IN THE DATA LINK AND THEN 2340 01:28:05,509 --> 01:28:06,844 THERE'S QUITE A LOT OF GOOD 2341 01:28:06,844 --> 01:28:08,446 THINGS THAT HAPPEN THERE. 2342 01:28:08,446 --> 01:28:10,881 I THINK REALISTICALLY IN THE 2343 01:28:10,881 --> 01:28:13,284 FUTURE, THAT IS PROBABLY NOT 2344 01:28:13,284 --> 01:28:14,652 EXACTLY THE SOLUTION THAT IS GO 2345 01:28:14,652 --> 01:28:17,788 TO BE EFFECTIVE PARTICULARLY FOR 2346 01:28:17,788 --> 01:28:19,790 VERY DIVERSE BIOMEDICAL RESEARCH 2347 01:28:19,790 --> 01:28:20,157 COMMUNITY. 2348 01:28:20,157 --> 01:28:22,159 SO WHAT WE ARE LOOKING AT NOW, 2349 01:28:22,159 --> 01:28:24,362 THIS IS HAPPENING IN INDUSTRY AS 2350 01:28:24,362 --> 01:28:28,432 WELL, IS CREATING FEDERATED BUT 2351 01:28:28,432 --> 01:28:30,368 INTEROPERABLE DATA CAPABILITIES. 2352 01:28:30,368 --> 01:28:31,569 WE HAVE GREAT CAPABILITIES IN 2353 01:28:31,569 --> 01:28:35,306 CANCER. 2354 01:28:35,306 --> 01:28:36,641 FOR THE CANCER COMMUNITIES. 2355 01:28:36,641 --> 01:28:39,410 WE HAVE GREAT CAPABILITIES IN 2356 01:28:39,410 --> 01:28:41,212 HEART LUNG AND BLOOD AND THEIR 2357 01:28:41,212 --> 01:28:43,547 TEAM FOR CARDIOVASCULAR 2358 01:28:43,547 --> 01:28:44,915 RESEARCH, THERE ARE PEOPLE WHO 2359 01:28:44,915 --> 01:28:46,250 RESEARCHERS WHO WANT TO LOOK AT 2360 01:28:46,250 --> 01:28:50,021 THOSE INTERSECTIONS. 2361 01:28:50,021 --> 01:28:51,255 BETWEEN CARDIOVASCULAR RESEARCH 2362 01:28:51,255 --> 01:28:52,156 AND CANCER RESEARCH. 2363 01:28:52,156 --> 01:28:53,858 THE SOLUTION THAT WE ARE LOOKING 2364 01:28:53,858 --> 01:28:56,293 AT IS CREATING INTEROPERABILITY 2365 01:28:56,293 --> 01:29:01,098 BETWEEN THOSE DATA SYSTEMS SO 2366 01:29:01,098 --> 01:29:03,401 RESEARCHERS CAN LOG IN AND FIND 2367 01:29:03,401 --> 01:29:04,602 DATA INTERESTED IN AND PULL INTO 2368 01:29:04,602 --> 01:29:06,237 THE ANALYTICS PLATFORM THAT THEY 2369 01:29:06,237 --> 01:29:09,874 FEEL COMFORTABLE USING. 2370 01:29:09,874 --> 01:29:11,208 SOUNDS EASY BUT THERE'S 2371 01:29:11,208 --> 01:29:12,777 TECHNICAL AND SOME SERIOUS 2372 01:29:12,777 --> 01:29:13,844 POLICY WORK TO DO. 2373 01:29:13,844 --> 01:29:17,014 BUT THIS IS THE CONCEPT OF DATA 2374 01:29:17,014 --> 01:29:19,216 MESH CREATE THE SMALL AMOUNT OF 2375 01:29:19,216 --> 01:29:21,218 CAPABILITIES ACROSS SYSTEMS THAT 2376 01:29:21,218 --> 01:29:22,987 UNITE THEM TOGETHER IN A 2377 01:29:22,987 --> 01:29:25,022 MEANINGFUL WAY FOR RESEARCHERS, 2378 01:29:25,022 --> 01:29:27,892 THIS WILL REQUIRE US TO AGREE 2379 01:29:27,892 --> 01:29:30,327 CERTAIN AMOUNT OF STANDARD 2380 01:29:30,327 --> 01:29:32,430 METADATA ACROSS SYSTEMS WHO CAN 2381 01:29:32,430 --> 01:29:33,864 TALK TO EACH OTHER AND CERTAIN 2382 01:29:33,864 --> 01:29:34,765 AMOUNT OF CAPABILITIES. 2383 01:29:34,765 --> 01:29:37,802 THIS IS HAPPENING IN NETFLIX. 2384 01:29:37,802 --> 01:29:39,804 US USES DATA MESH IN 2385 01:29:39,804 --> 01:29:40,771 ARCHITECTURE, SO THIS IS 2386 01:29:40,771 --> 01:29:42,440 SOMETHING WE ARE THINKING OF, 2387 01:29:42,440 --> 01:29:44,442 LOOKING AT SOPHISTICATED WAYS TO 2388 01:29:44,442 --> 01:29:45,509 FIND AND SEARCH DATA BEYOND WHAT 2389 01:29:45,509 --> 01:29:49,180 YOU WOULD DO IN GOOGLE. 2390 01:29:49,180 --> 01:29:52,817 RESEARCHERS SIMPLE LINE TEXT 2391 01:29:52,817 --> 01:29:54,585 ENTRY, IS NOT HOW RESEARCHERS 2392 01:29:54,585 --> 01:29:57,321 WILL FIND DATA AND HAVE 2393 01:29:57,321 --> 01:29:58,889 CONFIDENCE IN -- IF THAT DATA IS 2394 01:29:58,889 --> 01:30:01,459 TRUE AND NOT LEADING TO FALSE 2395 01:30:01,459 --> 01:30:02,793 CLAIMS. 2396 01:30:02,793 --> 01:30:04,462 SOPHISTICATED CAPABILITIES IN 2397 01:30:04,462 --> 01:30:06,163 SEARCH AND FINDING DATA. 2398 01:30:06,163 --> 01:30:08,999 THIS IS ALSO GOING TO REQUIRE 2399 01:30:08,999 --> 01:30:11,202 SOME INTERESTING NEW WAYS OF 2400 01:30:11,202 --> 01:30:12,169 TRAINING AND BECAUSE OF THE 2401 01:30:12,169 --> 01:30:13,504 PANDEMIC WE ARE LOOKING AT WAYS 2402 01:30:13,504 --> 01:30:15,172 OF TRAINING THAT ARE INNOVATIVE 2403 01:30:15,172 --> 01:30:17,875 AND A LITTLE OUT OF THE BOX. 2404 01:30:17,875 --> 01:30:19,443 AS WE ARE SITTING HERE ON ZOOM 2405 01:30:19,443 --> 01:30:20,911 WE NEED TO THINK DIFFERENTLY HOW 2406 01:30:20,911 --> 01:30:23,214 WE ARE GOING TO TRAIN OUR NEXT 2407 01:30:23,214 --> 01:30:25,216 GENERATION OF RESEARCHERS TO 2408 01:30:25,216 --> 01:30:28,252 UTILIZE DATA IN WAYS THAT ARE 2409 01:30:28,252 --> 01:30:28,753 DIFFERENT THAN BEFORE. 2410 01:30:28,753 --> 01:30:30,287 SO THESE ARE SOME OF THE THINGS 2411 01:30:30,287 --> 01:30:31,722 WE ARE THINKING IN TERMS OF 2412 01:30:31,722 --> 01:30:32,857 CREATING CAPABILITIES THAT 2413 01:30:32,857 --> 01:30:34,492 HARNESS WHAT IS HAPPENING 2414 01:30:34,492 --> 01:30:35,926 ENHANCE THE COMMUNITIES THAT 2415 01:30:35,926 --> 01:30:38,162 KNOW THAT DATA THE BEST BUT ALSO 2416 01:30:38,162 --> 01:30:39,864 CREATE SYNERGISTIC COMPLIMENTARY 2417 01:30:39,864 --> 01:30:41,766 WAYS TO INTEGRATE ACROSS OUR 2418 01:30:41,766 --> 01:30:43,834 DATA SYSTEMS. 2419 01:30:43,834 --> 01:30:47,571 >> THANK YOU, VERY INTERESTING. 2420 01:30:47,571 --> 01:30:48,739 >> THANKS. 2421 01:30:48,739 --> 01:30:52,543 >> DR. GREGURICK, GLAD YOU 2422 01:30:52,543 --> 01:30:53,711 MENTIONED TRAINING BECAUSE I 2423 01:30:53,711 --> 01:30:57,014 WANT TO FOLLOW-UP. 2424 01:30:57,014 --> 01:31:01,318 DURING YOUR PRESENTATION I WAS 2425 01:31:01,318 --> 01:31:03,621 THINKING I WOULD IMAGINE OUR 2426 01:31:03,621 --> 01:31:05,856 GRADUATE TRAINING PROGRAMS WE 2427 01:31:05,856 --> 01:31:08,526 MIGHT NEED TO START CONSIDER HOW 2428 01:31:08,526 --> 01:31:10,528 DO WE HAVE OUR NEXT GENERATION 2429 01:31:10,528 --> 01:31:13,931 OF TRAINEES FAMILIAR WITH THESE 2430 01:31:13,931 --> 01:31:16,200 RESOURCES AND BIG DATA. 2431 01:31:16,200 --> 01:31:21,005 AS A BASIC SCIENTIST, I WOULD 2432 01:31:21,005 --> 01:31:23,140 IMAGINE I COULD FIND A LOT OF 2433 01:31:23,140 --> 01:31:25,476 OPPORTUNITIES IF I KNOW HOW TO 2434 01:31:25,476 --> 01:31:27,244 GO ABOUT MINING THE DATABASES 2435 01:31:27,244 --> 01:31:28,913 AND THE INFORMATION THERE. 2436 01:31:28,913 --> 01:31:33,384 SO MY QUESTION IS CAN YOU 2437 01:31:33,384 --> 01:31:35,786 COMMENT ON -- IF YOU ARE OKAY 2438 01:31:35,786 --> 01:31:37,254 WITH COMMENTING ON WHAT DO YOU 2439 01:31:37,254 --> 01:31:41,759 THINK THAT WE SHOULD BE 2440 01:31:41,759 --> 01:31:43,894 CONSIDERING AS WE TRAIN FUTURE 2441 01:31:43,894 --> 01:31:45,296 GENERATION OF SCIENTIST, 2442 01:31:45,296 --> 01:31:45,930 SOMETHING WE SHOULD START EARLY 2443 01:31:45,930 --> 01:31:48,165 IN THE PROCESS OR YEAH SO IF YOU 2444 01:31:48,165 --> 01:31:49,233 CAN COMMENT ON THAT, THAT WOULD 2445 01:31:49,233 --> 01:31:50,000 BE GREAT. 2446 01:31:50,000 --> 01:31:52,102 >> ABSOLUTELY. 2447 01:31:52,102 --> 01:31:53,337 THIS SOMETHING ALSO I HAVE HEARD 2448 01:31:53,337 --> 01:31:55,673 IN FAIR NUMBER OF WORKSHOPS, WE 2449 01:31:55,673 --> 01:31:57,675 NEED TO START TRAINING 2450 01:31:57,675 --> 01:31:58,776 RESEARCHERS PRETTY EARLY IN 2451 01:31:58,776 --> 01:32:00,444 THEIR UNDERGRADUATE CAREER AND 2452 01:32:00,444 --> 01:32:02,746 DATA SCIENCE WHETHER THEY ARE AT 2453 01:32:02,746 --> 01:32:05,082 THE BENCH, LIKE MY SON IS OR 2454 01:32:05,082 --> 01:32:06,417 MORE LIKE ME SITTING AT A 2455 01:32:06,417 --> 01:32:10,054 COMPUTER WHERE I FEEL MUCH MORE 2456 01:32:10,054 --> 01:32:10,721 NATURAL. 2457 01:32:10,721 --> 01:32:12,223 SO STARTING EARLY IN CONCEPT OF 2458 01:32:12,223 --> 01:32:14,825 DATA SCIENCE WHICH ARE CONCEPTS 2459 01:32:14,825 --> 01:32:16,594 OF STATISTICS AND A FEW CONCEPTS 2460 01:32:16,594 --> 01:32:19,864 OF COMPUTER SCIENCE AS WELL. 2461 01:32:19,864 --> 01:32:21,866 AND STUDENTS OFTEN LEARN BY USE 2462 01:32:21,866 --> 01:32:23,367 CASES AND REPEATING WHAT HAS 2463 01:32:23,367 --> 01:32:26,303 BEEN DONE BY OTHERS BUT IN KNOWN 2464 01:32:26,303 --> 01:32:28,339 PREDICTIVE WAYS THIS IS ONE GOAL 2465 01:32:28,339 --> 01:32:30,875 CLOUD THAT IS ALSO TRAINING 2466 01:32:30,875 --> 01:32:33,110 PLATFORM TO HELP YOUNG PEOPLE 2467 01:32:33,110 --> 01:32:34,445 LEARN HOW SCIENCE IS DONE AND 2468 01:32:34,445 --> 01:32:37,248 LEARN KEY CONCEPTS BY DOING AS 2469 01:32:37,248 --> 01:32:37,882 YOU LEARN. 2470 01:32:37,882 --> 01:32:41,385 ALSO WANT TO MENTION THAT WE ARE 2471 01:32:41,385 --> 01:32:42,586 WORKING IN AN ENVIRONMENT 2472 01:32:42,586 --> 01:32:44,388 RECRUITING THE BEST FOLKS FROM 2473 01:32:44,388 --> 01:32:45,522 UNDERSERVED OR AMERICAN INDIAN 2474 01:32:45,522 --> 01:32:47,191 OR ALASKA NATIVE POPULATIONS 2475 01:32:47,191 --> 01:32:48,726 MEANS THAT WE HAVE TO BE 2476 01:32:48,726 --> 01:32:50,728 FLEXIBLE BUT CAN'T ALWAYS COME 2477 01:32:50,728 --> 01:32:52,062 TO NIH, WE HAVE A NUMBER OF 2478 01:32:52,062 --> 01:32:53,898 PROGRAMS FOR STUDENTS TO COME TO 2479 01:32:53,898 --> 01:32:54,899 NIH. 2480 01:32:54,899 --> 01:32:56,567 IN SOME CASES THAT IS NOT GOING 2481 01:32:56,567 --> 01:32:58,235 TO BE GOOD FIT. 2482 01:32:58,235 --> 01:32:59,670 SO WE CREATED PROGRAMS THAT 2483 01:32:59,670 --> 01:33:01,572 ALLOW TRAINEES THAT ARE COMMON 2484 01:33:01,572 --> 01:33:03,707 TO NIH TO WORK REMOTELY IN THEIR 2485 01:33:03,707 --> 01:33:05,376 LOCATIONS AND THEIR HOME SO 2486 01:33:05,376 --> 01:33:07,845 NUMBER OF FELLOWS THIS SUMMER 2487 01:33:07,845 --> 01:33:09,079 WHO WE STARTED THIS BECAUSE OF 2488 01:33:09,079 --> 01:33:10,347 THE PANDEMIC BUT IT IS JUST 2489 01:33:10,347 --> 01:33:11,682 WORKING OUT SO WELL THAT WE ARE 2490 01:33:11,682 --> 01:33:14,084 GOING TO CONTINUE BECAUSE WE 2491 01:33:14,084 --> 01:33:17,421 REALIZED THAT IN OUR BRINGING ON 2492 01:33:17,421 --> 01:33:19,757 NEW INTERNS, NEW FELLOWS IF WE 2493 01:33:19,757 --> 01:33:21,625 DESIGN PROGRAMS THAT ALLOW FOR 2494 01:33:21,625 --> 01:33:25,796 100% REMOTE WORK, WE GET REALLY 2495 01:33:25,796 --> 01:33:28,599 GREAT KIDS COMING FROM VERY 2496 01:33:28,599 --> 01:33:31,869 DIVERSE BACKGROUNDS. 2497 01:33:31,869 --> 01:33:32,903 THAT IS JUST FANTASTIC. 2498 01:33:32,903 --> 01:33:35,239 REALLY SATISFYING TO SEE THESE 2499 01:33:35,239 --> 01:33:36,874 YOUNG KIDS EXCEL WHEN THEY ARE 2500 01:33:36,874 --> 01:33:38,242 -- WHEN THE PROGRAMS ARE FIT FOR 2501 01:33:38,242 --> 01:33:40,577 THEIR NEEDS RATHER THAN FIT FOR 2502 01:33:40,577 --> 01:33:43,113 OUR NEEDS ENTIRELY. 2503 01:33:43,113 --> 01:33:43,814 >> FANTASTIC. 2504 01:33:43,814 --> 01:33:46,817 THANK YOU. 2505 01:33:46,817 --> 01:33:53,524 JONATHAN. 2506 01:33:53,524 --> 01:33:55,426 YOU LOGGED OUT, HEIDI. 2507 01:33:55,426 --> 01:33:56,493 >> I'M STILL HERE. 2508 01:33:56,493 --> 01:33:57,394 HI. 2509 01:33:57,394 --> 01:33:59,196 SO THAT WAS A GREAT PRESENTATION 2510 01:33:59,196 --> 01:34:04,368 AND REALLY INTERESTING AND I 2511 01:34:04,368 --> 01:34:05,369 APPRECIATE THE GOALS AN 2512 01:34:05,369 --> 01:34:07,104 DIRECTION THIS IS IS GOING. 2513 01:34:07,104 --> 01:34:08,038 AND I DON'T WANT TO PUT YOU ON 2514 01:34:08,038 --> 01:34:10,007 THE SPOT SO THIS WILL BE A 2515 01:34:10,007 --> 01:34:14,478 GENERAL COMMENT RATHER THAN 2516 01:34:14,478 --> 01:34:15,512 REQUIRING MAIN ANSWER BUT I 2517 01:34:15,512 --> 01:34:17,081 WOULD LOVE THE HEAR MORE WHEN 2518 01:34:17,081 --> 01:34:19,383 TALKING ABOUT THIS IN THE FUTURE 2519 01:34:19,383 --> 01:34:20,851 ABOUT SOME OF THE SPECIFIC 2520 01:34:20,851 --> 01:34:23,120 BARRIERS, THERE IS SO MUCH 2521 01:34:23,120 --> 01:34:26,323 NUANCE AND SOME PHENOTYPES AN 2522 01:34:26,323 --> 01:34:27,658 THINKING PHENOTYPES HAD TO MERGE 2523 01:34:27,658 --> 01:34:32,363 TO SELECT TO BE ABLE TO BRING 2524 01:34:32,363 --> 01:34:35,699 TOGETHER SOURCES WHERE DATA 2525 01:34:35,699 --> 01:34:36,900 QUALITY DIFFERED. 2526 01:34:36,900 --> 01:34:38,569 THINGS LIKE WHEN THEY START 2527 01:34:38,569 --> 01:34:39,603 TALKING ABOUT HEIGHT AND THINGS 2528 01:34:39,603 --> 01:34:40,738 VERY STRAIGHT FORWARD, I THINK 2529 01:34:40,738 --> 01:34:43,073 THAT IS GREAT. 2530 01:34:43,073 --> 01:34:44,575 BUT FUTURE LOVE TO HEAR MORE 2531 01:34:44,575 --> 01:34:45,843 ABOUT HOW TO DEAL WITH SOME OF 2532 01:34:45,843 --> 01:34:47,978 THE NUANCES WHERE THE DATA 2533 01:34:47,978 --> 01:34:49,346 QUALITY VARIOUS PHENOTYPES 2534 01:34:49,346 --> 01:34:52,216 ACROSS THE SYSTEMS ARE SO VERY 2535 01:34:52,216 --> 01:34:52,816 DIFFERENT. 2536 01:34:52,816 --> 01:34:55,853 SOME REALLY NEED VALIDATION OR 2537 01:34:55,853 --> 01:34:57,054 ADJUDICATION IN SOME TYPE TO BE 2538 01:34:57,054 --> 01:35:01,692 BELIEVABLE HOW YOU ARE GOING TO 2539 01:35:01,692 --> 01:35:03,260 SHOW THAT OR MERGE BUT MAKE SURE 2540 01:35:03,260 --> 01:35:05,262 RESEARCHERS ARE REALLY USING THE 2541 01:35:05,262 --> 01:35:07,164 QUALITY OF DATA THEY THINK THEY 2542 01:35:07,164 --> 01:35:10,300 ARE USING, THERE IS 90 PROBLEMS 2543 01:35:10,300 --> 01:35:13,404 AND INTERESTING QUESTIONS THAT 2544 01:35:13,404 --> 01:35:17,007 ARISE SO I WANT TO FUTURE 2545 01:35:17,007 --> 01:35:18,575 DISCUSSION BECAUSE THAT IS WHERE 2546 01:35:18,575 --> 01:35:20,744 MANY CHALLENGES ARE GOING TO BE 2547 01:35:20,744 --> 01:35:21,945 IMPLEMENTED AS WELL IS BUT SO 2548 01:35:21,945 --> 01:35:23,647 VERY EXCITING SO DON'T TAKE THIS 2549 01:35:23,647 --> 01:35:25,749 AS A WET BLANKET JUST LOVE TO 2550 01:35:25,749 --> 01:35:28,018 HEAR MORE ABOUT ISSUES AT SOME 2551 01:35:28,018 --> 01:35:28,452 POINT. 2552 01:35:28,452 --> 01:35:31,455 >> WE ARE LIVING THAT EVERY DAY. 2553 01:35:31,455 --> 01:35:34,158 WE HAVE THOUGHT OF COMMON DATA 2554 01:35:34,158 --> 01:35:36,660 ELEMENTS THAT ARE SIMILAR. 2555 01:35:36,660 --> 01:35:38,695 HEIGHT MEASURE LAYING DOWN, 2556 01:35:38,695 --> 01:35:39,696 VERSUS HEIGHT MEASURED STANDING 2557 01:35:39,696 --> 01:35:43,467 UP SO THAT DEEP LEVEL OF 2558 01:35:43,467 --> 01:35:43,734 METADATA. 2559 01:35:43,734 --> 01:35:45,803 >>PROFESSOR: HEIGHT IS EASY. 2560 01:35:45,803 --> 01:35:47,771 >> THAT IS THE EASY ONE. 2561 01:35:47,771 --> 01:35:49,673 >> WHEN YOU ARE TALKING ABOUT MI 2562 01:35:49,673 --> 01:35:51,442 AND CANCER AND ALL THAT, IT IS 2563 01:35:51,442 --> 01:35:55,045 SO MUCH MORE COMPLICATED, 100 2564 01:35:55,045 --> 01:35:55,412 FOLD. 2565 01:35:55,412 --> 01:35:58,082 THOSE NUANCES THAT WE WOULD LOVE 2566 01:35:58,082 --> 01:35:59,049 TO LEARN MORE ABOUT. 2567 01:35:59,049 --> 01:36:01,018 >> ACTUALLY IT WOULD BE A GREAT 2568 01:36:01,018 --> 01:36:02,152 WORKSHOP, GREAT DISCUSSION 2569 01:36:02,152 --> 01:36:03,287 BECAUSE THIS IS SOMETHING THAT 2570 01:36:03,287 --> 01:36:06,824 WE ARE -- WE ARE STRUGGLING 2571 01:36:06,824 --> 01:36:08,692 WITH, I WILL BE HONEST IS JUST 2572 01:36:08,692 --> 01:36:10,861 HARMONIZING DATA IS THE HARDEST 2573 01:36:10,861 --> 01:36:12,296 THING POSSIBLE, IT ISN'T EASY. 2574 01:36:12,296 --> 01:36:14,832 L THERE IS A LOT OF NUANCES IN 2575 01:36:14,832 --> 01:36:15,933 THE DATA. 2576 01:36:15,933 --> 01:36:19,002 AS YOU JUST DESCRIBED SO WE ARE 2577 01:36:19,002 --> 01:36:21,305 LOOK AT THIS, I CAN'T SAY WE 2578 01:36:21,305 --> 01:36:24,208 HAVE A SOLUTION BUT WE CERTAINLY 2579 01:36:24,208 --> 01:36:25,209 KNOW THE PROBLEM. 2580 01:36:25,209 --> 01:36:26,844 KNOWING LEADERSHIP LEVEL THIS IS 2581 01:36:26,844 --> 01:36:28,045 SOMETHING IC DIRECTORS ARE 2582 01:36:28,045 --> 01:36:30,247 TALKING AS WELL AS IF WE REALLY, 2583 01:36:30,247 --> 01:36:32,282 REALLY WANT TO MAKE THE FULL USE 2584 01:36:32,282 --> 01:36:34,952 OF DATA, WE HAVE TO DEAL WITH 2585 01:36:34,952 --> 01:36:36,086 THIS PROBLEM BUT WE CAN'T DO IT 2586 01:36:36,086 --> 01:36:38,489 IN A WAY THAT IS A HAMMER FOR 2587 01:36:38,489 --> 01:36:39,323 RESEARCHERS, THAT IS ALSO NOT 2588 01:36:39,323 --> 01:36:41,992 GOING TO REALLY WORK. 2589 01:36:41,992 --> 01:36:44,528 SO WE HAD A WORKSHOP ON SEARCH 2590 01:36:44,528 --> 01:36:46,763 AND ONE OF THE CONCEPTS IS 2591 01:36:46,763 --> 01:36:47,764 EMBRACING THE HETEROGENEITY OF 2592 01:36:47,764 --> 01:36:50,367 DATA AND TRYING TO DEVELOP 2593 01:36:50,367 --> 01:36:51,602 POTENTIALLY A LITTLE MORE 2594 01:36:51,602 --> 01:36:54,138 ADVANCE MACHINE LEARNING 2595 01:36:54,138 --> 01:36:57,274 ALGORITHMS TO HELP US PULL OUT 2596 01:36:57,274 --> 01:36:59,676 SOME OF THESE POINTS. 2597 01:36:59,676 --> 01:37:02,212 WHAT IS HARMONIZED, WHAT CAN'T, 2598 01:37:02,212 --> 01:37:03,113 WHAT CAN BE CONVERTED WHAT 2599 01:37:03,113 --> 01:37:03,881 CAN'T. 2600 01:37:03,881 --> 01:37:04,982 THIS IS VERY EARLY DAYS I HAVE 2601 01:37:04,982 --> 01:37:06,350 TO SAY. 2602 01:37:06,350 --> 01:37:07,918 SO NO SOLUTION BUS AWARENESS OF 2603 01:37:07,918 --> 01:37:09,286 THE PROBLEMS SO THANKS FOR 2604 01:37:09,286 --> 01:37:19,596 BRINGING THAT UP. 2605 01:37:25,903 --> 01:37:27,638 >> I COULDN'T GET TO THE -- I 2606 01:37:27,638 --> 01:37:31,408 WANT TO THANK SUSAN AND ALSO 2607 01:37:31,408 --> 01:37:33,877 MENTION SINCE SHE BROUGHT UP 2608 01:37:33,877 --> 01:37:35,078 ABOUT THE DIGITAL -- CIVIC 2609 01:37:35,078 --> 01:37:36,980 DIGITAL FELLOWS THAT WE ARE 2610 01:37:36,980 --> 01:37:40,617 THRILLED IN OAR BECAUSE LAST 2611 01:37:40,617 --> 01:37:42,553 YEAR INAUGURAL YEAR I THINK 2612 01:37:42,553 --> 01:37:43,820 INAUGURAL YEAR WE HAD TWO. 2613 01:37:43,820 --> 01:37:45,489 THIS YEAR WE HAD -- WE ARE 2614 01:37:45,489 --> 01:37:46,723 HOSTING TWO MORE. 2615 01:37:46,723 --> 01:37:49,259 WE ARE JUST THRILLED WITH THEM, 2616 01:37:49,259 --> 01:37:49,726 SUSAN. 2617 01:37:49,726 --> 01:37:50,127 GREAT PROGRAM. 2618 01:37:50,127 --> 01:37:54,998 >> IT IS A GREAT PROGRAM. 2619 01:37:54,998 --> 01:37:56,233 THESE ARE UNDERGRADS THEY COME 2620 01:37:56,233 --> 01:37:58,635 FROM ACROSS THE COUNTRY, THEY 2621 01:37:58,635 --> 01:38:00,137 ARE SOME OF THE BRIGHTEST PEOPLE 2622 01:38:00,137 --> 01:38:02,706 IN P COMPUTER SCIENCE 2623 01:38:02,706 --> 01:38:03,507 INFORMATION SCIENCE. 2624 01:38:03,507 --> 01:38:04,641 DATA SCIENCE AND SOMETIMES THEY 2625 01:38:04,641 --> 01:38:06,543 COME FROM UNUSUAL FIELDS LIKE 2626 01:38:06,543 --> 01:38:08,111 ECONOMICS OR HISTORY. 2627 01:38:08,111 --> 01:38:10,547 ONCE WE HAD AN ART MAJOR BUT 2628 01:38:10,547 --> 01:38:12,983 INTERESTING YOUNG PEOPLE SUPER 2629 01:38:12,983 --> 01:38:14,751 BRIGHT AND EMBEDDED WITH 2630 01:38:14,751 --> 01:38:16,520 INSTITUTE CENTERS AND OFFICES 2631 01:38:16,520 --> 01:38:18,956 LIKE OAR TO WORK ON CHALLENGES 2632 01:38:18,956 --> 01:38:20,057 THAT IMPACT THE PROGRAM. 2633 01:38:20,057 --> 01:38:22,626 EN THEY NOW WORK REMOTE BECAUSE 2634 01:38:22,626 --> 01:38:23,160 WE FOUND THEY CAN JUST -- 2635 01:38:23,160 --> 01:38:24,628 >> YEAH. 2636 01:38:24,628 --> 01:38:25,696 >> (OVERLAPPING SPEAKERS) 2637 01:38:25,696 --> 01:38:28,932 >> SO IT IS ENCOURAGE YOU IF YOU 2638 01:38:28,932 --> 01:38:32,135 ARE THINKING ABOUT BRINGING ON 2639 01:38:32,135 --> 01:38:33,870 UNDER-REPRESENTED POPULATIONS 2640 01:38:33,870 --> 01:38:36,873 THAT REMOTE IN SOME CASES REMOTE 2641 01:38:36,873 --> 01:38:40,277 DOES ALLOW THAT TYPE OF 2642 01:38:40,277 --> 01:38:40,577 RECRUITMENT. 2643 01:38:40,577 --> 01:38:43,413 >> JUST SO THAT YOU KNOW, SUSAN, 2644 01:38:43,413 --> 01:38:44,815 IT WAS KIND OF LIKE BEING BACK 2645 01:38:44,815 --> 01:38:46,450 AT THE UNIVERSITY, ONE OF OUR 2646 01:38:46,450 --> 01:38:48,352 FULL LOWS LAST YEAR -- FELLOWS 2647 01:38:48,352 --> 01:38:50,554 LAST YEAR APPLYING TO BUNCH OF 2648 01:38:50,554 --> 01:38:51,688 GRADUATE PROGRAMS SO WE HAD TO 2649 01:38:51,688 --> 01:38:57,694 WRITE LETTERS OF RECOMMENDATION. 2650 01:38:57,694 --> 01:38:58,829 IT WAS GREAT. 2651 01:38:58,829 --> 01:39:00,964 >> VERY FUN. 2652 01:39:00,964 --> 01:39:03,934 >> WITH THAT I THINK THAT'S AN 2653 01:39:03,934 --> 01:39:06,470 EXCELLENT WAY OF WRAPPING UP THE 2654 01:39:06,470 --> 01:39:07,671 SESSION. 2655 01:39:07,671 --> 01:39:09,840 AND SO LET'S THANK DR. GREGURICK 2656 01:39:09,840 --> 01:39:11,942 AGAIN FOR REALLY AMAZING 2657 01:39:11,942 --> 01:39:14,378 PRESENTATION AND A GREAT 2658 01:39:14,378 --> 01:39:14,778 DISCUSSION. 2659 01:39:14,778 --> 01:39:16,947 SO WE ARE GOING TO TAKE A BREAK 2660 01:39:16,947 --> 01:39:18,782 NOW, SO JUST WANT TO REMIND 2661 01:39:18,782 --> 01:39:19,883 EVERYONE TO NOT PLEASE DO NOT 2662 01:39:19,883 --> 01:39:22,019 LOG OUT OF THE THE ZOOM MEETING. 2663 01:39:22,019 --> 01:39:24,388 AND KEEP YOUR CAMERAS OFF. 2664 01:39:24,388 --> 01:39:26,490 WE'LL RETURN AT 2 P.M. PROMPTLY. 2665 01:39:26,490 --> 01:39:28,025 THANK YOU AGAIN, DR. GREGURICK 2666 01:39:28,025 --> 01:39:29,893 AND WE WILL SEE YOU BACK HERE 2667 01:39:29,893 --> 01:39:30,460 SOON. 2668 01:39:30,460 --> 01:39:39,289 THANKS. 2669 01:39:39,289 --> 01:39:40,257 WELCOME BACK EVERYONE. 2670 01:39:40,257 --> 01:39:42,158 I HOPE YOU HAD AN OPPORTUNITY TO 2671 01:39:42,158 --> 01:39:43,460 GET UP AND MOVE AROUND AND 2672 01:39:43,460 --> 01:39:44,928 STRETCH A LITTLE BIT. 2673 01:39:44,928 --> 01:39:47,797 NEXT WE WILL HAVE THREE 2674 01:39:47,797 --> 01:39:48,698 PRESENTATIONS FROM FOUR 2675 01:39:48,698 --> 01:39:49,766 DIFFERENT SPEAKERS, WE WILL 2676 01:39:49,766 --> 01:39:52,902 FIRST HEAR FROM MS. KAY HAYES, 2677 01:39:52,902 --> 01:39:55,338 DEPUTY ASSISTANT SECRETARY FOR 2678 01:39:55,338 --> 01:39:56,640 INFECTIOUS DISEASE AND DIRECTOR 2679 01:39:56,640 --> 01:39:59,542 OF OFFICE OF INFECTIOUS DISEASE 2680 01:39:59,542 --> 01:40:03,280 HIV AIDS POLICY. 2681 01:40:03,280 --> 01:40:05,615 AT OFFICE OF ASSISTANT SECRETARY 2682 01:40:05,615 --> 01:40:08,418 OF HEALTH ALSO KNOWN AS OASH. 2683 01:40:08,418 --> 01:40:10,854 WE WILL HEAR FROM DR. LAURA 2684 01:40:10,854 --> 01:40:14,024 CHEEVER, ASSOCIATE ADMINISTRATOR 2685 01:40:14,024 --> 01:40:15,692 HIV AIDS BUREAU OF HEALTH 2686 01:40:15,692 --> 01:40:17,927 RESOURCES AND SERVICE 2687 01:40:17,927 --> 01:40:20,563 ADMINISTRATION HRSA AND OARAC'S 2688 01:40:20,563 --> 01:40:23,933 OWN JONATHAN MIR MEN, RELEASE 2689 01:40:23,933 --> 01:40:25,502 ADMIRAL AND U.S. PUBLIC HEALTH 2690 01:40:25,502 --> 01:40:27,037 SERVICES SERVES AS DIRECTOR OF 2691 01:40:27,037 --> 01:40:29,706 THE CDC NATIONAL CENTER FOR HIV 2692 01:40:29,706 --> 01:40:32,242 AIDS VIRAL HEPATITIS, STD AND TB 2693 01:40:32,242 --> 01:40:34,311 PREVENTION. 2694 01:40:34,311 --> 01:40:37,447 SO DR.S CHEEVER AND MIR MEN 2695 01:40:37,447 --> 01:40:39,149 SERVE AS CO-CHAIRS OF THE CHAT 2696 01:40:39,149 --> 01:40:42,252 WHICH WE HEARD ABOUT EARLIER IN 2697 01:40:42,252 --> 01:40:42,852 MAUREEN'S PRESENTATION. 2698 01:40:42,852 --> 01:40:47,123 THE CDC HRSA ADVISORY COMMITTEE 2699 01:40:47,123 --> 01:40:49,659 ON HIV VIRAL HEPATITIS AND STD 2700 01:40:49,659 --> 01:40:51,194 PREVENTION AND TREATMENT, WE 2701 01:40:51,194 --> 01:40:53,530 WILL FINALLY HEAR FROM THE HHS 2702 01:40:53,530 --> 01:40:57,167 OFFICE OF GLOBAL AFFAIRS PEPFAR 2703 01:40:57,167 --> 01:40:58,501 DIRECTOR DR. JIN PARK, AFTER 2704 01:40:58,501 --> 01:40:59,703 THEIR PRESENTATIONS WE WILL HAVE 2705 01:40:59,703 --> 01:41:02,806 A PANEL DISCUSSION WITH THE 2706 01:41:02,806 --> 01:41:03,406 OARAC MEMBERS. 2707 01:41:03,406 --> 01:41:05,809 SO I WILL PROCEED AND READ 2708 01:41:05,809 --> 01:41:07,911 INTRODUCTION FOR ALL OF SPEAKERS 2709 01:41:07,911 --> 01:41:13,650 AND I WILL PASS OVER MS. HAYES, 2710 01:41:13,650 --> 01:41:17,454 THE FIRST IS KAY HAYES DEDICATED 2711 01:41:17,454 --> 01:41:18,555 PASSIONATE PUBLIC HEALTH 2712 01:41:18,555 --> 01:41:20,090 OFFICIAL WITH 25 YEARS SERVICE 2713 01:41:20,090 --> 01:41:22,425 IN THE OASH. 2714 01:41:22,425 --> 01:41:23,927 SHE PROVIDES STEADFAST 2715 01:41:23,927 --> 01:41:25,161 LEADERSHIP AND POLICY 2716 01:41:25,161 --> 01:41:26,696 DEVELOPMENT WHILE ENCOURAGING 2717 01:41:26,696 --> 01:41:28,631 COORDINATION AND INNOVATION FROM 2718 01:41:28,631 --> 01:41:31,401 VARIOUS PROGRAMS INCLUDING HIV 2719 01:41:31,401 --> 01:41:34,037 VACCINES VIRAL HEPATITIS, STI, 2720 01:41:34,037 --> 01:41:37,374 BLOOD AND TISSUE SAFETY 2721 01:41:37,374 --> 01:41:41,111 ANTIMICROBIAL RHESUS TAN, TICK 2722 01:41:41,111 --> 01:41:42,445 BORNE DISEASES AND MORE. 2723 01:41:42,445 --> 01:41:46,249 DR. LAURA CHEEVER IS A BOARD 2724 01:41:46,249 --> 01:41:47,050 CERTIFIED PHI SESSION IN 2725 01:41:47,050 --> 01:41:48,251 INFECTIOUS DISEASE AND 2726 01:41:48,251 --> 01:41:51,654 RESPONSIBLE FOR LEADING THE HRSA 2727 01:41:51,654 --> 01:41:53,656 RYAN WHITE HIV AIDS PROGRAM AND 2728 01:41:53,656 --> 01:41:55,458 PROGRAMMING FOR PEPFAR. 2729 01:41:55,458 --> 01:41:58,428 AS EVERYONE KNOWS HERE THE RYAN 2730 01:41:58,428 --> 01:41:59,729 WHITE PROGRAM PROVIDES 2731 01:41:59,729 --> 01:42:01,030 COMPREHENSIVE SYSTEM OF HIV 2732 01:42:01,030 --> 01:42:03,700 PRIMARY MEDICAL CARE MEDICATION 2733 01:42:03,700 --> 01:42:05,068 AND ESSENTIAL SUPPORT SERVICES 2734 01:42:05,068 --> 01:42:08,538 FOR LOW INCOME PEOPLE WITH HIV 2735 01:42:08,538 --> 01:42:09,172 SERVING APPROXIMATELY HALF OF 2736 01:42:09,172 --> 01:42:13,009 THE U.S. POPULATION DIAGNOSED 2737 01:42:13,009 --> 01:42:15,612 WITH HIV ANNUALLY. 2738 01:42:15,612 --> 01:42:18,381 SO REAR ADMIRAL JONATHAN MIR MEN 2739 01:42:18,381 --> 01:42:20,917 OVERSEES THE NATIONAL EFFORTS TO 2740 01:42:20,917 --> 01:42:22,886 PREVENT HIV VIRAL HEPATITIS, 2741 01:42:22,886 --> 01:42:26,790 SEXUALLY TRANSMITTED DISEASES, 2742 01:42:26,790 --> 01:42:27,290 TUBERCULOSIS. 2743 01:42:27,290 --> 01:42:29,526 HIS DIVISION FOCUSES ON HIGH 2744 01:42:29,526 --> 01:42:30,427 IMPACT PREVENTION STRATEGIES 2745 01:42:30,427 --> 01:42:32,629 THAT ARE COST EFFECTIVE, 2746 01:42:32,629 --> 01:42:33,863 SCALABLE AND GROUNDED IN MANY 2747 01:42:33,863 --> 01:42:35,765 THE LATEST RESEARCH. 2748 01:42:35,765 --> 01:42:37,867 DR. MERMIN. 2749 01:42:37,867 --> 01:42:40,937 LASTLY DR. JIN PARK PROVIDES 2750 01:42:40,937 --> 01:42:43,706 COORDINATION AND LEADERSHIP FOR 2751 01:42:43,706 --> 01:42:47,977 THE HHS OFFICE OF GLOBAL AFFAIRS 2752 01:42:47,977 --> 01:42:49,345 PEPFAR, DEPARTMENT OF STATE 2753 01:42:49,345 --> 01:42:51,114 OFFICE OF GLOBAL AIDS 2754 01:42:51,114 --> 01:42:53,016 COORDINATOR WHICH IS ALSO KNOWN 2755 01:42:53,016 --> 01:42:56,219 AS SGAC AND THE INTERAGENCY 2756 01:42:56,219 --> 01:42:56,586 PEPFAR TEAMS. 2757 01:42:56,586 --> 01:43:00,957 HE REPRESENTS HHS PEPFAR GLOBAL 2758 01:43:00,957 --> 01:43:02,425 FUND AND OTHER INTERNATIONAL 2759 01:43:02,425 --> 01:43:03,193 GLOBAL HEALTH AND POLICY 2760 01:43:03,193 --> 01:43:03,593 MATTERS. 2761 01:43:03,593 --> 01:43:06,830 WITH THAT I WILL PASS IT OVER TO 2762 01:43:06,830 --> 01:43:08,298 YOU, MS. HAYES TO -- FOR YOUR 2763 01:43:08,298 --> 01:43:08,631 PRESENTATION. 2764 01:43:08,631 --> 01:43:10,700 THANK YOU. 2765 01:43:10,700 --> 01:43:11,668 >> THANK YOU SO MUCH. 2766 01:43:11,668 --> 01:43:13,870 I WOULD LIKE TO SAY THANK YOU TO 2767 01:43:13,870 --> 01:43:17,574 DR. MAUREEN GOODENOW FOR THIS 2768 01:43:17,574 --> 01:43:18,308 INVITATION TO PRESENT. 2769 01:43:18,308 --> 01:43:20,610 ALSO LIKE TO SAY THE WORK WE DO 2770 01:43:20,610 --> 01:43:21,945 IS INCREDIBLY IMPORTANT AND 2771 01:43:21,945 --> 01:43:25,582 UNDER LEADERSHIP OF ADMIRAL 2772 01:43:25,582 --> 01:43:29,886 RACHEL LEVINE WE ARE BUSY BUSY 2773 01:43:29,886 --> 01:43:30,453 BUSY. 2774 01:43:30,453 --> 01:43:32,121 SO TO GIVE LATE BACKGROUND ABOUT 2775 01:43:32,121 --> 01:43:33,923 THE OFFICE OF INFECTIOUS DISEASE 2776 01:43:33,923 --> 01:43:37,093 AND HIV AIDS POLICY, WE HAVE OUR 2777 01:43:37,093 --> 01:43:40,029 HANDS IN QUITE A LARGE PORTFOLIO 2778 01:43:40,029 --> 01:43:42,031 BASICALLY PROVIDING STRATEGIC 2779 01:43:42,031 --> 01:43:43,900 LEADERSHIP BUT WE DO A LOT OF 2780 01:43:43,900 --> 01:43:45,134 WORK COLLABORATION AND 2781 01:43:45,134 --> 01:43:46,436 COORDINATION, AND THAT IS HOW WE 2782 01:43:46,436 --> 01:43:50,273 HAVE TO GET OUR WORK DONE. 2783 01:43:50,273 --> 01:43:52,008 OIDP, OFFICE WE HAVE FIVE 2784 01:43:52,008 --> 01:43:53,009 FEDERAL ADVISORY COMMITTEES THAT 2785 01:43:53,009 --> 01:43:54,244 SIT SO WE ARE WORKING ON HIV 2786 01:43:54,244 --> 01:43:56,246 WHICH IS THE PRESIDENTIAL 2787 01:43:56,246 --> 01:43:58,248 ADVISORY COUNCIL FOR HIV AIDS. 2788 01:43:58,248 --> 01:44:00,817 KNOWN AS PACHA. 2789 01:44:00,817 --> 01:44:03,286 NATIONAL VACCINE ADVISORY NVAC. 2790 01:44:03,286 --> 01:44:06,589 WE HAVE OUR WORK ON OUR 2791 01:44:06,589 --> 01:44:08,124 ANTIMICROBIAL RESISTANCE, WORK 2792 01:44:08,124 --> 01:44:09,692 THERE AND THEN BLOOD AND TISSUE 2793 01:44:09,692 --> 01:44:13,630 SAFETY AND AVAILABILITY. 2794 01:44:13,630 --> 01:44:14,964 EXTREMELY BUSY BECAUSE OF THE 2795 01:44:14,964 --> 01:44:17,500 BLOOD SHORTAGES AND TICK BORNE 2796 01:44:17,500 --> 01:44:19,102 DISEASE WORKING GROUP. 2797 01:44:19,102 --> 01:44:21,104 SO WITH OUR FIVE ADVISORY 2798 01:44:21,104 --> 01:44:23,239 COMMITTEES STAY INCREDIBLY BUSY. 2799 01:44:23,239 --> 01:44:25,141 WE WORK IN A HOST OF DIFFERENT 2800 01:44:25,141 --> 01:44:26,910 POLICY INITIATIVES ACROSS I 2801 01:44:26,910 --> 01:44:28,044 WOULD THINK MOST IMPORTANTLY ONE 2802 01:44:28,044 --> 01:44:30,146 OF THE KEY THINGS WE WORK ON IS 2803 01:44:30,146 --> 01:44:33,583 THE MINORITY HIV AIDS FUND LED 2804 01:44:33,583 --> 01:44:37,587 BY DR. TIM HARRISSON AN TEAM AND 2805 01:44:37,587 --> 01:44:39,589 WITH STRATEGIC PLANS OIDP IS 2806 01:44:39,589 --> 01:44:41,457 RESPONSIBLE FOR LAUNCHING FOUR 2807 01:44:41,457 --> 01:44:41,724 VEG PLANS. 2808 01:44:41,724 --> 01:44:43,960 WE WORK ON HEPATITIS, WORKING 2809 01:44:43,960 --> 01:44:45,795 WITH THE WHITE HOUSE ON THE 2810 01:44:45,795 --> 01:44:49,999 NATIONAL HIV AIDS STRATEGY, 2811 01:44:49,999 --> 01:44:51,467 WORKING ON VACCINE AND THEN ALSO 2812 01:44:51,467 --> 01:44:55,905 WITH OUR TICK BORNE AREAS. 2813 01:44:55,905 --> 01:44:57,206 THE FIRST EVER SEXUALLY 2814 01:44:57,206 --> 01:45:00,143 TRANSMITTED INFECTIONS REPORT. 2815 01:45:00,143 --> 01:45:03,346 NEXT SLIDE. 2816 01:45:03,346 --> 01:45:05,248 WE WORK THROUGH ENDEMIC APPROACH 2817 01:45:05,248 --> 01:45:06,616 THIS IS INCREASINGLY MORE 2818 01:45:06,616 --> 01:45:08,184 IMPORTANT AS WE DO OUR WORK 2819 01:45:08,184 --> 01:45:10,420 BECAUSE WE CAN'T WORK IN SILOS. 2820 01:45:10,420 --> 01:45:12,422 DOESN'T MAKE SENSE TO WE LOOK AT 2821 01:45:12,422 --> 01:45:17,694 HIV STI HEP AND VACCINES ENDEMIC 2822 01:45:17,694 --> 01:45:19,429 APPROACH, ALSO WITH EYE ON 2823 01:45:19,429 --> 01:45:21,898 OPIOID CRISIS, BECAUSE ALL OF 2824 01:45:21,898 --> 01:45:23,333 THIS INTERSECTIONALITY INCLUDING 2825 01:45:23,333 --> 01:45:25,001 OUR MENTAL HEALTH. 2826 01:45:25,001 --> 01:45:29,072 NEXT SLIDE. 2827 01:45:29,072 --> 01:45:31,708 WHEN I TALK NATIONAL HIV AIDS 2828 01:45:31,708 --> 01:45:34,510 STRATEGY IT WAS RERELEASED 2829 01:45:34,510 --> 01:45:37,780 DECEMBER 1, 2021 BY WHITE HOUSE, 2830 01:45:37,780 --> 01:45:41,217 COUPLE OF ELEMENTS FOUR GOALS, 2831 01:45:41,217 --> 01:45:45,722 21 OBJECTIVES, I WANT TO SPOT WE 2832 01:45:45,722 --> 01:45:46,956 WORK ON ONE AGAIN MENTAL 2833 01:45:46,956 --> 01:45:48,291 INDICATOR, WORKING WITH THE 2834 01:45:48,291 --> 01:45:49,626 WHITE HOUSE CRITICALLY IMPORTANT 2835 01:45:49,626 --> 01:45:55,832 I WILL DELVE INTO A LITTLE BIT. 2836 01:45:55,832 --> 01:45:59,902 FOR REMINDER THE N HOUSE GOALS 2837 01:45:59,902 --> 01:46:01,004 PREVENTIVE WITH HIVE INFECTION, 2838 01:46:01,004 --> 01:46:02,438 IMPROVE HI RELATED HEALTH 2839 01:46:02,438 --> 01:46:04,440 OUTCOMES FOR PEOPLE LIVING WITH 2840 01:46:04,440 --> 01:46:09,679 HIV, REDUCE DISPARITIES, ACHIEVE 2841 01:46:09,679 --> 01:46:11,314 INTEGRATED COORDINATED EFFORT 2842 01:46:11,314 --> 01:46:14,417 ACROSS HHS AND ALSO LOOKING AT 2843 01:46:14,417 --> 01:46:15,818 ADDRESSING THE HIV EPIDEMIC 2844 01:46:15,818 --> 01:46:17,053 AMONG PARTNERS AND INTERESTED 2845 01:46:17,053 --> 01:46:20,923 PARTIES. 2846 01:46:20,923 --> 01:46:23,660 I WANT TO HIGHLIGHT KEY CHANGES 2847 01:46:23,660 --> 01:46:26,195 TO UPDATED NHOS. 2848 01:46:26,195 --> 01:46:29,532 ONE WE RECOGNIZE AND AMPLIFY 2849 01:46:29,532 --> 01:46:31,634 RACISM IS A SERIOUS PUBLIC 2850 01:46:31,634 --> 01:46:33,403 HEALTH THREAT THAT IS NOT KNEW 2851 01:46:33,403 --> 01:46:35,071 NEWS TO ANYONE ON THIS PLATFORM 2852 01:46:35,071 --> 01:46:35,972 BUT IT WAS IMPORTANT TO LET THAT 2853 01:46:35,972 --> 01:46:37,240 UP IN THE STRATEGY. 2854 01:46:37,240 --> 01:46:38,908 WE WANT TO TALK ABOUT REALLY 2855 01:46:38,908 --> 01:46:40,576 STRENGTHENING THE EMPHASIS ON 2856 01:46:40,576 --> 01:46:42,378 BETTER INTEGRATION. 2857 01:46:42,378 --> 01:46:45,581 THAT IS WHY KEY TO THE ENDEMIC 2858 01:46:45,581 --> 01:46:47,016 APPROACH TO WORK WE DO, NOTHING 2859 01:46:47,016 --> 01:46:48,351 IS IN ISOLATION. 2860 01:46:48,351 --> 01:46:51,020 IMPORTANT ROLE OF HARM WEDUCTION 2861 01:46:51,020 --> 01:46:54,957 AND SYRINGE SERVICES PROGRAMS 2862 01:46:54,957 --> 01:46:56,292 AND GROWING POPULATION OF PEOPLE 2863 01:46:56,292 --> 01:47:02,365 LIVING WITH HIV WHO ARE AGING. 2864 01:47:02,365 --> 01:47:04,667 OTHER KEY CHANGE IN UPDATED NHAS 2865 01:47:04,667 --> 01:47:06,536 CALLS FOR EXPANDING PEOPLE WITH 2866 01:47:06,536 --> 01:47:08,404 LIVED EXPERIENCE SHARING IT, 2867 01:47:08,404 --> 01:47:10,073 MAKING SURE THEY ARE INVOLVED IN 2868 01:47:10,073 --> 01:47:13,276 RESEARCH, PLANNING, DELIVERY, 2869 01:47:13,276 --> 01:47:14,377 ASSESSMENT, ALL ACROSS THE WORK 2870 01:47:14,377 --> 01:47:17,380 THAT WE DO. 2871 01:47:17,380 --> 01:47:18,815 POPULATIONS LIVING WITH OR 2872 01:47:18,815 --> 01:47:20,917 EXPERIENCING RISK FOR HIV AND 2873 01:47:20,917 --> 01:47:22,485 UNIQUE EXPERIENCES, AND COME TO 2874 01:47:22,485 --> 01:47:24,587 THE TABLE AND SHARE THAT WITH US 2875 01:47:24,587 --> 01:47:26,823 IN PLANNING. 2876 01:47:26,823 --> 01:47:30,026 WE WANT TO MAKE SURE WE ARE 2877 01:47:30,026 --> 01:47:32,228 WEAVING HIV RESEARCH ACROSS OUR 2878 01:47:32,228 --> 01:47:33,029 PORTFOLIO. 2879 01:47:33,029 --> 01:47:34,464 ONE KEY THING WE HAVE BEEN 2880 01:47:34,464 --> 01:47:37,800 WORKING MOST RECENTLY SO 2881 01:47:37,800 --> 01:47:39,869 CRITICAL IS OUR WORK ON HIV 2882 01:47:39,869 --> 01:47:41,070 CRIMINALIZATION LAWS, 2883 01:47:41,070 --> 01:47:42,205 ENCOURAGING REFORM, BECAUSE SO 2884 01:47:42,205 --> 01:47:44,974 MUCH OF THAT WORK IS AT THE 2885 01:47:44,974 --> 01:47:46,876 STATE LEVEL WE HAVE TO PROVIDE 2886 01:47:46,876 --> 01:47:48,044 UPDATED INFORMATION, ENCOURAGE 2887 01:47:48,044 --> 01:47:50,046 REFORM. 2888 01:47:50,046 --> 01:47:53,182 NEXT SLIDE. 2889 01:47:53,182 --> 01:47:55,151 I WOULD SAY SOME OF THE LAST KEY 2890 01:47:55,151 --> 01:47:57,253 CHANGES TO THE NHAS IS AS I 2891 01:47:57,253 --> 01:48:00,156 MENTIONED QUALITY OF LIFE, FOR 2892 01:48:00,156 --> 01:48:03,192 PEOPLE LIVING WITH HIV, THAT WAS 2893 01:48:03,192 --> 01:48:04,026 ONE AGAIN DEVELOPMENTAL MEASURES 2894 01:48:04,026 --> 01:48:06,796 THAT I TALKED ABOUT IN THIS NEW 2895 01:48:06,796 --> 01:48:10,099 NHAS, REALLY SHOUT OUT TO THE 2896 01:48:10,099 --> 01:48:11,334 INCREDIBLE WORK DURING COVID-19 2897 01:48:11,334 --> 01:48:13,136 AND LESSONS LEARNED IN 2898 01:48:13,136 --> 01:48:15,571 SUSTAINING SOME OF WHAT WE 2899 01:48:15,571 --> 01:48:16,706 LEARNED DURING COVID-19 AND 2900 01:48:16,706 --> 01:48:17,640 WORKING WITH COMMUNITIES. 2901 01:48:17,640 --> 01:48:18,775 TO ADDRESSING THE SOCIAL 2902 01:48:18,775 --> 01:48:20,943 DETERMINANTS OF HEALTH, 2903 01:48:20,943 --> 01:48:22,211 INCREASINGLY ENGAGING OUR WORK 2904 01:48:22,211 --> 01:48:23,212 WITH THE PRIVATE SECTOR. 2905 01:48:23,212 --> 01:48:25,648 WE SAY THAT IT IS A WHOLE OF 2906 01:48:25,648 --> 01:48:27,617 SOCIETY, WHOLE OF COMMUNITY, IT 2907 01:48:27,617 --> 01:48:29,585 IS ALL HANDS ON DECK SO 2908 01:48:29,585 --> 01:48:30,920 EMPHASIZING OUR WORK WITH THE 2909 01:48:30,920 --> 01:48:31,854 PRIVATE SECTOR AND THE WORK THAT 2910 01:48:31,854 --> 01:48:36,692 WE DO. 2911 01:48:36,692 --> 01:48:38,561 AS I MENTION QUALITY OF LIFE, 2912 01:48:38,561 --> 01:48:40,696 INDICATOR WE HAVE A WORK GROUP 2913 01:48:40,696 --> 01:48:42,698 AND IT WAS REALLY DESIGNED FOR 2914 01:48:42,698 --> 01:48:46,836 PEOPLE WITH HIV REALLY TALKING 2915 01:48:46,836 --> 01:48:50,473 ABOUT DATA SOURCES, WHAT IS FAIR 2916 01:48:50,473 --> 01:48:51,073 IN DEVELOPING THAT. 2917 01:48:51,073 --> 01:48:53,042 WE HAD A WORK GROUP CONVENED 2918 01:48:53,042 --> 01:48:54,744 AMONG FEDERAL PARTNERS TO GIVE 2919 01:48:54,744 --> 01:48:56,145 DATA FOR THAT AS WE MOVE 2920 01:48:56,145 --> 01:48:56,746 FORWARD. 2921 01:48:56,746 --> 01:48:58,447 SO THIS IS A ISSUE THAT I KNOW 2922 01:48:58,447 --> 01:49:01,517 THE WHITE HOUSE IS REALLY 2923 01:49:01,517 --> 01:49:02,819 INTERESTED IN P, AS WE MOVE 2924 01:49:02,819 --> 01:49:04,253 FORWARD, COMMUNITY IS VERY 2925 01:49:04,253 --> 01:49:06,022 INTERESTED IN, WHAT THAT LOOKS 2926 01:49:06,022 --> 01:49:08,124 LIKE, WE ARE STILL WORKING ON 2927 01:49:08,124 --> 01:49:11,294 EVERYTHING AROUND IT BUT IT WAS 2928 01:49:11,294 --> 01:49:15,164 DETERMINED TO BE DEVELOPMENTAL 2929 01:49:15,164 --> 01:49:18,201 INDICATOR. 2930 01:49:18,201 --> 01:49:20,002 WE TALK IMPLEMENTATION AS I SAID 2931 01:49:20,002 --> 01:49:21,137 WE CAN'T DO THIS ALONE SO 2932 01:49:21,137 --> 01:49:23,005 WORKING WITH OUR FEDERAL 2933 01:49:23,005 --> 01:49:24,640 PARTNERS, SO I WILL SAY OUR 2934 01:49:24,640 --> 01:49:27,076 FEDERAL PARTNERS ARE AMAZING. 2935 01:49:27,076 --> 01:49:31,147 AND I SEE DR. CHEEVER HERE, DR. 2936 01:49:31,147 --> 01:49:32,815 MERMIN HERE AND WE LEAN ON EACH 2937 01:49:32,815 --> 01:49:34,250 OTHER AND SO GRATEFUL FOR THE 2938 01:49:34,250 --> 01:49:37,353 WORK THEY ARE DOING AT HRSA AND 2939 01:49:37,353 --> 01:49:40,223 CDC AND OTHER FEDERAL PARTNERS, 2940 01:49:40,223 --> 01:49:41,924 NIH DR. GOODENOW AND BRINGING 2941 01:49:41,924 --> 01:49:42,525 THAT RESEARCH LENS TO WHAT WE 2942 01:49:42,525 --> 01:49:43,059 DO. 2943 01:49:43,059 --> 01:49:48,865 ALL OF US HAVE TO WORK TOGETHER. 2944 01:49:48,865 --> 01:49:51,834 AS I TALK ABOUT ENDING THE HIV 2945 01:49:51,834 --> 01:49:54,670 EPIDEMIC WE ARE STILL ON POINT. 2946 01:49:54,670 --> 01:49:58,774 OUR GOAL AND STRATEGIES WE ARE 2947 01:49:58,774 --> 01:50:02,845 STILL ON COURSE WE ARE LOOK AT 2948 01:50:02,845 --> 01:50:04,881 BEST PRACTICE AND WHAT IS 2949 01:50:04,881 --> 01:50:05,848 WORKING AND CORRECTIVE NEED BE 2950 01:50:05,848 --> 01:50:07,350 ON THINGS NOT WORKING AS WELL AS 2951 01:50:07,350 --> 01:50:08,084 WE WOULD LIKE. 2952 01:50:08,084 --> 01:50:09,719 DURING A COVID-19 PANDEMIC WE 2953 01:50:09,719 --> 01:50:12,588 ARE STILL MOVING FORWARD. 2954 01:50:12,588 --> 01:50:16,325 WE ARE ON FOCUS TARGET IN THE 2955 01:50:16,325 --> 01:50:20,329 EPIDEMIC BY 90% REDUCTION IN 2956 01:50:20,329 --> 01:50:24,066 2030. 2957 01:50:24,066 --> 01:50:25,868 OUR STRATEGIES ARE THE SAMEFUL 2958 01:50:25,868 --> 01:50:28,004 FOUR PILLARS DIAGNOSE, TREAT, 2959 01:50:28,004 --> 01:50:30,039 PREVENT AND RESPOND. 2960 01:50:30,039 --> 01:50:32,008 SO THAT IS SORT OF REMINDER OF 2961 01:50:32,008 --> 01:50:34,543 THE WORK THAT WE DO, WE HAD SOME 2962 01:50:34,543 --> 01:50:35,578 DISCUSSIONS ABOUT HOW WE DOING 2963 01:50:35,578 --> 01:50:38,881 IN EACH OF THE AREAS OF OUR 2964 01:50:38,881 --> 01:50:40,116 PILLARS, BUT THIS IS THE 2965 01:50:40,116 --> 01:50:41,651 FOUNDATION FOR THE ENDING THE 2966 01:50:41,651 --> 01:50:43,819 HIV EPIDEMIC. 2967 01:50:43,819 --> 01:50:47,056 NEXT SLIDE. 2968 01:50:47,056 --> 01:50:49,392 COUPLE OF EHE UPDATES. 2969 01:50:49,392 --> 01:50:52,128 WE GET THE QUESTION HOW IS EHE 2970 01:50:52,128 --> 01:50:55,097 OR IF IT IS ALIGNED WITH NHAS, 2971 01:50:55,097 --> 01:50:56,432 ABSOLUTELY YES. 2972 01:50:56,432 --> 01:50:58,868 SO THESE ARE WORKING IN TANDEM, 2973 01:50:58,868 --> 01:51:00,569 WE TALK ACCELERATION OF 2974 01:51:00,569 --> 01:51:02,171 APPROACHES, AND WE TALK ABOUT 2975 01:51:02,171 --> 01:51:04,507 STATUS NEUTRAL APPROACHES NO 2976 01:51:04,507 --> 01:51:05,007 WRONG DOOR. 2977 01:51:05,007 --> 01:51:07,743 THAT IS A KEY SALIENT POINT 2978 01:51:07,743 --> 01:51:10,646 LOOKING AT EHE IN NHAS AND WHICH 2979 01:51:10,646 --> 01:51:13,015 WANT TO SHOUT OUT DESPITE 2980 01:51:13,015 --> 01:51:14,650 COVID-19 JURISDICTION SOME 2981 01:51:14,650 --> 01:51:16,185 JURISDICTIONS HAVE SHOWN 2982 01:51:16,185 --> 01:51:17,019 TREMENDOUS PROGRESS. 2983 01:51:17,019 --> 01:51:20,289 THE WORK THAT HRSA HAS BEEN 2984 01:51:20,289 --> 01:51:22,325 DOING THROUGH LINE FIGHT PROGRAM 2985 01:51:22,325 --> 01:51:25,761 SCALING UP NEW CLIENTS REENGAGE 2986 01:51:25,761 --> 01:51:26,896 CLIENTS IS STILL KEY. 2987 01:51:26,896 --> 01:51:30,933 WE SEE CONTINUOUS SUPPORT 2988 01:51:30,933 --> 01:51:33,469 ADMINISTRATION FOR ENDING THE 2989 01:51:33,469 --> 01:51:37,273 HIV EPIDEMIC. 2990 01:51:37,273 --> 01:51:38,674 I LIKE TO SHARE NEW CAMPAIGN 2991 01:51:38,674 --> 01:51:41,444 THAT OIDP LAUNCHED THIS PAST 2992 01:51:41,444 --> 01:51:44,580 WEEKEND IN MIAMI. 2993 01:51:44,580 --> 01:51:45,915 IT IS A VIRAL SUPPRESSION 2994 01:51:45,915 --> 01:51:47,249 CAMPAIGN, I AM A WORK OF ART. 2995 01:51:47,249 --> 01:51:49,652 WHEN I TALK ABOUT WORKING 2996 01:51:49,652 --> 01:51:51,087 COMMUNITY FROM THE BEGINNING OF 2997 01:51:51,087 --> 01:51:53,556 A CAMPAIGN, THIS IS JUST THAT 2998 01:51:53,556 --> 01:51:54,957 CAMPAIGN. 2999 01:51:54,957 --> 01:51:56,459 OUR PARTNERS IN THE COMMUNITY IS 3000 01:51:56,459 --> 01:51:58,728 WHAT WE CALL OUR CREATIVE 3001 01:51:58,728 --> 01:52:00,563 PARTNERS. 3002 01:52:00,563 --> 01:52:06,936 AND SO NEXT SLIDE. 3003 01:52:06,936 --> 01:52:08,637 THIS CAMPAIGN AUDIENCE PEOPLE 3004 01:52:08,637 --> 01:52:09,872 DIAGNOSE WITH HIV BUT NOT IN 3005 01:52:09,872 --> 01:52:11,207 REGULAR CARE SO WE WANT THAT 3006 01:52:11,207 --> 01:52:14,176 TAKE AWAY MESSAGE ONE SEAT CARE, 3007 01:52:14,176 --> 01:52:16,712 REMAIN IN CARE AND ACHIEVE VIRAL 3008 01:52:16,712 --> 01:52:17,113 SUPPRESSION. 3009 01:52:17,113 --> 01:52:20,483 THE LAUNCH IN MIAMI SHOWCASED 3010 01:52:20,483 --> 01:52:21,984 OUR CREATIVE PARTNERS SO THEY 3011 01:52:21,984 --> 01:52:24,053 CAN TELL THEIR OWN STORY, IN 3012 01:52:24,053 --> 01:52:25,187 THEIR OWN WORDS. 3013 01:52:25,187 --> 01:52:29,959 IT WAS SO POWERFUL, NEXT SLIDE. 3014 01:52:29,959 --> 01:52:33,629 WE ARE TARGETING THIS CAMPAIGN 3015 01:52:33,629 --> 01:52:35,097 IMPLEMENTATION IN EIGHT EHE 3016 01:52:35,097 --> 01:52:37,133 PRIORITY AREAS. 3017 01:52:37,133 --> 01:52:40,236 SO IN THIS AREA WASHINGTON D.C. 3018 01:52:40,236 --> 01:52:43,072 BALTIMORE, MARYLAND, ATLANTA, 3019 01:52:43,072 --> 01:52:45,975 AND WE LAUNCHED IN MIAMI BUT YOU 3020 01:52:45,975 --> 01:52:47,877 WILL SEE WE HAVE EIGHT PRIORITY 3021 01:52:47,877 --> 01:52:50,846 AREAS FOR THE I AM A WORK OF ART 3022 01:52:50,846 --> 01:52:51,347 CAMPAIGN. 3023 01:52:51,347 --> 01:52:53,916 A NICE PLAY ON THE WORDS 3024 01:52:53,916 --> 01:52:57,853 ANTI-RETROVIRAL THERAPY. 3025 01:52:57,853 --> 01:53:00,956 NEXT SLIDE, SHOWING YOU A COUPLE 3026 01:53:00,956 --> 01:53:02,425 OF POSTERS THESE ARE OUR 3027 01:53:02,425 --> 01:53:04,560 CREATIVE PARTNERS. 3028 01:53:04,560 --> 01:53:06,796 AND THEY DID RADIO INTERVIEWS, 3029 01:53:06,796 --> 01:53:09,331 PUSHED OUT THE MESSAGES, AND IF 3030 01:53:09,331 --> 01:53:14,970 YOU GO TO HIV.GOV/I AM WORK OF 3031 01:53:14,970 --> 01:53:18,240 ART, YOU WILL SEE OUR CAMPAIGN 3032 01:53:18,240 --> 01:53:20,109 MATERIALS THERE I WANT TO 3033 01:53:20,109 --> 01:53:21,744 SHOWCASE ALL OF OUR CREATIVE 3034 01:53:21,744 --> 01:53:24,914 PARTNERS IN THIS CAMPAIGN. 3035 01:53:24,914 --> 01:53:28,217 NEXT SLIDE. 3036 01:53:28,217 --> 01:53:29,118 CLOSE OUT THE PRESENTATION I 3037 01:53:29,118 --> 01:53:30,486 WANT TO TALK ABOUT THE 3038 01:53:30,486 --> 01:53:32,588 PRESIDENTIAL ADVISORY COUNCIL 3039 01:53:32,588 --> 01:53:36,826 HIV AIDS PACHA, ONE OF THE FIVE 3040 01:53:36,826 --> 01:53:40,362 COUNCILS I NEED IN OIDP. 3041 01:53:40,362 --> 01:53:42,865 IN THIS HAS BEEN AROUND SINCE 3042 01:53:42,865 --> 01:53:43,265 1987. 3043 01:53:43,265 --> 01:53:45,167 WHEN RONALD REGAIN CREATED THE 3044 01:53:45,167 --> 01:53:47,069 PRESIDENT COMMISSION ON HIV AIDS 3045 01:53:47,069 --> 01:53:50,039 EPIDEMIC AT THE TIME. 3046 01:53:50,039 --> 01:53:52,241 THE COUNCIL HAS MEMBERSHIP OF 3047 01:53:52,241 --> 01:53:54,243 PROMINENT COMMUNITY LEADERS, 3048 01:53:54,243 --> 01:53:57,213 SOME FROM ACADEMIA, GLOBAL 3049 01:53:57,213 --> 01:53:59,048 HEALTH, IT IS A DIVERSE GROUP OF 3050 01:53:59,048 --> 01:54:03,786 LEADERS. 3051 01:54:03,786 --> 01:54:07,089 I WOULD SAY THAT IN THIS PAST 3052 01:54:07,089 --> 01:54:09,758 YEAR IN AUGUST AND NOVEMBER OF 3053 01:54:09,758 --> 01:54:12,962 2021 WE ADDED NEW MEMBERS TO 3054 01:54:12,962 --> 01:54:13,529 PACHA. 3055 01:54:13,529 --> 01:54:15,464 THE ROSTER REALLY DOES REFLECT 3056 01:54:15,464 --> 01:54:17,433 THE RACIAL ETHNIC SEXUAL AND 3057 01:54:17,433 --> 01:54:20,536 GENDER MINORITY AND GEOGRAPHIC 3058 01:54:20,536 --> 01:54:21,904 DIVERSITY OF THE HIV EPIDEMIC IN 3059 01:54:21,904 --> 01:54:24,974 THE U.S. TODAY. 3060 01:54:24,974 --> 01:54:27,510 WE ALSO WE HAVE SOME GAPS 3061 01:54:27,510 --> 01:54:28,244 STRATEGICALLY ALSO LOOKING TO 3062 01:54:28,244 --> 01:54:30,279 FILL. 3063 01:54:30,279 --> 01:54:32,982 WE WILL BE HAVING NEW MEMBERS 3064 01:54:32,982 --> 01:54:34,049 JOIN WORKING WITH THE WHITE 3065 01:54:34,049 --> 01:54:36,185 HOUSE ON THAT NOW. 3066 01:54:36,185 --> 01:54:38,154 TO ROUND OUT SO THERE ARE COUPLE 3067 01:54:38,154 --> 01:54:40,489 OF AREAS, HIV AND AGING IS ONE, 3068 01:54:40,489 --> 01:54:41,090 SO CRITICAL. 3069 01:54:41,090 --> 01:54:42,525 THAT WE WANT TO HAVE SOMEONE 3070 01:54:42,525 --> 01:54:43,259 WITH THAT EXPERIENCE. 3071 01:54:43,259 --> 01:54:47,163 WE ARE LOOKING AT WOMEN IN HIV. 3072 01:54:47,163 --> 01:54:51,700 SUBSTANCE MISUSE SYRINGE,CHANGE. 3073 01:54:51,700 --> 01:54:53,169 HIV AND HOUSING. 3074 01:54:53,169 --> 01:54:55,171 YOUNG PEOPLE WE HAVE MEMBERS 3075 01:54:55,171 --> 01:54:56,739 THAT ARE YOUNG AND SOME THAT 3076 01:54:56,739 --> 01:54:58,607 WHEN THEY STARTED OUT WITH 3077 01:54:58,607 --> 01:55:00,075 PERHAPS YOUNGER BUT WE WANT TO 3078 01:55:00,075 --> 01:55:01,577 MAKE SURE WE ARE TARGETING 3079 01:55:01,577 --> 01:55:03,445 MAKING SURE WE HAVE THE YOUNGER 3080 01:55:03,445 --> 01:55:05,481 VOICE AT THE TABLE HELPING US GO 3081 01:55:05,481 --> 01:55:06,382 THANK YOU THESE IMPORTANT 3082 01:55:06,382 --> 01:55:11,353 ISSUES. 3083 01:55:11,353 --> 01:55:12,588 COUPLE OF RECOMMENDATIONS ONE, 3084 01:55:12,588 --> 01:55:14,623 ABOUT THE INCREASE OF UPTAKE IN 3085 01:55:14,623 --> 01:55:19,862 READY STEP PREP PROGRAM. 3086 01:55:19,862 --> 01:55:22,898 ONLY SURING EQUITY AND JUSTICE 3087 01:55:22,898 --> 01:55:24,300 ENDING THE HIV EPIDEMIC. 3088 01:55:24,300 --> 01:55:25,935 OUR STIGMA DISPARITIES GROUP 3089 01:55:25,935 --> 01:55:27,937 HELD CONVENING A SMALL CONVENING 3090 01:55:27,937 --> 01:55:30,773 ON MOLECULAR SURVEILLANCE, SO WE 3091 01:55:30,773 --> 01:55:32,308 CAN HEAR FROM COMMUNITY VOICEOR 3092 01:55:32,308 --> 01:55:35,177 VOICES ALSO LOOKING AT SOME 3093 01:55:35,177 --> 01:55:37,479 OTHER STIGMA IN DISPARITY 3094 01:55:37,479 --> 01:55:38,314 ISSUES. 3095 01:55:38,314 --> 01:55:41,617 THE IMPACT ON COVID-19 HIV 3096 01:55:41,617 --> 01:55:42,618 PREVENTION AND TREATMENT ARE 3097 01:55:42,618 --> 01:55:43,986 KEY. 3098 01:55:43,986 --> 01:55:46,855 PACHA WORK ON CREATION DUE TO 3099 01:55:46,855 --> 01:55:49,858 NATIONAL PREP PROGRAM, EXTREMELY 3100 01:55:49,858 --> 01:55:50,259 SUPPORTIVE. 3101 01:55:50,259 --> 01:55:54,396 OF THE NATIONAL PREP PROGRAM. 3102 01:55:54,396 --> 01:55:55,931 AS I CLOSE OUT THIS I WANT TO 3103 01:55:55,931 --> 01:55:59,501 TALK ABOUT PACHA TO THE PEOPLE. 3104 01:55:59,501 --> 01:56:01,704 FEDERAL ADVISORY, WE DECIDED TO 3105 01:56:01,704 --> 01:56:04,073 TAKE OUR ADVISORY COUNCIL ON THE 3106 01:56:04,073 --> 01:56:05,307 ROAD AND OUT OF WASHINGTON D.C. 3107 01:56:05,307 --> 01:56:07,209 AREA INTO COMMUNITIES. 3108 01:56:07,209 --> 01:56:10,446 BEFORE COVID-19 AND WE WERE 3109 01:56:10,446 --> 01:56:12,548 ISOLATING WE WERE IN JACKSON, 3110 01:56:12,548 --> 01:56:15,884 MISSISSIPPI MIAMI, FLORIDA AND 3111 01:56:15,884 --> 01:56:17,953 WASHINGTON D.C. AS PART OF THAT 3112 01:56:17,953 --> 01:56:19,154 WE GO TO COMMUNITY BASED 3113 01:56:19,154 --> 01:56:20,889 ORGANIZATIONS AND WE HAVE OUR 3114 01:56:20,889 --> 01:56:24,426 FEDERAL PARTNERS AND OUR PACHA 3115 01:56:24,426 --> 01:56:27,096 MEMBERS GO ON THESE SITE VISITS 3116 01:56:27,096 --> 01:56:29,498 AND HAVE CANDID CONVERSATIONS 3117 01:56:29,498 --> 01:56:31,200 WITH COMMUNITY LEADERS. 3118 01:56:31,200 --> 01:56:32,868 WE ARE PLANNING NEXT MEETING 3119 01:56:32,868 --> 01:56:35,771 LOOKING TO HAVE THAT IN LOS 3120 01:56:35,771 --> 01:56:37,072 ANGELES IN SEPTEMBER SO MORE TO 3121 01:56:37,072 --> 01:56:37,740 COME ON THAT. 3122 01:56:37,740 --> 01:56:39,775 THE SAME SORT OF FORMAT. 3123 01:56:39,775 --> 01:56:42,678 WE WILL GO TO COMMUNITY BASED 3124 01:56:42,678 --> 01:56:43,879 ORGANIZATIONS AND WORK WITH 3125 01:56:43,879 --> 01:56:45,447 REGIONAL COLLEAGUES BUT IT IS 3126 01:56:45,447 --> 01:56:46,915 REALLY AN OPPORTUNITY TO GET 3127 01:56:46,915 --> 01:56:48,917 DIFFERENT VOICES, NEW VOICES, 3128 01:56:48,917 --> 01:56:51,253 THAT COME INTO THIS SPACE AND 3129 01:56:51,253 --> 01:56:52,054 PROVIDE COMMENT. 3130 01:56:52,054 --> 01:56:53,822 SO IT HAS BEEN A SUCCESSFUL 3131 01:56:53,822 --> 01:56:56,792 MODEL WE WILL CONTINUE TO USE. 3132 01:56:56,792 --> 01:57:03,799 SEPTEMBER 19 AND 20, IN LA, MORE 3133 01:57:03,799 --> 01:57:09,705 TO COME. 3134 01:57:09,705 --> 01:57:10,873 THANK YOU FOR THE OPPORTUNITY. 3135 01:57:10,873 --> 01:57:12,007 LOOK FORWARD TO ANY QUESTIONS 3136 01:57:12,007 --> 01:57:13,842 LATER. 3137 01:57:13,842 --> 01:57:17,613 >> THANK YOU MS. HAYES. 3138 01:57:17,613 --> 01:57:19,848 WE WILL MOVE AHEAD TO DR. LAURA 3139 01:57:19,848 --> 01:57:20,382 CHEEVER. 3140 01:57:20,382 --> 01:57:26,955 >> HUE FOR THE INVITA THANK YOU. 3141 01:57:26,955 --> 01:57:33,262 (INAUDIBLE) OUR REASON TO 3142 01:57:33,262 --> 01:57:35,831 STUDENTS TO ALL AGES AT CENTER 3143 01:57:35,831 --> 01:57:38,967 FOR THE UNITED STATES. 3144 01:57:38,967 --> 01:57:41,537 WE PROVIDE (INAUDIBLE) 3145 01:57:41,537 --> 01:57:43,772 RESOURCES, WE ARE ALSO GOING TO 3146 01:57:43,772 --> 01:57:46,842 BE WORKING -- QUALITY CARE IN 3147 01:57:46,842 --> 01:57:47,476 THE UNITED STATES IN THE 3148 01:57:47,476 --> 01:57:57,953 (INAUDIBLE) PRIMARY CARE FOR 3149 01:58:03,759 --> 01:58:05,561 SUPPORT SERVICES. 3150 01:58:05,561 --> 01:58:15,137 WE (INAUDIBLE) PATIENT EMERGENCY 3151 01:58:15,137 --> 01:58:19,341 HOUSING, EMERGENCY (INAUDIBLE) 3152 01:58:19,341 --> 01:58:27,182 CHILD CARE (INAUDIBLE) OUR 3153 01:58:27,182 --> 01:58:28,050 GRANTS (INAUDIBLE) CITY STATE 3154 01:58:28,050 --> 01:58:31,487 COMMUNITY BASED ORGANIZATIONS 3155 01:58:31,487 --> 01:58:32,821 PROVIDE SOCIAL SERVICES. 3156 01:58:32,821 --> 01:58:35,057 IMPORTANTLY RECIPIENTS AT LOCAL 3157 01:58:35,057 --> 01:58:37,893 LEVEL BASED ON PERCEPTION DEFINE 3158 01:58:37,893 --> 01:58:41,130 THEIR FUNDING PRIORITY SO WE DO 3159 01:58:41,130 --> 01:58:44,967 NOT HAVE (INAUDIBLE) LAST 3160 01:58:44,967 --> 01:58:51,039 RESORT. 3161 01:58:51,039 --> 01:58:53,709 BY STATUTE, (INAUDIBLE) 3162 01:58:53,709 --> 01:58:55,277 COMPLICATED, FACILITIES PART D 3163 01:58:55,277 --> 01:58:57,146 GOES TO STATE AS WELL AS 3164 01:58:57,146 --> 01:58:59,581 (INAUDIBLE) PROGRAM, THE 3165 01:58:59,581 --> 01:59:01,583 (INAUDIBLE) PROGRAM FUNDS OVER 3166 01:59:01,583 --> 01:59:04,787 HALF VIRAL INDUCED IN THE UNITED 3167 01:59:04,787 --> 01:59:14,229 STATES (INAUDIBLE) PART C 3168 01:59:14,229 --> 01:59:15,664 FUNDING DIRECT TO COMMUNITY 3169 01:59:15,664 --> 01:59:20,869 BASED CLINIC PART D FOCUS ON 3170 01:59:20,869 --> 01:59:23,705 LIMITS (INAUDIBLE) SPECIFIED 3171 01:59:23,705 --> 01:59:25,174 NATIONAL PARTICIPANTS SO WE CAN 3172 01:59:25,174 --> 01:59:27,276 (INAUDIBLE) DO NOT HAVE ANY 3173 01:59:27,276 --> 01:59:28,710 AUTHORITY TO DO RESEARCH WHICH 3174 01:59:28,710 --> 01:59:32,014 IS WHY WE WORK CLOSE WITH 3175 01:59:32,014 --> 01:59:34,483 INMATES COLLEAGUES BUT THAT $25 3176 01:59:34,483 --> 01:59:38,854 MILLION A YEAR FOR (INAUDIBLE) 3177 01:59:38,854 --> 01:59:40,856 GRANTS SMALL PART AND SMALL PART 3178 01:59:40,856 --> 01:59:45,561 (INAUDIBLE) HERE YOU SEE BREAK 3179 01:59:45,561 --> 01:59:48,564 UP OF APPROPRIATION, MOST -- 3180 01:59:48,564 --> 01:59:50,232 WHERE THE MONEY DOES GO TO PART 3181 01:59:50,232 --> 01:59:51,667 D PROGRAM THE STATE PROGRAM BUT 3182 01:59:51,667 --> 01:59:55,304 OF THAT 90 MILLION IS FOR 3183 01:59:55,304 --> 01:59:57,539 REQUISITE MEDICATION WHICH MEANS 3184 01:59:57,539 --> 02:00:01,176 IF YOU ARE STATE WITHOUT LARGE 3185 02:00:01,176 --> 02:00:02,744 CITY, STATES HAVE LIMIT 3186 02:00:02,744 --> 02:00:06,081 (INAUDIBLE) MEDICATION. 3187 02:00:06,081 --> 02:00:08,750 THE PART A (INAUDIBLE) THE OTHER 3188 02:00:08,750 --> 02:00:10,652 IMPORTANT THING I WILL MAKE 3189 02:00:10,652 --> 02:00:11,820 ABOUT THIS IS OUR CORPORATION 3190 02:00:11,820 --> 02:00:14,122 HAS BEEN MAINTAINED IN THE 3191 02:00:14,122 --> 02:00:15,457 FEDERAL GOVERNMENT FOR THE PAST 3192 02:00:15,457 --> 02:00:18,126 DECADE WHICH MEANS THAT AS 3193 02:00:18,126 --> 02:00:19,995 MEDICINES AND OTHER THINGS 3194 02:00:19,995 --> 02:00:20,696 (INAUDIBLE) HAVE NOT BEEN 3195 02:00:20,696 --> 02:00:27,870 (INAUDIBLE) I WAS ASKED TO SHOW 3196 02:00:27,870 --> 02:00:30,506 HOW ORGANIZED -- SO I HAVE A 3197 02:00:30,506 --> 02:00:38,847 SMALL FRONT OFFICE, 30 THE RIGHT 3198 02:00:38,847 --> 02:00:40,849 SIDE OF THE SLIDE IS OUR PART C 3199 02:00:40,849 --> 02:00:43,519 AND D PROGRAM, ONE DIVISION PART 3200 02:00:43,519 --> 02:00:45,254 D PROGRAM IS SECOND DIVISION, 3201 02:00:45,254 --> 02:00:48,190 PART A PROGRAM IS THIRD 3202 02:00:48,190 --> 02:00:51,393 DIVISION. 3203 02:00:51,393 --> 02:00:52,528 DIVISION POLICY AND DATA AND 3204 02:00:52,528 --> 02:00:56,632 SPECIAL PROJECTS (INAUDIBLE) WE 3205 02:00:56,632 --> 02:00:59,568 HAVE OFFICE OF SUPPORT THAT 3206 02:00:59,568 --> 02:01:00,369 COORDINATES TECHNICAL ASSISTANTS 3207 02:01:00,369 --> 02:01:02,070 THAT HAPPENS ACROSS OUR BUREAU 3208 02:01:02,070 --> 02:01:09,878 AS WELL AS (INAUDIBLE) 3209 02:01:09,878 --> 02:01:15,050 >> SO WITHIN THE PROGRAM IN 3210 02:01:15,050 --> 02:01:16,385 2020, 561,000 PEOPLE WE DIDN'T 3211 02:01:16,385 --> 02:01:18,186 SEE DROP OFF DURING THE 3212 02:01:18,186 --> 02:01:21,523 PANDEMIC, NUMBER OF PEEP SERVED. 3213 02:01:21,523 --> 02:01:25,160 OF THAT 75% OF OUR CLIENTS ARE 3214 02:01:25,160 --> 02:01:28,130 RACIAL ETHNIC MINORITIES. 3215 02:01:28,130 --> 02:01:29,264 50 PEST BELOW POVERTY LINE, 3216 02:01:29,264 --> 02:01:32,167 AFTER ARE OVER 50 AND THAT IS A 3217 02:01:32,167 --> 02:01:33,835 BIG CHANGE, (INAUDIBLE) AND YOU 3218 02:01:33,835 --> 02:01:38,473 CAN SEE THERE THAT WE HAVE ABOUT 3219 02:01:38,473 --> 02:01:39,408 PEOPLE TEMPORARY OR UNSTABLE 3220 02:01:39,408 --> 02:01:44,212 HOUSING. 3221 02:01:44,212 --> 02:01:46,114 ON THE SLIDE IT GETS TO THE WORK 3222 02:01:46,114 --> 02:01:49,318 THAT WE HAVE BEEN DOING THE LAST 3223 02:01:49,318 --> 02:01:50,819 TEN YEARS. 3224 02:01:50,819 --> 02:01:52,788 THIS SLIDE SHOW VIRAL 3225 02:01:52,788 --> 02:01:54,389 SUPPRESSION RATES AMONG 3226 02:01:54,389 --> 02:01:57,326 (INAUDIBLE) PROGRAM MEDICAL 3227 02:01:57,326 --> 02:01:59,361 CARE, LOOKING AT COMMUNITY AND 3228 02:01:59,361 --> 02:02:02,864 DARK BLUE BARS AND THEN 2020 IN 3229 02:02:02,864 --> 02:02:05,000 THE LIGHT BLUE BARS. 3230 02:02:05,000 --> 02:02:08,370 SO IN 2010 THIS IS A KEY 3231 02:02:08,370 --> 02:02:10,138 POPULATION FAR LEFT-HAND SIDE 3232 02:02:10,138 --> 02:02:12,474 OVERALL OUR VIRAL SUPPRESSION 3233 02:02:12,474 --> 02:02:15,043 RATE IS 69.5%. 3234 02:02:15,043 --> 02:02:18,880 THAT WENT TO 89.4 BY 2020, 3235 02:02:18,880 --> 02:02:21,750 FOCUSED VERY MUCH ON (INAUDIBLE) 3236 02:02:21,750 --> 02:02:23,785 AS YOU CAN SEE IN THE DASH LOWER 3237 02:02:23,785 --> 02:02:28,056 LINE GOING ACROSS WE HAVE 3238 02:02:28,056 --> 02:02:28,857 DISPARITYINGS, THE SECOND TO 3239 02:02:28,857 --> 02:02:30,892 LAST SET OF BARS, VIRAL 3240 02:02:30,892 --> 02:02:33,395 SUPPRESSION RATE WAS 46.6% 3241 02:02:33,395 --> 02:02:34,396 DIFFERENCE. 3242 02:02:34,396 --> 02:02:37,733 OVERALL BETWEEN 2010 AND 2020 3243 02:02:37,733 --> 02:02:40,502 SUPPRESSION WENT UP TO 19 BUT 3244 02:02:40,502 --> 02:02:42,237 YOU CAN SEE FOR YOUTH FOR 3245 02:02:42,237 --> 02:02:46,975 EXAMPLE THEIR VIRAL SUPPRESSION 3246 02:02:46,975 --> 02:02:50,612 INCLUDES 39 -- 34.9 SO WE HAD A 3247 02:02:50,612 --> 02:02:52,347 REDUCTION IN THE DISPARITIES 3248 02:02:52,347 --> 02:02:54,149 THAT WE SAW IN 2010. 3249 02:02:54,149 --> 02:02:56,685 HOWEVER, IF YOU LOOK ACROSS THE 3250 02:02:56,685 --> 02:03:00,122 LIGHTER DOTTED LINE AT TOP, 3251 02:03:00,122 --> 02:03:04,292 DISPARITIES PERSIST FOR PEOPLE 3252 02:03:04,292 --> 02:03:06,194 THAT (INAUDIBLE) SMALL BUT 3253 02:03:06,194 --> 02:03:10,999 IMPORTANT DISPARITIES. 3254 02:03:10,999 --> 02:03:13,201 SO OUR STRATEGIES PROMOTING 3255 02:03:13,201 --> 02:03:15,070 HEALTH EQUITY REDUCING 3256 02:03:15,070 --> 02:03:18,073 DISPARITIES FALL INTO FIVE -- 3257 02:03:18,073 --> 02:03:21,043 ACTIVE PROCESS OF COMMUNITY 3258 02:03:21,043 --> 02:03:23,045 ENGAGEMENT, BEFORE PANDEMIC WE 3259 02:03:23,045 --> 02:03:26,481 TRAVEL TO ALL EHE -- ENGAGE 3260 02:03:26,481 --> 02:03:27,683 COMMUNITIES HERE DIRECTLY -- YOU 3261 02:03:27,683 --> 02:03:29,251 WILL HEAR FROM THEM, WE HAVE 3262 02:03:29,251 --> 02:03:30,452 DONE THAT VIRTUALLY DURING THE 3263 02:03:30,452 --> 02:03:31,653 PANDEMIC AND ONCE YOU GET INPUT 3264 02:03:31,653 --> 02:03:34,189 FROM THE COMMUNITY (INAUDIBLE) 3265 02:03:34,189 --> 02:03:35,557 IMPORTANT THING WE TELL THE 3266 02:03:35,557 --> 02:03:40,062 COMMUNITY WHAT WE DID, 3267 02:03:40,062 --> 02:03:40,996 (INAUDIBLE) WE HAVE QUALITY 3268 02:03:40,996 --> 02:03:43,732 MANAGERS AS PART OF OUR 3269 02:03:43,732 --> 02:03:44,599 LEGISLATION BUT WE SUPPORT 3270 02:03:44,599 --> 02:03:46,001 CONSUMER QUALITY IMPROVEMENT. 3271 02:03:46,001 --> 02:03:48,770 WE HAVE SERIES OF LARGE 3272 02:03:48,770 --> 02:03:51,506 COLLABORATORS FOCUSED ON KEY 3273 02:03:51,506 --> 02:03:56,144 POPULATIONS YOUNG BLACK OR 3274 02:03:56,144 --> 02:03:57,713 TRANSGENDER FOCUSED ON IMPROVING 3275 02:03:57,713 --> 02:03:59,014 VIRAL SUPPRESSION RATES IN 3276 02:03:59,014 --> 02:04:02,784 POPULATIONS ACROSS THE COUNTRY 3277 02:04:02,784 --> 02:04:05,654 VARIOUS (INAUDIBLE) WE LOOK AT 3278 02:04:05,654 --> 02:04:07,656 SERVICE DELIVERY MODELS 3279 02:04:07,656 --> 02:04:08,724 INCLUDING THE INTEGRATION OF 3280 02:04:08,724 --> 02:04:10,058 SOME OF THESE POTENTIAL SUPPORT 3281 02:04:10,058 --> 02:04:12,360 SERVICES THAT HELP ADDRESS 3282 02:04:12,360 --> 02:04:16,331 SOCIAL DETERMINANTS OF HEALTH 3283 02:04:16,331 --> 02:04:17,699 AND (INAUDIBLE) FOCUS OUR 3284 02:04:17,699 --> 02:04:21,870 EFFORTS ON AS WELL AS 3285 02:04:21,870 --> 02:04:23,171 (INAUDIBLE) WE HAVE VERY 3286 02:04:23,171 --> 02:04:26,508 DELIBERATELY EMPLOYED -- WE 3287 02:04:26,508 --> 02:04:29,177 START AT THE LOCATION 3288 02:04:29,177 --> 02:04:34,249 (INAUDIBLE) WORKING WITH NIH 3289 02:04:34,249 --> 02:04:39,855 COLLEAGUES FROM -- (INAUDIBLE). 3290 02:04:39,855 --> 02:04:43,258 IN TERMS OF ENDING THE EPIDEMIC, 3291 02:04:43,258 --> 02:04:46,161 PEOPLE STARTED LEFT HAND SIDE 3292 02:04:46,161 --> 02:04:47,429 WITH DIFFICULT IMPORTANT PART OF 3293 02:04:47,429 --> 02:04:50,599 THE WORK WE HAVE TO DO ENGAGING 3294 02:04:50,599 --> 02:04:53,135 PEOPLE WHO KNOW THEY HAVE 3295 02:04:53,135 --> 02:04:55,670 (INAUDIBLE) THAT IS REALLY 3296 02:04:55,670 --> 02:05:00,375 RETOOLING HOW WE PROVIDE 3297 02:05:00,375 --> 02:05:02,110 SERVICES THE SECOND GROUP OF 3298 02:05:02,110 --> 02:05:04,346 PEEP DIAGNOSED AS A RESULT OF 3299 02:05:04,346 --> 02:05:09,918 EHE MAKING SURE WE HAVE GOOD 3300 02:05:09,918 --> 02:05:11,853 ENGAGEMENT PROCESSES AND PROGRAM 3301 02:05:11,853 --> 02:05:13,321 AND OPINIONLY WE HAVE STILL 3302 02:05:13,321 --> 02:05:15,857 ABOUT 11% PEOPLE IN AND OUTSIDE 3303 02:05:15,857 --> 02:05:19,594 OF THE (INAUDIBLE) SO HAVING 3304 02:05:19,594 --> 02:05:26,168 LOWER BARRIERS TO BE ABLE TO 3305 02:05:26,168 --> 02:05:30,505 IMPROVE THAT LAST (INAUDIBLE). 3306 02:05:30,505 --> 02:05:33,508 SO DURING -- IN THE (INAUDIBLE) 3307 02:05:33,508 --> 02:05:38,079 FUNDING IN APRIL OF MARCH OF 3308 02:05:38,079 --> 02:05:40,115 2020 RIGHT WHEN COVID HIT SO WE 3309 02:05:40,115 --> 02:05:44,452 DIDN'T KNOW A LOT WOULD HAPPEN 3310 02:05:44,452 --> 02:05:47,155 BUT (INAUDIBLE) PEOPLE WERE ABLE 3311 02:05:47,155 --> 02:05:50,559 DO THINGS DIFFERENTLY, 3312 02:05:50,559 --> 02:05:53,995 STREAMLINING EARLY EXPERIENCES 3313 02:05:53,995 --> 02:05:58,800 AND DEVELOPING (INAUDIBLE) RAPID 3314 02:05:58,800 --> 02:06:00,702 ART HAS BEEN A STRATEGY USING IN 3315 02:06:00,702 --> 02:06:07,409 A LOT OF RAPID ART (INAUDIBLE) 3316 02:06:07,409 --> 02:06:11,546 AND WE KNOW FOR US THE EHE ONE 3317 02:06:11,546 --> 02:06:15,350 OF THE MIGHT BE -- IF WE BROUGHT 3318 02:06:15,350 --> 02:06:21,256 HOME THOUSAND PEOPLE (INAUDIBLE) 3319 02:06:21,256 --> 02:06:24,359 SO WE HAVE BEEN -- IN PARTICULAR 3320 02:06:24,359 --> 02:06:25,627 CLEAR NAVIGATORS AND COMMUNITY 3321 02:06:25,627 --> 02:06:26,928 HEALTH WORKERS TO REACH PEOPLE 3322 02:06:26,928 --> 02:06:28,997 WHO ARE OUT CARE, NOT 3323 02:06:28,997 --> 02:06:36,771 (INAUDIBLE) SO THE ADVISORY 3324 02:06:36,771 --> 02:06:38,373 COMMITTEE -- WE ARE EXCITED WE 3325 02:06:38,373 --> 02:06:43,511 HAVE THIS JOINT COMMITTEE HRSA 3326 02:06:43,511 --> 02:06:47,182 AND (INAUDIBLE) PROCESS TOGETHER 3327 02:06:47,182 --> 02:06:48,984 AND ON THE ADVISORY COMMITTEE WE 3328 02:06:48,984 --> 02:06:51,419 ARE LOOKING AT THE (INAUDIBLE) 3329 02:06:51,419 --> 02:06:56,992 HIV VIRAL HEPATITIS AND OTHER 3330 02:06:56,992 --> 02:06:59,361 STD ENDEMIC APPROACH, SUPPORT 3331 02:06:59,361 --> 02:07:01,229 HEALTH SERVICES FOR PEOPLE WITH 3332 02:07:01,229 --> 02:07:03,431 HIV, HEALTH PROFESSIONS AND OR 3333 02:07:03,431 --> 02:07:07,168 AGENCIES RESPONSIBLE FOR 3334 02:07:07,168 --> 02:07:08,970 PREVENTING HEALTH SERVICE 3335 02:07:08,970 --> 02:07:10,672 DELIVERY NEEDS IN THE COMMUNITY. 3336 02:07:10,672 --> 02:07:15,944 ONE EXAMPLE OF THINGS -- ONE IS 3337 02:07:15,944 --> 02:07:18,546 LOOKING SPECIFICALLY AT 3338 02:07:18,546 --> 02:07:20,248 TELEHEALTH, WHAT HAPPENS IN 3339 02:07:20,248 --> 02:07:23,151 TELEHEALTH AND HOW DO WE WANT TO 3340 02:07:23,151 --> 02:07:24,586 MOVE IT FORWARD FOR THINGS LIKE 3341 02:07:24,586 --> 02:07:26,521 HEALTH EQUITY, DIGITAL DIVIDE 3342 02:07:26,521 --> 02:07:28,790 QUITE A BIT MORE DISCUSSION. 3343 02:07:28,790 --> 02:07:32,761 THINKING HOW WE CAN DO PREP MORE 3344 02:07:32,761 --> 02:07:40,001 WITH RESPECT TO TELEHEALTH. 3345 02:07:40,001 --> 02:07:47,275 AND STI SCREENING IMPROVING 3346 02:07:47,275 --> 02:07:49,678 (INAUDIBLE) SPECIFICALLY AND 3347 02:07:49,678 --> 02:07:50,078 FDA. 3348 02:07:50,078 --> 02:07:51,780 IN TERMS OF WORK FORCE, THAT IS 3349 02:07:51,780 --> 02:07:54,516 ALSO COME UP QUITE A BIT ABOUT 3350 02:07:54,516 --> 02:07:56,751 TALKING ABOUT BURN OUT. 3351 02:07:56,751 --> 02:08:05,727 HOW WE CAN DO A BETTER JOB 3352 02:08:05,727 --> 02:08:09,197 (INAUDIBLE) POPULATION STD 3353 02:08:09,197 --> 02:08:10,231 HEPATITIS AND (INAUDIBLE). 3354 02:08:10,231 --> 02:08:12,067 NEXT SLIDE. 3355 02:08:12,067 --> 02:08:13,835 WITH THAT I WILL CONCLUDE THESE 3356 02:08:13,835 --> 02:08:15,837 ARE MY CONTACT INFORMATION AND I 3357 02:08:15,837 --> 02:08:21,176 WILL TURN IT OVER TO JOHN. 3358 02:08:21,176 --> 02:08:24,279 >> CAPTAIN GLENSHAW CAN YOU HEAR 3359 02:08:24,279 --> 02:08:24,679 ME? 3360 02:08:24,679 --> 02:08:26,915 OKAY THANK YOU SO MUCH, LAURA. 3361 02:08:26,915 --> 02:08:30,085 IT IS A TRUE SIGN OF 3362 02:08:30,085 --> 02:08:32,654 COLLABORATION THAT WE REALLY DO 3363 02:08:32,654 --> 02:08:35,757 WORK WELL TOGETHER AS FRIENDS, 3364 02:08:35,757 --> 02:08:38,059 COLLEAGUES AND AGENCIES, AND I 3365 02:08:38,059 --> 02:08:41,429 THINK THE IDEA THAT THERE IS IN 3366 02:08:41,429 --> 02:08:43,331 FACT FEDERAL ADVISORY COMMITTEE 3367 02:08:43,331 --> 02:08:47,502 THAT CROSSES AGENCIES IS A SIGN 3368 02:08:47,502 --> 02:08:50,071 OF HOW IMPORTANT THAT IS AND HOW 3369 02:08:50,071 --> 02:08:53,241 HELPFUL IT CAN BE ENCOURAGING 3370 02:08:53,241 --> 02:08:54,242 COLLABORATION AND AND WORKING 3371 02:08:54,242 --> 02:08:56,478 TOGETHER AND SOLVING PROBLEMS. 3372 02:08:56,478 --> 02:08:58,580 I AM -- I HAVE PREVIOUSLY TO 3373 02:08:58,580 --> 02:09:00,015 THIS GROUP GIVEN UPDATE ON A LOT 3374 02:09:00,015 --> 02:09:04,519 OF WHAT WE ARE DOING FOR HIV 3375 02:09:04,519 --> 02:09:06,287 EPIDEMIC SO FOR THIS PARTICULAR 3376 02:09:06,287 --> 02:09:08,690 PART OF THIS KIND OF AGENCY 3377 02:09:08,690 --> 02:09:13,094 UPDATE I WILL FOCUS ON COUPLE OF 3378 02:09:13,094 --> 02:09:14,929 THINGS, ENDEMIC APPROACH WHY IT 3379 02:09:14,929 --> 02:09:18,600 IS IMPORTANT FOR US AND KAY AND 3380 02:09:18,600 --> 02:09:20,769 LAURA TALKED ABOUT THAT. 3381 02:09:20,769 --> 02:09:24,205 SOME UPDATES OF CHAT MEETING, 3382 02:09:24,205 --> 02:09:26,508 AND A LITTLE ASSIGNED TASK FROM 3383 02:09:26,508 --> 02:09:27,609 DR. GOODENOW WHICH WAS 3384 02:09:27,609 --> 02:09:29,611 COLLABORATION WITHIN THE NIH 3385 02:09:29,611 --> 02:09:32,680 WHICH ARE EXTENSIVE AND 3386 02:09:32,680 --> 02:09:32,947 IMPORTANT. 3387 02:09:32,947 --> 02:09:34,549 NEXT SLIDE PLEASE. 3388 02:09:34,549 --> 02:09:37,652 THE FIRST IS MY CENTER NATIONAL 3389 02:09:37,652 --> 02:09:39,421 CENTER FOR HIV VIRAL HEPATITIS 3390 02:09:39,421 --> 02:09:41,523 AND TB PREVENTION GREW OUT OF 3391 02:09:41,523 --> 02:09:46,494 THE PAIN OF THE HIV EPIDEMIC AND 3392 02:09:46,494 --> 02:09:49,564 IS ALWAYS HAD BOTH VISION OF 3393 02:09:49,564 --> 02:09:52,233 TACKLING THESE INFECTIONS BUT 3394 02:09:52,233 --> 02:09:54,335 BECAUSE MANY OF THEM ARE CHRONIC 3395 02:09:54,335 --> 02:09:57,338 INFECTIOUS DISEASES AND MANY OF 3396 02:09:57,338 --> 02:10:00,341 THEM HAVE STIGMA OR 3397 02:10:00,341 --> 02:10:00,942 DISCRIMINATION ASSOCIATED, WE 3398 02:10:00,942 --> 02:10:02,010 HAVE ALWAYS TAKEN IN THE SOCIAL 3399 02:10:02,010 --> 02:10:03,111 DETERMINANTS AND INCORPORATED 3400 02:10:03,111 --> 02:10:05,847 INTO HOW WE ARE TRYING TO 3401 02:10:05,847 --> 02:10:07,449 ADDRESS SOLVING OR PROBLEMS. 3402 02:10:07,449 --> 02:10:10,118 ARE GETTING PERT AT IT. 3403 02:10:10,118 --> 02:10:12,654 IT IS A WORKS IN PROGRESS. 3404 02:10:12,654 --> 02:10:14,622 I HAVE FIVE DIVISIONS ONE ON HIV 3405 02:10:14,622 --> 02:10:17,592 ONE ON STI, ONE ON TD 3406 02:10:17,592 --> 02:10:19,694 ELIMINATION VIRAL HEPATITIS AND 3407 02:10:19,694 --> 02:10:21,596 ANOTHER DIVISION OF ADOLESCENT 3408 02:10:21,596 --> 02:10:22,697 SCHOOL HEALTH THAT WORKS 3409 02:10:22,697 --> 02:10:24,132 DIRECTLY WITH EDUCATIONAL 3410 02:10:24,132 --> 02:10:26,568 AGENCIES IN THE STATE LOCAL 3411 02:10:26,568 --> 02:10:30,538 LEVEL AND PRODUCES CURRICULUM 3412 02:10:30,538 --> 02:10:31,339 TOOLS. 3413 02:10:31,339 --> 02:10:34,242 AND RUNS YOUTH RISK BEHAVIORAL 3414 02:10:34,242 --> 02:10:35,243 SURVEILLANCE SYSTEM WHICH 3415 02:10:35,243 --> 02:10:37,812 MONITORS THE HEALTH OF YOUTH IN 3416 02:10:37,812 --> 02:10:39,681 THE NATION IN A NATIONALLY 3417 02:10:39,681 --> 02:10:41,449 REPRESENTATIVE WAY AND STATE 3418 02:10:41,449 --> 02:10:45,053 LEVEL FOR MANY STATES. 3419 02:10:45,053 --> 02:10:46,421 SO I WANTED TO TALK ABOUT WHAT I 3420 02:10:46,421 --> 02:10:51,025 THINK IT IS A LITTLE BIT TOO 3421 02:10:51,025 --> 02:10:56,131 POMPOUS TO CALL THESE ENDEMIC 3422 02:10:56,131 --> 02:10:57,832 APPROACH BUT A ENDEMIC APPROACH. 3423 02:10:57,832 --> 02:10:59,200 YOU SAW SO MANY DISEASES 3424 02:10:59,200 --> 02:11:00,268 RESPONSIBLE BUT THERE IS 3425 02:11:00,268 --> 02:11:02,036 POPULATION CLUSTERING OF THE 3426 02:11:02,036 --> 02:11:03,905 SOCIAL AND HEALTH ISSUE -- THE 3427 02:11:03,905 --> 02:11:05,140 SOCIAL ECONOMIC ISSUES THAT 3428 02:11:05,140 --> 02:11:06,708 CAUSE THESE HEALTH ISSUES. 3429 02:11:06,708 --> 02:11:08,676 SO I WANT TO HIGHLIGHT WHY 3430 02:11:08,676 --> 02:11:10,011 PEOPLE, WHY PLACE, WHY SCIENCE 3431 02:11:10,011 --> 02:11:12,347 AND POLICY ALL MATTER WHEN 3432 02:11:12,347 --> 02:11:13,481 THINKING ABOUT GETTING THE JOB 3433 02:11:13,481 --> 02:11:14,582 DONE THROUGH THIS ENDEMIC 3434 02:11:14,582 --> 02:11:18,052 APPROACH. 3435 02:11:18,052 --> 02:11:19,120 JOHN DID YOU HAVE YOUR HAND UP? 3436 02:11:19,120 --> 02:11:20,755 DID YOU WANT TO SAY SOMETHING 3437 02:11:20,755 --> 02:11:25,593 ABOUT MY PRIOR SLIDE? 3438 02:11:25,593 --> 02:11:28,663 >> ERROR ON MY PART SORRY. 3439 02:11:28,663 --> 02:11:31,332 >> YOU ARE WELCOME. 3440 02:11:31,332 --> 02:11:33,801 PEOPLE MATTER. 3441 02:11:33,801 --> 02:11:39,807 IT OFTEN SEEING DISPARITIES IN 3442 02:11:39,807 --> 02:11:42,143 DISEASE INVIGORATE AS ROBUST 3443 02:11:42,143 --> 02:11:43,511 RESPONSE IN US TO THINK IT IS A 3444 02:11:43,511 --> 02:11:45,480 REFLECTION OF PUBLIC HEALTH 3445 02:11:45,480 --> 02:11:47,248 INJUSTICE AN WE SHOULD CHANGE 3446 02:11:47,248 --> 02:11:47,815 THAT. 3447 02:11:47,815 --> 02:11:50,185 IT IS AN OPPORTUNITY TO MAKE A 3448 02:11:50,185 --> 02:11:51,953 BIGGER DIFFERENCE BECAUSE IF YOU 3449 02:11:51,953 --> 02:11:53,621 FOCUS YOUR EFFORTS AND BRING 3450 02:11:53,621 --> 02:11:56,057 RESOURCES TO PEOPLE WHO ARE MOST 3451 02:11:56,057 --> 02:11:57,392 EFFECT ED YOU WILL GET THE JOB 3452 02:11:57,392 --> 02:11:58,826 DONE BETTER. 3453 02:11:58,826 --> 02:12:01,362 THAT WE HAVE BEEN ASSIGNED BY 3454 02:12:01,362 --> 02:12:02,964 CONGRESS AND AMERICAN PEOPLE SO 3455 02:12:02,964 --> 02:12:04,899 ONE JUST TO HIGHLIGHT HOW SOME 3456 02:12:04,899 --> 02:12:07,402 OF THE CONCENTRATIONS OF OUR 3457 02:12:07,402 --> 02:12:08,870 INFECTIONS FOR MEN WHO HAVE SEX 3458 02:12:08,870 --> 02:12:10,605 WITH MEN IN THE UNITED STATES 3459 02:12:10,605 --> 02:12:14,576 70% HIV DIAGNOSES ARE AMONG GAY 3460 02:12:14,576 --> 02:12:17,345 BISEXUAL MEN, 42% PRIMARY AND 3461 02:12:17,345 --> 02:12:20,181 SECONDARY SYPHILIS, 17% 3462 02:12:20,181 --> 02:12:20,548 CHLAMYDIA. 3463 02:12:20,548 --> 02:12:22,517 PEOPLE WHO INJECT DRUGS MOST 3464 02:12:22,517 --> 02:12:25,053 ACUTE NEW HEPATITIS C VIRUS 3465 02:12:25,053 --> 02:12:26,854 INFECTIONS AND LARGE PROPORTION 3466 02:12:26,854 --> 02:12:30,391 OF HEPATITIS D VIRUS INFECTION 3467 02:12:30,391 --> 02:12:33,494 ACQUIRED AMONG YOUNG ADULTS AND 3468 02:12:33,494 --> 02:12:35,129 11% OCCUR AMONG PEOPLE WHO 3469 02:12:35,129 --> 02:12:37,799 INJECT DRUGS, THERE IS A LARGE 3470 02:12:37,799 --> 02:12:39,901 PROPORTION OF OVERDOSE DEATHS. 3471 02:12:39,901 --> 02:12:42,370 A GROUP THAT GETS AFFECTED 3472 02:12:42,370 --> 02:12:45,206 DEEPLY BY SOME OF THESE 3473 02:12:45,206 --> 02:12:50,745 INFECTIONS, IN THE CASE OF 3474 02:12:50,745 --> 02:12:52,380 OVERDOSES THERE ARE ALSO STARK 3475 02:12:52,380 --> 02:12:54,215 RACIAL ETHNIC DISPARITIES 3476 02:12:54,215 --> 02:12:55,683 AFRICAN AMERICANS ARE EIGHT 3477 02:12:55,683 --> 02:12:57,452 TIMES HISPANIC LATINOS THREE 3478 02:12:57,452 --> 02:13:00,021 TIMES MORE LIKELY TO GET NEW HIV 3479 02:13:00,021 --> 02:13:02,056 INFECTION AND MORE THAN A THIRD 3480 02:13:02,056 --> 02:13:06,461 OF TB HEPATITIS B AMONG ASIAN 3481 02:13:06,461 --> 02:13:06,828 AMERICANS. 3482 02:13:06,828 --> 02:13:09,831 AS FOR MANY OF US AS A VERY 3483 02:13:09,831 --> 02:13:11,599 IMPORTANT ISSUE JUSTICE INVOLVED 3484 02:13:11,599 --> 02:13:12,900 POPULATIONS HAVE HIGHER 3485 02:13:12,900 --> 02:13:16,671 INCIDENCE OF ALL THESE 3486 02:13:16,671 --> 02:13:18,306 INFECTIONS AND THEN SO MAKING 3487 02:13:18,306 --> 02:13:20,708 SURE WHAT WE ARE DOING FROM A 3488 02:13:20,708 --> 02:13:22,844 PUBLIC HEALTH STANDPOINT THINKS 3489 02:13:22,844 --> 02:13:25,146 ABOUT CORRECTIONAL INSTITUTIONS 3490 02:13:25,146 --> 02:13:27,982 AND THEIR OPPORTUNITIES IS 3491 02:13:27,982 --> 02:13:28,616 IMPORTANT TOO. 3492 02:13:28,616 --> 02:13:30,952 SO I ALSO WANTED TO TALK HOW 3493 02:13:30,952 --> 02:13:33,154 PLACE MATTERS. 3494 02:13:33,154 --> 02:13:34,756 THIS IS TWO MAPS. 3495 02:13:34,756 --> 02:13:37,025 ON THE RIGHT IS MAP OF THE 3496 02:13:37,025 --> 02:13:38,359 ENDING HIV EPIDEMIC PRIORITY 3497 02:13:38,359 --> 02:13:39,093 AREAS. 3498 02:13:39,093 --> 02:13:40,461 IN THIS MAP I WANT YOU TO LOOK 3499 02:13:40,461 --> 02:13:43,298 AT THAT TIME DARK BLUE COUNTIES. 3500 02:13:43,298 --> 02:13:44,532 THESE DARK BLUE COUNTIES SHOULD 3501 02:13:44,532 --> 02:13:46,734 BE HARD TO SEE BECAUSE THERE ARE 3502 02:13:46,734 --> 02:13:49,604 ONLY 50 OF THEM, IF YOU INCLUDE 3503 02:13:49,604 --> 02:13:50,471 SAWN HON JUAN AND WASHINGTON 3504 02:13:50,471 --> 02:13:53,908 D.C. AS COUNTIES AND COMPARED TO 3505 02:13:53,908 --> 02:13:55,643 3,300 COUNTIES IN AMERICAN. 3506 02:13:55,643 --> 02:13:57,845 SO 50% INFECTIONS ARE IN THE 3507 02:13:57,845 --> 02:13:59,213 PRETTY CONCENTRATED INTO THESE 3508 02:13:59,213 --> 02:14:01,215 AREAS SO IF WE CAN DO A GOOD JOB 3509 02:14:01,215 --> 02:14:04,118 AND FOCUS OUR EFFORTS AT LEAST 3510 02:14:04,118 --> 02:14:04,886 DISPROPORTIONATELY IN THOSE 3511 02:14:04,886 --> 02:14:07,088 AREAS WE WILL MAKE A DIFFERENCE 3512 02:14:07,088 --> 02:14:11,926 FASTER AND BETTER THAN IF WE 3513 02:14:11,926 --> 02:14:14,529 DISTRIBUTE WITHOUT THAT IN MIND. 3514 02:14:14,529 --> 02:14:16,197 WE ALSO DID INTERNAL CALCULATION 3515 02:14:16,197 --> 02:14:19,000 WHERE WE DID SIMILAR CONCEPT FOR 3516 02:14:19,000 --> 02:14:20,868 OUR OTHER INFECTIONS TOO SO IF 3517 02:14:20,868 --> 02:14:23,905 YOU LOOK AT CHLAMYDIA, 3518 02:14:23,905 --> 02:14:26,007 GONORRHEA, SYPHILIS AND TB, IF 3519 02:14:26,007 --> 02:14:28,543 YOU ARE IN THE SAME TOP 50% YOUR 3520 02:14:28,543 --> 02:14:30,745 COUNTY GETS INCLUDED AND DARKER 3521 02:14:30,745 --> 02:14:38,086 COLOR YOU ARE, SO DARK MAGENTA 3522 02:14:38,086 --> 02:14:41,322 VERSUS LAUGH DAR, AQUA, MEANS 3523 02:14:41,322 --> 02:14:43,991 YOU ARE COUNTY THAT HAS HIGH 3524 02:14:43,991 --> 02:14:46,661 NUMBER OF THOSE OTHER INFECTIONS 3525 02:14:46,661 --> 02:14:47,228 TOO. 3526 02:14:47,228 --> 02:14:48,863 MULTIPLE INFECTIONS, SO WHAT YOU 3527 02:14:48,863 --> 02:14:52,367 CAN SEE IS IT IS NOT THAT MANY 3528 02:14:52,367 --> 02:14:54,569 COUNTIES AND THERE'S OVERLAP FOR 3529 02:14:54,569 --> 02:14:55,937 MANY OF THESE COUNTIES. 3530 02:14:55,937 --> 02:14:57,405 SO AGAIN NOT THE JUST 3531 02:14:57,405 --> 02:15:00,608 POPULATIONS AND GROUPS OF PEOPLE 3532 02:15:00,608 --> 02:15:01,576 DISPROPORTIONATELY AFFECTED BY B 3533 02:15:01,576 --> 02:15:03,244 GEOGRAPHIC AREAS. 3534 02:15:03,244 --> 02:15:06,013 IT REMIND US OF HOW WE CAN MAKE 3535 02:15:06,013 --> 02:15:06,881 A DIFFERENCE BY FOCUSING ON 3536 02:15:06,881 --> 02:15:07,281 THAT. 3537 02:15:07,281 --> 02:15:09,350 I WILL SAY ALTHOUGH THIS IS 3538 02:15:09,350 --> 02:15:12,019 NATIONAL LEVEL FOR EVERY STATE 3539 02:15:12,019 --> 02:15:13,788 THEY ALSO CAN BE THINKING ABOUT 3540 02:15:13,788 --> 02:15:15,790 HOW AM I DISTRIBUTING MY 3541 02:15:15,790 --> 02:15:16,257 RESOURCES? 3542 02:15:16,257 --> 02:15:17,592 THERE ARE PRESSURES FROM HEALTH 3543 02:15:17,592 --> 02:15:18,693 DEPARTMENTS FROM ALL OVER TO 3544 02:15:18,693 --> 02:15:20,261 DISTRIBUTE EQUALLY, TO MAKE SURE 3545 02:15:20,261 --> 02:15:22,563 THAT EVERYONE HAS THE CAPACITY, 3546 02:15:22,563 --> 02:15:26,634 TO REALLY LOOK CAREFULLY PLACES 3547 02:15:26,634 --> 02:15:27,535 DISPROPORTIONATELY AFFECTED IN 3548 02:15:27,535 --> 02:15:28,536 POPULATIONS GETTING THE 3549 02:15:28,536 --> 02:15:30,638 RESOURCES THEY NEED. 3550 02:15:30,638 --> 02:15:32,607 THEN OBVIOUSLY WITHIN LOCAL 3551 02:15:32,607 --> 02:15:33,741 JURISDICTIONS, IT IS ALSO NOT 3552 02:15:33,741 --> 02:15:34,976 THE SAME. 3553 02:15:34,976 --> 02:15:37,311 I LIVE IN DECAB COUNTY, GEORGIA, 3554 02:15:37,311 --> 02:15:40,681 THAT IS A HUGE COUNTY, IT IS NOT 3555 02:15:40,681 --> 02:15:43,384 ALL DECALB COUNTY, SOMETIMES IT 3556 02:15:43,384 --> 02:15:45,353 IS JUST A FEW BLOCKS MAKING SURE 3557 02:15:45,353 --> 02:15:46,721 RESOURCES ARE AVAILABLE WHETHER 3558 02:15:46,721 --> 02:15:47,555 TESTING TREATMENT OR REMEMBER, 3559 02:15:47,555 --> 02:15:53,094 IT CAN MAKE A BIG DIFFERENCE. 3560 02:15:53,094 --> 02:15:54,495 SO WHAT ARE POTENTIAL BENEFITS 3561 02:15:54,495 --> 02:15:55,630 OF USING THIS ENDEMIC? 3562 02:15:55,630 --> 02:15:56,964 ONE IS HOLISTIC SERVICE 3563 02:15:56,964 --> 02:15:57,665 DELIVERY. 3564 02:15:57,665 --> 02:16:00,635 SO JUST AS A PRIMARY CARE DOC MY 3565 02:16:00,635 --> 02:16:04,338 JOB IS TO THINK ABOUT ALL OF THE 3566 02:16:04,338 --> 02:16:06,741 HEALTH OF A PATIENT SO THEY CAN 3567 02:16:06,741 --> 02:16:09,010 LIVE A LONG HEALTHY LIFE. 3568 02:16:09,010 --> 02:16:10,111 IT CAN BE FRUSTRATING IF YOU 3569 02:16:10,111 --> 02:16:11,579 HAVE TO GO TO DIFFERENT 3570 02:16:11,579 --> 02:16:13,014 SPECIALISTS. 3571 02:16:13,014 --> 02:16:14,215 BUT IF YOU CAN BE GUIDE WITH 3572 02:16:14,215 --> 02:16:16,417 PRIMARY CARE DOC THAT CAN BE 3573 02:16:16,417 --> 02:16:17,251 HELPFUL. 3574 02:16:17,251 --> 02:16:19,520 AND PATIENTS OFTEN FRUSTRATED BY 3575 02:16:19,520 --> 02:16:20,988 NOT BEING ABLE TO HAVE SOMEONE 3576 02:16:20,988 --> 02:16:22,757 CARE ABOUT THEM THEIR WHOLE 3577 02:16:22,757 --> 02:16:23,224 SELF. 3578 02:16:23,224 --> 02:16:25,393 AND INCLUDING SOME OF THE 3579 02:16:25,393 --> 02:16:26,928 FACTORS THAT ARE SOCIAL AROUND 3580 02:16:26,928 --> 02:16:28,629 THEM RATHER THAN OR IN THEM OR 3581 02:16:28,629 --> 02:16:30,531 IN THEIR COMMUNITY RATHER THAN 3582 02:16:30,531 --> 02:16:31,866 JUST MEDICALIZE IT. 3583 02:16:31,866 --> 02:16:33,835 THAT ALSO HAPPENS AT A 3584 02:16:33,835 --> 02:16:35,837 POPULATION LEVEL, THERE IS A WAY 3585 02:16:35,837 --> 02:16:38,639 WE ARE FRUSTRATED WHEN DOING HIV 3586 02:16:38,639 --> 02:16:41,275 PROGRAMS, AND WE CAN'T 3587 02:16:41,275 --> 02:16:42,710 INCORPORATE SOME OF THE WORK IN 3588 02:16:42,710 --> 02:16:43,845 ADJUSTING SOCIAL ECONOMIC 3589 02:16:43,845 --> 02:16:48,549 DETERMINANTS. 3590 02:16:48,549 --> 02:16:50,117 LAURA HIGHLIGHTED HOW EFFECTIVE 3591 02:16:50,117 --> 02:16:51,552 THE RYAN WHITE CARE ACT PROGRAM 3592 02:16:51,552 --> 02:16:53,488 HAS BEEN IN REDUCING SOME OF THE 3593 02:16:53,488 --> 02:16:55,823 DISPARITIES THAT EXISTED BEFORE 3594 02:16:55,823 --> 02:16:57,258 HER ARRIVAL AND FIRST FEW YEARS 3595 02:16:57,258 --> 02:16:58,326 OF HER JOB. 3596 02:16:58,326 --> 02:17:00,428 SO THAT FOCUS HAS MADE A HUGE 3597 02:17:00,428 --> 02:17:01,062 DIFFERENCE. 3598 02:17:01,062 --> 02:17:02,330 WHAT IS INTERESTING IS WHAT IS 3599 02:17:02,330 --> 02:17:03,598 ABSENT NOW, AND WE CAN TALK 3600 02:17:03,598 --> 02:17:06,434 ABOUT THAT LATER IS IF THE RYAN 3601 02:17:06,434 --> 02:17:10,171 WHITE PROGRAM IS DOING SO WELL, 3602 02:17:10,171 --> 02:17:11,739 WHY IS I'M SORRY DENSE STILL 3603 02:17:11,739 --> 02:17:11,939 HIGH? 3604 02:17:11,939 --> 02:17:15,109 WHAT IS GOING ON, PEOPLE WHO ARE 3605 02:17:15,109 --> 02:17:16,210 CHURNING IN AND OUT CARE OR 3606 02:17:16,210 --> 02:17:17,945 PEOPLE WHO AREN'T GET INK TO 3607 02:17:17,945 --> 02:17:19,046 CARE GETTING DIAGNOSED IN THE 3608 02:17:19,046 --> 02:17:19,413 FIRST PLACE. 3609 02:17:19,413 --> 02:17:21,883 SO WE HAVE TO KEEP THAT IN MIND 3610 02:17:21,883 --> 02:17:22,416 THAT EVERYONE LIVING HERE 3611 02:17:22,416 --> 02:17:25,887 MATTERS. 3612 02:17:25,887 --> 02:17:27,488 ENDEMIC APPROACHES CAN INCREASE 3613 02:17:27,488 --> 02:17:29,490 COST EFFECTIVENESS, IF THEY ARE 3614 02:17:29,490 --> 02:17:30,825 DONE WELL THEY CAN SAVE MONEY. 3615 02:17:30,825 --> 02:17:32,326 THEY CAN REDUCE STIGMA, BECAUSE 3616 02:17:32,326 --> 02:17:34,095 YOU HAVE A HOLISTIC APPROACH AND 3617 02:17:34,095 --> 02:17:35,196 PEOPLE AREN'T JUST GOING TO THE 3618 02:17:35,196 --> 02:17:36,030 HIV CLINIC. 3619 02:17:36,030 --> 02:17:37,899 SUPPORT FOCUS ON POLICY AND 3620 02:17:37,899 --> 02:17:39,133 SOCIAL DETERMINANT OF HEALTH 3621 02:17:39,133 --> 02:17:39,667 DRIVERS. 3622 02:17:39,667 --> 02:17:41,369 YOU HAVE TO DO THAT. 3623 02:17:41,369 --> 02:17:44,906 IF YOU ARE THINKING ABOUT THIS 3624 02:17:44,906 --> 02:17:46,374 ENDEMIC APPROACH IN THAT WAY 3625 02:17:46,374 --> 02:17:47,975 THAT DOESN'T HAPPEN IF YOU ARE 3626 02:17:47,975 --> 02:17:49,944 THINKING MOSTLY FOR CERTAIN 3627 02:17:49,944 --> 02:17:52,547 INDIVIDUAL DISEASES, IT FORCES 3628 02:17:52,547 --> 02:17:54,982 THIS PERSPECTIVE IN A POSITIVE 3629 02:17:54,982 --> 02:17:55,149 WAY. 3630 02:17:55,149 --> 02:17:56,717 IT CAN INCREASE FLEXIBILITY BY 3631 02:17:56,717 --> 02:17:58,719 ENABLING PARTNERS TO ADAPT AND 3632 02:17:58,719 --> 02:18:00,922 IMPLEMENT AND MODIFY INTEGRATED 3633 02:18:00,922 --> 02:18:02,723 SERVICES SO THEY CAN BE MORE 3634 02:18:02,723 --> 02:18:04,492 RESPONSIVE TO OUTBREAKS OR 3635 02:18:04,492 --> 02:18:06,160 CHANGE IN CONTEXT AND PROVIDES 3636 02:18:06,160 --> 02:18:07,595 PARTNERS WITH INCREASE CONTRACT 3637 02:18:07,595 --> 02:18:09,063 AND ABILITY TO PROVIDE 3638 02:18:09,063 --> 02:18:10,164 COMPREHENSIVE SERVICES WHICH CAN 3639 02:18:10,164 --> 02:18:14,902 BE BENEFICIAL. 3640 02:18:14,902 --> 02:18:16,304 INTERNALLY WE HAVE BEEN THINKING 3641 02:18:16,304 --> 02:18:17,672 ABOUT WHAT ARE THE MOST HIGH 3642 02:18:17,672 --> 02:18:19,407 IMPACT ENDEMIC STRATEGIES? 3643 02:18:19,407 --> 02:18:20,474 BECAUSE NOT EVERYTHING IS GOING 3644 02:18:20,474 --> 02:18:21,943 TO MAKE THE GREATEST DIFFERENCE 3645 02:18:21,943 --> 02:18:23,844 AND WHAT IS BUBBLELING UP TO THE 3646 02:18:23,844 --> 02:18:26,747 TOP IS MULTI-PATHOGEN TESTING. 3647 02:18:26,747 --> 02:18:29,850 IT IS PRETTY FREQUENT YOU CAN GO 3648 02:18:29,850 --> 02:18:31,719 GET A PLACE ROUTINE HIV 3649 02:18:31,719 --> 02:18:32,286 SCREENING IN EMERGENCY 3650 02:18:32,286 --> 02:18:35,256 DEPARTMENT AND NOT DOING ROUTINE 3651 02:18:35,256 --> 02:18:37,792 HEPATITIS C SCREENING THOUGH NOT 3652 02:18:37,792 --> 02:18:39,160 PREVENTED BY U.S. PREVENTIVE 3653 02:18:39,160 --> 02:18:40,428 TASK FORCE CDC. 3654 02:18:40,428 --> 02:18:42,863 SO AN EXAMPLE OF THINKING 3655 02:18:42,863 --> 02:18:44,398 MULTI-PATHOGEN IF YOU ARE GOING 3656 02:18:44,398 --> 02:18:45,633 TO DRAW BLOOD OR SET UP A 3657 02:18:45,633 --> 02:18:46,634 STANDING ORDER IN THE LAB THAT 3658 02:18:46,634 --> 02:18:48,202 IS GOING TO CHECK THE ELECTRONIC 3659 02:18:48,202 --> 02:18:49,303 MEDICAL RECORD AND AUTOMATICALLY 3660 02:18:49,303 --> 02:18:50,605 ADD ON THE TEST TO YOUR 3661 02:18:50,605 --> 02:18:52,273 CHOLESTEROL TEST IF YOU DON'T 3662 02:18:52,273 --> 02:18:53,507 HAVE SOMETHING IN RECORD. 3663 02:18:53,507 --> 02:18:56,944 DO IT FOR INFECTIONS THAT THAT 3664 02:18:56,944 --> 02:18:57,979 POPULATION HAVE A HIGHER 3665 02:18:57,979 --> 02:19:00,281 FREQUENCY OF RATHER THAN JUST 3666 02:19:00,281 --> 02:19:04,619 ONE. 3667 02:19:04,619 --> 02:19:06,320 POLICY CHANGE, THERE IS A LOT OF 3668 02:19:06,320 --> 02:19:07,655 THINGS WE CAN DO WHETHER 3669 02:19:07,655 --> 02:19:10,958 MEDICAID EXPANSION OR WHETHER 3670 02:19:10,958 --> 02:19:12,159 STUDENT SERVICE PROGRAM 3671 02:19:12,159 --> 02:19:12,960 LEGISLATION, THERE ARE THINGS 3672 02:19:12,960 --> 02:19:14,528 THAT CAN SET ENABLING 3673 02:19:14,528 --> 02:19:15,930 ENVIRONMENT AT THE POLICY LEVEL 3674 02:19:15,930 --> 02:19:17,632 THAT WILL AFFECT MULTIPLE 3675 02:19:17,632 --> 02:19:17,999 OUTCOMES. 3676 02:19:17,999 --> 02:19:20,568 NOT JUST INFECTIOUS DISEASE BUT 3677 02:19:20,568 --> 02:19:23,337 SOMETIMES SOME OF THOSE CHANGES 3678 02:19:23,337 --> 02:19:25,039 AFFECT PEOPLE ENTIRE LIFE 3679 02:19:25,039 --> 02:19:26,874 EXEMPTION FANCY AS WELL AS WELL 3680 02:19:26,874 --> 02:19:28,442 BEING -- EXPECTANCY AS WELL AS 3681 02:19:28,442 --> 02:19:28,943 WELL BEING. 3682 02:19:28,943 --> 02:19:31,345 PREVENTION AND OUTBREAKS WE ARE 3683 02:19:31,345 --> 02:19:33,014 FRUSTRATED WHEN WE DO OUTBREAK 3684 02:19:33,014 --> 02:19:34,782 RESPONSE, FOR EXAMPLE HIV 3685 02:19:34,782 --> 02:19:36,584 OUTBREAK AMONG PEOPLE WHO INJECT 3686 02:19:36,584 --> 02:19:39,120 DRUGS OR DOING A LOT FOR HIV BUT 3687 02:19:39,120 --> 02:19:41,088 MAYBE DIAGNOSING BUT NOT SETTING 3688 02:19:41,088 --> 02:19:42,657 UP A TREATMENT PROGRAM AND 3689 02:19:42,657 --> 02:19:43,858 MAKING SURE ENABLING THE STATE 3690 02:19:43,858 --> 02:19:45,526 OR LOCAL HEALTH DEPARTMENT TO DO 3691 02:19:45,526 --> 02:19:48,195 SO SO WE CAN PREVENT MORE THAN 3692 02:19:48,195 --> 02:19:49,430 ONE INFECTION. 3693 02:19:49,430 --> 02:19:50,798 VENUE AND PROGRAM BASED 3694 02:19:50,798 --> 02:19:51,699 MULTI-DISEASE PREVENTION, THE 3695 02:19:51,699 --> 02:19:53,167 IDEA IS IF YOU HAVE A VENUE 3696 02:19:53,167 --> 02:19:55,036 WHETHER THAT VENUE CAN BE 3697 02:19:55,036 --> 02:19:57,004 VETERANS ADMINISTRATION OR 3698 02:19:57,004 --> 02:19:58,673 STUDENT SERVICE PROGRAM, SDI 3699 02:19:58,673 --> 02:19:59,040 CLINIC. 3700 02:19:59,040 --> 02:20:01,909 ARE WE THINKING ENDEMIC 3701 02:20:01,909 --> 02:20:02,276 STRATEGY. 3702 02:20:02,276 --> 02:20:04,178 DATA SHARING ANAL SEEDS WE HAVE 3703 02:20:04,178 --> 02:20:06,080 TALKED' -- ANALYSES, WE HAVE 3704 02:20:06,080 --> 02:20:08,282 TALKED ABOUT DISCUSSION ALREADY 3705 02:20:08,282 --> 02:20:09,817 THERE IS SPACES WHERE WE CAN DO 3706 02:20:09,817 --> 02:20:12,053 BETTER WITH THAT, THEN DIGITAL 3707 02:20:12,053 --> 02:20:13,487 COMMUNICATION CAMPAIGNS AND 3708 02:20:13,487 --> 02:20:14,455 INTERVENTIONS WE THINK WE HAVE 3709 02:20:14,455 --> 02:20:15,923 -- WE WANT TO GROW MORE INTO 3710 02:20:15,923 --> 02:20:19,894 THAT ARENA TO BECOME MORE 3711 02:20:19,894 --> 02:20:22,530 EFFECTIVE IN AGAIN REACHING 3712 02:20:22,530 --> 02:20:24,131 POPULATIONS WHO NEED TO HAVE 3713 02:20:24,131 --> 02:20:25,933 ACCESS TO THAT INFORMATION AND 3714 02:20:25,933 --> 02:20:28,936 DOING IT IN A VERY ACCEPTED 3715 02:20:28,936 --> 02:20:30,671 EXPLICIT WAY THAT WHERE EVERYONE 3716 02:20:30,671 --> 02:20:31,572 DOES NEED THE GET THAT 3717 02:20:31,572 --> 02:20:32,673 INFORMATION AND WE CAN TALK 3718 02:20:32,673 --> 02:20:34,341 ABOUT I THINK MONKEY POX IS A 3719 02:20:34,341 --> 02:20:35,910 GREAT EXAMPLE WHERE THERE'S SOME 3720 02:20:35,910 --> 02:20:36,944 INFORMATION NEEDS TO GO OUT TO 3721 02:20:36,944 --> 02:20:39,714 THE GENERAL PUBLIC BUT RIGHT NOW 3722 02:20:39,714 --> 02:20:42,550 WE NEED POPULATION MOST 3723 02:20:42,550 --> 02:20:43,751 EFFECTIVE IN THIS CASE IN THE 3724 02:20:43,751 --> 02:20:47,321 UNITED STATES AND ELSEWHERE BY 3725 02:20:47,321 --> 02:20:48,656 SEXUAL MEN TO GET EXPLICIT ABOUT 3726 02:20:48,656 --> 02:20:49,690 WHAT THEY DO TO PROTECT 3727 02:20:49,690 --> 02:20:52,093 THEMSELVES AND OTHERS. 3728 02:20:52,093 --> 02:20:53,027 MENTION SLIDE PLEASE. 3729 02:20:53,027 --> 02:20:54,495 SO SOME OF THE KEY ACTIONS TO 3730 02:20:54,495 --> 02:20:56,464 ADDRESSING ENDEMICS PUT PEOPLE 3731 02:20:56,464 --> 02:20:57,398 FIRST FOCUS ON EQUITY. 3732 02:20:57,398 --> 02:20:59,800 PUT YOUR MONEY WHERE YOUR 3733 02:20:59,800 --> 02:21:01,135 EPIDEMIC IS, LEVERAGE POLICIES 3734 02:21:01,135 --> 02:21:02,369 TO HEALTH TOOL AND PRIORITIZE 3735 02:21:02,369 --> 02:21:04,939 INNOVATION AND THAT IS SOMETHING 3736 02:21:04,939 --> 02:21:08,576 THAT NIH AND HRSA HAVE BEEN 3737 02:21:08,576 --> 02:21:09,977 DOING ALREADY. 3738 02:21:09,977 --> 02:21:12,780 SO THIS IS JUST I HAVE TWO MAYBE 3739 02:21:12,780 --> 02:21:14,648 THREE SLIDES ABOUT HIV 3740 02:21:14,648 --> 02:21:16,283 SPECIFICALLY BUT THIS SLIDE ON 3741 02:21:16,283 --> 02:21:18,285 THE LEFT IS ABOUT INCIDENCE, 3742 02:21:18,285 --> 02:21:20,888 ESTIMATED HIV INCIDENCE. 3743 02:21:20,888 --> 02:21:23,557 YOU CAN SEE WE HAVE HAD SUCCESS 3744 02:21:23,557 --> 02:21:25,059 AS COMMUNITY NATION DECREASING 3745 02:21:25,059 --> 02:21:27,762 INCIDENCE OF HIV FROM ABOUT -- 3746 02:21:27,762 --> 02:21:32,233 IT WAS INTO THE THERE ARE OVER 3747 02:21:32,233 --> 02:21:33,901 150,000 INFECTION AS YEAR IN THE 3748 02:21:33,901 --> 02:21:35,636 1980s, DOWN TO 50,000, KIND OF 3749 02:21:35,636 --> 02:21:38,172 STAYED THAT FOR A WHILE, WE GOT 3750 02:21:38,172 --> 02:21:42,143 DOWN TO 39, 40,000 AND WE 3751 02:21:42,143 --> 02:21:44,545 LOWERED FEW THOUSAND DOWN TO 3752 02:21:44,545 --> 02:21:46,514 34,800 BY 2019. 3753 02:21:46,514 --> 02:21:48,616 IT IS TOO SLOW TO ELIMINATE HIV 3754 02:21:48,616 --> 02:21:50,417 IF GOING AT THIS RATE. 3755 02:21:50,417 --> 02:21:52,019 WE NEED TO DO BETTER. 3756 02:21:52,019 --> 02:21:54,455 BUT I THINK IT ALSO HIGHLIGHTS 3757 02:21:54,455 --> 02:21:55,289 SEVERAL THINGS. 3758 02:21:55,289 --> 02:21:58,592 ONE IS THAT IF THE KIND OF 3759 02:21:58,592 --> 02:22:00,694 SUCCESS THAT DR. CHEEVER 3760 02:22:00,694 --> 02:22:01,796 HIGHLIGHTED FOR RYAN WHITE 3761 02:22:01,796 --> 02:22:05,332 CLIENTS ARE ACHIEVED FOR 3762 02:22:05,332 --> 02:22:06,700 EVERYONE WITH HIV IN THE NATION 3763 02:22:06,700 --> 02:22:08,269 WE WILL START SEEING THIS GO 3764 02:22:08,269 --> 02:22:11,272 DOWN AND IF WE CAN EXPAND OUR 3765 02:22:11,272 --> 02:22:15,376 PREP COVERAGE TO BE ON THE 25% 3766 02:22:15,376 --> 02:22:19,380 WHO ARE CURRENTLY RECEIVING PREP 3767 02:22:19,380 --> 02:22:24,418 OF PEOPLE WHO WE THINK WOULD BE 3768 02:22:24,418 --> 02:22:26,086 ELIGIBLE, WE SHOULD SEE THIS GO 3769 02:22:26,086 --> 02:22:26,687 DOWN FASTER. 3770 02:22:26,687 --> 02:22:28,322 ON THE RIGHT I SHOW PREVENIENCE. 3771 02:22:28,322 --> 02:22:30,624 I DO THAT BECAUSE I WANTED TO 3772 02:22:30,624 --> 02:22:32,159 HIGHLIGHT THAT THE NUMBER OF 3773 02:22:32,159 --> 02:22:33,093 PEOPLE, ABSOLUTE NUMBER OF 3774 02:22:33,093 --> 02:22:34,962 PEOPLE WITH HIV IS GOING UP 3775 02:22:34,962 --> 02:22:36,063 EVERY YEAR. 3776 02:22:36,063 --> 02:22:40,434 MANY THE PEPFAR WORLD WE HAVE 3777 02:22:40,434 --> 02:22:42,236 NOT REACHED EPIDEMIC CONTROL YET 3778 02:22:42,236 --> 02:22:44,572 BUT IT MEANS THE FASTER WE 3779 02:22:44,572 --> 02:22:47,241 REDUCE INCIDENCE THE FASTER THE 3780 02:22:47,241 --> 02:22:49,009 OVERALL BURDEN OF HIV IN THE 3781 02:22:49,009 --> 02:22:50,477 NATION IS GOING TO GO DOWN. 3782 02:22:50,477 --> 02:22:51,812 THAT MEANS WE CAN START 3783 02:22:51,812 --> 02:22:53,147 PROVIDING SERVICES TO FEWER 3784 02:22:53,147 --> 02:22:56,050 NUMBERS OF PEOPLE AND HELPING 3785 02:22:56,050 --> 02:22:56,984 THEM EVEN MORE. 3786 02:22:56,984 --> 02:22:59,987 IF WE HAD BEEN ABLE TO DECREASE 3787 02:22:59,987 --> 02:23:02,857 HIV MORE, 10, 15 YEARS AGO WE 3788 02:23:02,857 --> 02:23:04,859 WOULDN'T HAVE 1.2 MILLION PEOPLE 3789 02:23:04,859 --> 02:23:06,427 LIVING WITH HIV. 3790 02:23:06,427 --> 02:23:09,630 INFECTIOUS DISEASE THAT SPREADS, 3791 02:23:09,630 --> 02:23:11,966 DO GOOD JOB PREVENTING SPREAD WE 3792 02:23:11,966 --> 02:23:13,934 CAN REAP THE BENEFITS FROM 3793 02:23:13,934 --> 02:23:18,973 PUBLIC HEALTH AND COST BENEFIT 3794 02:23:18,973 --> 02:23:20,875 FOR -- PERSPECTIVES FOR YEARS TO 3795 02:23:20,875 --> 02:23:21,976 COME. 3796 02:23:21,976 --> 02:23:23,344 SO THIS IS SOME OF THE 3797 02:23:23,344 --> 02:23:24,645 INNOVATION THAT WE HAVE BEEN 3798 02:23:24,645 --> 02:23:26,647 DOING, ONE IS SELF -TESTING, LAST 3799 02:23:26,647 --> 02:23:30,584 YEAR WE DISTRIBUTED 150,000 SELF 3800 02:23:30,584 --> 02:23:33,420 TESTS, THROUGH THE INTERNET, WE 3801 02:23:33,420 --> 02:23:35,456 HAVE DONE PRIOR RANDOMIZE RILES 3802 02:23:35,456 --> 02:23:36,557 TO SHOW THAT IT IS EFFECTIVE AND 3803 02:23:36,557 --> 02:23:38,359 COST SAVING AND THIS YEAR WE ARE 3804 02:23:38,359 --> 02:23:41,295 PLANNING ON 175,000 TESTS IT IS 3805 02:23:41,295 --> 02:23:43,731 A USEFUL TOOL TO GET TO PEOPLE 3806 02:23:43,731 --> 02:23:45,799 WHO CAN'T OR DON'T GET ACCESS TO 3807 02:23:45,799 --> 02:23:47,668 TESTING ABOUT 20% OF THE PEOPLE 3808 02:23:47,668 --> 02:23:48,903 WHO GET TESTING THEY HAVE NEVER 3809 02:23:48,903 --> 02:23:51,906 HAD HIV TEST BEFOREMENT OF BUT 3810 02:23:51,906 --> 02:23:53,340 HELPFUL FOR PEOPLE TO HAVE 3811 02:23:53,340 --> 02:23:54,808 FREQUENT TESTING WE RECOMMEND 3812 02:23:54,808 --> 02:23:56,010 ONCE EVERY THREE TO SIX MONTHS 3813 02:23:56,010 --> 02:23:57,011 BECAUSE IT IS HARD FOR THEM TO 3814 02:23:57,011 --> 02:23:58,979 GO TO THE CLINIC EVERY THREE TO 3815 02:23:58,979 --> 02:24:02,383 SIX MONTHS BUT THEY CAN GET HIV 3816 02:24:02,383 --> 02:24:03,617 TEST IN THEIR HOUSE, IT CAN BE 3817 02:24:03,617 --> 02:24:06,120 EFFECTIVE. 3818 02:24:06,120 --> 02:24:08,522 THEY ALSO ARE AVON MEN, THESE 3819 02:24:08,522 --> 02:24:11,458 ARE PEOPLE WHO CAN ACTUALLY 3820 02:24:11,458 --> 02:24:14,662 SHARE TEST KITS BECAUSE WE WILL 3821 02:24:14,662 --> 02:24:16,196 SEND TWO IF THEY REQUEST THAT 3822 02:24:16,196 --> 02:24:18,098 WITH THEIR FRIENDS AND TRIALS 3823 02:24:18,098 --> 02:24:19,900 NOT ONLY SHARE WITH THEIR 3824 02:24:19,900 --> 02:24:21,235 FRIENDS BUT FRIENDS DIAGNOSE 3825 02:24:21,235 --> 02:24:23,170 THEMSELVES WITH HIV. 3826 02:24:23,170 --> 02:24:26,240 SO IT IS FREE DELIVERY FOR 3827 02:24:26,240 --> 02:24:28,909 FRUITS FOR US SO BENEFICIAL, IT 3828 02:24:28,909 --> 02:24:31,078 IS LIMITED IN SCOPE BECAUSE COST 3829 02:24:31,078 --> 02:24:34,715 OF THESE TESTS IS HIGH. 3830 02:24:34,715 --> 02:24:40,387 WE ARE EXPANDING STD CLINICS 3831 02:24:40,387 --> 02:24:41,755 CAPACITY TO DELIVER PREP AS WELL 3832 02:24:41,755 --> 02:24:44,625 AS OTHER SERVICES, AN NOW 3833 02:24:44,625 --> 02:24:46,593 ACTUALLY TO EXPAND SOME OF THE 3834 02:24:46,593 --> 02:24:49,363 PREVENTIVE TOOLS WE HAVE FOR 3835 02:24:49,363 --> 02:24:49,964 MONKEY POX. 3836 02:24:49,964 --> 02:24:51,498 WE THINK ABOUT HOW TO USE 3837 02:24:51,498 --> 02:24:53,734 PHARMACIES FOR DATA TO CARE WORK 3838 02:24:53,734 --> 02:24:54,969 SO THAT WHEN SOMEONE DOESN'T 3839 02:24:54,969 --> 02:24:57,471 PICK UP MEDICATION THEY ARE 3840 02:24:57,471 --> 02:24:58,806 RAPIDLY CONTACTED. 3841 02:24:58,806 --> 02:25:02,009 AND ENCOURAGED WE ESSENTIALLY 3842 02:25:02,009 --> 02:25:03,577 HELP THEM OVERCOME WHAT WHATEVER 3843 02:25:03,577 --> 02:25:04,645 PREVENTED THEM FROM GETTING 3844 02:25:04,645 --> 02:25:09,149 THEIR TREATMENT SO THEY CAN STAY 3845 02:25:09,149 --> 02:25:11,151 ON TREATMENT OR SOME CASES STAY 3846 02:25:11,151 --> 02:25:11,552 ON PREP. 3847 02:25:11,552 --> 02:25:13,554 WE ARE EXPANDING PREP AND WORK 3848 02:25:13,554 --> 02:25:15,889 ON CLUSTER DETECTION AN RESPONSE 3849 02:25:15,889 --> 02:25:17,057 WORK THAT KAY MENTIONED BUT IT 3850 02:25:17,057 --> 02:25:19,426 IS TO MAKE SURE THAT WHEN WE 3851 02:25:19,426 --> 02:25:21,662 RESPOND RAPIDLY AND EFFECTIVELY, 3852 02:25:21,662 --> 02:25:23,263 TO OUTBREAKS. 3853 02:25:23,263 --> 02:25:25,165 RIGHT NOW WE HAVE A CERTAIN 3854 02:25:25,165 --> 02:25:26,433 NUMBER OF PEOPLE THAT HAVE TO BE 3855 02:25:26,433 --> 02:25:29,636 IN A CLUSTER BEFORE THAT HEALTH 3856 02:25:29,636 --> 02:25:33,440 DEPARTMENT TEND TO RESPOND WE 3857 02:25:33,440 --> 02:25:38,045 HAVE TO LOWER THAT NUMBER TO 3858 02:25:38,045 --> 02:25:39,346 RESPOND MORE EFFECTIVELY BEFORE 3859 02:25:39,346 --> 02:25:39,780 THINGS SPREAD. 3860 02:25:39,780 --> 02:25:42,916 THIS IS A LIST OF NIH 3861 02:25:42,916 --> 02:25:44,385 COLLABORATION FROM BOTH JOINT 3862 02:25:44,385 --> 02:25:45,486 FUNDING, LITERALLY JOINED WITH 3863 02:25:45,486 --> 02:25:48,255 NIH TO HAVE A JOINT FUNDED NOFO 3864 02:25:48,255 --> 02:25:50,991 FOR EXAMPLE ONE TO PREVENT 3865 02:25:50,991 --> 02:25:52,659 INFECTIOUS DISEASES PRIMARILY 3866 02:25:52,659 --> 02:25:54,862 HEPATITIS C AND HIV IN PEOPLE 3867 02:25:54,862 --> 02:25:57,598 INJECT DRUGS IN RURAL US. 3868 02:25:57,598 --> 02:25:59,266 COLLABORATIVE RESEARCH WHERE WE 3869 02:25:59,266 --> 02:26:03,704 ARE PART OF C FARES WE ARE A CTU 3870 02:26:03,704 --> 02:26:05,506 FOR THE CLINICAL TRIALS OR WHERE 3871 02:26:05,506 --> 02:26:07,441 WE HAVE COLLABORATIVE -- 3872 02:26:07,441 --> 02:26:08,675 COLLABORATIONS ON ADOLESCENT 3873 02:26:08,675 --> 02:26:10,444 BRAIN COGNITIVE DEVELOPMENT 3874 02:26:10,444 --> 02:26:12,579 STUDY WHICH IS A LARGE STUDY RUN 3875 02:26:12,579 --> 02:26:14,114 BY NIH THAT HAS COLLABORATING 3876 02:26:14,114 --> 02:26:14,715 PARTNERS. 3877 02:26:14,715 --> 02:26:16,683 SO WE LIKE TO COLLABORATE ON 3878 02:26:16,683 --> 02:26:18,685 RESEARCH AND WE ALSO HAVE NUMBER 3879 02:26:18,685 --> 02:26:25,192 OF PARTNERSHIPS WITH DR. 3880 02:26:25,192 --> 02:26:26,193 GOODENOW'S GROUP AN MULTIPLE 3881 02:26:26,193 --> 02:26:30,297 OTHER PARTS OF NIH AND CONTINUE 3882 02:26:30,297 --> 02:26:32,533 TO HAVE EVEN RETREATS WITH 3883 02:26:32,533 --> 02:26:34,635 COLLEAGUES AT NIH WHERE WE TRY 3884 02:26:34,635 --> 02:26:36,070 TO DETERMINE WHAT ARE MOST 3885 02:26:36,070 --> 02:26:37,938 IMPORTANT RESEARCH PRIORITIES 3886 02:26:37,938 --> 02:26:38,972 AND SHARE INFORMATION WHAT WE 3887 02:26:38,972 --> 02:26:40,808 ARE DOING SO WE DON'T OVERLAP. 3888 02:26:40,808 --> 02:26:43,877 AND THAT WE ALSO SOMETIMES 3889 02:26:43,877 --> 02:26:45,546 LEVERAGE EACH OTHER CAPACITY TO 3890 02:26:45,546 --> 02:26:46,046 ANSWER QUESTIONS FASTER. 3891 02:26:46,046 --> 02:26:50,651 OF BECAUSE WE HAVE EXISTING 3892 02:26:50,651 --> 02:26:51,985 GRANTS OR BECAUSE WE HAVE RAPID 3893 02:26:51,985 --> 02:26:53,053 MECHANISM TO GET THE RESEARCH 3894 02:26:53,053 --> 02:26:57,658 DONE. 3895 02:26:57,658 --> 02:27:00,327 THIS IS HIGHLIGHTS, OF THE CHAT 3896 02:27:00,327 --> 02:27:01,395 MEETING. 3897 02:27:01,395 --> 02:27:03,697 WE HAD ONE SESSION ON LEVERAGING 3898 02:27:03,697 --> 02:27:05,933 POLICY TO ADVANCE HIV VIRAL 3899 02:27:05,933 --> 02:27:08,235 HEPATITIS AND STI PRIORITIES, I 3900 02:27:08,235 --> 02:27:11,438 DID INCLUDE TB BECAUSE IT HAS 3901 02:27:11,438 --> 02:27:13,006 SEPARATE FEDERAL ADVISORY 3902 02:27:13,006 --> 02:27:13,640 COMMITTEE. 3903 02:27:13,640 --> 02:27:16,710 SO THIS CHAT IS PRIMARILY 3904 02:27:16,710 --> 02:27:18,679 FOCUSED ON THESE THREE 3905 02:27:18,679 --> 02:27:18,979 INFECTIONS. 3906 02:27:18,979 --> 02:27:20,948 IT WAS HELPFUL SOME OF THE MAJOR 3907 02:27:20,948 --> 02:27:22,382 PRIORITIES THAT CAME UP AS BEING 3908 02:27:22,382 --> 02:27:28,555 MOST EFFECTIVE WOULD BE NOT 3909 02:27:28,555 --> 02:27:31,959 REMOVING MEDICAID AND PRIVATE 3910 02:27:31,959 --> 02:27:33,527 INSURANCE TREATMENT 3911 02:27:33,527 --> 02:27:34,194 RESTRICTIONS, THAT PREVENT 3912 02:27:34,194 --> 02:27:36,930 PEOPLE WITH HEPATITIS C FROM 3913 02:27:36,930 --> 02:27:37,731 GETTING TREATMENT THOSE 3914 02:27:37,731 --> 02:27:39,466 RESTRICTIONS ARE PUT INTO PLACE 3915 02:27:39,466 --> 02:27:41,368 NOT FOR PATIENTS HEALTH BUT TO 3916 02:27:41,368 --> 02:27:42,603 SAVE MONEY. 3917 02:27:42,603 --> 02:27:44,438 FOR THE INSURERS. 3918 02:27:44,438 --> 02:27:48,809 THEY HAVE BEEN SHOWN TO RESULT 3919 02:27:48,809 --> 02:27:51,578 IN MORBIDITY AND MORTALITY OF 3920 02:27:51,578 --> 02:27:54,314 PATIENTS WITH HEPATITIS C BUT 3921 02:27:54,314 --> 02:27:56,216 STILL ONLY SMALL PROPORTION OF 3922 02:27:56,216 --> 02:27:57,885 PEOPLE WITH HEAP C WHO ARE 3923 02:27:57,885 --> 02:28:01,155 DIAGNOSED AND ARE IN CARE GET 3924 02:28:01,155 --> 02:28:03,590 CURED THOUGH IT IS 8 TO 12 WEEKS 3925 02:28:03,590 --> 02:28:04,424 ORAL REGIMEN. 3926 02:28:04,424 --> 02:28:06,226 BECAUSE RESTRICTIONS MAKE IT 3927 02:28:06,226 --> 02:28:06,660 DIFFICULT. 3928 02:28:06,660 --> 02:28:08,629 EVEN IF IT IS JUST PAPERWORK 3929 02:28:08,629 --> 02:28:09,730 DIFFICULT BUT SOMETIMES IT IS 3930 02:28:09,730 --> 02:28:12,299 RESTRICTION YOU HAVE TO HAVE 3931 02:28:12,299 --> 02:28:13,433 SEVERE DISEASE OR YOU CAN BE 3932 02:28:13,433 --> 02:28:16,837 TREATED BY G, DOC OR INFECTIOUS 3933 02:28:16,837 --> 02:28:18,472 DISEASE DOC SO A VARIETY ARE PUT 3934 02:28:18,472 --> 02:28:19,773 INTO PLACE. 3935 02:28:19,773 --> 02:28:20,407 REMOVING THOSE COULD MAKE A 3936 02:28:20,407 --> 02:28:24,111 DIFFERENCE. 3937 02:28:24,111 --> 02:28:26,313 POLICY CHANGES CALIFORNIA PASSED 3938 02:28:26,313 --> 02:28:27,414 LEGISLATION THAT ALLOWS 3939 02:28:27,414 --> 02:28:32,252 PHARMACISTS TO PROVIDE HEAP 3940 02:28:32,252 --> 02:28:34,755 AND/OR PREP, THERE'S A 3941 02:28:34,755 --> 02:28:36,657 REQUIREMENT THAT HEALTH PLANS 3942 02:28:36,657 --> 02:28:39,426 COVER AT HOME TEST FOR HIV STD 3943 02:28:39,426 --> 02:28:40,227 AND THERE IS LIABILITY 3944 02:28:40,227 --> 02:28:42,095 PROTECTION FOR DISPENSING 3945 02:28:42,095 --> 02:28:44,765 EXPEDITED PARTNER THERAPY FOR 3946 02:28:44,765 --> 02:28:46,500 STI, EASIER TO GET PEOPLE 3947 02:28:46,500 --> 02:28:48,368 TREATMENT PARTNER EXPOSED BUT 3948 02:28:48,368 --> 02:28:50,270 PARTNER CAN'T COME INTO THE 3949 02:28:50,270 --> 02:28:50,837 CLINIC. 3950 02:28:50,837 --> 02:28:52,606 WE HAD PRESENTATION FROM 3951 02:28:52,606 --> 02:28:55,842 LOUISIANA ON THEIR HCV TREATMENT 3952 02:28:55,842 --> 02:28:57,744 NETFLIX MODEL FOR WAYS REDUCING 3953 02:28:57,744 --> 02:28:59,813 ESSENTIALLY THE BARRIERS FOR 3954 02:28:59,813 --> 02:29:00,948 ACCESSING TREATMENT BECAUSE IF 3955 02:29:00,948 --> 02:29:03,150 IT COMES FREE TO THE CLINIC OR 3956 02:29:03,150 --> 02:29:05,552 USER TO BE ABLE TO GET ACCESS 3957 02:29:05,552 --> 02:29:07,621 INSTEAD OF BEING OBSTACLE 3958 02:29:07,621 --> 02:29:09,389 BECAUSE IT IS PAID AT THE STATE 3959 02:29:09,389 --> 02:29:11,325 LEVEL TO COVER THIS IN -- IF -- 3960 02:29:11,325 --> 02:29:14,628 AND THE INCENTIVE IN LOUISIANA 3961 02:29:14,628 --> 02:29:15,862 PROGRAM, IS DIAGNOSE TREAT AND 3962 02:29:15,862 --> 02:29:18,498 MANY PEOPLE AS POSSIBLE. 3963 02:29:18,498 --> 02:29:20,467 BECAUSE THE DRUGS AREN'T RIGHT 3964 02:29:20,467 --> 02:29:21,969 NOW IT IS ESSENTIALLY BECAUSE WE 3965 02:29:21,969 --> 02:29:23,537 PAID FOR CERTAIN MINIMUM AMOUNT 3966 02:29:23,537 --> 02:29:25,505 AND ANY MORE PEOPLE WHO TREAT IT 3967 02:29:25,505 --> 02:29:26,707 DOESN'T COST THE STATE 3968 02:29:26,707 --> 02:29:29,309 GOVERNMENT ANY MORE. 3969 02:29:29,309 --> 02:29:31,845 THEN THERE IS ANOTHER ASPECT 3970 02:29:31,845 --> 02:29:33,981 WHICH IS FEDERAL LEGISLATION ON 3971 02:29:33,981 --> 02:29:35,749 MEDICAID WHICH IS THAT ANYONE 3972 02:29:35,749 --> 02:29:37,417 NCI INCARCERATED IS EXCLUDED 3973 02:29:37,417 --> 02:29:40,087 FROM HAVING ACCESS TO MEDICAID 3974 02:29:40,087 --> 02:29:42,656 THAT CAUSES TWO PROBLEMS, IT 3975 02:29:42,656 --> 02:29:44,091 MAKES CORRECTIONAL INSTITUTIONS 3976 02:29:44,091 --> 02:29:47,127 LIKE TO SCREEN PEOPLE HIV OR 3977 02:29:47,127 --> 02:29:47,794 HEAP C BECAUSE THEY ARE 3978 02:29:47,794 --> 02:29:48,962 RESPONSIBLE FOR TREATING THEM. 3979 02:29:48,962 --> 02:29:51,798 AND THEN THE OTHER IS THAT WHEN 3980 02:29:51,798 --> 02:29:54,468 PEOPLE, THEIR MEDICAID STOPS 3981 02:29:54,468 --> 02:29:57,237 THEY HAVE TO RESTART WHEN THEY 3982 02:29:57,237 --> 02:29:58,905 REENTER SOCIETY AND RELEASED 3983 02:29:58,905 --> 02:30:01,775 FROM CORRECTIONS AND WHEN THAT 3984 02:30:01,775 --> 02:30:02,976 HAPPENS IT IS HARDER TO ACCESS. 3985 02:30:02,976 --> 02:30:05,045 THERE ARE STATES WITH CERTAIN 3986 02:30:05,045 --> 02:30:07,814 PROGRAMS THAT CAN HAVE 3987 02:30:07,814 --> 02:30:09,549 SUSPENSION OF MEDICAID SUCH THAT 3988 02:30:09,549 --> 02:30:11,351 ACTUALLY STOPPING AN RESTARTS 3989 02:30:11,351 --> 02:30:12,219 AUTOMATICALLY WHEN THEY LEAVE 3990 02:30:12,219 --> 02:30:15,055 BUT THIS IS AN AREA THAT IS KIND 3991 02:30:15,055 --> 02:30:16,223 OF WELL KNOWN IF YOU ARE IN THAT 3992 02:30:16,223 --> 02:30:19,660 WORLD BUT IF NOT, IT IS NOT 3993 02:30:19,660 --> 02:30:22,162 FOCUSED ON. 3994 02:30:22,162 --> 02:30:24,898 NEXT SLIDE PLEASE. 3995 02:30:24,898 --> 02:30:26,933 THEN THIS IS -- WE HAD EXAMPLES 3996 02:30:26,933 --> 02:30:30,437 OF APPLIED ENDEMIC APPROACH A 3997 02:30:30,437 --> 02:30:31,571 COMPREHENSIVE SYRINGE SERVICE 3998 02:30:31,571 --> 02:30:33,106 PROGRAMS IN NEW MEXICO THEY 3999 02:30:33,106 --> 02:30:34,107 INCORPORATE NOT JUST SCREENING 4000 02:30:34,107 --> 02:30:37,277 FOR INFECTIOUS DISEASE BUT ALSO 4001 02:30:37,277 --> 02:30:37,544 TREATMENT. 4002 02:30:37,544 --> 02:30:39,646 T AND PARTNER SERVICES, THERE IS 4003 02:30:39,646 --> 02:30:41,381 A NICE PRESENTATION IN NORTH 4004 02:30:41,381 --> 02:30:42,049 DAKOTA WHAT THEY HAVE BEEN ABLE 4005 02:30:42,049 --> 02:30:44,084 TO DO IN CORRECTIONS, SAN 4006 02:30:44,084 --> 02:30:46,353 FRANCISCO HAD UNIFIED SCHOOL 4007 02:30:46,353 --> 02:30:49,122 DISTRICTS COMMUNITY PARTNERSHIPS 4008 02:30:49,122 --> 02:30:49,923 WITH SCHOOLS AND HEALTH 4009 02:30:49,923 --> 02:30:51,258 DEPARTMENTS TO PROVIDE 4010 02:30:51,258 --> 02:30:52,159 COMPREHENSIVE SEXUAL HEALTH 4011 02:30:52,159 --> 02:30:55,262 SERVICES TO ADOLESCENTS AND THEN 4012 02:30:55,262 --> 02:30:57,064 AS MENTIONED WE HAVE ENDEMIC 4013 02:30:57,064 --> 02:30:58,165 APPROACHES TO CLUSTER DETECTION 4014 02:30:58,165 --> 02:31:03,170 AND RESPONSE FOR OUTBREAKS. 4015 02:31:03,170 --> 02:31:04,871 WE ALSO HAD A SESSION ON 4016 02:31:04,871 --> 02:31:08,208 SELF-TESTING AND A LOT OF THE 4017 02:31:08,208 --> 02:31:09,576 OBSTACLES TO HIV SELF-TESTING 4018 02:31:09,576 --> 02:31:12,079 STEMS FROM THE FACT THAT BECAUSE 4019 02:31:12,079 --> 02:31:15,582 FOR HISTORICAL REASONS HIV 4020 02:31:15,582 --> 02:31:18,552 DIAGNOSTIC TESTS HAVE BEEN CLASS 4021 02:31:18,552 --> 02:31:19,886 3 DEVICES AT THE FDA. 4022 02:31:19,886 --> 02:31:23,290 PUT IN PERSPECTIVE MOST CLASS 3 4023 02:31:23,290 --> 02:31:25,759 DEVICES ARE LIKE CARDIAC STINTS. 4024 02:31:25,759 --> 02:31:28,962 THEY ARE NOT TESTS BUT THAT IS 4025 02:31:28,962 --> 02:31:29,863 BECAUSE FOR VARIETY OF REASONS 4026 02:31:29,863 --> 02:31:31,832 WE CAN TALK ABOUT. 4027 02:31:31,832 --> 02:31:34,901 FDA HAS BEEN RETHINKING FOR 4028 02:31:34,901 --> 02:31:36,470 DECADES ABOUT TRYING TO CHANGE 4029 02:31:36,470 --> 02:31:37,971 THIS BUT IT HAS BEEN A SLOW 4030 02:31:37,971 --> 02:31:39,172 PROCESS. 4031 02:31:39,172 --> 02:31:40,640 AND THOUGH THEY MODIFIED SOME OF 4032 02:31:40,640 --> 02:31:42,943 THE TESTS, AND ANTICIPATE 4033 02:31:42,943 --> 02:31:44,144 MODIFYING BECAUSE THERE IS A 4034 02:31:44,144 --> 02:31:46,580 FEDERAL REGISTER NOTICE ABOUT 4035 02:31:46,580 --> 02:31:49,950 THE ANTIVIRAL LOADS AND ALLOWING 4036 02:31:49,950 --> 02:31:53,353 THEM TO BE CLASS 2 DEVICES, 4037 02:31:53,353 --> 02:31:54,855 SELF-TESTING FOR HIV. 4038 02:31:54,855 --> 02:31:57,824 IS STILL CLASS 3 DEVICE. 4039 02:31:57,824 --> 02:31:59,960 SO THAT MEANS THAT TO GET IT 4040 02:31:59,960 --> 02:32:02,929 DONE TO GET IT PAST FDA APPROVED 4041 02:32:02,929 --> 02:32:06,767 IS FAR MORE COSTLY BOTH IN TERMS 4042 02:32:06,767 --> 02:32:08,902 OF KINDS OF STUDIES THAT NEED TO 4043 02:32:08,902 --> 02:32:11,171 BE CONDUCTED AND FEES THEMSELVES 4044 02:32:11,171 --> 02:32:15,308 AS PMA THAN IT IS CLASS 2 4045 02:32:15,308 --> 02:32:15,876 DEVICE. 4046 02:32:15,876 --> 02:32:17,210 SO HOPEFULLY THAT CAN CHANGE 4047 02:32:17,210 --> 02:32:17,577 OVER TIME. 4048 02:32:17,577 --> 02:32:19,045 WE HAD A PRESENTATION THAT 4049 02:32:19,045 --> 02:32:20,447 INCLUDED FDA TALKING ABOUT SOME 4050 02:32:20,447 --> 02:32:21,815 OF THE ISSUES AND THE 4051 02:32:21,815 --> 02:32:22,416 PERSPECTIVES THAT THEY HAVE 4052 02:32:22,416 --> 02:32:25,852 ABOUT THIS. 4053 02:32:25,852 --> 02:32:30,991 NEXT SLIDE PLEASE. 4054 02:32:30,991 --> 02:32:32,626 I THINK I'M DONE WITH MY 4055 02:32:32,626 --> 02:32:33,460 SECTION. 4056 02:32:33,460 --> 02:32:38,498 >> THANK YOU H. JONATHAN, I 4057 02:32:38,498 --> 02:32:40,133 THINK MR. JIN PARK IS NEXT. 4058 02:32:40,133 --> 02:32:43,336 >> HOPING YOU CAN HEAR ME. 4059 02:32:43,336 --> 02:32:44,671 >> WE CAN. 4060 02:32:44,671 --> 02:32:46,907 >> I'LL GET STARTED. 4061 02:32:46,907 --> 02:32:49,810 MY ASSIGNMENT WAS TO TALK ABOUT 4062 02:32:49,810 --> 02:32:53,079 OJ AND THE ROLE OF OJ IN PEP FAR 4063 02:32:53,079 --> 02:32:57,284 TO TAKE A MOMENT, WHEN I TRAVEL 4064 02:32:57,284 --> 02:32:59,119 ABROAD, THE QUESTION IS SO WHAT 4065 02:32:59,119 --> 02:33:01,455 IS OGA AND HOW DOES IT INVOLVE 4066 02:33:01,455 --> 02:33:02,589 ITSELF IN PEPFAR? 4067 02:33:02,589 --> 02:33:05,659 I THIS I THAT IS REST OF THE 4068 02:33:05,659 --> 02:33:12,466 PRESENTATION JUST 4069 02:33:12,466 --> 02:33:14,501 SET THE HIGHLIGHTS ABOUT 4070 02:33:14,501 --> 02:33:15,302 HETEROGENEITY AND SOME THINGS 4071 02:33:15,302 --> 02:33:19,105 THAT I THINK TODAY LAURA AND 4072 02:33:19,105 --> 02:33:20,273 JOHN HAVE IN THEIR PRESENTATIONS 4073 02:33:20,273 --> 02:33:22,175 ABILITY COLLABORATIONS AND 4074 02:33:22,175 --> 02:33:23,443 COORDINATION AS AN INTERAGENCY 4075 02:33:23,443 --> 02:33:25,378 BODY. 4076 02:33:25,378 --> 02:33:30,417 >> JUST AS A SUMMARY, PEPFAR 4077 02:33:30,417 --> 02:33:31,184 STANDS TORR EMERGENCY 4078 02:33:31,184 --> 02:33:33,854 (INAUDIBLE) LAUNCHED IN 2003 BY 4079 02:33:33,854 --> 02:33:35,722 GEORGE BUSH AND IT'S SOMEWHAT 4080 02:33:35,722 --> 02:33:37,190 UNIQUE IN THE SENSE THAT IT HAS 4081 02:33:37,190 --> 02:33:39,593 BEEN INTERAGENCY BODY THAT 4082 02:33:39,593 --> 02:33:41,061 IMPLEMENTS A PEP FAR PROGRAM 4083 02:33:41,061 --> 02:33:43,363 COORDINATED BY OFFICE OF AIDS 4084 02:33:43,363 --> 02:33:45,131 COORDINATOR AT THE STATE 4085 02:33:45,131 --> 02:33:47,934 DEPARTMENT AND POSITION ITSELF 4086 02:33:47,934 --> 02:33:49,903 AS RANK OF AMBASSADOR TO ENSURE 4087 02:33:49,903 --> 02:33:53,006 THERE IS COLLABORATION AT A 4088 02:33:53,006 --> 02:33:54,908 BILATERAL LEVEL, DIPLOMACY LEVEL 4089 02:33:54,908 --> 02:33:57,110 TO ENSURE THERE THERE'S GOOD 4090 02:33:57,110 --> 02:33:58,845 WORK AND IMPLEMENTATION PROGRAMS 4091 02:33:58,845 --> 02:33:59,479 ON THE GROUND. 4092 02:33:59,479 --> 02:34:02,516 SO NEXT SLIDE PLEASE. 4093 02:34:02,516 --> 02:34:05,619 I THINK THE BIG UPDATE FOR US IS 4094 02:34:05,619 --> 02:34:09,689 THE SQUARENING OF (INAUDIBLE) 4095 02:34:09,689 --> 02:34:11,024 NEW AIDS COORDINATOR AND SERVES 4096 02:34:11,024 --> 02:34:12,592 AS A SPECIAL REPRESENTATIVE FOR 4097 02:34:12,592 --> 02:34:14,427 GLOBAL HEALTH DIPLOMACY FOR THE 4098 02:34:14,427 --> 02:34:19,266 U.S. AND STATE DEPARTMENT. 4099 02:34:19,266 --> 02:34:21,902 ARRIVAL WORKER ON COORDINATOR 4100 02:34:21,902 --> 02:34:23,303 AND HAS DONE IMPRESSIVE JOB 4101 02:34:23,303 --> 02:34:25,238 ENSURING OUR PROGRAM IS ONGOING 4102 02:34:25,238 --> 02:34:26,373 AND AS WE WENT THROUGH THIS 4103 02:34:26,373 --> 02:34:32,178 TRANSITION BUT I THINK OVERALL 4104 02:34:32,178 --> 02:34:32,412 EXCITED. 4105 02:34:32,412 --> 02:34:34,548 THE FACT HE WAS SWORN IN LAST 4106 02:34:34,548 --> 02:34:36,082 WEEK, IS MEETING WITH FOLKS AND 4107 02:34:36,082 --> 02:34:37,717 GETTING A SENSE OF THE 4108 02:34:37,717 --> 02:34:39,152 PRIORITIES OR CONSTITUENCY AND 4109 02:34:39,152 --> 02:34:40,620 THINKING ABOUT WHAT IS NEXT 4110 02:34:40,620 --> 02:34:42,322 PHASE OF THE PLATFORM. 4111 02:34:42,322 --> 02:34:49,062 NEXT SLIDE PLEASE. 4112 02:34:49,062 --> 02:34:50,497 SO I LIKE THIS SLIDE BECAUSE IT 4113 02:34:50,497 --> 02:34:54,034 GIVES A SENSE OF PEPFAR, ONGOING 4114 02:34:54,034 --> 02:34:54,634 FOR 20 YEARS. 4115 02:34:54,634 --> 02:35:00,106 THERE IS ISSUE IN 2003 BUT 4116 02:35:00,106 --> 02:35:02,108 PRESIDENT BUSH, FOR ME T THE 4117 02:35:02,108 --> 02:35:04,544 TIME I SAW STATE OF THE UNION 4118 02:35:04,544 --> 02:35:06,046 AND NATURALLY ANNOUNCED PEP FAR 4119 02:35:06,046 --> 02:35:09,316 WHICH WAS GREAT AT THE TIME, $15 4120 02:35:09,316 --> 02:35:11,985 BILLION OVER FIVE YEARS, 4121 02:35:11,985 --> 02:35:13,320 INCREDIBLE HONOR SUM OF MONEY AT 4122 02:35:13,320 --> 02:35:15,188 THE TIME ESPECIALLY FOR GLOBAL 4123 02:35:15,188 --> 02:35:16,957 HEALTH AND JUST IN TERMS OF 4124 02:35:16,957 --> 02:35:18,959 QUESTION IS COMPARISON, I 4125 02:35:18,959 --> 02:35:21,962 ACTUALLY HAVE NOT WORKED ON A 4126 02:35:21,962 --> 02:35:26,032 PROJECT IN THE ADMINISTRATION 4127 02:35:26,032 --> 02:35:28,702 INITIATIVE. 4128 02:35:28,702 --> 02:35:30,403 $100 MILLION PREVENTION 4129 02:35:30,403 --> 02:35:31,104 TRANSMISSION. 4130 02:35:31,104 --> 02:35:33,707 SO AGAIN WE HAD A LONG HISTORY 4131 02:35:33,707 --> 02:35:35,141 OF PEP FAR LEADERS AN NOW 4132 02:35:35,141 --> 02:35:36,576 CURRENT ADMINISTRATION IS 4133 02:35:36,576 --> 02:35:40,280 TALKING ABOUT HOW DO WE SUPPORT 4134 02:35:40,280 --> 02:35:42,082 PROGRAMS (INAUDIBLE) PROGRESSION 4135 02:35:42,082 --> 02:35:43,316 IN EVOLUTION OF THESE PROGRAMS 4136 02:35:43,316 --> 02:35:44,084 AND SUCCESS THAT WE HAVE 4137 02:35:44,084 --> 02:35:47,420 ACHIEVED. 4138 02:35:47,420 --> 02:35:50,690 JUST ALONG THAT LINE I WANT TO 4139 02:35:50,690 --> 02:35:53,560 SHARE THAT THIS IS DATA FROM THE 4140 02:35:53,560 --> 02:35:55,662 WORLD AIDS DAY PEPFAR RESULTS 4141 02:35:55,662 --> 02:35:56,496 FROM LAST YEAR. 4142 02:35:56,496 --> 02:36:00,100 AS I NOTED, A LOT OF COUNTRIES 4143 02:36:00,100 --> 02:36:03,903 HAVE REACHED CONTROL SO 20 4144 02:36:03,903 --> 02:36:06,272 COUNTRIES THAT HAS ACHIEVED 4145 02:36:06,272 --> 02:36:08,475 ACADEMIC CONTROL HAS REACHED THE 4146 02:36:08,475 --> 02:36:10,677 9090 TARGETS ORGANIZED BY UN 4147 02:36:10,677 --> 02:36:11,211 AIDS. 4148 02:36:11,211 --> 02:36:15,148 IN ADDITION TO THAT IN TERMS OF 4149 02:36:15,148 --> 02:36:16,883 (INAUDIBLE) 1900 PEOPLE ON ARV. 4150 02:36:16,883 --> 02:36:21,588 COMPARED TO 17.2 MILLION 4151 02:36:21,588 --> 02:36:22,222 REPORTED LAST YERKES THIS IS AT 4152 02:36:22,222 --> 02:36:27,160 THE SAME TIME MANAGING THE COVID 4153 02:36:27,160 --> 02:36:29,229 RESPONSE SOP TALKS REPRESENTS 4154 02:36:29,229 --> 02:36:32,098 THE RESILIENCY OF THE PROGRAM ON 4155 02:36:32,098 --> 02:36:34,834 THE GROUND. 4156 02:36:34,834 --> 02:36:39,739 I THINK IN TERMS OF HOW WE GOT 4157 02:36:39,739 --> 02:36:40,974 (INAUDIBLE) TREATMENT, THIS 4158 02:36:40,974 --> 02:36:42,976 SLIDE INDICATES SO THE 4159 02:36:42,976 --> 02:36:44,644 COMPARISON OF OUR RESULTS 4160 02:36:44,644 --> 02:36:46,079 COMPARE TO THE BUDGETS, SO THE 4161 02:36:46,079 --> 02:36:48,314 BLUE LINE REPRESENTS THE PEPFAR 4162 02:36:48,314 --> 02:36:48,848 BUDGET. 4163 02:36:48,848 --> 02:36:54,187 SO THE PEPFAR BUDGET IS STEADY 4164 02:36:54,187 --> 02:36:55,622 SINCE 2009 AROUND $6 BILLION 4165 02:36:55,622 --> 02:36:57,757 ANNUALLY AND THAT INCLUDES THE 4166 02:36:57,757 --> 02:36:59,292 U.S. CONTRIBUTION TO GLOBAL 4167 02:36:59,292 --> 02:36:59,893 (INAUDIBLE) $2 BILLION. 4168 02:36:59,893 --> 02:37:02,896 I THINK THE KEY THING IS THAT 4169 02:37:02,896 --> 02:37:04,898 GIVEN FLAT BUDGET FOR OVER A 4170 02:37:04,898 --> 02:37:05,932 DECADE, INCREASE NUMBER OF 4171 02:37:05,932 --> 02:37:08,068 PEOPLE IN TREATMENT AS WELL AS 4172 02:37:08,068 --> 02:37:11,137 IN THIS CASE NUMBER OF PEOPLE 4173 02:37:11,137 --> 02:37:16,443 THAT RECEIVED VOLUNTARY 4174 02:37:16,443 --> 02:37:17,310 CIRCUMCISION IN SERVICES. 4175 02:37:17,310 --> 02:37:18,878 NEXT SLIDE. 4176 02:37:18,878 --> 02:37:20,313 SO HOW WE GET THERE? 4177 02:37:20,313 --> 02:37:22,182 ONE OF THE THINGS WHICH I 4178 02:37:22,182 --> 02:37:24,284 REALIZE THAT HAVING WORKED ON 4179 02:37:24,284 --> 02:37:27,287 PEPFAR A LOT OF YEARS IS THAT I 4180 02:37:27,287 --> 02:37:28,521 HAVE BECOME EXPERT IN IT 4181 02:37:28,521 --> 02:37:29,122 BASICALLY. 4182 02:37:29,122 --> 02:37:30,557 SO IN TERMS OF HOW WE ESTABLISH 4183 02:37:30,557 --> 02:37:32,325 THIS, THERE IS ACTUALLY A 4184 02:37:32,325 --> 02:37:34,661 PROCESS CALLED OPERATIONAL PLAN, 4185 02:37:34,661 --> 02:37:36,996 SO IT IS A UNIQUE IN A SENSE 4186 02:37:36,996 --> 02:37:40,734 THAT BRINGS IN COUNTRY PARTNERS, 4187 02:37:40,734 --> 02:37:42,402 COORDINATOR ACROSS THE U.S. 4188 02:37:42,402 --> 02:37:44,070 AGENCY, CIVIL SOCIETY, 4189 02:37:44,070 --> 02:37:46,372 MULTI-LEVEL STAKEHOLDERS 4190 02:37:46,372 --> 02:37:47,707 INCLUDING (INAUDIBLE) SIT IN A 4191 02:37:47,707 --> 02:37:50,477 LOOM TO TALK COUNTRY PROGRAM 4192 02:37:50,477 --> 02:37:51,611 WHAT COUNTRY PLATFORM IS WORKING 4193 02:37:51,611 --> 02:37:55,014 IN AND DOING IT IN A NATIONALLY 4194 02:37:55,014 --> 02:37:56,382 (INAUDIBLE) ROLE CONTRIBUTIONS 4195 02:37:56,382 --> 02:37:57,517 THAT ARE PART OF THIS SEASONED 4196 02:37:57,517 --> 02:38:00,920 GOING REALLY DEEP AND COURSE 4197 02:38:00,920 --> 02:38:03,790 CORRECTING AND ENSURING THE 4198 02:38:03,790 --> 02:38:05,125 PROGRAM (INAUDIBLE) FOR THE 4199 02:38:05,125 --> 02:38:06,192 EPIDEMIC CONFRONTING AT THE 4200 02:38:06,192 --> 02:38:06,593 TIME. 4201 02:38:06,593 --> 02:38:08,962 IN ADDITION TO THE PROCESS, 4202 02:38:08,962 --> 02:38:14,334 THERE IS A REGULAR REVIEW 4203 02:38:14,334 --> 02:38:17,737 PROCESS WORK -- PEPFAR 4204 02:38:17,737 --> 02:38:21,174 ACCOUNTABILITY REPORTING TEAM SO 4205 02:38:21,174 --> 02:38:23,209 USING DATA TO INFLUENCE A 4206 02:38:23,209 --> 02:38:25,712 PROGRAM REAL TIME IS FROM 4207 02:38:25,712 --> 02:38:28,181 PEPFAR. 4208 02:38:28,181 --> 02:38:31,351 ASSURE THIS SLIDE ACTUALLY 4209 02:38:31,351 --> 02:38:34,754 SHARED SIMILAR FROM HIS PROGRAMS 4210 02:38:34,754 --> 02:38:39,959 AND FROM THE PEP FAR PER 4211 02:38:39,959 --> 02:38:41,261 SPECKTIVE PERSON CENTERED 4212 02:38:41,261 --> 02:38:42,529 APPROACH EVIDENCE DATA 4213 02:38:42,529 --> 02:38:43,630 TRAVERSING GENEROUS 4214 02:38:43,630 --> 02:38:46,499 RESPONSIVENESS, ALL THESE THINGS 4215 02:38:46,499 --> 02:38:48,301 ARE KEY TO THE PEPFAR PROGRAM 4216 02:38:48,301 --> 02:38:49,736 THAT IS GOING TO BE IMPORTANT 4217 02:38:49,736 --> 02:38:52,038 FOR ANY GLOBAL HEALTH PROGRAMS 4218 02:38:52,038 --> 02:38:53,139 OR DOMESTIC PROGRAMS FOR THAT 4219 02:38:53,139 --> 02:38:53,873 MATTER IN TERMS OF PROVIDING 4220 02:38:53,873 --> 02:39:02,515 SERVICES TO THE PEOPLE. 4221 02:39:02,515 --> 02:39:04,717 SO PEP FAR IS AN INTERAGENCY 4222 02:39:04,717 --> 02:39:08,988 ORGANIZATION OR INTERAGENCY 4223 02:39:08,988 --> 02:39:10,456 PROGRAM THIS GIVES YOU SNAP SHOT 4224 02:39:10,456 --> 02:39:13,693 OF AGENCIES THAT ARE 4225 02:39:13,693 --> 02:39:15,328 PARTICIPATING IN OUR PROGRAM, 4226 02:39:15,328 --> 02:39:18,531 LEARNING THAT HUB IS OFFICE 4227 02:39:18,531 --> 02:39:20,400 COORDINATOR SATE DEPARTMENT, 4228 02:39:20,400 --> 02:39:22,869 (INAUDIBLE) TO COORDINATE THE 4229 02:39:22,869 --> 02:39:26,072 PEPFAR PROGRAM IN OUR AGENCY. 4230 02:39:26,072 --> 02:39:27,807 HHS PROBABLY SERVES AS THE 4231 02:39:27,807 --> 02:39:31,377 UMBRELLA FOR VARIOUS (INAUDIBLE) 4232 02:39:31,377 --> 02:39:32,679 PROGRAM BUT IN TERMS OF NATIONAL 4233 02:39:32,679 --> 02:39:35,882 IMPLEMENTATION AS WELL AS 4234 02:39:35,882 --> 02:39:40,086 (INAUDIBLE) CDC AND BRB BIGGEST 4235 02:39:40,086 --> 02:39:41,654 PARTICIPANTS ON THE (INAUDIBLE) 4236 02:39:41,654 --> 02:39:42,121 PROGRAMS. 4237 02:39:42,121 --> 02:39:45,491 NEXT SLIDE. 4238 02:39:45,491 --> 02:39:50,563 SO HOW DOES PEP FAR OR PEP FAR 4239 02:39:50,563 --> 02:39:51,664 ORGANIZE THEMSELVES IN THESE 4240 02:39:51,664 --> 02:39:52,265 PROGRAMS? 4241 02:39:52,265 --> 02:39:55,134 AND IT IS STRUCTURED THROUGH THE 4242 02:39:55,134 --> 02:39:57,337 PEPFAR PRINCIPLES SO THE KEY 4243 02:39:57,337 --> 02:39:58,938 PARTNERS, KEY DEPARTMENT AGENCY 4244 02:39:58,938 --> 02:40:02,242 PARTNERS HAS REPRESENTATIVE IN 4245 02:40:02,242 --> 02:40:06,312 THEIR PURCHASE PRINCIPLES 4246 02:40:06,312 --> 02:40:09,482 CONSISTENTLY TO MEET ON 4247 02:40:09,482 --> 02:40:12,085 QUARTERLY BASIS, THEY MEET ON 4248 02:40:12,085 --> 02:40:13,553 REGULAR BASIS TO DISCUSS POLICY 4249 02:40:13,553 --> 02:40:15,555 ISSUES AND PRIORITIES ON THE 4250 02:40:15,555 --> 02:40:18,491 PROGRAM TO ENSURE PEOPLE ARE 4251 02:40:18,491 --> 02:40:20,126 AWARE VARIOUS AGENCIES ARE WARE, 4252 02:40:20,126 --> 02:40:21,494 AT THE SAME TIME HAVING AGENCIES 4253 02:40:21,494 --> 02:40:23,696 CONTRIBUTE TO THE PROGRESSION 4254 02:40:23,696 --> 02:40:26,633 AND GOALS OF THE PEPFAR PROGRAM. 4255 02:40:26,633 --> 02:40:28,868 THE NEXT LEVEL, DEPUTY 4256 02:40:28,868 --> 02:40:32,572 PRINCIPLES MORE OF THE SENIOR 4257 02:40:32,572 --> 02:40:35,008 CLINICAL LEADERSHIP WITHIN THE 4258 02:40:35,008 --> 02:40:35,375 AGENCIES. 4259 02:40:35,375 --> 02:40:37,310 WE ADDRESS A LOT OF ISSUES 4260 02:40:37,310 --> 02:40:38,978 IMPACTING THE PEPFAR PROGRAM IN 4261 02:40:38,978 --> 02:40:40,246 THE NEAR TERM. 4262 02:40:40,246 --> 02:40:44,217 SO BASICALLY THE KEY PIECE IN 4263 02:40:44,217 --> 02:40:46,920 GENERAL TO ENSURE COORDINATION 4264 02:40:46,920 --> 02:40:47,954 AND ENSURE IMPLEMENTATION 4265 02:40:47,954 --> 02:40:49,555 POLICIES ARE TAKING PLACE 4266 02:40:49,555 --> 02:40:51,157 THROUGH THEIR PARTNERS. 4267 02:40:51,157 --> 02:40:53,626 IN TERMS OF THE PROGRAMMATIC 4268 02:40:53,626 --> 02:40:57,363 OVERSIGHT AND PROGRAMMATIC 4269 02:40:57,363 --> 02:41:01,367 SUPPORT PEPFAR MANAGES 4270 02:41:01,367 --> 02:41:05,905 (INAUDIBLE) TEAM ADDRESSES 4271 02:41:05,905 --> 02:41:08,241 PROGRAMMATIC GAPS THAT ARE 4272 02:41:08,241 --> 02:41:09,342 ENSURING THAT THE BEST EVIDENCE 4273 02:41:09,342 --> 02:41:13,313 IN INNER AGENCIES TO ADDRESS 4274 02:41:13,313 --> 02:41:14,747 THESE ISSUES REAL TIME AND ONCE 4275 02:41:14,747 --> 02:41:17,850 THE ISSUE IS ADDRESSED THEN 4276 02:41:17,850 --> 02:41:18,918 (INAUDIBLE) TO SOLVE AND 4277 02:41:18,918 --> 02:41:19,619 BASICALLY BACK TO 4278 02:41:19,619 --> 02:41:20,687 RESPONSIBILITIES. 4279 02:41:20,687 --> 02:41:24,757 THE ONGOING ENGAGEMENT OF INNER 4280 02:41:24,757 --> 02:41:26,960 AGENCY IS MANAGED THROUGH THE 4281 02:41:26,960 --> 02:41:27,660 (INAUDIBLE) SUPPORT ALSO KNOWN 4282 02:41:27,660 --> 02:41:29,028 AS CAS. 4283 02:41:29,028 --> 02:41:31,130 SO THESE ARE INTERAGENCY 4284 02:41:31,130 --> 02:41:32,699 REPRESENTATIVES THAT SUPPORT 4285 02:41:32,699 --> 02:41:33,800 DIRECTLY SUPPORT THE 4286 02:41:33,800 --> 02:41:34,233 (INAUDIBLE). 4287 02:41:34,233 --> 02:41:37,503 T THEY WOULD BE PART OF PROCESS 4288 02:41:37,503 --> 02:41:39,806 POINT PROCESS AND SOMETIMES 4289 02:41:39,806 --> 02:41:41,874 PROCESS TO ENSURE THE AGENCIES 4290 02:41:41,874 --> 02:41:43,977 ARE SUPPORTED AT -- ON THE 4291 02:41:43,977 --> 02:41:45,979 GROUND AND BASICALLY MAKING SURE 4292 02:41:45,979 --> 02:41:47,880 THAT IT IS ALIGNED WITH THE 4293 02:41:47,880 --> 02:41:54,087 (INAUDIBLE) AS A WHOLE. 4294 02:41:54,087 --> 02:41:56,222 NOW SHIFTING GEARS TO TALK ABOUT 4295 02:41:56,222 --> 02:42:00,626 OJ OFFICE OF GLOBAL AFFAIRS, OJ 4296 02:42:00,626 --> 02:42:01,627 RESIDES (INAUDIBLE) SECRETARY 4297 02:42:01,627 --> 02:42:06,499 PRIMARY FUNCTION TO PROVIDE 4298 02:42:06,499 --> 02:42:10,003 DIPLOMATIC OUTREACH, BILATERAL 4299 02:42:10,003 --> 02:42:11,137 PARTNERS, MULTI -LATERAL AGENCIES 4300 02:42:11,137 --> 02:42:13,339 TO ENSURE WE ARE ACTUALLY 4301 02:42:13,339 --> 02:42:14,207 PROMOTING BIG SCIENCE AND 4302 02:42:14,207 --> 02:42:16,642 EVIDENCE IN SUPPORT OF THE 4303 02:42:16,642 --> 02:42:18,978 DEPARTMENT AND OFFICE ITSELF IS 4304 02:42:18,978 --> 02:42:20,546 DIVIDED BETWEEN REGIONAL OFFICES 4305 02:42:20,546 --> 02:42:23,316 AND THEN AS WELL AS THE POLICY 4306 02:42:23,316 --> 02:42:26,386 PROGRAM OFFICE, PEP FAR PROGRAM 4307 02:42:26,386 --> 02:42:27,320 AND THESE ARE (INAUDIBLE) 4308 02:42:27,320 --> 02:42:28,254 PROGRAM OFFICE. 4309 02:42:28,254 --> 02:42:31,457 ONE OF THE THINGS THAT HAPPENED 4310 02:42:31,457 --> 02:42:34,727 IS AGAIN OJ PARTICIPATION IN WHO 4311 02:42:34,727 --> 02:42:36,896 SO THAT IS MANAGED THROUGH OUR 4312 02:42:36,896 --> 02:42:39,198 MULTI-LATERAL AFFAIRS OFFICE, AT 4313 02:42:39,198 --> 02:42:42,101 THE G 7 G 20 NOW RESIDES IN THE 4314 02:42:42,101 --> 02:42:45,004 NEW YORK MALAYSIA OFFICE. 4315 02:42:45,004 --> 02:42:46,005 RETURN TO COVID RESPONSE A LOT 4316 02:42:46,005 --> 02:42:49,809 OF THAT RESPONSIBILITY FALLS 4317 02:42:49,809 --> 02:42:53,513 UNDER THE (INAUDIBLE) HEALTH 4318 02:42:53,513 --> 02:42:55,448 DEPARTMENT OFFICEGA. 4319 02:42:55,448 --> 02:42:57,450 WE COVER A RANGE OF ACTIVITIES 4320 02:42:57,450 --> 02:43:02,655 IN SUPPORT OF THE DEPARTMENT. 4321 02:43:02,655 --> 02:43:06,793 IN TERMS OF PEP FAR I MENTIONED 4322 02:43:06,793 --> 02:43:10,229 BEFORE, THE GOVERNANCE STRUCTURE 4323 02:43:10,229 --> 02:43:11,898 IS MANAGED IN PRESENCE BILLS AND 4324 02:43:11,898 --> 02:43:15,134 HHS PERSPECTIVE REPRESENTED FDA 4325 02:43:15,134 --> 02:43:18,104 AND HIV AND OREGON SMALLER 4326 02:43:18,104 --> 02:43:19,572 AGENCIES BUT OTHER AGENCIES THAT 4327 02:43:19,572 --> 02:43:22,575 DO NOT HAVE ON THE GROUND 4328 02:43:22,575 --> 02:43:23,142 PRESENCE. 4329 02:43:23,142 --> 02:43:28,548 CKC AND HRSA HAS PRINCIPLE LEVEL 4330 02:43:28,548 --> 02:43:30,516 AS WELL AS U.S. PEACE CORPS BUT 4331 02:43:30,516 --> 02:43:32,718 IN TERMS OF OUR LEADERSHIP, WE 4332 02:43:32,718 --> 02:43:35,354 ENSURE THAT THE COORDINATION 4333 02:43:35,354 --> 02:43:37,123 ACROSS THE DEPARTMENTS IN 4334 02:43:37,123 --> 02:43:38,891 CENTRAL PART ARE CORE FUNCTION 4335 02:43:38,891 --> 02:43:41,561 AND ENSURE PEP FAR IS PART OF A 4336 02:43:41,561 --> 02:43:45,431 CORE COLLABORATION, SOME 4337 02:43:45,431 --> 02:43:46,766 EXAMPLES IN THE SLIDE BUT IN 4338 02:43:46,766 --> 02:43:49,435 ADDITION TO OUR SUPPORTING PEP 4339 02:43:49,435 --> 02:43:52,438 FAR PRINCIPLES, ASSISTANT SEC 4340 02:43:52,438 --> 02:43:55,475 FOR GLOBAL AFFAIRS SENDS 4341 02:43:55,475 --> 02:43:56,375 (INAUDIBLE) APPROVAL AS WELL SO 4342 02:43:56,375 --> 02:43:58,611 THE PRINCIPLE BOARD MEMBER OF 4343 02:43:58,611 --> 02:43:59,812 THE U.S. IS DR. (INAUDIBLE) AT 4344 02:43:59,812 --> 02:44:04,117 THE OFFICE OF COORDINATOR BUT WE 4345 02:44:04,117 --> 02:44:05,017 WORK TOGETHER IN COLLABORATION 4346 02:44:05,017 --> 02:44:08,221 TO ENSURE THAT THE PEP FAR 4347 02:44:08,221 --> 02:44:14,660 PROGRAM WORK IN HARMONY AND 4348 02:44:14,660 --> 02:44:17,063 NAMHC DISTINCT TRANSACTIONAL WAY 4349 02:44:17,063 --> 02:44:17,363 (INAUDIBLE). 4350 02:44:17,363 --> 02:44:20,766 THIS HIGHLIGHTS SOME OF OUR OGA 4351 02:44:20,766 --> 02:44:23,336 PEP FAR PRIORITIES WE ARE TRYING 4352 02:44:23,336 --> 02:44:24,704 TO USE TO GAIN THE BEST OF HHS 4353 02:44:24,704 --> 02:44:26,706 TO INFORM PROGRAMS AND POLICIES 4354 02:44:26,706 --> 02:44:28,608 FOR PEP FAR. 4355 02:44:28,608 --> 02:44:31,811 WHEN IT COMES IN APPROACH HHS, 4356 02:44:31,811 --> 02:44:39,318 HHS AND SPECTRUM, WE NEED TO 4357 02:44:39,318 --> 02:44:42,288 ENSURE SPECTRUM ADDRESSING THE 4358 02:44:42,288 --> 02:44:44,957 ISSUES FOR EXAMPLE, OUR 4359 02:44:44,957 --> 02:44:46,092 ENGAGEMENT WITH FDA MAKING SURE 4360 02:44:46,092 --> 02:44:48,728 THE FDA IS ON THE -- AT THE 4361 02:44:48,728 --> 02:44:50,296 TABLE WITH DISCUSSION AROUND 4362 02:44:50,296 --> 02:44:52,932 REGULATORY CAPACITY BUILDING, 4363 02:44:52,932 --> 02:44:53,733 WHEN (INAUDIBLE) IS TAKING 4364 02:44:53,733 --> 02:44:54,100 PLACE. 4365 02:44:54,100 --> 02:44:55,868 AGAIN ENGAGING NATIONAL 4366 02:44:55,868 --> 02:44:57,069 INSTITUTE OF MENTAL HEALTH, AS 4367 02:44:57,069 --> 02:44:59,939 WELL AS SAM TO ADDRESS MENTAL 4368 02:44:59,939 --> 02:45:01,908 HEALTH SERVICES PROGRAM 4369 02:45:01,908 --> 02:45:02,742 ASSOCIATED WITH HIV PROGRAMS. 4370 02:45:02,742 --> 02:45:05,912 WE HAD EXAMPLES OF -- WE SUPPORT 4371 02:45:05,912 --> 02:45:06,479 WITH OGA. 4372 02:45:06,479 --> 02:45:09,582 IN ADDITION TO ENGAGEMENT AND 4373 02:45:09,582 --> 02:45:10,850 BRINGING (INAUDIBLE) TO BEAR WE 4374 02:45:10,850 --> 02:45:13,019 SUPPORTED LEADERSHIP THAT THEY 4375 02:45:13,019 --> 02:45:15,755 ARE AWARE OF PRIORITIES FOR 4376 02:45:15,755 --> 02:45:18,824 PEPFAR OTHER POLICY ISSUES AND 4377 02:45:18,824 --> 02:45:21,827 ENSURING THAT ASSISTANT 4378 02:45:21,827 --> 02:45:22,962 SECRETARY AS WELL AS (INAUDIBLE) 4379 02:45:22,962 --> 02:45:24,630 IS AWARE OF OUTCOME ISSUES. 4380 02:45:24,630 --> 02:45:25,965 LAST THING, IF YOU CAN REFER 4381 02:45:25,965 --> 02:45:28,834 BACK TO OUR THINK ABOUT THE ORG 4382 02:45:28,834 --> 02:45:30,937 CHART HHS SERVES AS UMBRELLA FOR 4383 02:45:30,937 --> 02:45:33,339 THE DEPARTMENT OF -- VARIOUS 4384 02:45:33,339 --> 02:45:35,208 OFFICES SO PEPFAR FUNDS ARE 4385 02:45:35,208 --> 02:45:35,975 MANAGED THROUGH MULTIPLE 4386 02:45:35,975 --> 02:45:38,277 BARRIERS AND ENSURES THAT OUR 4387 02:45:38,277 --> 02:45:41,480 OFFICE ENSURES THE FUNDS ARE 4388 02:45:41,480 --> 02:45:42,682 DIRECTED TO THE APPROPRIATE -- 4389 02:45:42,682 --> 02:45:44,350 AND MONITOR AND KNOW 4390 02:45:44,350 --> 02:45:48,387 ACCORDINGLY. 4391 02:45:48,387 --> 02:45:50,723 SO AS I WAS MENTIONING BEFORE, 4392 02:45:50,723 --> 02:45:56,128 OUR EXAMPLES OF SOME OF THE OGA 4393 02:45:56,128 --> 02:45:59,865 ROLE IN COLLABORATION, MAYBE 4394 02:45:59,865 --> 02:46:01,434 WORKING WITH KAY HAYES TO 4395 02:46:01,434 --> 02:46:04,904 ORGANIZE A BIDIRECTIONAL SESSION 4396 02:46:04,904 --> 02:46:06,038 NATIONAL AIDS (INAUDIBLE) TAKING 4397 02:46:06,038 --> 02:46:08,107 PLACE IN MONTREAL, THEY THINK 4398 02:46:08,107 --> 02:46:12,645 THAT JUST RECOGNIZING WHERE OGA 4399 02:46:12,645 --> 02:46:13,946 RESIDES, WE BRUNCH GLOBAL 4400 02:46:13,946 --> 02:46:16,682 DOMESTIC IN TERMS OF HEALTH, WE 4401 02:46:16,682 --> 02:46:18,551 SUPPORT VARIOUS OUTPUTS, IT IS A 4402 02:46:18,551 --> 02:46:19,385 UNIQUE PLACE TO SIT IN. 4403 02:46:19,385 --> 02:46:23,222 AND I THINK THAT MANY WAYS 4404 02:46:23,222 --> 02:46:24,290 NATURALLY LEVERAGE OUR 4405 02:46:24,290 --> 02:46:25,625 EXPERIENCE WITH GLOBAL AND 4406 02:46:25,625 --> 02:46:27,293 DOMESTIC AND DOMESTIC TO GLOBAL 4407 02:46:27,293 --> 02:46:29,562 AND INCLUDING A FORM FOR THESE 4408 02:46:29,562 --> 02:46:30,863 TO TAKE PLACE HARK ARE THE 4409 02:46:30,863 --> 02:46:33,132 INITIATIVES AND OGA THAT IS 4410 02:46:33,132 --> 02:46:36,002 SUPPORTING TO ENSURE THERE IS A 4411 02:46:36,002 --> 02:46:38,337 GOOD OPPORTUNITY FOR US TO 4412 02:46:38,337 --> 02:46:39,672 (INAUDIBLE) MAKING SURE SHARING 4413 02:46:39,672 --> 02:46:42,108 OUR EXPERIENCES KNOWLEDGE AND 4414 02:46:42,108 --> 02:46:45,878 EXPERTISE FOR VARIOUS TECHNICAL 4415 02:46:45,878 --> 02:46:46,212 AREAS. 4416 02:46:46,212 --> 02:46:48,281 (INAUDIBLE) FOR EXAMPLE, THIS 4417 02:46:48,281 --> 02:46:49,815 SATELLITE SESSION WE ARE GOING 4418 02:46:49,815 --> 02:46:51,751 TO BE -- TOPICS OF CONVERSATION 4419 02:46:51,751 --> 02:46:56,122 FOCUS AROUND PREP AND UMBRELLAS 4420 02:46:56,122 --> 02:46:57,723 SO CREATING FURTHER 4421 02:46:57,723 --> 02:46:58,424 COLLABORATION. I HAVE ALSO 4422 02:46:58,424 --> 02:47:00,493 MENTIONED THE FACT THAT WE ARE 4423 02:47:00,493 --> 02:47:01,961 CREATING -- TRYING TO CREATE 4424 02:47:01,961 --> 02:47:03,729 OPPORTUNITIES FOR PEOPLE 4425 02:47:03,729 --> 02:47:05,598 INSURANCE PREMIUMS ACROSS THE 4426 02:47:05,598 --> 02:47:06,599 BOARD WHETHER DOMESTIC AND 4427 02:47:06,599 --> 02:47:08,934 GLOBAL ISSUES FROM MENTAL HEALTH 4428 02:47:08,934 --> 02:47:10,136 AND (INAUDIBLE) CAPACITY, THOSE 4429 02:47:10,136 --> 02:47:13,572 ARE EXAMPLES OF WHERE WE TRY TO 4430 02:47:13,572 --> 02:47:15,741 ENCOURAGE PROGRAMS TO THINK 4431 02:47:15,741 --> 02:47:16,542 ABOUT BEYOND JUST THEIR 4432 02:47:16,542 --> 02:47:19,245 INDIVIDUAL PRY YOUR I IT IS AND 4433 02:47:19,245 --> 02:47:20,746 MAKING POWER HOLISTIC IN A 4434 02:47:20,746 --> 02:47:23,282 SENSE, AS COUNTRIES ACHIEVE 4435 02:47:23,282 --> 02:47:25,318 CONTROL THINK ABOUT LONG 4436 02:47:25,318 --> 02:47:27,953 (INAUDIBLE) ABILITY OF THESE 4437 02:47:27,953 --> 02:47:28,487 PROGRAMS. 4438 02:47:28,487 --> 02:47:31,424 SO I WILL STOP THERE, AND TURN 4439 02:47:31,424 --> 02:47:34,060 IT BACK OVER TO YOU. 4440 02:47:34,060 --> 02:47:35,361 >> THANK YOU. 4441 02:47:35,361 --> 02:47:38,931 LET'S THANK ALL THE PRESENTERS 4442 02:47:38,931 --> 02:47:39,832 IN THIS SESSION. 4443 02:47:39,832 --> 02:47:42,968 THAT WAS REALLY NICE TO SEE THE 4444 02:47:42,968 --> 02:47:47,106 DEGREES OF SYNERGY AND 4445 02:47:47,106 --> 02:47:47,740 CONNECTIVE THEMES THROUGHOUT THE 4446 02:47:47,740 --> 02:47:48,107 DIFFERENT TALKS. 4447 02:47:48,107 --> 02:47:54,413 SO I WANT TO OPEN UP NOW FOR 4448 02:47:54,413 --> 02:47:55,781 COMMENTS OR QUESTIONS, WE HAVE A 4449 02:47:55,781 --> 02:47:57,883 FEW MINUTE BEFORE THE NEXT 4450 02:47:57,883 --> 02:48:02,988 SESSION. 4451 02:48:02,988 --> 02:48:07,993 >> DR. SLEASMAN. 4452 02:48:07,993 --> 02:48:14,467 YOU ARE MUTED. 4453 02:48:14,467 --> 02:48:17,703 >> (INAUDIBLE) I JUST WANTED TO 4454 02:48:17,703 --> 02:48:18,838 CIRCLE BACK, GREAT PRESENTATIONS 4455 02:48:18,838 --> 02:48:22,375 AN CIRCLE BACK TO THE WHOLE 4456 02:48:22,375 --> 02:48:27,913 INTERFACE BETWEEN BAC NIH AND 4457 02:48:27,913 --> 02:48:28,781 BRIAN WHITE. 4458 02:48:28,781 --> 02:48:31,283 HISTORICAL PERSPECTIVE, 4459 02:48:31,283 --> 02:48:33,452 TESTIFIED BEFORE CONGRESS IN 4460 02:48:33,452 --> 02:48:36,389 1995 RE-AUTHORIZATION RYAN WHITE 4461 02:48:36,389 --> 02:48:36,655 CARIS ACT. 4462 02:48:36,655 --> 02:48:37,356 AND FOR -- CARES ACT. 4463 02:48:37,356 --> 02:48:38,691 FOR THOSE THAT DON'T KNOW WHAT 4464 02:48:38,691 --> 02:48:40,993 WAS HAPPENING THAT TIME, THAT 4465 02:48:40,993 --> 02:48:42,962 WAS PEAK OF MATERNAL TO 4466 02:48:42,962 --> 02:48:46,198 CHILDHOOD TRANSMISSION, ROLL OUT 4467 02:48:46,198 --> 02:48:48,834 IN 1994 AND WE DID NOT HAVE 4468 02:48:48,834 --> 02:48:49,969 ANTI-RETROVIRAL THERAPY FOR 4469 02:48:49,969 --> 02:48:51,203 CHILDREN. 4470 02:48:51,203 --> 02:48:52,705 AND HIV AIDS WAS A MAJOR CAUSE 4471 02:48:52,705 --> 02:48:56,108 OF DEATH IN CHILDREN 4472 02:48:56,108 --> 02:48:56,709 PARTICULARLY UNDERSERVED 4473 02:48:56,709 --> 02:48:57,042 CHILDREN. 4474 02:48:57,042 --> 02:49:02,748 SO THE ADVENT OF RYAN WHITE WAS 4475 02:49:02,748 --> 02:49:07,253 EXTREMELY IMPORTANT PROVIDING 4476 02:49:07,253 --> 02:49:14,627 FAMILY CARE RETROVIRALS AS WELL 4477 02:49:14,627 --> 02:49:19,899 AS IDENTIFYING HIV INFECTED 4478 02:49:19,899 --> 02:49:21,934 WOMEN THROUGHOUT THE COUNTRY. 4479 02:49:21,934 --> 02:49:23,836 I THINK RIGHT NOW WE HAVE 4480 02:49:23,836 --> 02:49:24,270 ANOTHER OPPORTUNITY. 4481 02:49:24,270 --> 02:49:26,172 I WANTED TO REACH OUT 4482 02:49:26,172 --> 02:49:29,041 PARTICULARLY TO LAURA AND SAY 4483 02:49:29,041 --> 02:49:34,647 ASK HER IF THAT SAMEIUS OF 4484 02:49:34,647 --> 02:49:35,748 RESOURCES THAT ARE WITHIN THE 4485 02:49:35,748 --> 02:49:38,184 RYAN WHITE CARES ACT IS BEING 4486 02:49:38,184 --> 02:49:39,151 FULLY IMPLEMENTED IN TERMS OF 4487 02:49:39,151 --> 02:49:42,788 THE PARTNERSHIP WITH NIH AND 4488 02:49:42,788 --> 02:49:44,557 STOPPING THE CURRENT EPIDEMIC. 4489 02:49:44,557 --> 02:49:50,496 AND HOW CAN WE DO BETTER. 4490 02:49:50,496 --> 02:49:52,698 >> I THINK OVER THE YEARS WE 4491 02:49:52,698 --> 02:49:59,071 LOOKED CLOSELY AT NIH AND VERY 4492 02:49:59,071 --> 02:50:05,711 SPECIFIC (INAUDIBLE) FUNDED 4493 02:50:05,711 --> 02:50:09,014 RESEARCH APPLICABLE IN REAL LIFE 4494 02:50:09,014 --> 02:50:11,584 CLINICAL STUDIES AND THAT 4495 02:50:11,584 --> 02:50:12,218 (INAUDIBLE) EXISTING THROUGHOUT 4496 02:50:12,218 --> 02:50:17,189 THE VARIOUS MODELS (INAUDIBLE) 4497 02:50:17,189 --> 02:50:20,259 CDC. 4498 02:50:20,259 --> 02:50:24,096 (INAUDIBLE) GETTING WORK DONE 4499 02:50:24,096 --> 02:50:24,563 (INAUDIBLE). 4500 02:50:24,563 --> 02:50:26,665 I THINK WHERE WE HAVE GONE NOW 4501 02:50:26,665 --> 02:50:30,269 IS REALLY EXCITING IN THE 4502 02:50:30,269 --> 02:50:33,806 (INAUDIBLE) PEP FAR PROGRAM AND 4503 02:50:33,806 --> 02:50:34,607 (INAUDIBLE) WORKING WITH HEALTH 4504 02:50:34,607 --> 02:50:36,809 DEPARTMENTS IN DIFFERENT PLACES. 4505 02:50:36,809 --> 02:50:41,013 AND JUST LIKE CDC WE ARE 4506 02:50:41,013 --> 02:50:43,916 (INAUDIBLE) WORK OF (INAUDIBLE) 4507 02:50:43,916 --> 02:50:46,619 WE HAVE HAD GOOD SUCCESS WITH 4508 02:50:46,619 --> 02:50:48,320 THE PEPFAR. 4509 02:50:48,320 --> 02:50:52,458 I THINK WE HAVE USUALLY MUCH 4510 02:50:52,458 --> 02:50:55,127 MORE -- NIH FOR HIV THAT WOULD 4511 02:50:55,127 --> 02:51:00,933 BE SPECIFIC BUT SURE -- BUT 4512 02:51:00,933 --> 02:51:04,603 SHORT OF THAT HAVING (INAUDIBLE) 4513 02:51:04,603 --> 02:51:10,109 HAS NOT BEEN -- BIG RISE IN -- 4514 02:51:10,109 --> 02:51:12,645 IN PARTICULAR BUT (INAUDIBLE) 4515 02:51:12,645 --> 02:51:17,249 HAVE THE GROUP TRY TO BE MORE 4516 02:51:17,249 --> 02:51:17,917 PRACTICAL IN TERMS OF -- 4517 02:51:17,917 --> 02:51:19,184 >> I WAS GOING TO SAY THERE WAS 4518 02:51:19,184 --> 02:51:20,719 A TIME YOU WEREN'T ALLOWED TO 4519 02:51:20,719 --> 02:51:23,188 SAY IMPLEMENTATION IN NIH GRANT. 4520 02:51:23,188 --> 02:51:25,991 I THINK THAT THAT'S BEEN A MAJOR 4521 02:51:25,991 --> 02:51:26,859 CHANGE, IF WE THINK ABOUT SOME 4522 02:51:26,859 --> 02:51:28,928 OF THE THINGS THAT JONATHAN WAS 4523 02:51:28,928 --> 02:51:32,331 MENTIONING LIKE POINT OF CARE, 4524 02:51:32,331 --> 02:51:34,567 TESTING, COMMUNITY BASED 4525 02:51:34,567 --> 02:51:38,304 DELIVERY, ENGAGEMENT IN OTHER 4526 02:51:38,304 --> 02:51:43,475 LOCATIONS, TALKED ABOUT GETTING 4527 02:51:43,475 --> 02:51:44,476 MORE HEALTHCARE DELIVERY INTO 4528 02:51:44,476 --> 02:51:47,146 TARGETED COMMUNITIES, THOSE 4529 02:51:47,146 --> 02:51:49,582 WOULD SEEM TO ME SOMETHING THAT 4530 02:51:49,582 --> 02:51:52,284 NIH SPEAKING TO MAUREEN NOW OF 4531 02:51:52,284 --> 02:51:52,952 COURSE. 4532 02:51:52,952 --> 02:51:54,820 NIH SHOULD CONSIDER LOOKING TO 4533 02:51:54,820 --> 02:52:00,192 THEIR EXPANDING (INAUDIBLE) -- 4534 02:52:00,192 --> 02:52:10,703 >> (INAUDIBLE) HIV -- BARRIERS 4535 02:52:14,873 --> 02:52:16,642 TO (INAUDIBLE) HOW TO DO THAT 4536 02:52:16,642 --> 02:52:19,979 BETTER I DON'T KNOW IF THAT IS 4537 02:52:19,979 --> 02:52:23,315 NIH TACKLING (INAUDIBLE) FROM 4538 02:52:23,315 --> 02:52:28,921 OTHERS BUT I THINK NIMH 4539 02:52:28,921 --> 02:52:31,123 (INAUDIBLE) CARE AND HOW TO 4540 02:52:31,123 --> 02:52:33,592 ADDRESS THEM HOW TO ENGAGE WITH 4541 02:52:33,592 --> 02:52:36,462 PEOPLE WHO MIGHT HAVE AVOIDANCE 4542 02:52:36,462 --> 02:52:42,368 COPING MECHANISMS (INAUDIBLE) 4543 02:52:42,368 --> 02:52:45,571 THERE IS THIS KIND OF SPECIFIC 4544 02:52:45,571 --> 02:52:51,243 AREAS WHERE (INAUDIBLE) 4545 02:52:51,243 --> 02:52:53,612 >> DR. BRANDEAU. 4546 02:52:53,612 --> 02:52:55,714 >> I HAVE A QUESTION FOR DR. 4547 02:52:55,714 --> 02:52:56,115 MERMIN. 4548 02:52:56,115 --> 02:52:57,116 THANK YOU FOR THE INTERESTING 4549 02:52:57,116 --> 02:52:57,549 PRESENTATION. 4550 02:52:57,549 --> 02:53:00,386 SO U YOU TALKED ABOUT THE FOCUS 4551 02:53:00,386 --> 02:53:02,287 ON ENDEMICS WHICH EVERYONE 4552 02:53:02,287 --> 02:53:03,656 REALIZES IS SO IMPORTANT BECAUSE 4553 02:53:03,656 --> 02:53:05,124 NOBODY HAS ONE HEALTH CONDITION 4554 02:53:05,124 --> 02:53:07,860 IN THE SILO. 4555 02:53:07,860 --> 02:53:09,228 MY QUESTION YOU DIDN'T MENTION 4556 02:53:09,228 --> 02:53:11,096 IT AND I'M WONDERING THE EXTENT 4557 02:53:11,096 --> 02:53:13,866 TO WHICH YOU VIEW DRUG USE 4558 02:53:13,866 --> 02:53:16,835 DISORDER AND OPIOID ADDICTION AS 4559 02:53:16,835 --> 02:53:20,205 ANOTHER ENDEMIC DISEASE. 4560 02:53:20,205 --> 02:53:22,574 >> I INCLUDED IT. 4561 02:53:22,574 --> 02:53:23,609 I MUST HAVE MISSED IT. 4562 02:53:23,609 --> 02:53:26,645 >> BUT WE -- IT IS ACTUALLY -- 4563 02:53:26,645 --> 02:53:31,450 IT IS THE MOST COMMONLY 4564 02:53:31,450 --> 02:53:32,751 DISCUSSED CONDITION BUT RECENTLY 4565 02:53:32,751 --> 02:53:34,920 STARTED TO WONDER WHETHER EVEN 4566 02:53:34,920 --> 02:53:36,655 THAT TERMINOLOGY, THERE -- IT 4567 02:53:36,655 --> 02:53:39,692 MAY BE THAT POOR MENTAL HEALTH 4568 02:53:39,692 --> 02:53:42,895 OR SOME OTHER TERM MENTAL 4569 02:53:42,895 --> 02:53:43,862 UNHEALTH, WHATEVER IT IS 4570 02:53:43,862 --> 02:53:46,432 SUBSTANCE USE BECOME A CONDITION 4571 02:53:46,432 --> 02:53:48,734 IN AN ENVIRONMENT THAT 4572 02:53:48,734 --> 02:53:49,435 INTERSECTS IN THE SAME WAY AND 4573 02:53:49,435 --> 02:53:50,669 YOU CAN THEN START THINKING 4574 02:53:50,669 --> 02:53:55,874 ABOUT OTHER THINGS LIKE POVERTY. 4575 02:53:55,874 --> 02:54:00,079 OR THESE OTHER RACISM, ITSELF IS 4576 02:54:00,079 --> 02:54:02,981 A ENDEMIC OR EPIDEMIC -- NOT 4577 02:54:02,981 --> 02:54:05,084 SURE ABOUT TERMINOLOGY, 4578 02:54:05,084 --> 02:54:08,520 SOMETIMES WE ARE IN THE WAKE OF 4579 02:54:08,520 --> 02:54:09,722 CHANGING TERMINOLOGY IN THE REST 4580 02:54:09,722 --> 02:54:11,924 OF SOCIETY AND WE FOLLOW ALONG 4581 02:54:11,924 --> 02:54:13,258 AND SOMETIMES WE CAN THINK 4582 02:54:13,258 --> 02:54:17,429 CREATIVELY IN ADVANCE AND CHANGE 4583 02:54:17,429 --> 02:54:18,130 THE LANGUAGE ITSELF. 4584 02:54:18,130 --> 02:54:19,765 NOT SURE WHERE WE ARE WITH THIS 4585 02:54:19,765 --> 02:54:21,400 BUT I SUPPORT YOUR POINT. 4586 02:54:21,400 --> 02:54:24,036 T IF WE ONLY THINK FROM A 4587 02:54:24,036 --> 02:54:25,337 DISEASE INFECTIOUS DISEASE 4588 02:54:25,337 --> 02:54:26,839 STANDPOINT WE ARE GOING TO MISS 4589 02:54:26,839 --> 02:54:32,044 SOME OF THE REALLY IMPORTANT 4590 02:54:32,044 --> 02:54:34,146 CONDITIONS EPIDEMICS INFLUENCING 4591 02:54:34,146 --> 02:54:35,581 AND WE WON'T COME UP WITH 4592 02:54:35,581 --> 02:54:36,181 SOLUTIONS. 4593 02:54:36,181 --> 02:54:39,017 >> I TOTALLY AGREE YOU ABOUT 4594 02:54:39,017 --> 02:54:40,652 BROADER SOCIAL PROBLEMS, THAT IS 4595 02:54:40,652 --> 02:54:43,288 THE HIGHLIGHT OF WHAT WE SAID 4596 02:54:43,288 --> 02:54:44,389 TODAY. 4597 02:54:44,389 --> 02:54:45,991 YOU HAVE PROBABLY SEEN IT BETTER 4598 02:54:45,991 --> 02:54:48,894 RECENT REPORT OF LANSETT OPIOID 4599 02:54:48,894 --> 02:54:49,895 COMMISSION, WE TALK ABOUT 4600 02:54:49,895 --> 02:54:51,130 ENVIRONMENTAL FACTOR AND IT IS 4601 02:54:51,130 --> 02:54:52,264 ON POINT WITH EVERYTHING YOU 4602 02:54:52,264 --> 02:54:52,664 SAID NOW. 4603 02:54:52,664 --> 02:54:54,633 THANK YOU. 4604 02:54:54,633 --> 02:54:56,001 >> THAT WAS A GREAT SUPPORT. 4605 02:54:56,001 --> 02:54:57,836 THANKS FOR THE TIME. 4606 02:54:57,836 --> 02:55:00,205 IF IT IS OKAY JOHN IF I CAN ALSO 4607 02:55:00,205 --> 02:55:03,075 -- SUSAN, I THINK THAT IT IS 4608 02:55:03,075 --> 02:55:05,511 REALLY INTERESTING, THERE IS 4609 02:55:05,511 --> 02:55:08,614 PERFECTION IN ORGANIZATIONAL 4610 02:55:08,614 --> 02:55:10,783 STRUCTURES AND DICHOTEMIZING 4611 02:55:10,783 --> 02:55:12,584 WORK CAN CREATE PROBLEMS SO WILL 4612 02:55:12,584 --> 02:55:14,686 IS A -- IF YOU TAKE THE HIV 4613 02:55:14,686 --> 02:55:17,356 WORLD, I THINK IN TERMS OF WHERE 4614 02:55:17,356 --> 02:55:20,759 IS THE RESEARCH? 4615 02:55:20,759 --> 02:55:22,828 WELL, NIH TENDS TOWARDS BASIC 4616 02:55:22,828 --> 02:55:27,132 APPLIED RESEARCH WITH SOME 4617 02:55:27,132 --> 02:55:28,100 IMPLEMENTATION RESEARCH. 4618 02:55:28,100 --> 02:55:30,569 LAURA IS TALKING ABOUT HOW HRSA 4619 02:55:30,569 --> 02:55:33,806 AT LEAST THE RYAN WHITE PROGRAM 4620 02:55:33,806 --> 02:55:36,508 FOCUSES ON CREATIVE PROGRAMS 4621 02:55:36,508 --> 02:55:37,643 EVALUATING THE PROGRAMS, 4622 02:55:37,643 --> 02:55:38,744 THINKING ABOUT HOW WE CAN LEARN 4623 02:55:38,744 --> 02:55:39,878 FROM THAT AND DOING BETTER. 4624 02:55:39,878 --> 02:55:40,979 SO ESSENTIALLY IMPLEMENTATION 4625 02:55:40,979 --> 02:55:44,149 SCIENCE. 4626 02:55:44,149 --> 02:55:45,784 AND PROGRAM -- EVIDENCE BASED 4627 02:55:45,784 --> 02:55:47,286 PROGRAM IMPLEMENTATION. 4628 02:55:47,286 --> 02:55:48,954 CDC WHAT WE SEE IS WE CAN CROSS 4629 02:55:48,954 --> 02:55:50,589 -- WE DON'T TEND TO DO BASIC 4630 02:55:50,589 --> 02:55:51,723 STUFF, THOUGH MAYBE IN 4631 02:55:51,723 --> 02:55:53,025 DIAGNOSTICS WE DO THAT BUT 4632 02:55:53,025 --> 02:55:55,027 MOSTLY WE DO APPLIED RESEARCH UP 4633 02:55:55,027 --> 02:55:57,462 UNTIL IMPLEMENTATION AN PROGRAM 4634 02:55:57,462 --> 02:55:58,197 EVALUATION. 4635 02:55:58,197 --> 02:55:59,965 AND I THINK IT IS OUR DIFFERENT 4636 02:55:59,965 --> 02:56:01,433 PERSPECTIVES OF WHAT WE ARE 4637 02:56:01,433 --> 02:56:04,102 DOING AS LONG AS WE SHARE IDEAS, 4638 02:56:04,102 --> 02:56:05,771 WE SAY HEY SOMEONE ELSE YOU CAN 4639 02:56:05,771 --> 02:56:08,540 DO BETTER THAN IF YOU ARE SAYING 4640 02:56:08,540 --> 02:56:10,843 NO, THE ONLY THING NIH SHOULD BE 4641 02:56:10,843 --> 02:56:12,945 DOING IS BASIC SCIENCE, ANYTHING 4642 02:56:12,945 --> 02:56:16,381 ELSE NO, CDC SHOULDN'T BE DOING 4643 02:56:16,381 --> 02:56:17,716 THIS, SOMETIMES HAS MORE MONEY 4644 02:56:17,716 --> 02:56:20,352 OR CREATIVE LABORATORY OR STAFF, 4645 02:56:20,352 --> 02:56:21,453 BUT IT IS ALSO WHERE THE 4646 02:56:21,453 --> 02:56:23,222 QUESTIONS COMING FROM SO WE SEE 4647 02:56:23,222 --> 02:56:24,823 THIS CONTINUUM BETWEEN IF YOU 4648 02:56:24,823 --> 02:56:25,624 FAULK TO THE PEOPLE WHO ARE OUT 4649 02:56:25,624 --> 02:56:27,593 THERE, EXPERIENCING THE 4650 02:56:27,593 --> 02:56:32,664 OBSTACLES, WHETHER PROVIDERS OR 4651 02:56:32,664 --> 02:56:34,233 CLIENTS, THEY WILL TELL YOU THE 4652 02:56:34,233 --> 02:56:36,235 PROBLEMS AND YOU CAN DESIGN 4653 02:56:36,235 --> 02:56:38,003 STUDIES THAT ENUP AND CONDUCT 4654 02:56:38,003 --> 02:56:39,137 RESEARCH THAT WILL ANSWER SOME 4655 02:56:39,137 --> 02:56:40,372 OF THOSE PROBLEMS AND YOU CHANGE 4656 02:56:40,372 --> 02:56:41,707 THAT WITH GUIDELINES AND 4657 02:56:41,707 --> 02:56:42,841 PROGRAMS, AND THEN THAT CYCLE 4658 02:56:42,841 --> 02:56:43,909 CONTINUES. 4659 02:56:43,909 --> 02:56:45,544 I THINK THAT IS HOW WE DEAL WITH 4660 02:56:45,544 --> 02:56:47,980 A LOT OF THE EQUITY ISSUES, 4661 02:56:47,980 --> 02:56:50,182 BECAUSE IF YOU JUST -- IF YOU 4662 02:56:50,182 --> 02:56:51,750 ARE NOT LISTENING TO PEOPLE YOU 4663 02:56:51,750 --> 02:56:53,185 WILL MAKE MISTAKES. 4664 02:56:53,185 --> 02:56:59,024 BUT IT ALSO ALLOWS US TO TO BE 4665 02:56:59,024 --> 02:57:01,593 MORE EFFECTIVE AS COLLABORATING 4666 02:57:01,593 --> 02:57:02,828 GROUPS SO WE ARE BETTER THAN 4667 02:57:02,828 --> 02:57:04,263 WHEN YOU DESCRIBE THE SITUATION 4668 02:57:04,263 --> 02:57:06,365 OR CALL TO CONGRESS TO TRY TO -- 4669 02:57:06,365 --> 02:57:10,002 BUT I ACTUALLY THINK THAT IT IS 4670 02:57:10,002 --> 02:57:12,638 -- BUT IT HAS TO CONTINUE, HAS 4671 02:57:12,638 --> 02:57:13,839 TO CONTINUE AND SOMETIMES IT 4672 02:57:13,839 --> 02:57:15,307 ALWAYS COMES UP, SOMEONE SAYING 4673 02:57:15,307 --> 02:57:17,843 WHY IS THIS AGENCY DOING THAT? 4674 02:57:17,843 --> 02:57:21,380 AND YOU FEEL LIKE SAYING WHY ONE 4675 02:57:21,380 --> 02:57:22,614 SPOUSE DOING THE DISHES AND THE 4676 02:57:22,614 --> 02:57:24,182 OTHER COOKING? 4677 02:57:24,182 --> 02:57:25,384 THAT IS WHAT WORKED FOR OUR 4678 02:57:25,384 --> 02:57:26,752 FAMILY AND WE ARE GETTING THE 4679 02:57:26,752 --> 02:57:28,053 JOB DONE P AND THERE'S SOMETHING 4680 02:57:28,053 --> 02:57:30,022 ABOUT THAT HERE TOO. 4681 02:57:30,022 --> 02:57:31,556 >> I THINK IT IS IMPORTANT TO 4682 02:57:31,556 --> 02:57:32,991 POINT OUT COMMUNITY ENGAGEMENT 4683 02:57:32,991 --> 02:57:38,130 HAS TO BE BIDIRECTIONAL. 4684 02:57:38,130 --> 02:57:40,699 THAT IS SOMETHING HELLS 4685 02:57:40,699 --> 02:57:42,034 PARTICULARLY C FAR COMMUNITY 4686 02:57:42,034 --> 02:57:43,902 ADVISORY BOARD, BECOMING MORE 4687 02:57:43,902 --> 02:57:46,905 AND MORE BIDIRECTIONAL. 4688 02:57:46,905 --> 02:57:48,006 WE HAVE TO KEEP THAT IN MINE AS 4689 02:57:48,006 --> 02:57:48,573 WELL. 4690 02:57:48,573 --> 02:57:52,644 >> MAUREEN. 4691 02:57:52,644 --> 02:57:56,048 >> I WANTED TO JUMP IN QUICKLY 4692 02:57:56,048 --> 02:57:59,351 ABOUT TRANSITIONS IN ACTIVITIES 4693 02:57:59,351 --> 02:58:01,820 AND YOU THINK EARLY ON -- THIS 4694 02:58:01,820 --> 02:58:05,223 IS FROM THE NIH POINT OF VIEW, 4695 02:58:05,223 --> 02:58:06,525 BASIC RESEARCH IS REALLY 4696 02:58:06,525 --> 02:58:10,062 IMPORTANT GETTING THE INITIAL 4697 02:58:10,062 --> 02:58:13,799 WORK DONE IN THE HIV FIELD AND 4698 02:58:13,799 --> 02:58:19,604 AS THE PRODUCTS DRUGS AND 4699 02:58:19,604 --> 02:58:20,772 DIAGNOSISSICS WERE DEVELOPED IT 4700 02:58:20,772 --> 02:58:21,974 WAS FOUND NUMBER ONE THAT IT WAS 4701 02:58:21,974 --> 02:58:25,510 HARD TO GET APPROVED BECAUSE 4702 02:58:25,510 --> 02:58:28,280 THERE WERE NO CLINICAL TRIAL 4703 02:58:28,280 --> 02:58:30,048 NETWORKS WITHIN THE NIH AT THAT 4704 02:58:30,048 --> 02:58:33,352 TIME WHEN PHARMA WASN'T 4705 02:58:33,352 --> 02:58:35,420 INTERESTED, ALONG THE WAY THIS 4706 02:58:35,420 --> 02:58:37,089 CATALYZED A LOT OF DEVELOPMENT 4707 02:58:37,089 --> 02:58:39,958 OF THE CLINICAL TRIAL NETWORKS 4708 02:58:39,958 --> 02:58:40,993 WITHIN THE NIH. 4709 02:58:40,993 --> 02:58:44,730 BOTH HIV AND LOT OF OTHER 4710 02:58:44,730 --> 02:58:45,964 CONDITIONS AS WELL. 4711 02:58:45,964 --> 02:58:50,569 WHAT IS TURNED OUT PARTICULARLY 4712 02:58:50,569 --> 02:58:54,206 WITH AS OTHER USES IMPROVEMENTS 4713 02:58:54,206 --> 02:58:57,709 MANY THE CARE AND TYPES OF 4714 02:58:57,709 --> 02:59:00,445 PRODUCTS THERE IS NOW AN 4715 02:59:00,445 --> 02:59:01,546 UNDERSTANDING THAT WE NEED TO 4716 02:59:01,546 --> 02:59:04,416 FOCUS ON HAVING PEOPLE 4717 02:59:04,416 --> 02:59:07,652 UNDERSTAND WHAT THESE ARE AND BE 4718 02:59:07,652 --> 02:59:09,421 WILLING TO SEE TO UNDERSTAND THE 4719 02:59:09,421 --> 02:59:12,290 BENEFITS THAT WOULD MAKE THEM 4720 02:59:12,290 --> 02:59:17,662 WILLING TO BE UPTAKE THESE 4721 02:59:17,662 --> 02:59:18,263 ADVANCES. 4722 02:59:18,263 --> 02:59:20,999 SO THE IMPLEMENTATION SCIENCE 4723 02:59:20,999 --> 02:59:24,870 PIECE FOR THE HIV PROGRAM IS -- 4724 02:59:24,870 --> 02:59:27,305 HAS DEVELOPED ALONG THIS PATHWAY 4725 02:59:27,305 --> 02:59:29,174 IF YOU WILL, BUT THERE IS A LOT 4726 02:59:29,174 --> 02:59:30,942 OF IMPLEMENTATION SCIENCE 4727 02:59:30,942 --> 02:59:33,912 RESEARCH AT THE NIH IN OTHER 4728 02:59:33,912 --> 02:59:35,113 AREAS, CANCER IS A BIG ONE, 4729 02:59:35,113 --> 02:59:38,283 NATIONAL INSTITUTE OF MENTAL 4730 02:59:38,283 --> 02:59:40,852 HEALTH BOTH OUTSIDE AND WITHIN 4731 02:59:40,852 --> 02:59:41,953 THEIR NIH PROGRAM REALLY HAVE 4732 02:59:41,953 --> 02:59:43,989 BEEN LEADERS AND CONTINUE TO BE 4733 02:59:43,989 --> 02:59:46,058 LEADERS BUT THEN IT IS AGAIN 4734 02:59:46,058 --> 02:59:47,659 DIFFERENT PATCHES OR DIFFERENT 4735 02:59:47,659 --> 02:59:49,661 AREAS OF EXPERTISE ACROSS THE 4736 02:59:49,661 --> 02:59:52,898 NIH AND SO WHAT WE ARE DOING NOW 4737 02:59:52,898 --> 02:59:57,469 IS REALLY BUILDING UP THE 4738 02:59:57,469 --> 02:59:59,271 CAPACITY AND APPLYING WHAT IS 4739 02:59:59,271 --> 03:00:00,272 KNOWN ABOUT IMPLEMENTATION 4740 03:00:00,272 --> 03:00:01,406 SCIENCE RESEARCH AND WHAT WORKED 4741 03:00:01,406 --> 03:00:03,742 IN OTHER AREAS, TO THE HIV FIELD 4742 03:00:03,742 --> 03:00:07,212 AS WE FIND OUT. 4743 03:00:07,212 --> 03:00:08,013 OUT WHERE GAPS ARE 4744 03:00:08,013 --> 03:00:10,248 AND PROVIDE THOSE RESULTS AND 4745 03:00:10,248 --> 03:00:12,317 THAT OUTCOME -- THOSE OUTCOMES 4746 03:00:12,317 --> 03:00:13,919 FROM RESEARCH FOR THE PARTNERS 4747 03:00:13,919 --> 03:00:18,056 THAT YOU HEARD ABOUT TODAY WHO 4748 03:00:18,056 --> 03:00:23,295 ARE ON THE GROUND. 4749 03:00:23,295 --> 03:00:26,498 TAKING ADVANTAGE OF THIS AND 4750 03:00:26,498 --> 03:00:27,499 HELPING UNDERSTAND WHAT IT IS 4751 03:00:27,499 --> 03:00:30,802 DIFFERENT COMMUNITIES AND 4752 03:00:30,802 --> 03:00:36,708 DIFFERENT NEEDS DIFFERENT AREAS. 4753 03:00:36,708 --> 03:00:38,176 KAY SAID THIS, IT IS NOT ONE 4754 03:00:38,176 --> 03:00:44,516 SIZE PITTS ALL, YOU HAVE TO 4755 03:00:44,516 --> 03:00:45,951 FIGURE HOW TO DO THIS IN 4756 03:00:45,951 --> 03:00:46,818 DIFFERENT COMMUNITIES BUT THE 4757 03:00:46,818 --> 03:00:50,989 WORK GOING ON IN THESE 4758 03:00:50,989 --> 03:00:52,124 COMMUNITY, AT OTHER PARTS OF THE 4759 03:00:52,124 --> 03:00:55,794 NIH WE CAN CERTAINLY LEVERAGE 4760 03:00:55,794 --> 03:00:57,028 THAT FOR THE HIV -- LEVERAGE 4761 03:00:57,028 --> 03:00:58,864 THAT FOR THE HIV FIELD. 4762 03:00:58,864 --> 03:01:02,134 >> THANK YOU, MAUREEN. 4763 03:01:02,134 --> 03:01:02,701 KAY. 4764 03:01:02,701 --> 03:01:04,569 >> I WANTED TO CHIME IN AND TALK 4765 03:01:04,569 --> 03:01:07,072 ABOUT THE NIH AND HOW INCREDIBLY 4766 03:01:07,072 --> 03:01:08,573 HELPFUL MAUREEN WAS WHEN WE TALK 4767 03:01:08,573 --> 03:01:09,508 ABOUT STIGMA. 4768 03:01:09,508 --> 03:01:11,543 AND THE RESEARCH THAT NIH REALLY 4769 03:01:11,543 --> 03:01:13,278 HELPED US WE START TALKING ABOUT 4770 03:01:13,278 --> 03:01:19,384 STIGMA, STIGMA IT IS 4771 03:01:19,384 --> 03:01:20,952 A TOUCH ISSUES IN COMMUNITIES 4772 03:01:20,952 --> 03:01:22,053 BUT SO CRITICAL MANY THE PIECE 4773 03:01:22,053 --> 03:01:23,622 OF WORK THAT WE DO AND ALSO 4774 03:01:23,622 --> 03:01:25,290 WANTED TO CHIME IN BECAUSE WE DO 4775 03:01:25,290 --> 03:01:29,661 INCORPORATE THE OPIOID CRISIS IN 4776 03:01:29,661 --> 03:01:31,129 THE WORK FROM THIS ENDEMIC 4777 03:01:31,129 --> 03:01:36,635 APPROACH BUT WE ARE TALKING ALSO 4778 03:01:36,635 --> 03:01:37,936 HOUSING MENTAL HEALTH, IT IS NOT 4779 03:01:37,936 --> 03:01:39,538 JUST -- UNFORTUNATELY THERE'S 4780 03:01:39,538 --> 03:01:43,408 LOTS OF ISSUES THAT IMPACT THE 4781 03:01:43,408 --> 03:01:45,577 OUTCOMES OF THE WORK WE DO SO 4782 03:01:45,577 --> 03:01:47,979 DEFINITELY LOOKING AT ENDEMIC OR 4783 03:01:47,979 --> 03:01:48,980 HOLISTIC APPROACH IN THE WORK 4784 03:01:48,980 --> 03:01:50,182 THAT WE DO BECAUSE THERE'S SO 4785 03:01:50,182 --> 03:01:55,987 MANY FACTORS THAT ARE IMPACTED. 4786 03:01:55,987 --> 03:01:57,522 >> THANK YOU, KAY. 4787 03:01:57,522 --> 03:02:01,793 JIN. 4788 03:02:01,793 --> 03:02:08,266 >> I WANT TO REFLECT ON IN TERMS 4789 03:02:08,266 --> 03:02:10,035 OF (INAUDIBLE) HAVING THIS SPACE 4790 03:02:10,035 --> 03:02:15,240 TO LEARN, I THINK MANY WAYS TO 4791 03:02:15,240 --> 03:02:16,141 BE LOCAL OR GLOBAL. 4792 03:02:16,141 --> 03:02:18,910 WE NEED TO MAKE SURE WE ARE 4793 03:02:18,910 --> 03:02:21,580 THERE IS HAVING WORKED UNDER DR. 4794 03:02:21,580 --> 03:02:24,382 CHEEVER, LAURA, AT HRSA THERE 4795 03:02:24,382 --> 03:02:28,019 WAS SO MUCH THAT WENT FROM 4796 03:02:28,019 --> 03:02:30,288 DOMESTIC TO GLOBAL, LEVEL OF 4797 03:02:30,288 --> 03:02:31,856 MATURITY IN THE PROGRAM, WE HAVE 4798 03:02:31,856 --> 03:02:33,758 MANY LESSONS TO BE LEARNED FROM 4799 03:02:33,758 --> 03:02:36,628 THE GLOBAL SECTOR TO DOMESTIC 4800 03:02:36,628 --> 03:02:39,364 AND THE SHARED UNDERSTAND, 4801 03:02:39,364 --> 03:02:41,233 SHARED INFORMATION ACROSS THE 4802 03:02:41,233 --> 03:02:44,636 BOARD P. BASICALLY EXPANDING 4803 03:02:44,636 --> 03:02:48,373 COMMUNITY BASE 4804 03:02:48,373 --> 03:02:50,609 >> SO WE'LL TAKE ONE MORE 4805 03:02:50,609 --> 03:02:53,378 COMMENT FROM JONATHAN. 4806 03:02:53,378 --> 03:02:55,046 BEFORE YOU COMMENT I HAD A QUICK 4807 03:02:55,046 --> 03:02:57,182 QUESTION I WANT TO TRY AND SLIDE 4808 03:02:57,182 --> 03:02:59,951 INTO YOU. 4809 03:02:59,951 --> 03:03:01,820 WITH YOUR ENDEMIC APPROACH WITH 4810 03:03:01,820 --> 03:03:03,388 HOLISTIC STRATEGY YOU DESCRIBE 4811 03:03:03,388 --> 03:03:06,758 EARLIER, IS THERE ONE COMPONENT 4812 03:03:06,758 --> 03:03:11,963 THAT YOU FIND MORE EFFECTIVE 4813 03:03:11,963 --> 03:03:14,532 TELEHEALTH VERSUS TESTING AT 4814 03:03:14,532 --> 03:03:17,702 HOME, CAN YOU COMMENT ON THAT 4815 03:03:17,702 --> 03:03:20,372 AND PLEASE SHARE YOUR COMMENT OR 4816 03:03:20,372 --> 03:03:20,672 QUESTION. 4817 03:03:20,672 --> 03:03:25,944 >> I THINK WE KNOW FOR CERTAIN 4818 03:03:25,944 --> 03:03:29,848 SPECIFIC MORE SMALLER SCALE 4819 03:03:29,848 --> 03:03:33,251 PROBLEMS WHAT MIGHT BE BETTER, 4820 03:03:33,251 --> 03:03:36,021 LIKE MULTI -INFECTIOUS SCREENING 4821 03:03:36,021 --> 03:03:37,622 THROUGH STANDING ORDER. 4822 03:03:37,622 --> 03:03:39,624 THAT WORKS. 4823 03:03:39,624 --> 03:03:43,461 THEN THERE IS A LARGER SCALE 4824 03:03:43,461 --> 03:03:47,966 ABOUT DON'T FORGET POLICIES, AND 4825 03:03:47,966 --> 03:03:51,369 YOU CAN DO PILOT PROGRAMS NEVER 4826 03:03:51,369 --> 03:03:52,671 -- OR CHANGE THE LAW IN YOUR 4827 03:03:52,671 --> 03:03:55,040 STATE OR NATION. 4828 03:03:55,040 --> 03:03:56,741 THAT STUFF APPLIES BUT THERE IS 4829 03:03:56,741 --> 03:03:58,777 ALSO A LOT WE DON'T KNOW. 4830 03:03:58,777 --> 03:03:59,978 AND THERE'S CERTAINLY SOME 4831 03:03:59,978 --> 03:04:02,414 RESEARCH THAT CAN BE CONDUCTED 4832 03:04:02,414 --> 03:04:04,182 TONS OF RESEARCH, LOOKING AT 4833 03:04:04,182 --> 03:04:05,950 WHAT CHANGES WHERE WE HAVE DATA 4834 03:04:05,950 --> 03:04:08,053 OR PROSPECTIVELY DESIGNING 4835 03:04:08,053 --> 03:04:10,088 STUDIES THAT ARE MULTI-LEVEL 4836 03:04:10,088 --> 03:04:12,757 MODELING THAT ENABLE US TO LEARN 4837 03:04:12,757 --> 03:04:15,994 QUICKLY. 4838 03:04:15,994 --> 03:04:17,429 I TAKE THAT AS A CHALLENGE 4839 03:04:17,429 --> 03:04:19,030 BECAUSE I CAN'T ANSWER. 4840 03:04:19,030 --> 03:04:20,932 BUT I ALSO -- I WANT TO SAY 4841 03:04:20,932 --> 03:04:26,171 THINKING RESEARCH I ALSO I FEEL 4842 03:04:26,171 --> 03:04:28,039 LIKE JUST AS RYAN WHITE IS 4843 03:04:28,039 --> 03:04:29,607 PRACTICALLY IMPROVING EQUITY BY 4844 03:04:29,607 --> 03:04:31,009 THINKING ABOUT A LOT OF THESE 4845 03:04:31,009 --> 03:04:33,878 ISSUES AND PLEA AGREEMENTINGS 4846 03:04:33,878 --> 03:04:35,880 PROGRAMS EFFECTIVELY, I THINK 4847 03:04:35,880 --> 03:04:37,449 RESEARCH ALSO CAN BE A TOOL FOR 4848 03:04:37,449 --> 03:04:38,083 EQUITY. 4849 03:04:38,083 --> 03:04:40,018 IF WE KNOW ABOUT THE PROBLEMS 4850 03:04:40,018 --> 03:04:41,252 THAT ARE BEING CREATED THAT 4851 03:04:41,252 --> 03:04:46,825 PREVENT PEOPLE FROM LEADING THE 4852 03:04:46,825 --> 03:04:49,027 HEALTHIEST LIFE THEY CAN OR 4853 03:04:49,027 --> 03:04:51,896 GETTING HIV, YOU CAN DO DEVELOP 4854 03:04:51,896 --> 03:04:54,866 NEW TECHNOLOGIES OR CONDUCT 4855 03:04:54,866 --> 03:04:57,302 STUDIES GOING TO MAKE IT EASIER 4856 03:04:57,302 --> 03:04:59,804 TO OVERCOME THAT TRADITION. 4857 03:04:59,804 --> 03:05:02,507 SOME EXAMPLES ANTI-RETROVIRAL 4858 03:05:02,507 --> 03:05:08,513 THERAPY ITSELF, ONCE A DAY ART. 4859 03:05:08,513 --> 03:05:10,782 PREP, IF PREP DIDN'T EXIST IT 4860 03:05:10,782 --> 03:05:11,583 WAS MOUSE ONCE A DAY PILL FOR 4861 03:05:11,583 --> 03:05:14,819 PREP, INJECTABLE PREP, PROBABLY 4862 03:05:14,819 --> 03:05:20,191 NICHE MARKET SOME WAYS THERE'S 4863 03:05:20,191 --> 03:05:21,993 CERTAINLY PEOPLE WHO REQUEST 4864 03:05:21,993 --> 03:05:24,095 THAT, EASIER FOR THEM TO HEAR 4865 03:05:24,095 --> 03:05:28,600 AND IMPLANT LONG ACTING AGENTS, 4866 03:05:28,600 --> 03:05:30,335 ARE THEIR SCIENCE TIGHT MUST 4867 03:05:30,335 --> 03:05:31,436 MOSTIC SUIT TALKED ABOUT BUT 4868 03:05:31,436 --> 03:05:34,639 THEY WILL OVERCOME BARRIERS THAT 4869 03:05:34,639 --> 03:05:37,008 ALLOW US TOP REDUCE DISPARITIES 4870 03:05:37,008 --> 03:05:40,211 THAT WE ARE SEEING IN HIV AND 4871 03:05:40,211 --> 03:05:41,479 OTHER INFECTIONS THAT IS HOW WE 4872 03:05:41,479 --> 03:05:44,349 ARE THINKING SOME OF THE 4873 03:05:44,349 --> 03:05:45,283 SELF-TESTING TOO. 4874 03:05:45,283 --> 03:05:49,454 YOU CAN BRING TESTING TO PEOPLE, 4875 03:05:49,454 --> 03:05:51,990 EASILY THAN REDUCE OBSTACLES, 4876 03:05:51,990 --> 03:05:53,191 THEY WILL GET TESTED MORE. 4877 03:05:53,191 --> 03:05:53,925 >> ALL RIGHT. 4878 03:05:53,925 --> 03:05:54,859 SO WE WILL MOVE ON. 4879 03:05:54,859 --> 03:05:57,429 I WANT TO THANK ALL THE SPEAKERS 4880 03:05:57,429 --> 03:05:58,463 AGAIN, IN THE LAST SESSION. 4881 03:05:58,463 --> 03:06:01,332 THIS HAS BEEN A RICH DISCUSSION. 4882 03:06:01,332 --> 03:06:03,334 SO WE WILL MOVE AHEAD WITH THE 4883 03:06:03,334 --> 03:06:04,436 AGENDA. 4884 03:06:04,436 --> 03:06:05,837 OUR NEXT SESSION WILL HAVE 4885 03:06:05,837 --> 03:06:09,707 UPDATES FROM THE HIV CLINICAL 4886 03:06:09,707 --> 03:06:11,109 GUIDELINES WORKING GROUP, THESE 4887 03:06:11,109 --> 03:06:12,677 INCLUDE GUIDELINES AND PANEL 4888 03:06:12,677 --> 03:06:14,145 UPDATES SO WE HAVE TWO 4889 03:06:14,145 --> 03:06:18,082 PRESENTERS, DR. HENRY MASUR AND 4890 03:06:18,082 --> 03:06:19,217 DR. ROHAN HAZRA. 4891 03:06:19,217 --> 03:06:20,285 DR. MASUR IS CHIEF OF THE 4892 03:06:20,285 --> 03:06:21,419 CRITICAL CARE MEDICINE 4893 03:06:21,419 --> 03:06:25,590 DEPARTMENT OF THE CLINICAL 4894 03:06:25,590 --> 03:06:28,760 CENTER ANOTHER NIH, MASUR WELL 4895 03:06:28,760 --> 03:06:30,195 KNOWN FOR MANAGEMENT AND 4896 03:06:30,195 --> 03:06:32,864 EXPERTISE THIS HIV AND CO-MORE 4897 03:06:32,864 --> 03:06:35,066 BITTIES AND EXPERTISE IN I 4898 03:06:35,066 --> 03:06:37,869 CRACKU RELATED INFECTION. 4899 03:06:37,869 --> 03:06:41,105 -- ICU INFECTIONS. 4900 03:06:41,105 --> 03:06:46,611 TRAUMA SURDR. MASUR, OVER TO YO. 4901 03:06:46,611 --> 03:06:48,947 >> EACH OF THE INFECTION GUIDE 4902 03:06:48,947 --> 03:06:51,316 PIPELINES ARE VERY MUCH USED -- 4903 03:06:51,316 --> 03:06:52,684 GUIDELINES ARE USED AS I WILL 4904 03:06:52,684 --> 03:06:54,118 SHOW YOU THE DATA AND WE MAKE A 4905 03:06:54,118 --> 03:06:55,987 REAL EFFORT TO KEEP THEM CURRENT 4906 03:06:55,987 --> 03:06:59,190 AND KEEP THEM GUIDELINE FOCUSED 4907 03:06:59,190 --> 03:07:00,625 RATHER THAN -- SO WHAT I WILL 4908 03:07:00,625 --> 03:07:03,127 SHOW YOU IN FIVE SLIDES IS JUST 4909 03:07:03,127 --> 03:07:06,164 HOW MUCH THEY ARE USED AND WHAT 4910 03:07:06,164 --> 03:07:07,065 CHANGES WE MADE OVER THE LAST 4911 03:07:07,065 --> 03:07:10,435 YEAR. 4912 03:07:10,435 --> 03:07:12,570 SHOW THE NEXT SLIDE. 4913 03:07:12,570 --> 03:07:14,639 THIS SHOWS USAGE OVER THE LAST 4914 03:07:14,639 --> 03:07:18,710 CALENDAR YEAR, FOR THE 4915 03:07:18,710 --> 03:07:21,913 GUIDELINES,YOU MAY SEE THIS 4916 03:07:21,913 --> 03:07:25,917 AGAIN FROM ROHAN BUT THIS WAS -- 4917 03:07:25,917 --> 03:07:27,685 YOU CAN LOOK DOWNLOADS, LOOK AT 4918 03:07:27,685 --> 03:07:31,623 VARIETY OF ISSUES BUT GETTING 4919 03:07:31,623 --> 03:07:34,826 400,000 PAGE VIEWS WE THINK IS 4920 03:07:34,826 --> 03:07:36,461 EVIDENCE THESE ARE WIDELY USED, 4921 03:07:36,461 --> 03:07:42,934 WE HAVE DATA ABOUT WHAT THE 4922 03:07:42,934 --> 03:07:43,601 GLOBAL DISTRIBUTION LARGELY U.S. 4923 03:07:43,601 --> 03:07:46,304 NOT EXCLUSIVELY AND WHILE THE 4924 03:07:46,304 --> 03:07:50,375 ANNUAL RETROVIRAL GUIDELINES GET 4925 03:07:50,375 --> 03:07:54,479 PRIZE FOR MOST USE, THE OTHER 4926 03:07:54,479 --> 03:07:56,014 GUIDELINE NIH DOES COVID 4927 03:07:56,014 --> 03:07:58,016 GUIDELINE IS IN THE TENS OF 4928 03:07:58,016 --> 03:07:59,784 MILLIONS. 4929 03:07:59,784 --> 03:08:01,152 WE THINK THIS STILL SHOWS THERE 4930 03:08:01,152 --> 03:08:04,455 IS A NEED FOR THIS EVEN THOUGH 4931 03:08:04,455 --> 03:08:05,790 TEXT BOOKS EXIST ONLINE 4932 03:08:05,790 --> 03:08:08,326 RESOURCES UP TO DATE, PEOPLE 4933 03:08:08,326 --> 03:08:12,330 REFER TO THESE GUIDELINES. 4934 03:08:12,330 --> 03:08:15,400 THIS SHOWS THE USE OF THE 4935 03:08:15,400 --> 03:08:16,301 GUIDELINES OVER LAST FIVE YEARS. 4936 03:08:16,301 --> 03:08:20,738 YOU CAN SEE THE NUMBERS ARE 4937 03:08:20,738 --> 03:08:21,573 RELATIVELY FLAT. 4938 03:08:21,573 --> 03:08:24,509 AGAIN, WE THINK THERE IS STILL 4939 03:08:24,509 --> 03:08:26,844 NEED FOR THESE NIH STILL HAS 4940 03:08:26,844 --> 03:08:28,713 REPUTATION FOR PRODUCING USEFUL 4941 03:08:28,713 --> 03:08:34,218 BUT UNBIASED GUIDELINES WE ARE 4942 03:08:34,218 --> 03:08:35,053 CONSTANTLY ASKING WHETHER OR NOT 4943 03:08:35,053 --> 03:08:35,820 TO SUNSET THESE. 4944 03:08:35,820 --> 03:08:38,990 AT THIS POINT WE THINK THAT WE 4945 03:08:38,990 --> 03:08:40,425 SHOULD CONTINUE AND WOULD BE 4946 03:08:40,425 --> 03:08:41,893 INTERESTED IN YOUR FEEDBACK ON 4947 03:08:41,893 --> 03:08:42,093 THAT. 4948 03:08:42,093 --> 03:08:44,162 NEXT SLIDE. 4949 03:08:44,162 --> 03:08:47,098 IF YOU LOOK AT THE PAGES THAT 4950 03:08:47,098 --> 03:08:50,001 ARE LOOKED AT, IT IS INTERESTING 4951 03:08:50,001 --> 03:08:53,838 THAT FOCUS IS REALLY ON THE SAME 4952 03:08:53,838 --> 03:08:57,675 INFECTIONS FOCUS ON THE LAST 30 4953 03:08:57,675 --> 03:08:58,843 YEARS. 4954 03:08:58,843 --> 03:09:03,348 THOUGH LESS PNEUMOSISTIS AND 4955 03:09:03,348 --> 03:09:04,816 MYCOBACTERIUM AND THERE BEING 4956 03:09:04,816 --> 03:09:08,353 SEEN IN TERMS OF CASES IN THE 4957 03:09:08,353 --> 03:09:09,887 UNITED STATES, MIGHT EMPHASIZE 4958 03:09:09,887 --> 03:09:11,556 FOR THOSE WHO ARE NEW, OUR 4959 03:09:11,556 --> 03:09:14,826 GUIDELINES ARE FOCUS ON THE 4960 03:09:14,826 --> 03:09:15,627 UNITED STATES, WERE ARE NOT 4961 03:09:15,627 --> 03:09:17,328 CONSTITUTED IN TERMS OF MEMBERS 4962 03:09:17,328 --> 03:09:21,699 NOR WE THINK WE HAVE ANY REAL 4963 03:09:21,699 --> 03:09:23,334 AUTHORITY TO PERUSE GUIDELINES 4964 03:09:23,334 --> 03:09:24,969 TO THE WORLD, WE DON'T WANT TO 4965 03:09:24,969 --> 03:09:26,504 COMPETE WITH WHO SO THESE ARE 4966 03:09:26,504 --> 03:09:27,672 SUPPOSED TO BE FOCUSED ON THE 4967 03:09:27,672 --> 03:09:29,073 UNITED STATES, EVEN THOUGH AGAIN 4968 03:09:29,073 --> 03:09:32,076 THEY ARE LOOKED AT OUTSIDE SO 4969 03:09:32,076 --> 03:09:35,613 YOU CAN SEE COMMON AIDS RELATED 4970 03:09:35,613 --> 03:09:39,250 OPPORTUNITY INFECTIONS, ARE MOST 4971 03:09:39,250 --> 03:09:41,152 COMMONLY USED. 4972 03:09:41,152 --> 03:09:42,220 AND EVEN FOR SOME OF THE ONES 4973 03:09:42,220 --> 03:09:45,423 BOTTOM OF THE LIST THAT ARE NOT 4974 03:09:45,423 --> 03:09:49,227 LOOKED AT AZON, THESE ARE 4975 03:09:49,227 --> 03:09:51,229 IMPORTANT BECAUSE FOR SOME OF 4976 03:09:51,229 --> 03:09:54,766 THESE WHETHER YOU TAKE SOMETHING 4977 03:09:54,766 --> 03:09:55,667 OBSCURE LIKE (INDISCERNIBLE) 4978 03:09:55,667 --> 03:09:57,268 WHEN CLINICIANS SEE ONE OF THESE 4979 03:09:57,268 --> 03:09:58,803 UNUSUAL CASES THEY REALLY NEED A 4980 03:09:58,803 --> 03:10:02,740 PLACE TO LOOK FOR QUICK GUIDANCE 4981 03:10:02,740 --> 03:10:04,776 ON WHAT TO DO. 4982 03:10:04,776 --> 03:10:07,211 WE THINK IN SOME WAYS THEY ARE 4983 03:10:07,211 --> 03:10:12,517 JUST AS IMPORTANT AS THE MORE 4984 03:10:12,517 --> 03:10:13,317 COMMONLY USED OPPORTUNITIES BASE 4985 03:10:13,317 --> 03:10:15,520 SO AGAIN WE TRY TO MAKE SURE 4986 03:10:15,520 --> 03:10:20,591 THESE SECTIONS ARE BEING USED. 4987 03:10:20,591 --> 03:10:22,794 PART OF THE GUIDELINE IS TO 4988 03:10:22,794 --> 03:10:26,998 ALERT READERS AS TO WHAT IS NEW. 4989 03:10:26,998 --> 03:10:30,968 ALERT YOU AS TO WHAT IS NEW. 4990 03:10:30,968 --> 03:10:34,272 WE HAVE A PROCESS WHERE EVERY 4991 03:10:34,272 --> 03:10:36,074 THREE MONTHS WITH WE MEET WITH 4992 03:10:36,074 --> 03:10:43,181 SUBJECT GROUP LEAVES AND SMALL 4993 03:10:43,181 --> 03:10:45,917 COMMITTEE OF CONTENT EXPERTS AND 4994 03:10:45,917 --> 03:10:48,319 EACH QUARTER WE ASK WHETHER OR 4995 03:10:48,319 --> 03:10:50,555 NOT ANYTHING NEEDS TO BE 4996 03:10:50,555 --> 03:10:51,255 REVIEWED. 4997 03:10:51,255 --> 03:10:52,056 NEEDS TO BE UPDATED. 4998 03:10:52,056 --> 03:10:54,625 IF THERE IS WE GO OVER WHAT THE 4999 03:10:54,625 --> 03:10:56,427 SCHEDULE IS AND MAKE EFFORTS TO 5000 03:10:56,427 --> 03:10:58,963 TRY TO GET THAT UPDATED AS 5001 03:10:58,963 --> 03:11:00,598 RAPIDLY AS FEASIBLE GIVEN THE 5002 03:11:00,598 --> 03:11:02,934 FACT THESE ARE VOLUNTEER, 5003 03:11:02,934 --> 03:11:04,702 ESPECIALLY DURING THE COVID ERA 5004 03:11:04,702 --> 03:11:06,270 WHO ARE VERY BUSY. 5005 03:11:06,270 --> 03:11:09,674 BUT WE MOVE THIS ALONG AND WE 5006 03:11:09,674 --> 03:11:13,311 MAKE SURE THAT THESE ARE 5007 03:11:13,311 --> 03:11:15,747 ACCEPTABLE TO OUR CO-CHAIRS WHO 5008 03:11:15,747 --> 03:11:19,917 REPRESENT IN OUR CASE NIH IGSA 5009 03:11:19,917 --> 03:11:22,854 FISMA AND CDC. 5010 03:11:22,854 --> 03:11:24,989 IN TERMS OF ENTERIC INFECTION 5011 03:11:24,989 --> 03:11:27,625 THIS AREA WE UPDATED WHAT WE SAY 5012 03:11:27,625 --> 03:11:30,461 ABOUT C DIFFICILE WHICH IS NOT 5013 03:11:30,461 --> 03:11:33,765 AN INFECTION BUT COMMON IN THE 5014 03:11:33,765 --> 03:11:34,699 DIFFERENTIAL AND AMONG PATIENTS 5015 03:11:34,699 --> 03:11:36,334 WITH HIV WE DO HAVE A SECTION 5016 03:11:36,334 --> 03:11:38,770 THAT WE JUST MADE THAT 5017 03:11:38,770 --> 03:11:41,806 COMPATIBLE WITH THE OTHER IGSP 5018 03:11:41,806 --> 03:11:42,340 RECOMMENDATIONS WITH NEWER 5019 03:11:42,340 --> 03:11:45,009 DRUGS. 5020 03:11:45,009 --> 03:11:50,047 WE ARE BACK TO UPDATE HEPATITIS 5021 03:11:50,047 --> 03:11:53,251 B SECTION AND IMMUNIZATION 5022 03:11:53,251 --> 03:11:54,285 SECTION. 5023 03:11:54,285 --> 03:11:58,356 THERE IS LOT OF WHAT IS OPTIMAL 5024 03:11:58,356 --> 03:12:00,391 RATES RENEWS AN COMMITTEE 5025 03:12:00,391 --> 03:12:02,693 DECIDES THOUGH ACIP AND CDC 5026 03:12:02,693 --> 03:12:04,262 DON'T NECESSARILY SEE IT EXACTLY 5027 03:12:04,262 --> 03:12:06,264 THE SAME WAY, THAT THE OUR 5028 03:12:06,264 --> 03:12:08,466 GUIDELINE RECOMMEND, THE DOUBLE 5029 03:12:08,466 --> 03:12:11,869 DOSE PRE-DOSE REGIMEN, WE TALK 5030 03:12:11,869 --> 03:12:13,771 EXTENSIVELY WITH THE CDC AND 5031 03:12:13,771 --> 03:12:17,508 WHERE WE DISAGREE WITH CDC OR 5032 03:12:17,508 --> 03:12:19,177 ACIP WE AGREE WE WILL LET 5033 03:12:19,177 --> 03:12:20,845 CONTENT EXPERTS LOOK AT IT, 5034 03:12:20,845 --> 03:12:24,282 COMMENT ON IT AND THEN JUST IN A 5035 03:12:24,282 --> 03:12:25,082 COLLEGIAL WAY RECOGNIZE THAT 5036 03:12:25,082 --> 03:12:26,717 THERE IS A DIFFERENCE OF 5037 03:12:26,717 --> 03:12:27,218 OPINION. 5038 03:12:27,218 --> 03:12:28,753 BUT THIS IS OUR OPINION. 5039 03:12:28,753 --> 03:12:31,222 THEY HAVE THEIR OPINION. 5040 03:12:31,222 --> 03:12:32,390 OBVIOUSLY EVERYBODY IS LOOKING 5041 03:12:32,390 --> 03:12:34,058 AT THE SAME DATA AS A MATTER OF 5042 03:12:34,058 --> 03:12:35,126 FACT OF HOW YOU INTERPRET THAT 5043 03:12:35,126 --> 03:12:36,627 DATA. 5044 03:12:36,627 --> 03:12:39,764 IN THE IMMUNIZATION SECTION IN 5045 03:12:39,764 --> 03:12:41,666 ADDITION TO REITERATING WHAT WE 5046 03:12:41,666 --> 03:12:43,534 SAY ABOUT HEPATIZETIS B AS YOU 5047 03:12:43,534 --> 03:12:47,338 KNOW THERE'S NEWER 5048 03:12:47,338 --> 03:12:51,075 RECOMMENDATIONS ON PNEUMOCOCCAL 5049 03:12:51,075 --> 03:12:52,376 VACCINE, PARTICULARLY 15 AND 20 5050 03:12:52,376 --> 03:12:54,545 SO WE UPDATED THAT TO ALIGN WITH 5051 03:12:54,545 --> 03:12:56,414 CDC AND ACIP SO NOTHING IS 5052 03:12:56,414 --> 03:12:59,817 DIFFERENT FROM WHAT WE DO AND 5053 03:12:59,817 --> 03:13:05,623 WHAT CDC OR ACIP. 5054 03:13:05,623 --> 03:13:09,594 WE CAN SKIP THIS. 5055 03:13:09,594 --> 03:13:11,062 IN THE NEAR FUTURE IMMUNIZATION 5056 03:13:11,062 --> 03:13:16,267 WILL BE UPDATED AGAIN, HEPATITIS 5057 03:13:16,267 --> 03:13:17,835 B PNEUMOCOCCUS ARE MAJOR 5058 03:13:17,835 --> 03:13:22,640 CHANGES, I MENTIONED HEPATITIS B 5059 03:13:22,640 --> 03:13:24,775 MY MOANIA, THAT OVERLAPS WITH 5060 03:13:24,775 --> 03:13:26,110 PNEUMOCOCCAL IMMUNIZATION SO 5061 03:13:26,110 --> 03:13:27,712 THAT IS GOING TO BE UPDATED TO 5062 03:13:27,712 --> 03:13:30,414 BE HARMONIZED WITH THE 5063 03:13:30,414 --> 03:13:30,882 IMMUNIZATION SECTION. 5064 03:13:30,882 --> 03:13:34,852 THERE IS DATA ABOUT THE SPECTRUM 5065 03:13:34,852 --> 03:13:38,155 OF PATHOGENS AND SUSCEPTIBILITY 5066 03:13:38,155 --> 03:13:39,557 AND RECOMMENDED DRUGS. 5067 03:13:39,557 --> 03:13:42,293 THESE AGAIN ARE GOING TO BE 5068 03:13:42,293 --> 03:13:45,596 HARMONIZED WITH OTHER UPDATES TO 5069 03:13:45,596 --> 03:13:47,732 OTHER IGSA AND COMMUNITY 5070 03:13:47,732 --> 03:13:51,936 ACQUIRED GUIDELINES. 5071 03:13:51,936 --> 03:13:53,371 THEN A VARY SELL LA, NEW 5072 03:13:53,371 --> 03:13:56,007 INFORMATION INCLUDING AGE RAGE 5073 03:13:56,007 --> 03:14:02,613 FOR VA VERISELLA. 5074 03:14:02,613 --> 03:14:04,048 WITH THAT I WILL TURN IT TO 5075 03:14:04,048 --> 03:14:05,149 ROHAN AND THEN ANSWER QUESTIONS. 5076 03:14:05,149 --> 03:14:06,951 >> WE WILL HAVE A BRIEF CHANGE 5077 03:14:06,951 --> 03:14:12,623 IN THE AGENDA, WE WILL COME BACK 5078 03:14:12,623 --> 03:14:15,760 TO DR. HAZRA. 5079 03:14:15,760 --> 03:14:17,762 RIGHT NOW I WANT TO INTRODUCE 5080 03:14:17,762 --> 03:14:19,730 DR. LIGHTFOOT AND ALLOW HER 5081 03:14:19,730 --> 03:14:20,231 UPDATE. 5082 03:14:20,231 --> 03:14:22,400 SO DR. LIGHTFOOT SERVES AS 5083 03:14:22,400 --> 03:14:24,402 ASSOCIATE DEAN FOR OREGON HEALTH 5084 03:14:24,402 --> 03:14:25,937 AND SCIENCE UNIVERSITY PORTLAND 5085 03:14:25,937 --> 03:14:26,737 STATE UNIVERSITY SCHOOL OF 5086 03:14:26,737 --> 03:14:27,338 PUBLIC HEALTH. 5087 03:14:27,338 --> 03:14:29,106 HER COMMUNITY ENGAGE RESEARCH 5088 03:14:29,106 --> 03:14:30,541 FOCUSES ON IMPROVING THE HEALTH 5089 03:14:30,541 --> 03:14:32,076 AND WELL BEING OF ADOLESCENTS 5090 03:14:32,076 --> 03:14:33,244 AND YOUNG ADULTS. 5091 03:14:33,244 --> 03:14:36,147 AS WELL AS THE DEVELOPMENT OF 5092 03:14:36,147 --> 03:14:38,215 CULTURALLY COMPETENT EFFICACIOUS 5093 03:14:38,215 --> 03:14:40,117 ENTERMITT TENSE TO REDUCE 5094 03:14:40,117 --> 03:14:41,252 ACQUISITION TRANSMISSION OF HIV 5095 03:14:41,252 --> 03:14:43,788 AMONG POPULATIONS 5096 03:14:43,788 --> 03:14:44,789 DISPROPORTIONATELY BURDENED BY 5097 03:14:44,789 --> 03:14:45,589 THE EPIDEMIC. 5098 03:14:45,589 --> 03:14:47,725 SO THANK YOU WE WILL HEAR FROM 5099 03:14:47,725 --> 03:14:48,225 YOU NOW. 5100 03:14:48,225 --> 03:14:50,461 >> THANK YOU, DR. TOLBERT. 5101 03:14:50,461 --> 03:14:51,262 APPRECIATE THE FLEXIBILITY YOU 5102 03:14:51,262 --> 03:14:53,597 ARE HAVING TODAY. 5103 03:14:53,597 --> 03:14:54,699 APOLOGIES NOT ABLE TO JOIN THE 5104 03:14:54,699 --> 03:14:57,335 WHOLE MEETING TODAY. 5105 03:14:57,335 --> 03:14:58,903 I APPRECIATE PROVIDING THIS 5106 03:14:58,903 --> 03:15:00,671 UPDATE EARLIER ON THE AGENDA. 5107 03:15:00,671 --> 03:15:01,405 NEXT SLIDE PLEASE. 5108 03:15:01,405 --> 03:15:02,974 TO GIVE YOU ALL A LITTLE BIT OF 5109 03:15:02,974 --> 03:15:05,609 UPDATE ON WHAT IS GOING ON WITH 5110 03:15:05,609 --> 03:15:08,946 NIMH, THIS FIRST SLIDE BASICALLY 5111 03:15:08,946 --> 03:15:10,214 GOES OVER DIRECTORS UPDATE. 5112 03:15:10,214 --> 03:15:11,882 SO HIGHLIGHTS THAT I WANTED TO 5113 03:15:11,882 --> 03:15:14,118 BRING TO YOUR ATTENTION UNDER 5114 03:15:14,118 --> 03:15:16,320 THE UNITY AGENDA, THE 5115 03:15:16,320 --> 03:15:18,823 PRESIDENT'S BUDGET REQUEST, AS 5116 03:15:18,823 --> 03:15:20,291 Y'ALL KNOW THE PRESIDENT 5117 03:15:20,291 --> 03:15:21,826 ANNOUNCED BIPARTISAN STRATEGY TO 5118 03:15:21,826 --> 03:15:23,094 RESPOND TO THE NATIONAL MENTAL 5119 03:15:23,094 --> 03:15:24,328 HEALTH AND SUBSTANCE USE 5120 03:15:24,328 --> 03:15:26,897 DISORDER CRISIS AS PART OF ITS 5121 03:15:26,897 --> 03:15:29,166 UNITY AGENDA, AS PART OF THAT, 5122 03:15:29,166 --> 03:15:30,534 THE PRESIDENT'S BUDGET REQUEST 5123 03:15:30,534 --> 03:15:34,572 FOR NIMH FOR FY 23 INCLUDES $5 5124 03:15:34,572 --> 03:15:36,273 MILLION IN RESEARCH FOR 5125 03:15:36,273 --> 03:15:38,843 INNOVATIVE TREATMENT MODELS AND 5126 03:15:38,843 --> 03:15:40,177 $5 MILLION TOWARDS ADVANCING 5127 03:15:40,177 --> 03:15:42,279 RESEARCH ON SOCIAL MEDIA. 5128 03:15:42,279 --> 03:15:43,047 IMPACTS. 5129 03:15:43,047 --> 03:15:45,082 IN TERMS OF CONGRESSIONAL 5130 03:15:45,082 --> 03:15:47,184 INTERACTIONS NIMH HAD WITH 5131 03:15:47,184 --> 03:15:48,419 CONGRESS, COUPLE OF TO BRING TO 5132 03:15:48,419 --> 03:15:50,521 YOUR ATTENTION, THE DIRECTOR 5133 03:15:50,521 --> 03:15:51,756 TESTIFIED BEFORE THE SENATE 5134 03:15:51,756 --> 03:15:54,959 COMMITTEE ON HEALTH EDUCATION 5135 03:15:54,959 --> 03:15:56,660 LABOR INTENTION -- AND PENSIONS 5136 03:15:56,660 --> 03:15:59,430 THE HEARING WAS ON STRENGTHENING 5137 03:15:59,430 --> 03:16:00,464 FEDERAL MENTAL HEALTH AND 5138 03:16:00,464 --> 03:16:02,967 SUBSTANCE USE DISORDER PROGRAMS, 5139 03:16:02,967 --> 03:16:05,169 ALSO TESTIFIED BEFORE THE SENATE 5140 03:16:05,169 --> 03:16:06,170 APPROPRIATION SUBCOMMITTEE ON 5141 03:16:06,170 --> 03:16:08,039 LABOR HEALTH AND HUMAN SERVICES 5142 03:16:08,039 --> 03:16:09,874 EDUCATION RELATED AGENCIES. 5143 03:16:09,874 --> 03:16:13,277 ON THE PROPOSED FY 2023 BUDGET 5144 03:16:13,277 --> 03:16:16,313 FOR NIH. 5145 03:16:16,313 --> 03:16:17,815 IN TERMS OF EXPANDING THE WHITE 5146 03:16:17,815 --> 03:16:18,783 HOUSE OFFICE OR ENGAGING WITH 5147 03:16:18,783 --> 03:16:19,917 THE WHITE HOUSE OFFICE OF 5148 03:16:19,917 --> 03:16:23,287 SCIENCE AND TECHNOLOGY POLICY, 5149 03:16:23,287 --> 03:16:26,290 NIMH PARTICIPATED IN A VIRTUAL 5150 03:16:26,290 --> 03:16:29,360 FIRE SIDE CHAT WITH THE WHITE 5151 03:16:29,360 --> 03:16:32,630 HOUSE OSTP TO DISCUSS ADOLESCENT 5152 03:16:32,630 --> 03:16:36,067 BRAIN DEVELOPMENT IMPACTS OF 5153 03:16:36,067 --> 03:16:37,301 STRESS, THE COVID-19 PANDEMIC 5154 03:16:37,301 --> 03:16:37,802 AND SOCIAL MEDIA. 5155 03:16:37,802 --> 03:16:40,671 LOOKING AGENT THAT FROM THE 5156 03:16:40,671 --> 03:16:42,773 PERSPECTIVE OF YOUNG PEOPLE. 5157 03:16:42,773 --> 03:16:47,711 AS YOU MAY KNOW, THE OMNIBUS 5158 03:16:47,711 --> 03:16:49,814 SPENDING PACKAGE 1.5 TRILLION 5159 03:16:49,814 --> 03:16:52,483 PACKAGE PROVIDED NIH WITH $45 5160 03:16:52,483 --> 03:16:55,653 BILLION BUT ALSO NIMH WITH 5161 03:16:55,653 --> 03:16:57,221 $2.2 BILLION. 5162 03:16:57,221 --> 03:16:59,690 ONE IS ALSO YOU WILL KNOW HHS IS 5163 03:16:59,690 --> 03:17:01,392 CURRENTLY ON THIS NATIONAL TOUR 5164 03:17:01,392 --> 03:17:02,426 TO STRENGTHEN HEALTH MENTAL 5165 03:17:02,426 --> 03:17:06,097 HEALTH. 5166 03:17:06,097 --> 03:17:08,966 SO THAT WAS ANNOUNCED AND WILL 5167 03:17:08,966 --> 03:17:13,504 BE FOCUSING ON THE WORK OF NIH 5168 03:17:13,504 --> 03:17:16,607 THINKING NATIONAL STRATEGIES FOR 5169 03:17:16,607 --> 03:17:17,608 STRENGTHENING MENTAL HEALTH IN 5170 03:17:17,608 --> 03:17:17,975 OUR COUNTRY. 5171 03:17:17,975 --> 03:17:20,878 IN TERMS OF NIMH STRATEGIC PLAN, 5172 03:17:20,878 --> 03:17:23,547 THERE WAS UPDATE TO THE 5173 03:17:23,547 --> 03:17:25,082 STRATEGIC PLAN IN 2021. 5174 03:17:25,082 --> 03:17:29,153 SOME OF THOSE CHANGES INCLUDED 5175 03:17:29,153 --> 03:17:29,954 EXPANDING INFORMATION ON 5176 03:17:29,954 --> 03:17:34,458 DIVERSITY EQUITY INCLUSION 5177 03:17:34,458 --> 03:17:35,159 ACCESS EFFORTS. 5178 03:17:35,159 --> 03:17:37,361 OTHER CHANGES INCLUDED LINKING 5179 03:17:37,361 --> 03:17:39,563 THE PLAN TO NIMH MORE CLEARLY 5180 03:17:39,563 --> 03:17:40,865 LINKING THE PLAN TO NIMH 5181 03:17:40,865 --> 03:17:42,633 APPROACH TO MENTAL HEALTH 5182 03:17:42,633 --> 03:17:43,834 DISPARITIES RESEARCH AND 5183 03:17:43,834 --> 03:17:46,837 INCLUDED INFO ON THE NEW NIH 5184 03:17:46,837 --> 03:17:48,472 CLIMATE CHANGE AND HEALTH 5185 03:17:48,472 --> 03:17:49,940 INITIATIVE. 5186 03:17:49,940 --> 03:17:51,642 AS WELL AS TWO NEW INTEREST 5187 03:17:51,642 --> 03:17:53,010 AREAS FOCUSING ON ECONOMIC 5188 03:17:53,010 --> 03:17:55,212 FACTORS. 5189 03:17:55,212 --> 03:17:56,881 AS PARTS OF THAT PLANNING AND 5190 03:17:56,881 --> 03:17:58,682 UPDATING PROCESS, THEY ALSO 5191 03:17:58,682 --> 03:18:01,685 RELEASED THE 2021 STRATEGIC PLAN 5192 03:18:01,685 --> 03:18:03,020 PROGRESS REPORT. 5193 03:18:03,020 --> 03:18:05,990 LASTLY THE DIRECTOR TALKED ABOUT 5194 03:18:05,990 --> 03:18:10,728 WHAT NIMH IS DOING IN TERMS OF 5195 03:18:10,728 --> 03:18:13,464 ALIGNING WITH NIH RACIAL ETHNIC 5196 03:18:13,464 --> 03:18:14,398 EQUITY PLAN. 5197 03:18:14,398 --> 03:18:16,967 AS YOU MAY KNOW THAT RACIAL -- 5198 03:18:16,967 --> 03:18:19,603 NIH PLAN HAS THREE GOALS, THE 5199 03:18:19,603 --> 03:18:22,139 FIRST GOAL IS AROUND APPLYING 5200 03:18:22,139 --> 03:18:24,875 THE RACIAL ETHNIC EQUITY LENS 5201 03:18:24,875 --> 03:18:28,078 FRAMEWORK TO THE IC WORK FORCE 5202 03:18:28,078 --> 03:18:30,514 STRUCTURES AND SYSTEMS NIMH, 5203 03:18:30,514 --> 03:18:32,650 THIS GOAL FOCUSING ON LEVERAGING 5204 03:18:32,650 --> 03:18:34,885 EXISTING DATA TO IMPROVE NEW 5205 03:18:34,885 --> 03:18:38,622 INITIATIVES AND SUPPORT SYSTEMS. 5206 03:18:38,622 --> 03:18:40,457 THE SECOND GOAL OF THE NIH 5207 03:18:40,457 --> 03:18:42,993 RACIAL EQUITY PLAN IDENTIFY 5208 03:18:42,993 --> 03:18:44,228 DISMANTLE RACIAL ETHNIC 5209 03:18:44,228 --> 03:18:49,366 DISPARITIES IN THE IC WORK FORCE 5210 03:18:49,366 --> 03:18:51,135 NIMH FOCUSES ON USING STAFF 5211 03:18:51,135 --> 03:18:52,903 FEEDBACK TO ADDRESS RACIAL 5212 03:18:52,903 --> 03:18:56,440 DISPARITIES RELATED TO 5213 03:18:56,440 --> 03:18:59,977 LEADERSHIP TRUST REPRIZALS AND 5214 03:18:59,977 --> 03:19:00,477 ANTI-HARASSMENT. 5215 03:19:00,477 --> 03:19:03,447 THE THIRD GOAL OF THE NIH PLAN 5216 03:19:03,447 --> 03:19:06,984 ENHANCING DIVERSITY OF WORK 5217 03:19:06,984 --> 03:19:09,220 FORCE, NIMH GOAL IS IMPROVING 5218 03:19:09,220 --> 03:19:10,154 RETENTION AND RECRUITMENT 5219 03:19:10,154 --> 03:19:13,724 PROCESSES SO BEGINNING TO LAY 5220 03:19:13,724 --> 03:19:15,759 OUT TACTICS AND STRATEGIES TO 5221 03:19:15,759 --> 03:19:20,397 MITOSOME OF THOSE GOALS. 5222 03:19:20,397 --> 03:19:25,202 NIMH HAS DIVISION OF AIDS 5223 03:19:25,202 --> 03:19:28,072 RESEARCH AS YOU KNOW ABOUT THE 5224 03:19:28,072 --> 03:19:33,310 NIH STRATEGY OR NATIONAL HIV 5225 03:19:33,310 --> 03:19:34,745 STRATEGY HIV EPIDEMIC 5226 03:19:34,745 --> 03:19:35,646 INITIATIVES GOALS AROUND 5227 03:19:35,646 --> 03:19:38,983 REDUCING TRANSMISSION BY 75% BY 5228 03:19:38,983 --> 03:19:44,221 2025 AND BY 90% IN 2030, THE 5229 03:19:44,221 --> 03:19:46,423 DIVISION OF NIMH DIVISION OF 5230 03:19:46,423 --> 03:19:48,325 OFFICE RESEARCH HAS BEEN 5231 03:19:48,325 --> 03:19:49,593 THINKING ABOUT STRATEGIC PLAN IN 5232 03:19:49,593 --> 03:19:52,930 ORDER TO BE CONSISTENT WITH BOTH 5233 03:19:52,930 --> 03:19:54,832 ALIGNING WITH THE STRATEGY AS 5234 03:19:54,832 --> 03:19:58,335 WELL AS ALIGNING WITH NIH 5235 03:19:58,335 --> 03:20:02,640 STRATEGIC PLAN AND SO IN THAT 5236 03:20:02,640 --> 03:20:08,012 NIMH STRATEGIC PLAN FOCUSING ON 5237 03:20:08,012 --> 03:20:09,980 PREVENTION, AROUND BEHAVIORAL 5238 03:20:09,980 --> 03:20:11,415 BIOMEDICAL INTERVENTION, 5239 03:20:11,415 --> 03:20:12,883 FOCUSING ON TREATMENT, ABOUT 5240 03:20:12,883 --> 03:20:14,752 IMPROVING HEALTH OUTCOMES AND 5241 03:20:14,752 --> 03:20:16,220 PREVENTING FURTHER TRANSMISSION. 5242 03:20:16,220 --> 03:20:19,189 AND THE INTERVENTION TARGETS 5243 03:20:19,189 --> 03:20:21,959 THAT THEY ARE HIGHLIGHTING OR 5244 03:20:21,959 --> 03:20:23,527 INDIVIDUAL COMMUNITY STRUCTURAL 5245 03:20:23,527 --> 03:20:29,867 LEVEL AS WELL AS KEY POPULATIONS 5246 03:20:29,867 --> 03:20:30,701 AT HIGH RISK. 5247 03:20:30,701 --> 03:20:33,971 ALSO FOCUS ON IMPLEMENTATION 5248 03:20:33,971 --> 03:20:35,906 SCIENCE, ABOUT BRINGING 5249 03:20:35,906 --> 03:20:36,540 EFFECTIVE INTERVENTION TO SCALE 5250 03:20:36,540 --> 03:20:38,909 MORE BROADLY. 5251 03:20:38,909 --> 03:20:42,780 THEY WILL BE FOCUSING ON NIMH 5252 03:20:42,780 --> 03:20:46,517 NEURAL HIV SO THE IMPACT OF HIV 5253 03:20:46,517 --> 03:20:50,154 ON PATHOLOGY AND FUNCTION 5254 03:20:50,154 --> 03:20:51,588 BIORESERVOIRS AS WELL AS CURE 5255 03:20:51,588 --> 03:20:55,359 RESEARCH. 5256 03:20:55,359 --> 03:20:57,594 NEXT SLIDE PLEASE. 5257 03:20:57,594 --> 03:20:59,930 GIVEN THE IMPACT OF HIV ON SOME 5258 03:20:59,930 --> 03:21:02,066 POPULATIONS NIMH BEGINNING TO 5259 03:21:02,066 --> 03:21:03,500 LOOK AT WHAT KEY POPULATIONS 5260 03:21:03,500 --> 03:21:05,602 THEY ARE WANTING TO FOCUS ON AS 5261 03:21:05,602 --> 03:21:07,471 I MENTIONED EARLIER, ONE OF 5262 03:21:07,471 --> 03:21:10,674 THOSE POPULATIONS IS TRANSGENDER 5263 03:21:10,674 --> 03:21:11,241 POPULATIONS IN PARTICULAR. 5264 03:21:11,241 --> 03:21:15,646 OF PROBABLY PRODONE NEED TO 5265 03:21:15,646 --> 03:21:17,648 PROVIDE Y'ALL WITH THE RATIONALE 5266 03:21:17,648 --> 03:21:20,050 FOR DOING THAT. 5267 03:21:20,050 --> 03:21:23,454 IN TERMS OF NUMBERS OF FOLKS IN 5268 03:21:23,454 --> 03:21:24,555 TRANSGENDER POPULATION IMPACTED 5269 03:21:24,555 --> 03:21:27,891 BY HIV SO THIS SLIDE GIVES YOU A 5270 03:21:27,891 --> 03:21:31,929 LITTLE SUMMARY OF SOME OF THE 5271 03:21:31,929 --> 03:21:33,097 THINGS DIVISION OF AIDS RESEARCH 5272 03:21:33,097 --> 03:21:36,400 IS DOING TO FOCUS ON THIS 5273 03:21:36,400 --> 03:21:39,269 POPULATION AND THEIR RESEARCH 5274 03:21:39,269 --> 03:21:39,970 THEY ARE FUNDING. 5275 03:21:39,970 --> 03:21:44,007 SO IT WILL INCLUDE THINGS LIKE 5276 03:21:44,007 --> 03:21:48,445 MOBILE TECHNOLOGY, LOOK AT PEER 5277 03:21:48,445 --> 03:21:50,080 NAVIGATION AS WAY OF REACHING 5278 03:21:50,080 --> 03:21:53,183 COMMUNITIES, AS WELL AS A LOT OF 5279 03:21:53,183 --> 03:21:54,985 WORK AROUND HIV AND TRANSGENDER 5280 03:21:54,985 --> 03:21:56,653 POPULATION FOCUSED ON 5281 03:21:56,653 --> 03:21:58,088 TRANSGENDER WOMEN, SO BRINGING 5282 03:21:58,088 --> 03:22:01,091 ATTENTION TO TRANSGENDER MEN AS 5283 03:22:01,091 --> 03:22:01,959 WELL. 5284 03:22:01,959 --> 03:22:03,460 AND FUNDED STUDIES AROUND PREP 5285 03:22:03,460 --> 03:22:04,828 DELIVERY TO TRANSGENDER 5286 03:22:04,828 --> 03:22:09,900 POPULATIONS. 5287 03:22:09,900 --> 03:22:11,769 LASTLY I WANT TO SHARE WITH 5288 03:22:11,769 --> 03:22:16,407 Y'ALL RECENT RFAs REVIEWED BY 5289 03:22:16,407 --> 03:22:18,709 NIMH SO THEY JUST FINISHED 5290 03:22:18,709 --> 03:22:20,244 REVIEWING AN RFA AROUND 5291 03:22:20,244 --> 03:22:21,578 EXPANDING DIFFERENTIATED CARE 5292 03:22:21,578 --> 03:22:22,746 APPROACHES FOR AS LENT SENTS 5293 03:22:22,746 --> 03:22:26,884 LIVING WITH HIV THAT WAS A 5294 03:22:26,884 --> 03:22:28,352 ROBUST APPLICANT POOL RESPONDING 5295 03:22:28,352 --> 03:22:30,020 TO THAT. 5296 03:22:30,020 --> 03:22:31,889 SO THAT IS A DECISION MAKING 5297 03:22:31,889 --> 03:22:32,489 PROCESS NOW. 5298 03:22:32,489 --> 03:22:36,593 THE SECOND RFA THAT DIVISION OF 5299 03:22:36,593 --> 03:22:39,563 AIDS RESEARCH NIMH RELEASED AND 5300 03:22:39,563 --> 03:22:43,167 FINISHED THE REVIEW PROCESS FOR 5301 03:22:43,167 --> 03:22:45,169 IMMUNE CNS INTERACTIONS IN 5302 03:22:45,169 --> 03:22:47,638 PEOPLE LIVING WITH HIV ON 5303 03:22:47,638 --> 03:22:48,405 ANTI-RETROVIRAL THERAPY. 5304 03:22:48,405 --> 03:22:51,842 FROM THESE RFAs HOW THEY ARE 5305 03:22:51,842 --> 03:22:52,709 IMPLEMENTING STRATEGIC PLANNING 5306 03:22:52,709 --> 03:22:53,710 THINGS THAT I WAS TALKING ABOUT 5307 03:22:53,710 --> 03:22:55,679 BEFORE. 5308 03:22:55,679 --> 03:22:56,580 THAT IS ALL. 5309 03:22:56,580 --> 03:22:57,214 THANK YOU VERY MUCH FOR YOUR 5310 03:22:57,214 --> 03:23:00,717 TIME AND ATTENTION. 5311 03:23:00,717 --> 03:23:02,986 >> THANK YOU, DR. LIGHTFOOT. 5312 03:23:02,986 --> 03:23:06,390 ARE THERE ANY QUESTIONS FOR DR. 5313 03:23:06,390 --> 03:23:07,724 LIGHTFOOT BEFORE WE MOVE ON TO 5314 03:23:07,724 --> 03:23:12,763 THE AGENDA? 5315 03:23:12,763 --> 03:23:15,532 HEARING NO QUESTIONS, DR. 5316 03:23:15,532 --> 03:23:18,702 GANDHI. 5317 03:23:18,702 --> 03:23:22,940 YOU ARE MUTED. 5318 03:23:22,940 --> 03:23:25,843 >> I WAS WONDERING IF THERE WERE 5319 03:23:25,843 --> 03:23:27,277 DESIGNATED FUNDS PUT INTO THE 5320 03:23:27,277 --> 03:23:31,448 MENTAL HEALTH ADOLESCENCE WITH 5321 03:23:31,448 --> 03:23:33,383 COVID PANDEMIC AND SOCIAL MEDIA, 5322 03:23:33,383 --> 03:23:35,052 THESE ARE NEW FUNDS THAT ARE 5323 03:23:35,052 --> 03:23:37,721 ADDED RECOGNIZING THIS MENTAL 5324 03:23:37,721 --> 03:23:39,423 HEALTH CRISIS IN OUR COUNTRY. 5325 03:23:39,423 --> 03:23:40,090 OF YOUNG PEOPLE. 5326 03:23:40,090 --> 03:23:40,891 >> YES. 5327 03:23:40,891 --> 03:23:46,296 >> REALLY GREAT. 5328 03:23:46,296 --> 03:23:52,202 >> AS YOU MENTION SO NEEDED. 5329 03:23:52,202 --> 03:23:53,303 >> THANK YOU AGAIN, DR. 5330 03:23:53,303 --> 03:23:54,905 LIGHTFOOT. 5331 03:23:54,905 --> 03:23:59,510 WE ARE GOING TO MOVE ON WITH THE 5332 03:23:59,510 --> 03:24:00,077 AGENDA. 5333 03:24:00,077 --> 03:24:02,312 SO BACK TO THE GUIDELINES AND 5334 03:24:02,312 --> 03:24:02,713 DR. HAZRA. 5335 03:24:02,713 --> 03:24:04,448 SO DR. HAZRA IS THE DIRECTOR OF 5336 03:24:04,448 --> 03:24:05,816 THE DIVISION OF EXTRAMURAL 5337 03:24:05,816 --> 03:24:08,485 RESEARCH AT NICHD. 5338 03:24:08,485 --> 03:24:10,153 HE PROVIDES SCIENTIFIC 5339 03:24:10,153 --> 03:24:11,255 LEADERSHIP DOMESTIC 5340 03:24:11,255 --> 03:24:12,956 INTERNATIONAL RESEARCH, RESEARCH 5341 03:24:12,956 --> 03:24:14,791 TRAINING AND CAREER DEVELOPMENT 5342 03:24:14,791 --> 03:24:16,026 PROGRAMS RELATED TO 5343 03:24:16,026 --> 03:24:17,227 EPIDEMIOLOGY, DIAGNOSIS, 5344 03:24:17,227 --> 03:24:19,396 PATHOGENESIS, TRANSMISSIONING 5345 03:24:19,396 --> 03:24:22,065 TREATMENT PREVENTION OF HIV AND 5346 03:24:22,065 --> 03:24:24,501 COMPLICATIONS, AS WELL AS 5347 03:24:24,501 --> 03:24:28,238 PATHOGENS IN INFANTS, CHILDREN, 5348 03:24:28,238 --> 03:24:29,806 ADOLESCENTS AND PREGNANT 5349 03:24:29,806 --> 03:24:30,207 INDIVIDUALS. 5350 03:24:30,207 --> 03:24:31,909 WITH THAT DR. HAZRA I WILL HAND 5351 03:24:31,909 --> 03:24:34,077 TO YOU. 5352 03:24:34,077 --> 03:24:37,414 >> THANK YOU VERY MUCH, GOOD 5353 03:24:37,414 --> 03:24:37,981 AFTERNOON. 5354 03:24:37,981 --> 03:24:39,783 EVERYONE, I WANT TO HIGHLIGHT 5355 03:24:39,783 --> 03:24:42,319 TWO SETS OF GUIDELINES ON THE 5356 03:24:42,319 --> 03:24:42,953 PEDIATRIC SIDE. 5357 03:24:42,953 --> 03:24:45,255 FIRST PEDIATRIC FIDE LINES I 5358 03:24:45,255 --> 03:24:47,357 WANT TO THANK DEB STORM WHO IS A 5359 03:24:47,357 --> 03:24:50,661 LONG TIME COLLABORATOR EDITOR 5360 03:24:50,661 --> 03:24:53,330 COORDINATOR STANDARDIZE NOT ONLY 5361 03:24:53,330 --> 03:24:55,332 WITHIN PEDIATRIC GUIDELINES AND 5362 03:24:55,332 --> 03:24:57,367 PERINATAL GUIDELINES BUT ACROSS 5363 03:24:57,367 --> 03:24:59,570 BOTH THOSE SETS OF GUIDELINES, 5364 03:24:59,570 --> 03:25:01,371 ALSO ACKNOWLEDGE HER. 5365 03:25:01,371 --> 03:25:04,675 IN PEDIATRIC GUIDELINES FOR MANY 5366 03:25:04,675 --> 03:25:08,045 YEARS WE AIMED TO HAVE AN ANNUAL 5367 03:25:08,045 --> 03:25:08,512 UPDATE SOON 5368 03:25:08,512 --> 03:25:10,647 CROW SO WE GET SET TO PUBLISH 5369 03:25:10,647 --> 03:25:12,282 MAKE SURE THERE IS NOTHING 5370 03:25:12,282 --> 03:25:13,984 ABSOLUTELY NEW OR GROUND 5371 03:25:13,984 --> 03:25:16,620 BREAKING AT CROW, INCLUDE THAT 5372 03:25:16,620 --> 03:25:18,088 WHEN POSSIBLE, PUBLISH. 5373 03:25:18,088 --> 03:25:20,357 THESE WERE PUBLISHED PROBABLY IN 5374 03:25:20,357 --> 03:25:22,926 APRIL. 5375 03:25:22,926 --> 03:25:25,696 WE DO -- THE SCHEDULE DOES ALLOW 5376 03:25:25,696 --> 03:25:27,898 TO DO RAPID UPDATES IF THERE IS 5377 03:25:27,898 --> 03:25:29,600 SOMETHING COMPELLING THAT COMES 5378 03:25:29,600 --> 03:25:31,301 UP IN THE INTERIM BUT OTHERWISE 5379 03:25:31,301 --> 03:25:34,738 WE DO CONCENTRATE STILL ON 5380 03:25:34,738 --> 03:25:40,277 ANNUAL UPDATE. 5381 03:25:40,277 --> 03:25:44,081 SO FULL GUIDELINES THEY PUBLISH 5382 03:25:44,081 --> 03:25:46,717 APRIL 11, WE DO HAVE VERY MUCH 5383 03:25:46,717 --> 03:25:48,485 THANKS TO DEB SWARM'S HELP WITH 5384 03:25:48,485 --> 03:25:49,653 THIS, SOME SECTIONS WE SHARE 5385 03:25:49,653 --> 03:25:52,422 WITH THE PERINATAL GUIDELINES, 5386 03:25:52,422 --> 03:25:53,290 THESE ARE BASICALLY SECTIONS 5387 03:25:53,290 --> 03:25:55,258 THAT UNDERGO REVIEW IN PARALLEL 5388 03:25:55,258 --> 03:25:56,460 BY BOTH GROUPS. 5389 03:25:56,460 --> 03:25:58,328 AND THEN THOSE WERE PUBLISHED 5390 03:25:58,328 --> 03:25:59,763 BACK IN PERINATAL GUIDELINES 5391 03:25:59,763 --> 03:26:02,132 PUBLISHED THE END OF LAST YEAR. 5392 03:26:02,132 --> 03:26:07,204 OUR BIG ISSUE IS TO MAJOR ISSUE 5393 03:26:07,204 --> 03:26:10,307 FOR US PEDIATRIC ANTI-RETROVIRAL 5394 03:26:10,307 --> 03:26:13,877 AND HAS EVOLVED SINCE I FIRST 5395 03:26:13,877 --> 03:26:16,079 STARTED BECOMING ASSOCIATED WITH 5396 03:26:16,079 --> 03:26:17,614 GUIDELINES BACK IN 2007. 5397 03:26:17,614 --> 03:26:19,383 I THINK AT THE BEGINNING, WE 5398 03:26:19,383 --> 03:26:22,786 WERE VERY MUCH A PLACE WHERE WE 5399 03:26:22,786 --> 03:26:24,921 HAD EXPERT INPUT, PREDOMINANTLY 5400 03:26:24,921 --> 03:26:25,622 WHAT THE FDA SAID. 5401 03:26:25,622 --> 03:26:29,726 WE REALLY EVOLVED NOW, WHERE WE 5402 03:26:29,726 --> 03:26:31,194 ARE IN VERY CLOSE CONSULTATION 5403 03:26:31,194 --> 03:26:33,730 AND COLLABORATION WITH FDA, 5404 03:26:33,730 --> 03:26:37,501 BEING ABLE TO MAKE SOME OTHER 5405 03:26:37,501 --> 03:26:38,735 JUDGMENTS THAT MAY BE NOT IN 5406 03:26:38,735 --> 03:26:40,671 ALIGNMENT WITH WHAT THE FDA 5407 03:26:40,671 --> 03:26:41,171 PROCESS HAS BEEN. 5408 03:26:41,171 --> 03:26:44,141 AS I SAID, I EMPHASIZE THAT AS A 5409 03:26:44,141 --> 03:26:46,343 TRUE COLLABORATION WITH FDA 5410 03:26:46,343 --> 03:26:48,578 STAFF AND WANT TO ACKNOWLEDGE 5411 03:26:48,578 --> 03:26:50,881 DR. (INAUDIBLE) WHO HELPS US 5412 03:26:50,881 --> 03:26:54,885 NAVIGATE SOME OF THOSE ISSUES. 5413 03:26:54,885 --> 03:26:56,186 FORTUNATELY WITH THESE FIXED 5414 03:26:56,186 --> 03:26:57,754 DOSE COMBINATIONS COMING OUT 5415 03:26:57,754 --> 03:26:59,523 MORE RECENTLY IN PEDIATRIC 5416 03:26:59,523 --> 03:27:01,158 DOSAGE FORMS, THOSE HAVE BEEN 5417 03:27:01,158 --> 03:27:02,225 RELATIVELY STRAIGHT FORWARD. 5418 03:27:02,225 --> 03:27:05,762 SO FOR THE LAST YEAR OUR UPDATES 5419 03:27:05,762 --> 03:27:07,364 ARE MATCHED WHAT WAS APPROVED BY 5420 03:27:07,364 --> 03:27:08,198 THE FDA. 5421 03:27:08,198 --> 03:27:15,672 SO THERE IS THE TAP FTC, THE 5422 03:27:15,672 --> 03:27:17,340 30-MILLIGRAM CONTAINING 5423 03:27:17,340 --> 03:27:20,777 COMBINATION AND THEN THE FTC SO 5424 03:27:20,777 --> 03:27:22,345 WE UPDATED THE GUIDELINES OF 5425 03:27:22,345 --> 03:27:22,913 INFORMATION ABOUT THAT. 5426 03:27:22,913 --> 03:27:25,148 I WILL HAVE MORE DETAILS AROUND 5427 03:27:25,148 --> 03:27:25,949 THOSE. 5428 03:27:25,949 --> 03:27:28,151 AS I MENTION WE WILL PLAN 5429 03:27:28,151 --> 03:27:30,987 POTENTIALLY SOME REAL TIME 5430 03:27:30,987 --> 03:27:34,524 UPDATES SO WE INCORPORATE THE 5431 03:27:34,524 --> 03:27:39,796 LONG ACTING INJECTABLES AND NEW 5432 03:27:39,796 --> 03:27:40,664 DISPERSIBLE (INAUDIBLE) FIXED 5433 03:27:40,664 --> 03:27:41,998 DOSE COMBINATION AS WELL SO THAT 5434 03:27:41,998 --> 03:27:43,867 IS REALLY EXITING. 5435 03:27:43,867 --> 03:27:47,637 THAT IS BASED UPON NIH IMPACT 5436 03:27:47,637 --> 03:27:52,275 2019 TRIAL. 5437 03:27:52,275 --> 03:27:53,243 THESE UPDATED RECOMMENDATIONS 5438 03:27:53,243 --> 03:27:56,346 MORE DETAIL HERE, FOR THE -- 5439 03:27:56,346 --> 03:27:59,015 PEEDIA I CAN TRICK FORMULATION 5440 03:27:59,015 --> 03:28:02,352 NOW IS APPROVED DOWN TO AGE 2 5441 03:28:02,352 --> 03:28:05,822 BUT IMPORTANTLY 14-KILOGRAMS SO 5442 03:28:05,822 --> 03:28:07,023 GENERALLY GOING TO BE OLDER THAN 5443 03:28:07,023 --> 03:28:09,392 TWO YEARS OF AGE. 5444 03:28:09,392 --> 03:28:11,461 BECAUSE OF PEDIATRIC FORMULATION 5445 03:28:11,461 --> 03:28:12,896 ALLOWED US TO DO THIS, 5446 03:28:12,896 --> 03:28:14,664 PREVIOUSLY LIMITED TO USE IN 5447 03:28:14,664 --> 03:28:16,233 CHILDREN GREATER THAN OR EQUAL 5448 03:28:16,233 --> 03:28:19,436 TO SIX AND WEIGH 25 KILOS. 5449 03:28:19,436 --> 03:28:21,605 THE (INAUDIBLE) FIXED DOSE 5450 03:28:21,605 --> 03:28:24,674 COMBINATION IS RECOMMENDED AS 5451 03:28:24,674 --> 03:28:25,809 ALTERNATIVE. 5452 03:28:25,809 --> 03:28:27,544 FOR CHILDREN GREATER THAN OR 5453 03:28:27,544 --> 03:28:29,079 EQUAL TO 35 KILOS I SHOULD 5454 03:28:29,079 --> 03:28:31,481 HIGHLIGHT THERE THAT'S BASED 5455 03:28:31,481 --> 03:28:32,549 UPON DATA FROM IMPACT TRIAL AS 5456 03:28:32,549 --> 03:28:35,185 WELL. 5457 03:28:35,185 --> 03:28:39,256 THIS FTC TAF PEDIATRIC 5458 03:28:39,256 --> 03:28:40,090 FORMULATION FIX DOSE 5459 03:28:40,090 --> 03:28:40,490 COMBINATION. 5460 03:28:40,490 --> 03:28:43,326 SO ALLOWS US TO NOW SAY TO 5461 03:28:43,326 --> 03:28:47,631 PREFER DUAL NRTI FOR CHILDREN 5462 03:28:47,631 --> 03:28:51,034 DOWN TO 14 KILOS PREVIOUSLY 5463 03:28:51,034 --> 03:28:52,602 LIMITED TO CHILDREN WEIGHING 25 5464 03:28:52,602 --> 03:28:56,940 KILOS. THEN ANOTHER THING WHEN 5465 03:28:56,940 --> 03:29:01,311 I MENTION HERE, ABACOVIR, FDA 5466 03:29:01,311 --> 03:29:02,746 APPROVED FOR THREE MONTHS OF AGE 5467 03:29:02,746 --> 03:29:03,246 AND BEYOND. 5468 03:29:03,246 --> 03:29:05,882 BUT WHAT WE NOW HAVE BECAUSE 5469 03:29:05,882 --> 03:29:10,654 USED PRIMARILY IN INTERNATIONAL 5470 03:29:10,654 --> 03:29:12,989 SETTING AND ENDORSED BY WHO, A 5471 03:29:12,989 --> 03:29:14,891 FAIR AMOUNT OF DATA BOTH FOR 5472 03:29:14,891 --> 03:29:17,160 SAFETY AND EFFICACY BUT ALSO 5473 03:29:17,160 --> 03:29:18,662 SOME PHARMACO KINETICS STUDIES 5474 03:29:18,662 --> 03:29:20,230 AS WELL DONE PRIMARILY IN THE 5475 03:29:20,230 --> 03:29:23,867 CURE SETTING EARLY TREATMENT 5476 03:29:23,867 --> 03:29:24,601 SETTING WE HAVE MORE DATA. 5477 03:29:24,601 --> 03:29:27,604 SO HERE IS AN EXAMPLE OF WHERE 5478 03:29:27,604 --> 03:29:32,008 WE ARE NOW ENDORSING ABACAVIR ON 5479 03:29:32,008 --> 03:29:34,978 FULL TERM INFANTS FROM BIT ON 5480 03:29:34,978 --> 03:29:35,579 THOUGH FDA APPROVAL IS THREE 5481 03:29:35,579 --> 03:29:36,580 MONTHS OF AGE AND OVER. 5482 03:29:36,580 --> 03:29:42,552 THIS IS BASED UPON SOME COMING 5483 03:29:42,552 --> 03:29:44,020 FROM PHARMACOKINETIC STUDIES AND 5484 03:29:44,020 --> 03:29:45,922 MODELING AND THIS APPROACH IS 5485 03:29:45,922 --> 03:29:53,363 ALSO ENDORSED BY THE WHO SOME 5486 03:29:53,363 --> 03:29:55,365 OTHER UPDATES SECTIONS UPDATED, 5487 03:29:55,365 --> 03:29:58,902 WE HAVE A SPECIAL CONSIDERATION 5488 03:29:58,902 --> 03:30:01,004 ARD AND ADOLESCENTS INCLUDES 5489 03:30:01,004 --> 03:30:02,806 ADDITIONAL CONTENT ABOUT 5490 03:30:02,806 --> 03:30:04,174 SUBSTANCE USE CONCERNS. 5491 03:30:04,174 --> 03:30:05,375 TESTIFY SECTION WAS RESLIDESSED 5492 03:30:05,375 --> 03:30:07,911 TO PROVIDE RECENT DATA, MOST 5493 03:30:07,911 --> 03:30:10,614 STUDIES ARE INTERNATIONAL. 5494 03:30:10,614 --> 03:30:12,182 BUT DATA RELEVANT TO ADOLESCENT 5495 03:30:12,182 --> 03:30:13,383 POPULATION BUT AROUND SMART 5496 03:30:13,383 --> 03:30:17,454 PHONE BASED REMINDERS, PEER 5497 03:30:17,454 --> 03:30:27,030 SUPPORT INTERVENTIONS, SO WE 5498 03:30:27,030 --> 03:30:28,698 UPDATED FROM THOSE AREAS. 5499 03:30:28,698 --> 03:30:32,235 DIFFERENT ARV, I ALREADY 5500 03:30:32,235 --> 03:30:34,337 MENTIONED CHANGING 5501 03:30:34,337 --> 03:30:35,338 RECOMMENDATION ABOUT WHEN TO 5502 03:30:35,338 --> 03:30:36,907 USE, WE HAD TO MAKE CHANGES IN 5503 03:30:36,907 --> 03:30:38,708 OTHER SECTIONS AS WELL ABOUT 5504 03:30:38,708 --> 03:30:43,847 MANAGEMENT OF ANTI-RETROVIRAL 5505 03:30:43,847 --> 03:30:45,982 THERAPY, WITH TOXICITY SECTION 5506 03:30:45,982 --> 03:30:47,384 SO THOSE CHANGES ARE MADE 5507 03:30:47,384 --> 03:30:52,289 THROUGHOUT. 5508 03:30:52,289 --> 03:30:56,226 AS I MENTION THE TABLES FOR 5509 03:30:56,226 --> 03:30:57,360 TOXICITIES MANAGING ADVERSE 5510 03:30:57,360 --> 03:31:00,730 EFFECTS WE REVIEW THOSE, REALLY 5511 03:31:00,730 --> 03:31:04,834 NOT MUCH CHANGE BUT WE DO UPDATE 5512 03:31:04,834 --> 03:31:06,569 THOSE. INCREASINGLY THERE IS 5513 03:31:06,569 --> 03:31:08,338 FAIR AMOUNT USED SO THERE IS 5514 03:31:08,338 --> 03:31:12,175 REALLY NOW I THINK SUBSTANTIAL 5515 03:31:12,175 --> 03:31:15,345 DATA SHOWING THE NEED FOR 5516 03:31:15,345 --> 03:31:18,782 VITAMIN D SUPPLEMENTATION IN 5517 03:31:18,782 --> 03:31:19,249 CHILDREN. 5518 03:31:19,249 --> 03:31:21,284 THIS HAS BEEN AN ISSUE ABOUT 5519 03:31:21,284 --> 03:31:22,919 VITAMIN D DEFICIENCY, ONGOING 5520 03:31:22,919 --> 03:31:23,954 DEBATE WITHIN THE GUIDELINES. 5521 03:31:23,954 --> 03:31:26,656 THERE ARE CERTAINLY SOME 5522 03:31:26,656 --> 03:31:27,791 PEDIATRIC HIV EXPERTS IN THE 5523 03:31:27,791 --> 03:31:30,026 UNITED STATES THAT ROUTINELY 5524 03:31:30,026 --> 03:31:31,828 TEST THEIR CLINIC POPULATION, 5525 03:31:31,828 --> 03:31:33,697 FOR VITAMIN D DEFICIENCY AND 5526 03:31:33,697 --> 03:31:35,065 OTHERS THAT DON'T ROUTINELY DO 5527 03:31:35,065 --> 03:31:36,933 SO. 5528 03:31:36,933 --> 03:31:40,570 SO WE HAVE BEEN SOMEWHAT LOOSE, 5529 03:31:40,570 --> 03:31:42,806 WHERE WE SAY SOME EXPERTS DO IT 5530 03:31:42,806 --> 03:31:43,506 SOME DON'T. 5531 03:31:43,506 --> 03:31:46,076 NOW SPECIFICALLY FOR (INAUDIBLE) 5532 03:31:46,076 --> 03:31:49,479 BASED UPON DATA FROM ADULTS, BUT 5533 03:31:49,479 --> 03:31:51,047 ALSO SOME PEDIATRIC DATA AS WELL 5534 03:31:51,047 --> 03:31:53,750 THAT WE ARE RECOMMENDING IT. 5535 03:31:53,750 --> 03:31:58,855 NEXT SLIDE. 5536 03:31:58,855 --> 03:32:02,258 THIS IS -- THE FIRST BULLET 5537 03:32:02,258 --> 03:32:04,694 SAYING CHANGES ABOUT DRUG 5538 03:32:04,694 --> 03:32:08,531 APPROVALS ANTI-RETROVIRAL DRUG 5539 03:32:08,531 --> 03:32:09,899 BUT THE SECOND BULLET IS 5540 03:32:09,899 --> 03:32:11,034 INTERESTING. 5541 03:32:11,034 --> 03:32:13,370 AS FOLK KNOW NOW WE CAN PUT 5542 03:32:13,370 --> 03:32:16,406 TOGETHER A REGIMEN FOR FULL TERM 5543 03:32:16,406 --> 03:32:22,112 INFANTS. 5544 03:32:22,112 --> 03:32:23,913 OPTIONS ARE (INAUDIBLE) AMONG 5545 03:32:23,913 --> 03:32:25,982 WOMEN WITH HIV, IS ABOUT DOUBLE 5546 03:32:25,982 --> 03:32:27,951 WHAT IT IS AMONG WOMEN WHO DO 5547 03:32:27,951 --> 03:32:28,551 NOT HAVE HIV. 5548 03:32:28,551 --> 03:32:32,822 SO THE NEED FOR DOSING AND 5549 03:32:32,822 --> 03:32:34,524 PREMATURE BABIES IS SUBSTANTIAL. 5550 03:32:34,524 --> 03:32:38,962 THIS IS ACTUALLY BASED UPON 5551 03:32:38,962 --> 03:32:42,265 IMPACT STUDY 1106 DONE IN SOUTH 5552 03:32:42,265 --> 03:32:43,500 AFRICA, THEY HAVE DONE A FAIR 5553 03:32:43,500 --> 03:32:47,270 AMOUNT OF PHARMACOKINETIC 5554 03:32:47,270 --> 03:32:49,239 STUDIES AND WITH MODELING SO 5555 03:32:49,239 --> 03:32:50,607 WITH THAT INFORMATION WE ARE 5556 03:32:50,607 --> 03:32:52,809 ABLE TO RECOMMEND A DOSE OF 5557 03:32:52,809 --> 03:32:55,378 (INAUDIBLE) DOWN TO INFANTS AT 5558 03:32:55,378 --> 03:32:57,514 32 WEEKS GESTATIONAL AGE. 5559 03:32:57,514 --> 03:32:58,882 AGAIN, THIS IS ANOTHER EXAMPLE 5560 03:32:58,882 --> 03:33:00,417 OF WHERE WE ARE RECOMMENDING 5561 03:33:00,417 --> 03:33:02,619 SOMETHING BASED UPON MORE RECENT 5562 03:33:02,619 --> 03:33:04,821 DATA THAT IS NOT IN THE FDA 5563 03:33:04,821 --> 03:33:07,690 LABEL BUT CERTAINLY ENDORSED 5564 03:33:07,690 --> 03:33:09,659 INTELLECTUALLY BY THE FDA 5565 03:33:09,659 --> 03:33:10,660 THROUGH THEIR REPRESENTATION ON 5566 03:33:10,660 --> 03:33:14,164 THE GUIDELINES. 5567 03:33:14,164 --> 03:33:15,498 I PROBABLY SHOULDN'T SAY 5568 03:33:15,498 --> 03:33:16,733 ANYTHING ABOUT FDA ENDORSING 5569 03:33:16,733 --> 03:33:23,239 SOMETHING, THAT IS BEYOND MY PAY 5570 03:33:23,239 --> 03:33:23,640 GRADE. 5571 03:33:23,640 --> 03:33:25,041 I'M STRETCHING TO SAY ANYTHING 5572 03:33:25,041 --> 03:33:26,943 FOR THE FDA BUT ACKNOWLEDGE THE 5573 03:33:26,943 --> 03:33:28,945 IMPORTANCE OF DR. (INAUDIBLE) ON 5574 03:33:28,945 --> 03:33:30,713 THE TABID LINES PANEL. 5575 03:33:30,713 --> 03:33:32,148 THAT IS A PEDIATRIC GUIDELINE 5576 03:33:32,148 --> 03:33:33,149 UPDATE. 5577 03:33:33,149 --> 03:33:35,518 ON BEHALF OF BILL, I WILL GIVE 5578 03:33:35,518 --> 03:33:37,620 PEDIATRIC OI UPDATES, NEXT SLIDE 5579 03:33:37,620 --> 03:33:40,690 PLEASE. 5580 03:33:40,690 --> 03:33:44,627 BILL HASN'T PAST SHARED 5581 03:33:44,627 --> 03:33:46,329 PEDIATRIC O, WENT THREW A 5582 03:33:46,329 --> 03:33:48,098 MEETING PROCESS TO LOOK AT 5583 03:33:48,098 --> 03:33:49,766 RESCOPING THEIR GUIDELINES. 5584 03:33:49,766 --> 03:33:53,203 REALLY LOOKING AT AGAIN HOW MUCH 5585 03:33:53,203 --> 03:33:56,072 DO WE NEED A SEPARATE PEDIATRIC 5586 03:33:56,072 --> 03:33:57,407 OI GUIDELINE AND IMPORTANTLY 5587 03:33:57,407 --> 03:33:59,142 WHAT THE AREAS IF WE ARE GOING 5588 03:33:59,142 --> 03:34:01,044 TO CONTINUE TO HAVE ONE WE NEED 5589 03:34:01,044 --> 03:34:03,079 TO SPEND TIME AND EFFORT ON. 5590 03:34:03,079 --> 03:34:05,048 SO THAT RESCOPING WAS 5591 03:34:05,048 --> 03:34:05,748 SUCCESSFULLY DONE. 5592 03:34:05,748 --> 03:34:07,717 THERE IS NEW STANDARD OPERATING 5593 03:34:07,717 --> 03:34:09,919 PROCEDURE WITH UPDATED SECTION 5594 03:34:09,919 --> 03:34:12,122 REVISION C FREQUENCY BASED ON 5595 03:34:12,122 --> 03:34:13,790 EPIDEMIOLOGY NEW ADVANCE SIMILAR 5596 03:34:13,790 --> 03:34:17,093 TO WHAT HENRY DOES WITH ADULT OI 5597 03:34:17,093 --> 03:34:19,195 AND THEY HAVE DONE A NICE JOB OF 5598 03:34:19,195 --> 03:34:20,663 EXPANDING THE PANEL MEMBERSHIP 5599 03:34:20,663 --> 03:34:22,765 AND ALSO SHOW THAT IS ALSO BEING 5600 03:34:22,765 --> 03:34:24,667 ABLE TO SERVE AS RESOURCE FOR 5601 03:34:24,667 --> 03:34:30,306 OTHER GROUPS AS WELL, ALSO SET 5602 03:34:30,306 --> 03:34:31,174 UP WITH SUPPORT INFRASTRUCTURE 5603 03:34:31,174 --> 03:34:34,277 AND REVISIONS UNDERWAY FOR THE 5604 03:34:34,277 --> 03:34:38,414 VACCINE SECTION TB AND CMV. 5605 03:34:38,414 --> 03:34:40,617 AS I MENTION SUCCESSFUL 5606 03:34:40,617 --> 03:34:41,284 SOLICITATION FOR PANEL 5607 03:34:41,284 --> 03:34:43,386 MEMBERSHIP AND FOR THE 5608 03:34:43,386 --> 03:34:45,155 LEADERSHIP GROUP THEY HAD EIGHT 5609 03:34:45,155 --> 03:34:47,390 QUALIFIED APPLICANTS, TWO ROUNDS 5610 03:34:47,390 --> 03:34:49,492 OF INTERVIEWS, ONE MORE IS 5611 03:34:49,492 --> 03:34:50,059 PENDING. 5612 03:34:50,059 --> 03:34:52,228 FOR SECTION AUTHORSHIP 13 5613 03:34:52,228 --> 03:34:53,163 QUALIFIED APPLICANTS AND 5614 03:34:53,163 --> 03:34:54,330 SELECTION FOR INTERVIEWS ARE 5615 03:34:54,330 --> 03:34:55,331 UNDERWAY. 5616 03:34:55,331 --> 03:34:57,934 NEXT SLIDE PLEASE. 5617 03:34:57,934 --> 03:34:59,903 CURRENTLY HERE IS THE 5618 03:34:59,903 --> 03:35:02,539 LEADERSHIP, EXTENDED LEADERSHIP 5619 03:35:02,539 --> 03:35:03,973 EXECUTIVE SECRETARY FOR NICHD, 5620 03:35:03,973 --> 03:35:07,977 CO-CHAIRS ARE DR.S EKERT AND 5621 03:35:07,977 --> 03:35:11,347 RODRIGUEZ AND CORE LEADERSHIP 5622 03:35:11,347 --> 03:35:12,882 GROUP BOTH ACADEMIC CLINICAL 5623 03:35:12,882 --> 03:35:15,018 CENTERS AS WELL AS FROM THE CDC 5624 03:35:15,018 --> 03:35:18,521 AND HERE I WILL ACKNOWLEDGE THE 5625 03:35:18,521 --> 03:35:21,191 RETIREMENT OF STEVE (INAUDIBLE) 5626 03:35:21,191 --> 03:35:22,392 BOTH LONG TIME COLLEAGUE AND 5627 03:35:22,392 --> 03:35:23,826 COLLABORATOR ON THE PEDIATRIC 5628 03:35:23,826 --> 03:35:25,962 GUIDELINES AS WELL AS BEAR NATAL 5629 03:35:25,962 --> 03:35:27,530 GUIDELINES AND ALL AROUND GOOD 5630 03:35:27,530 --> 03:35:29,499 GUY SO WANT TO ACKNOWLEDGE HOW 5631 03:35:29,499 --> 03:35:34,070 MUCH HE HAS MEANT TO OUR FIELD. 5632 03:35:34,070 --> 03:35:35,772 NEXT SLIDE PLEASE. 5633 03:35:35,772 --> 03:35:38,441 AS I MENTION THIS NEW EXPANDED 5634 03:35:38,441 --> 03:35:39,976 GROUP IS ALSO SERVING AS A 5635 03:35:39,976 --> 03:35:44,314 RESOURCE FOR OREGONS. 5636 03:35:44,314 --> 03:35:45,915 BILL IS NIH LIAISON TO AMERICAN 5637 03:35:45,915 --> 03:35:47,150 ACADEMY OF PEDIATRICS COMMITTEE 5638 03:35:47,150 --> 03:35:48,685 FOR INFECTIOUS DISEASE WHICH IS 5639 03:35:48,685 --> 03:35:50,386 CHAIRED BY DAVID TIMBERLAND. 5640 03:35:50,386 --> 03:35:52,422 WHO IS ALSO THE EDITOR FOR -- 5641 03:35:52,422 --> 03:35:53,656 MAY NOT CHAIR THAT GROUP BUT 5642 03:35:53,656 --> 03:35:56,526 CERTAINLY ON IT BUT HE IS EDITOR 5643 03:35:56,526 --> 03:35:57,527 FOR RED BOOK RECOGNIZING THAT 5644 03:35:57,527 --> 03:35:59,095 THERE IS NOW THIS EXPANDED GROUP 5645 03:35:59,095 --> 03:36:02,098 ON PEDIATRIC OPPORTUNISTIC 5646 03:36:02,098 --> 03:36:03,866 INFECTIONS AND LOT OF NEED TO 5647 03:36:03,866 --> 03:36:06,002 REVIEW CHAPTERS IN THE RED BOOK 5648 03:36:06,002 --> 03:36:07,770 THESE GROUPS COME TOGETHER IN 5649 03:36:07,770 --> 03:36:09,639 THE -- OI GROUP PROVIDED 5650 03:36:09,639 --> 03:36:11,474 CRITICAL REVIEWS OF 13 CHAPTERS 5651 03:36:11,474 --> 03:36:13,443 IN THE RED BOOK THAT HAVE 5652 03:36:13,443 --> 03:36:15,645 CORRESPONDING SECTIONS WITHIN 5653 03:36:15,645 --> 03:36:16,779 THE GUIDELINES. 5654 03:36:16,779 --> 03:36:20,216 THAT WAS A NICE WAY TO LEVERAGE 5655 03:36:20,216 --> 03:36:24,187 EXPERTISE ACROSS THE TWO GROUPS. 5656 03:36:24,187 --> 03:36:27,824 HERE IS THE DATA FROM THE 5657 03:36:27,824 --> 03:36:28,758 DOWNLOADS. 5658 03:36:28,758 --> 03:36:31,694 HENRY SHOWED, CERTAINLY THE 5659 03:36:31,694 --> 03:36:33,329 PEDIATRIC GUIDELINES ARE USED 5660 03:36:33,329 --> 03:36:34,998 MUCH LESS EXTENSIVELY BUT 5661 03:36:34,998 --> 03:36:38,835 REFLECTS THE FACT THAT HIV 5662 03:36:38,835 --> 03:36:40,036 DESPITE 10% WHAT THE ADULT 5663 03:36:40,036 --> 03:36:41,571 POPULATION IS BUT AS HENRY 5664 03:36:41,571 --> 03:36:45,108 SHOWED ADULT OI GUIDELINES IT IS 5665 03:36:45,108 --> 03:36:46,909 STEADY SO YOU CAN SEE CLOSE TO 5666 03:36:46,909 --> 03:36:48,978 4600 DOWNLOADS IN 2020 AND SAME 5667 03:36:48,978 --> 03:36:53,916 IN 2021. 5668 03:36:53,916 --> 03:36:55,485 THESE ARE INDIVIDUAL PAGES 5669 03:36:55,485 --> 03:36:58,021 INTERESTING SAME COMMENT THAT IN 5670 03:36:58,021 --> 03:36:59,589 FACT I FEEL LIKE ORDER IS 5671 03:36:59,589 --> 03:37:01,991 SIMILAR TO WHAT HENRY SHOWED AS 5672 03:37:01,991 --> 03:37:04,227 WELL WITH PNEUMOSIS AT THIS 5673 03:37:04,227 --> 03:37:07,297 BEING NUMBER ONE BUT RARE 5674 03:37:07,297 --> 03:37:08,531 PATHOGENS WHEN SOMEONE IS 5675 03:37:08,531 --> 03:37:10,266 CONFRONTED WITH THEM IT IS 5676 03:37:10,266 --> 03:37:13,836 IMPORTANT TO HAVE THIS RESOURCE. 5677 03:37:13,836 --> 03:37:14,337 NEXT SLIDE. 5678 03:37:14,337 --> 03:37:18,007 THESE ARE JUST ANCILLARY PAGE 5679 03:37:18,007 --> 03:37:19,976 VIEWS AS WELL HIGHLIGHTED THERE, 5680 03:37:19,976 --> 03:37:21,411 THE IMPORTANCE OF IMMUNIZATION 5681 03:37:21,411 --> 03:37:26,683 SCHEDULE IN THE VACCINE SECTION. 5682 03:37:26,683 --> 03:37:28,117 I THINK THAT IS IT. 5683 03:37:28,117 --> 03:37:29,352 I WANTED LIKE HENRY WANT TO 5684 03:37:29,352 --> 03:37:30,520 ACKNOWLEDGE THE VOLUNTEERS. 5685 03:37:30,520 --> 03:37:32,822 I THINK ACROSS THE FIVE 5686 03:37:32,822 --> 03:37:37,860 GUIDELINES PANELS IT IS OVER 200 5687 03:37:37,860 --> 03:37:39,429 VOLUNTEERS, IT IS A LABOR OF 5688 03:37:39,429 --> 03:37:40,763 LOVE BUT THESE ARE JUST VERY 5689 03:37:40,763 --> 03:37:43,666 DEDICATED PEOPLE, BUT ALSO I 5690 03:37:43,666 --> 03:37:47,036 HAVE TO SAY A TREMENDOUS 5691 03:37:47,036 --> 03:37:48,404 ACTIVITY TO BE PART OF. 5692 03:37:48,404 --> 03:37:50,206 NUMBER OF FOLKS ON THE OARAC 5693 03:37:50,206 --> 03:37:53,176 HAVE BEEN PART OF THE GUIDELINES 5694 03:37:53,176 --> 03:37:55,478 IT IS A FULFILLING ACTIVITY. 5695 03:37:55,478 --> 03:37:57,814 SO GLAD TO BE ABLE TO PRESENT 5696 03:37:57,814 --> 03:38:01,718 THESE UPDATES. 5697 03:38:01,718 --> 03:38:02,685 BACK TO YOU BLANTON. 5698 03:38:02,685 --> 03:38:03,986 >> THANK YOU, DR. HAZRA. 5699 03:38:03,986 --> 03:38:05,621 WE WILL NOW TAKE QUESTIONS ABOUT 5700 03:38:05,621 --> 03:38:09,592 THE GUIDELINES FOR DR. MASUR AND 5701 03:38:09,592 --> 03:38:10,927 HAZRA, IF THERE ARE ANY 5702 03:38:10,927 --> 03:38:21,371 QUESTIONS RAISE YOUR HAND. 5703 03:38:23,973 --> 03:38:25,241 IF THERE ARE NO QUESTIONS THANK 5704 03:38:25,241 --> 03:38:26,809 YOU AGAIN DR. HAS RA AND MASUR 5705 03:38:26,809 --> 03:38:29,679 FOR THE UPDATES TO -- HAZRA AND 5706 03:38:29,679 --> 03:38:30,947 MASUR TO THE UPDATE TO FIDE 5707 03:38:30,947 --> 03:38:31,214 LINES. 5708 03:38:31,214 --> 03:38:35,852 WE WILL MOVE WITH OUR AGENDA AND 5709 03:38:35,852 --> 03:38:40,123 IN THE SAKE OF TIME I WILL 5710 03:38:40,123 --> 03:38:41,457 INTRODUCE THE NEXT SPEAKERS 5711 03:38:41,457 --> 03:38:42,692 ADVISORY COUNCIL REPRESENTATIVES 5712 03:38:42,692 --> 03:38:44,827 AND I ASK THAT YOU PLEASE LOOK 5713 03:38:44,827 --> 03:38:49,399 IN THE BRIEFING BOOK TO SEE THE 5714 03:38:49,399 --> 03:38:51,567 FULL BIOE. 5715 03:38:51,567 --> 03:38:54,670 WE WILL HEAR FROM DR. MONICA 5716 03:38:54,670 --> 03:38:56,539 GANDHI, REPRESENTING THE AIDS 5717 03:38:56,539 --> 03:38:57,440 RESEARCH ADVISORY COMMITTEE. 5718 03:38:57,440 --> 03:38:59,542 WE WILL NEXT HEAR FROM DR. 5719 03:38:59,542 --> 03:39:01,778 REDONNA CHANDLER WHO IS 5720 03:39:01,778 --> 03:39:02,945 REPRESENTING THE NATIONAL 5721 03:39:02,945 --> 03:39:05,314 ADVISORY COUNCIL ON DRUG ABUSE. 5722 03:39:05,314 --> 03:39:07,750 THAT WILL BE FOLLOWED BY DR. 5723 03:39:07,750 --> 03:39:08,985 YARCHOAN, NATIONAL CANCER 5724 03:39:08,985 --> 03:39:12,221 ADVISORY BOARD AND THEN LASTLY 5725 03:39:12,221 --> 03:39:14,257 DR. JULIO ALBERTI FROM NATIONAL 5726 03:39:14,257 --> 03:39:15,691 AIDS EXECUTIVE COMMITTEE. 5727 03:39:15,691 --> 03:39:17,827 DR. GANDHI, PASS IT OVER TO YOU 5728 03:39:17,827 --> 03:39:18,060 NOW. 5729 03:39:18,060 --> 03:39:24,667 THANKS. 5730 03:39:24,667 --> 03:39:25,935 >> I WILL BE FROM THE NINE 5731 03:39:25,935 --> 03:39:29,906 ADVISORY COUNCIL TO OARAC SO WE 5732 03:39:29,906 --> 03:39:31,340 ALSO LOOK AT THE BUDGET, 5733 03:39:31,340 --> 03:39:34,444 EVERYONE LOOKING AT THE BUDGET, 5734 03:39:34,444 --> 03:39:38,381 WAS HOPEFUL TO SEE THAT NIAID 5735 03:39:38,381 --> 03:39:40,616 FUNDING ACTUALLY SOMETHING ART 5736 03:39:40,616 --> 03:39:41,684 FACTUAL HAPPENED THAT LOOKED 5737 03:39:41,684 --> 03:39:45,188 LIKE DECREASE BUT IT INCREASED 5738 03:39:45,188 --> 03:39:46,556 BY 4.2%. 5739 03:39:46,556 --> 03:39:48,891 I WOULD COMMENT HERE THAT ECTG 5740 03:39:48,891 --> 03:39:51,093 AND COMMUNITY IS VERY INTERESTED 5741 03:39:51,093 --> 03:39:53,329 IN AGING AGENDA SO HAPPY TO SEE 5742 03:39:53,329 --> 03:39:54,664 THE INCREASE IN NATIONAL 5743 03:39:54,664 --> 03:39:59,902 INSTITUTE OF AGING BUDGET HERE 5744 03:39:59,902 --> 03:40:01,804 IN THE CONGRESS BUDGET. 5745 03:40:01,804 --> 03:40:03,172 NEXT SLIDE. 5746 03:40:03,172 --> 03:40:07,009 ALSO GRATIFIED THAT WE -- THAT 5747 03:40:07,009 --> 03:40:08,110 FINANCIAL PAY LINES WERE 5748 03:40:08,110 --> 03:40:10,279 RELEASED FROM NIAID AND YOU CAN 5749 03:40:10,279 --> 03:40:13,883 SEE THE RO1 PAY LINES RIGHT NOW 5750 03:40:13,883 --> 03:40:17,520 ALWAYS ANNOUNCED AT NIAID THAW 5751 03:40:17,520 --> 03:40:19,088 POST THEM AND IT IS 12 5752 03:40:19,088 --> 03:40:20,556 PERCENTILE ESTABLISHED PIs AND 5753 03:40:20,556 --> 03:40:23,426 NEW PIs ARE 16 PERCENTILE. 5754 03:40:23,426 --> 03:40:26,429 SO THAT GIVES SUCCESS RATE OF 5755 03:40:26,429 --> 03:40:30,266 RO1s 18 TO 22% WHICH WAS 5756 03:40:30,266 --> 03:40:33,669 ENCOURAGING FOR THIS PHASE OF 5757 03:40:33,669 --> 03:40:34,737 POST PANDEMIC. 5758 03:40:34,737 --> 03:40:36,305 ONE THING ALSO THAT IS NOT ON 5759 03:40:36,305 --> 03:40:40,510 THE SLIDE IS THE KAY PAY LINE 5760 03:40:40,510 --> 03:40:41,811 BOTHST PROKED BY NIAID AT 20, 5761 03:40:41,811 --> 03:40:43,679 IMPROVEMENT FROM 18. 5762 03:40:43,679 --> 03:40:46,916 THERE IS A LOT OF PRAISE OF THE 5763 03:40:46,916 --> 03:40:53,923 INSTITUTE FOR THIS. 5764 03:40:53,923 --> 03:40:55,992 THERE IS SPECIFIC EARMARKED AN 5765 03:40:55,992 --> 03:40:57,460 NON-EARMARKED IN TERMS OF 5766 03:40:57,460 --> 03:40:59,795 CONGRESSIONAL NIAID BUDGET. 5767 03:40:59,795 --> 03:41:02,565 THE EARMARK RESEARCH IS VERY 5768 03:41:02,565 --> 03:41:03,566 IMPORTANT SPECIFICALLY ENDING 5769 03:41:03,566 --> 03:41:06,769 THE HIV EPIDEMIC MONEY SO THAT 5770 03:41:06,769 --> 03:41:09,539 GOES TOWARD CFAR SUPPLEMENTS AND 5771 03:41:09,539 --> 03:41:12,742 OTHER C FAR GRANTS BASICALLY GO 5772 03:41:12,742 --> 03:41:15,778 TOWARDS -- THE NIH ITSELF BEYOND 5773 03:41:15,778 --> 03:41:18,014 CDC AND HRSA NIH GETTING 5774 03:41:18,014 --> 03:41:19,215 RESEARCH MONEY IMPLEMENTATION 5775 03:41:19,215 --> 03:41:21,350 SCIENCE FOCUSED TO WORK ON THE 5776 03:41:21,350 --> 03:41:23,920 PILLARS OF ENDING HIV EPIDEMIC 5777 03:41:23,920 --> 03:41:27,089 PREVENTION TREATMENT RETENTION 5778 03:41:27,089 --> 03:41:27,590 OUTBREAK INVESTIGATION. 5779 03:41:27,590 --> 03:41:30,459 QUITE A BIT FOR UNIVERSAL 5780 03:41:30,459 --> 03:41:31,894 INFLUENZA VACCINE WE NEED TICK 5781 03:41:31,894 --> 03:41:34,564 BORN DISEASE FOR ANTIMICROBIAL 5782 03:41:34,564 --> 03:41:36,899 RESISTANCE OF COVID FUNDING 5783 03:41:36,899 --> 03:41:40,636 STAYED FLAT BUT IMMUNITY LAB AND 5784 03:41:40,636 --> 03:41:43,706 REGIONAL BIOCONTAINMENT AND FOOD 5785 03:41:43,706 --> 03:41:45,374 ALLERGY RESEARCH WENT UP QUITE A 5786 03:41:45,374 --> 03:41:46,842 BIT. 5787 03:41:46,842 --> 03:41:51,547 SO JUST LIKE THE REPORT FROM 5788 03:41:51,547 --> 03:41:53,883 MARGUERITA ABOUT NIMH THERE IS 5789 03:41:53,883 --> 03:41:57,320 ATTEMPT BY NIAID AND THE NIH IN 5790 03:41:57,320 --> 03:41:59,055 GENERAL, INSTITUTIONS SHOULD 5791 03:41:59,055 --> 03:42:01,157 FOLLOW SUIT TO NOT ONLY WORK ON 5792 03:42:01,157 --> 03:42:03,359 DIVERSITY EQUITY INCLUSION 5793 03:42:03,359 --> 03:42:04,160 ACCESSIBILITY WITH A SPECIFIC 5794 03:42:04,160 --> 03:42:08,364 COUNCIL FOR THAT, BUT WORKPLACE 5795 03:42:08,364 --> 03:42:09,899 CIVILITY TASK FORCE WHICH WAS 5796 03:42:09,899 --> 03:42:12,335 AMAZING AND SENT TO OUR DEAN 5797 03:42:12,335 --> 03:42:13,102 HERE. 5798 03:42:13,102 --> 03:42:15,471 ANYONE GET NIH FUNDING WE SHOULD 5799 03:42:15,471 --> 03:42:18,140 BE WORKING ON NATURAL BEHAVIOR. 5800 03:42:18,140 --> 03:42:19,008 THE NEXT SLIDE SHOWS WHAT THAT 5801 03:42:19,008 --> 03:42:21,143 MEANS. 5802 03:42:21,143 --> 03:42:25,247 NEXT SLIDE PLEASE. 5803 03:42:25,247 --> 03:42:28,417 WORKPLACE CIVILITY TASK FORCE IS 5804 03:42:28,417 --> 03:42:30,119 EXPECTATION STATEMENT TO CREATE 5805 03:42:30,119 --> 03:42:33,556 A CIVIL WORKPLACE NIAID EXPECTS 5806 03:42:33,556 --> 03:42:35,324 STAFF REGARDLESS OF POSITION TO 5807 03:42:35,324 --> 03:42:37,660 ACT WITH PROFESSIONALISM AND 5808 03:42:37,660 --> 03:42:39,528 RESPECT LISTEN WITH OPEN MIND 5809 03:42:39,528 --> 03:42:40,863 COMMUNICATE CONSTRUCTIVELY AND 5810 03:42:40,863 --> 03:42:41,831 WORK COLLABORATIVELY. 5811 03:42:41,831 --> 03:42:43,499 YOU CAN SO THESE PRINCIPLES ON 5812 03:42:43,499 --> 03:42:47,003 THE RIGHT OF A CIVIL WORK FORCE. 5813 03:42:47,003 --> 03:42:48,638 I THINK I JUST THINK THIS IS AN 5814 03:42:48,638 --> 03:42:50,973 AMAZING THING FOR THE NIH TO DO 5815 03:42:50,973 --> 03:42:52,642 ESPECIALLY DURING THESE 5816 03:42:52,642 --> 03:42:56,479 POLARIZING DIFFICULT TIMES. 5817 03:42:56,479 --> 03:42:58,247 AND ENCOURAGE INSTITUTIONS THAT 5818 03:42:58,247 --> 03:43:00,549 ACCEPT NIH FUNDING TO ADOPT 5819 03:43:00,549 --> 03:43:02,818 SIMILAR PLEDGE. 5820 03:43:02,818 --> 03:43:02,952 . 5821 03:43:02,952 --> 03:43:03,919 PEOPLE HAVE HAVE TO SIGN THIS 5822 03:43:03,919 --> 03:43:07,456 PLEDGE. 5823 03:43:07,456 --> 03:43:12,194 IN ADDITION THE DEIA COUNCIL IS 5824 03:43:12,194 --> 03:43:14,196 REALLY TO FUNDAMENTALLY BOTH 5825 03:43:14,196 --> 03:43:16,632 WORK INTERNALLY AND WITH 5826 03:43:16,632 --> 03:43:19,068 EXTERNAL EXTRAMURAL WORKPLACE 5827 03:43:19,068 --> 03:43:23,873 FUNDING TO WORK ON DIVERSE 5828 03:43:23,873 --> 03:43:25,107 INCLUSIVE WORKPLACE AND WORK 5829 03:43:25,107 --> 03:43:30,012 STAFF FOR ALL RESEARCHERS. 5830 03:43:30,012 --> 03:43:33,516 IN TERMS OF ONE MORE DIVERSITY 5831 03:43:33,516 --> 03:43:35,117 INITIATIVE I SHOULD MENTION 5832 03:43:35,117 --> 03:43:36,419 WHICH IS A BRAIN DIVERSITY 5833 03:43:36,419 --> 03:43:40,489 INITIATIVE BUT ESSENTIALLY THAT 5834 03:43:40,489 --> 03:43:41,757 ANYONE APPLYING FOR ANY RANGE OF 5835 03:43:41,757 --> 03:43:43,325 FUNDING HAS TO WORK ON MORE 5836 03:43:43,325 --> 03:43:45,194 DIVERSE PERSPECTIVES ABOUT 5837 03:43:45,194 --> 03:43:46,729 CULTURE CHANGE THAT IS NECESSARY 5838 03:43:46,729 --> 03:43:49,131 TO ADDRESS OUR INEQUITIES AND 5839 03:43:49,131 --> 03:43:51,367 SOCIETY AND SYSTEMIC BIASES IN 5840 03:43:51,367 --> 03:43:53,803 BIOMEDICAL RESEARCH AND I WILL 5841 03:43:53,803 --> 03:43:57,106 TALK LATER VERY IMPRESSIVE RO1 5842 03:43:57,106 --> 03:44:01,377 OPPORTUNITY AT NIAID AND 5843 03:44:01,377 --> 03:44:03,145 CROSSING ENTIRE INSTITUTE 5844 03:44:03,145 --> 03:44:05,147 WORKING ON DIVERSITY AND 5845 03:44:05,147 --> 03:44:06,482 EXTRAMURAL APPLICATIONS. 5846 03:44:06,482 --> 03:44:11,220 NEXT SLIDE. 5847 03:44:11,220 --> 03:44:15,057 ACTUALLY, THIS IS MORE ON HOW 5848 03:44:15,057 --> 03:44:15,825 IMPORTANT INFRASTRUCTURE IS TO 5849 03:44:15,825 --> 03:44:17,326 -- THAT EVERYONE WILL HAVE TO 5850 03:44:17,326 --> 03:44:20,162 INCLUDE IN BRAIN INITIATIVE 5851 03:44:20,162 --> 03:44:22,565 GRANTS, ONE PAGE ADDITION TO 5852 03:44:22,565 --> 03:44:24,233 EXPLAIN HOW TO MAXIMIZE 5853 03:44:24,233 --> 03:44:25,568 PARTICIPATION OF INVESTIGATORS 5854 03:44:25,568 --> 03:44:27,536 FROM DIVERSE BACKGROUNDS AND 5855 03:44:27,536 --> 03:44:29,705 ENGAGE WITH DIFFERENT TYPES OF 5856 03:44:29,705 --> 03:44:31,373 INSTITUTIONS, BLACK HISPANIC 5857 03:44:31,373 --> 03:44:33,142 ORGANIZATIONS FOR EXAMPLE THAT 5858 03:44:33,142 --> 03:44:35,010 AND COMMUNITY BASED 5859 03:44:35,010 --> 03:44:39,014 ORGANIZATIONS THAT SERVE DIVERSE 5860 03:44:39,014 --> 03:44:42,218 RESEARCH INFRASTRUCTURE. 5861 03:44:42,218 --> 03:44:45,755 THIS IS A VERY EXCITING NEW 5862 03:44:45,755 --> 03:44:47,089 RESEARCH OPPORTUNITY THAT WAS 5863 03:44:47,089 --> 03:44:48,691 ANNOUNCED ACROSS NIAID. 5864 03:44:48,691 --> 03:44:51,660 THIS WOULD BE BOTH IN DADE AND 5865 03:44:51,660 --> 03:44:53,462 DMID ACROSS THE ENTIRE INSTITUTE 5866 03:44:53,462 --> 03:44:55,531 WHICH IS ESSENTIALLY AN RO1 5867 03:44:55,531 --> 03:44:57,867 AWARD THAT IS SPECIFICALLY 5868 03:44:57,867 --> 03:45:01,704 TARGETED AS MUCH AS POSSIBLE 5869 03:45:01,704 --> 03:45:04,106 TOWARD RESEARCHERS FROM DIVERSE 5870 03:45:04,106 --> 03:45:04,673 BACKGROUNDS. 5871 03:45:04,673 --> 03:45:06,709 SO IT IS RO1 WHICH IS AMAZING 5872 03:45:06,709 --> 03:45:07,710 BECAUSE THAT IS WHAT PEOPLE 5873 03:45:07,710 --> 03:45:08,177 NEED. 5874 03:45:08,177 --> 03:45:13,015 TO MAKE THAT NEXT STEP, IT IS 5875 03:45:13,015 --> 03:45:16,118 YOU CAN'T SPECIFICALLY WRITE 5876 03:45:16,118 --> 03:45:18,120 EXAMLY THAT YOU CAN ONLY BE FROM 5877 03:45:18,120 --> 03:45:20,790 CERTAIN GROUPS, IT IS TO 5878 03:45:20,790 --> 03:45:21,423 ENCOURAGE CERTAIN 5879 03:45:21,423 --> 03:45:22,258 UNDER-REPRESENTED GROUPS IN 5880 03:45:22,258 --> 03:45:25,194 RESEARCH TO APPLY. 5881 03:45:25,194 --> 03:45:29,265 AND IT CAN BE ANY TOPIC IN 5882 03:45:29,265 --> 03:45:30,032 INFECTIOUS DISEASE AND I THINK 5883 03:45:30,032 --> 03:45:31,901 THIS IS THE KIND OF -- THIS IS 5884 03:45:31,901 --> 03:45:34,570 ONLY BEEN DONE TWICE BEFORE ONCE 5885 03:45:34,570 --> 03:45:36,038 IN 2004 I BELIEVE AND ONCE IN 5886 03:45:36,038 --> 03:45:39,575 2009 I BELIEVE AND IT JUST IS A 5887 03:45:39,575 --> 03:45:41,210 INCREDIBLE BOON TO HELP WORK ON 5888 03:45:41,210 --> 03:45:43,179 GETTING MORE INVESTIGATORS 5889 03:45:43,179 --> 03:45:45,381 FROMTY VERSE BACKGROUNDS TO RO1 5890 03:45:45,381 --> 03:45:49,618 LEVEL RESEARCH. 5891 03:45:49,618 --> 03:45:51,487 THEN THE NEXT TOPIC WE DISCUSSED 5892 03:45:51,487 --> 03:45:55,357 AT THIS MEETING IS REALLY THE 5893 03:45:55,357 --> 03:45:58,227 FOCUS IN C FAR EARMARKED MONEY 5894 03:45:58,227 --> 03:46:01,564 FOR END THE HIV EPIDEMIC GRAB. 5895 03:46:01,564 --> 03:46:05,067 SO THESE ARE SUPPLEMENT GRABS, 5896 03:46:05,067 --> 03:46:06,836 FIVE AWARDED, EVERYONE HEARD 5897 03:46:06,836 --> 03:46:09,371 ABOUT IT YESTERDAY AND THESE ARE 5898 03:46:09,371 --> 03:46:10,472 REALLY IMPORTANT GRANTS TO WORK 5899 03:46:10,472 --> 03:46:12,975 ON EQUITY FOCUSED APPROACHES, TO 5900 03:46:12,975 --> 03:46:14,310 REDUCE HEALTH DISPARITIES 5901 03:46:14,310 --> 03:46:15,845 BEHAVIORAL ECONOMIC APPROACH ON 5902 03:46:15,845 --> 03:46:18,280 HIV TEST AND PREVENTION AND 5903 03:46:18,280 --> 03:46:19,114 COURSE, STRATEGIC ALLIANCE, 5904 03:46:19,114 --> 03:46:22,351 ACROSS IMPLEMENTATION SCIENCE, 5905 03:46:22,351 --> 03:46:23,752 RESEARCH AND IMPLEMENTATION 5906 03:46:23,752 --> 03:46:24,854 STRATEGIES AND PLANNING 5907 03:46:24,854 --> 03:46:25,554 PROJECTS. 5908 03:46:25,554 --> 03:46:29,558 SO THESE ARE ALL GIVEN OUT NOW 5909 03:46:29,558 --> 03:46:31,994 BOUGHING THE TO BE 135 OF EHE 5910 03:46:31,994 --> 03:46:37,566 SUPPLEMENTS ACROSS C FAR. 5911 03:46:37,566 --> 03:46:40,302 THEN REALLY DISCUSSED THE 5912 03:46:40,302 --> 03:46:41,971 RENEWAL OF THE NIH C FAR GRANT 5913 03:46:41,971 --> 03:46:45,040 AWARDS WHICH IS REALLY HIGH 5914 03:46:45,040 --> 03:46:46,442 IMPACT. 5915 03:46:46,442 --> 03:46:48,110 AND REISSUE OF THAT FOR FIVE 5916 03:46:48,110 --> 03:46:49,979 YEAR AWARDS AND HOPEFULLY EXPAND 5917 03:46:49,979 --> 03:46:54,817 SOME C FARES AND EXPAND ALLOW 5918 03:46:54,817 --> 03:46:58,721 MORE INSTITUTION C FAR PROGRAM. 5919 03:46:58,721 --> 03:47:01,156 BECAUSE C FARES ARE SO 5920 03:47:01,156 --> 03:47:02,358 MULTI-DISCIPLINARY THIS IS 5921 03:47:02,358 --> 03:47:05,027 REALLY THE CO-FUNDED BY 11 NIH 5922 03:47:05,027 --> 03:47:06,395 INSTITUTES SO NOT JUST NIAID 5923 03:47:06,395 --> 03:47:07,863 THAT PUTS THE MAJORITY OF THE 5924 03:47:07,863 --> 03:47:09,965 FUNDING IN IN AND SO BECAUSE OF 5925 03:47:09,965 --> 03:47:12,601 THAT WE TRY TO BE 5926 03:47:12,601 --> 03:47:14,069 INTERDISCIPLINARY IN OUR CFR 5927 03:47:14,069 --> 03:47:16,939 INITIATIVES. 5928 03:47:16,939 --> 03:47:19,408 THESE ARE THE C FARES AROUND THE 5929 03:47:19,408 --> 03:47:20,409 COUNTRY, THERE ARE DIFFERENT 5930 03:47:20,409 --> 03:47:23,279 TIERS OF TYPE C FARES AND ALSO 5931 03:47:23,279 --> 03:47:24,647 DEVELOPMENTAL C FAR SITES. 5932 03:47:24,647 --> 03:47:26,849 SOME REALLY EXPANDING AROUND THE 5933 03:47:26,849 --> 03:47:28,183 COUNTRY AND AMAZING TO BE PART 5934 03:47:28,183 --> 03:47:32,955 OF THE C FAR PROGRAM. 5935 03:47:32,955 --> 03:47:34,089 IMPORTANTLY THERE WAS JUST A NEW 5936 03:47:34,089 --> 03:47:35,658 INITIATIVE STARTED TO ENHANCE 5937 03:47:35,658 --> 03:47:37,993 DIVERSITY EQUITY INCLUSION AT C 5938 03:47:37,993 --> 03:47:40,062 FARES FOR EARLY PIPELINE 5939 03:47:40,062 --> 03:47:41,397 INVESTIGATORS, THESE ARE 5940 03:47:41,397 --> 03:47:42,598 UNDERGRADUATES MASTER STUDENTS 5941 03:47:42,598 --> 03:47:45,467 AT HISTORICALLY BLACK HISPANIC 5942 03:47:45,467 --> 03:47:47,269 INSTITUTIONS AND THIS IS REALLY 5943 03:47:47,269 --> 03:47:49,038 IMPORTANT WE LAUNCHED OUR C FAR 5944 03:47:49,038 --> 03:47:51,807 SCHOLAR PROGRAM BECAUSE WE GOT 5945 03:47:51,807 --> 03:47:54,543 ONE OF THESE GRANTS AND STARTED 5946 03:47:54,543 --> 03:47:56,745 SCHOLARS OFF RESEARCH PROJECTS 5947 03:47:56,745 --> 03:47:57,546 FOR SAN FRANCISCO STATE THIS 5948 03:47:57,546 --> 03:48:00,783 SUMMER. 5949 03:48:00,783 --> 03:48:03,118 A COUPLE OF RFAs I WILL END 5950 03:48:03,118 --> 03:48:06,655 WITH THAT WERE ANNOUNCED THAT 5951 03:48:06,655 --> 03:48:07,122 ARE IMPORTANT. 5952 03:48:07,122 --> 03:48:09,591 ONE DEFINING NOT HIV INDUCED 5953 03:48:09,591 --> 03:48:12,995 INFLAMMATION BUT THE MECHANISMS 5954 03:48:12,995 --> 03:48:14,863 HIV INDUCED IMPLEMENTATION AND 5955 03:48:14,863 --> 03:48:15,965 IMMUNE ACTIVATION DURING 5956 03:48:15,965 --> 03:48:17,232 SUPPRESSIVE ART. 5957 03:48:17,232 --> 03:48:18,534 STILL ONGOING IMPLEMENTATION 5958 03:48:18,534 --> 03:48:20,069 DURING THIS TIME AND SO WHAT ARE 5959 03:48:20,069 --> 03:48:21,770 THE MECHANISMS OF THAT, THIS IS 5960 03:48:21,770 --> 03:48:25,140 AN R 61 R 33 TYPE PROPOSAL 5961 03:48:25,140 --> 03:48:25,774 MECHANISM. 5962 03:48:25,774 --> 03:48:28,744 NEXT SLIDE. 5963 03:48:28,744 --> 03:48:30,079 SPECIFICALLY IT IS TO EFFECT 5964 03:48:30,079 --> 03:48:32,715 PEOPLE SUPPRESSIVE ART AND VERY 5965 03:48:32,715 --> 03:48:33,816 INTERESTING MECHANISM WHICH 5966 03:48:33,816 --> 03:48:36,752 FIRST THREE YEARS ARE BASIC 5967 03:48:36,752 --> 03:48:38,320 RESEARCH TO DETERMINE LANDSCAPE 5968 03:48:38,320 --> 03:48:40,856 AND DIFFERENT CELLULAR 5969 03:48:40,856 --> 03:48:42,191 POPULATIONS, THE NEXT TWO YEARS 5970 03:48:42,191 --> 03:48:45,194 ARE APPLIED RESEARCH TO DEVELOP 5971 03:48:45,194 --> 03:48:46,929 NOVEL THERAPEUTICS TO WORK 5972 03:48:46,929 --> 03:48:50,699 AGAINST -- COUNTER THIS IMMUNE 5973 03:48:50,699 --> 03:48:52,034 ACTIVATION AND ON SUPPRESSIVE 5974 03:48:52,034 --> 03:48:55,237 ART. 5975 03:48:55,237 --> 03:48:58,140 NEXT RFA ANNOUNCED WHICH IS 5976 03:48:58,140 --> 03:48:59,475 INTERESTING WHICH IS EARLY 5977 03:48:59,475 --> 03:49:01,343 EVENTS IN TB AND TB HIV 5978 03:49:01,343 --> 03:49:03,846 INFECTION SO THIS IS EVEN 5979 03:49:03,846 --> 03:49:05,614 ESSENTIALLY IMMUNOPATHOGENESIS 5980 03:49:05,614 --> 03:49:08,050 MECHANISMS IN VERY EARLY 5981 03:49:08,050 --> 03:49:08,550 INFECTION. 5982 03:49:08,550 --> 03:49:11,820 AND THE IDEA IS NOT TO -- TO 5983 03:49:11,820 --> 03:49:13,055 ESSENTIALLY IDENTIFY NOVEL 5984 03:49:13,055 --> 03:49:15,057 TARGETS FOR NEW INTERVENTIONS. 5985 03:49:15,057 --> 03:49:17,092 FOR THE HOST TO PREVENTED LONG 5986 03:49:17,092 --> 03:49:18,460 TERM DAMAGE. 5987 03:49:18,460 --> 03:49:19,595 FROM TUBERCULOSIS. 5988 03:49:19,595 --> 03:49:22,464 NEXT SLIDE SHOWS THE ACTUAL 5989 03:49:22,464 --> 03:49:24,500 MECHANISTIC STUDIES ENCOURAGED. 5990 03:49:24,500 --> 03:49:26,902 BEFORE YOU ETCH GET INTO 5991 03:49:26,902 --> 03:49:28,237 ADAPTIVE IMMUNE FUNCTION, WHAT 5992 03:49:28,237 --> 03:49:30,706 ARE ALL THE INFLAMMATION 5993 03:49:30,706 --> 03:49:33,008 MECHANISMS THAT OCCUR IN TB THAT 5994 03:49:33,008 --> 03:49:35,778 CAN LEADS TO FIBROSIS AND OTHER 5995 03:49:35,778 --> 03:49:37,413 LUNG DAMAGE, THE IDEA WOULD BE 5996 03:49:37,413 --> 03:49:39,948 TRY AGAIN BASIC -- THESE 5997 03:49:39,948 --> 03:49:41,750 PRE-CLINICAL STUDIES, YOU WANT 5998 03:49:41,750 --> 03:49:43,385 NOVEL THERAPY TARGETS TO 5999 03:49:43,385 --> 03:49:44,453 INTERACT EVEN PRIOR TO STARTING 6000 03:49:44,453 --> 03:49:45,320 TREATMENT. 6001 03:49:45,320 --> 03:49:48,991 NEXT SLIDE. 6002 03:49:48,991 --> 03:49:49,792 THERE SEARCH AND SEIZURE TWO 6003 03:49:49,792 --> 03:49:51,660 OTHER INITIATIVES WHICH I WILL 6004 03:49:51,660 --> 03:49:55,064 JUST MENTION, ONE IS CELLULAR 6005 03:49:55,064 --> 03:49:56,165 IMMUNOLOGY CORE LABORATORY, 6006 03:49:56,165 --> 03:49:58,600 PROVIDE CENTRALIZED LABORATORY 6007 03:49:58,600 --> 03:50:00,969 TO MEASURE CELLULAR IMMUNITY, WE 6008 03:50:00,969 --> 03:50:05,607 HAVE GOTTEN INTEREST THE COVID 6009 03:50:05,607 --> 03:50:06,942 VACCINES ON SPECIFIC HOW MUCH 6010 03:50:06,942 --> 03:50:08,377 CELLULAR IMMUNITY MATTERS AND B 6011 03:50:08,377 --> 03:50:10,612 CELL IMMUNITY, THIS IS FOR NOT 6012 03:50:10,612 --> 03:50:12,381 COVID BUT PRE-CLINICAL AIDS 6013 03:50:12,381 --> 03:50:13,315 VACCINE STUDIES. 6014 03:50:13,315 --> 03:50:17,486 THESE ASSAYS ARE ESSENTIAL TO 6015 03:50:17,486 --> 03:50:18,854 DEVELOP NOT JUST AGAIN ANTIBODY 6016 03:50:18,854 --> 03:50:20,255 RESPONSE BUT CELLULAR IMMUNE 6017 03:50:20,255 --> 03:50:22,291 RESPONSES FROM CANDIDATE AIDS 6018 03:50:22,291 --> 03:50:22,858 VACCINE. 6019 03:50:22,858 --> 03:50:28,630 THIS IS AN NO 1 MECHANISM. 6020 03:50:28,630 --> 03:50:31,233 THIS CORE LABORATORY WILL BE -- 6021 03:50:31,233 --> 03:50:33,102 BECAUSE HIV VACCINE DEVELOPING 6022 03:50:33,102 --> 03:50:35,237 INTO CORE PRIORITY FOR HIV AND 6023 03:50:35,237 --> 03:50:39,942 NIAID, THIS IS GOING TO BE A 6024 03:50:39,942 --> 03:50:41,877 INTERNAL CELLULAR IMMUNE 6025 03:50:41,877 --> 03:50:43,946 LABORATORY TO STUDY PARTICULAR 6026 03:50:43,946 --> 03:50:45,380 VACCINE CANDIDATES IN THE 6027 03:50:45,380 --> 03:50:46,482 PRE-CLINICAL PHASE AND LOOK AT 6028 03:50:46,482 --> 03:50:48,150 WHAT HAPPENS WITH CELLULAR 6029 03:50:48,150 --> 03:50:50,719 IMMUNITY. 6030 03:50:50,719 --> 03:50:52,988 NEXT SLIDE. 6031 03:50:52,988 --> 03:50:57,059 ONE FINAL INITIATIVE WHICH IS 6032 03:50:57,059 --> 03:50:59,061 MYCOBACTERIUM TB QUALITY 6033 03:50:59,061 --> 03:51:01,230 ASSESSMENT PROGRAM TO PROVIDE 6034 03:51:01,230 --> 03:51:03,031 RESOURCE IN NO 1 CONTRACT OVER 6035 03:51:03,031 --> 03:51:04,399 SEVEN YEARS TO SUPPORT THE 6036 03:51:04,399 --> 03:51:06,368 ABILITY OF LABS TO RELIABLY 6037 03:51:06,368 --> 03:51:09,938 PERFORM STUDIES SPECIFIED MTB 6038 03:51:09,938 --> 03:51:14,510 TESTS AND THIS IS NOT JUST NTB 6039 03:51:14,510 --> 03:51:18,347 WHOLE HOST OF ASSAYS BUT NTB 6040 03:51:18,347 --> 03:51:19,815 ASSAY TESTING THERE IS 6041 03:51:19,815 --> 03:51:23,152 EFFICIENCY LAP TO ENSURING LABS 6042 03:51:23,152 --> 03:51:26,288 DEVELOPING THESE ASSAYS HAVE 6043 03:51:26,288 --> 03:51:30,159 HIGH LEVEL QUALITY EFFICIENCY 6044 03:51:30,159 --> 03:51:30,792 TESTING. 6045 03:51:30,792 --> 03:51:35,230 SO NEXT SLIDE SHOWS KEY TASK 6046 03:51:35,230 --> 03:51:35,864 PERFORMANCE EXTERNAL QUALITY 6047 03:51:35,864 --> 03:51:38,433 ASSURANCE OF LABS AND ASSET 6048 03:51:38,433 --> 03:51:41,537 VALIDATION AT PARTICIPATING LABS 6049 03:51:41,537 --> 03:51:43,539 SO THIS IS SUPPORT EXTENDED TO 6050 03:51:43,539 --> 03:51:44,139 ALL THINGS SUPPORTED 6051 03:51:44,139 --> 03:51:46,241 INVESTIGATORS. 6052 03:51:46,241 --> 03:51:50,312 AND I BELIEVE THAT'S THE LAST 6053 03:51:50,312 --> 03:51:50,812 SLIDE. 6054 03:51:50,812 --> 03:51:55,317 THIS IS SUMMARIZES THE ONE MORE 6055 03:51:55,317 --> 03:51:57,052 IDEA ACT EXTERNAL QUALITY 6056 03:51:57,052 --> 03:51:57,819 ASSURANCE PROGRAM OVERSIGHT 6057 03:51:57,819 --> 03:51:59,388 LABORATORY AND THIS IS TO LOOK 6058 03:51:59,388 --> 03:52:02,691 AT QUALITY ASSURANCE PROGRAMS 6059 03:52:02,691 --> 03:52:03,926 THAT FOR LABS THAT ARE INVOLVED 6060 03:52:03,926 --> 03:52:05,861 IN HIV RESEARCH, THIS IS OUR 6061 03:52:05,861 --> 03:52:08,263 THIRD NO 1 CONTRACT THAT HAS 6062 03:52:08,263 --> 03:52:10,465 BEEN ANNOUNCED THIS IS 6063 03:52:10,465 --> 03:52:12,367 SPECIFICALLY RENEWAL, NOT DE 6064 03:52:12,367 --> 03:52:13,602 NOVO LIKE THE OTHER TWO. 6065 03:52:13,602 --> 03:52:16,672 AND THE NEXT SLIDE REALLY 6066 03:52:16,672 --> 03:52:18,840 EXPLAINS WHAT THE DADE 6067 03:52:18,840 --> 03:52:19,641 LABORATORY OVERSIGHT DOES, THE 6068 03:52:19,641 --> 03:52:21,543 MISSION OF THIS PROGRAM. 6069 03:52:21,543 --> 03:52:25,347 FOR EXAMPLE CPQA I REPORT TO AS 6070 03:52:25,347 --> 03:52:28,617 A PHARMACOLOGY LAB, DOES -- IS 6071 03:52:28,617 --> 03:52:31,053 EM BED WITHIN THIS PROGRAM THESE 6072 03:52:31,053 --> 03:52:33,288 ARE ESSENTIALLY DADE OVERSIGHT 6073 03:52:33,288 --> 03:52:34,056 SUPPORT PROGRAMS THAT PERFORM 6074 03:52:34,056 --> 03:52:35,857 EFFICIENCY TESTING FOR ALL SORTS 6075 03:52:35,857 --> 03:52:39,228 OF HIV RELATED VIROLOGY 6076 03:52:39,228 --> 03:52:43,765 PHARMACOLOGY TB AND OTHER 6077 03:52:43,765 --> 03:52:45,133 ASSESSMENT LABORATORY TESTS TO 6078 03:52:45,133 --> 03:52:46,468 ENSURE WE ARE DOING HIGH QUALITY 6079 03:52:46,468 --> 03:52:47,703 WORK. 6080 03:52:47,703 --> 03:52:48,303 I WILL END THERE. 6081 03:52:48,303 --> 03:52:50,739 THANK YOU SO MUCH. 6082 03:52:50,739 --> 03:52:52,841 >> THANK YOU DR. GANDHI, ANY 6083 03:52:52,841 --> 03:52:56,578 QUESTIONS BEFORE WE MOVE ON? 6084 03:52:56,578 --> 03:52:58,380 IN THE AGENDA? 6085 03:52:58,380 --> 03:52:58,947 OKAY. 6086 03:52:58,947 --> 03:53:02,551 HEARING NONE I WILL MOVE ON NOW 6087 03:53:02,551 --> 03:53:04,519 TO DR. CHANDLER, DIRECTOR OF 6088 03:53:04,519 --> 03:53:06,755 AIDS RESEARCH PROGRAM AT NIDA. 6089 03:53:06,755 --> 03:53:09,157 SO WELCOME WE LOOK FORWARD TO 6090 03:53:09,157 --> 03:53:12,127 YOUR REPORT. 6091 03:53:12,127 --> 03:53:15,797 SO THANK YOU VERY MUCH. 6092 03:53:15,797 --> 03:53:16,265 NEXT SLIDE. 6093 03:53:16,265 --> 03:53:20,569 I WANT TO START BY THANKING CA 6094 03:53:20,569 --> 03:53:24,206 DEL RIO WHO FINISHED HIS TERM IN 6095 03:53:24,206 --> 03:53:25,741 DRUG ABUSE COUNCIL ON MAY, HE 6096 03:53:25,741 --> 03:53:27,009 SERVED A YOU ARE TO YEAR TERM 6097 03:53:27,009 --> 03:53:28,977 AND THANKS FOR HIS DIDCATION FOR 6098 03:53:28,977 --> 03:53:32,381 FUTURE RESEARCH BUT ALSO HIV AND 6099 03:53:32,381 --> 03:53:34,816 REPRESENTED NIDA WELL ON OARAC 6100 03:53:34,816 --> 03:53:36,618 SO WE WISH HIM THE BEST. 6101 03:53:36,618 --> 03:53:39,788 WE ARE GOING TO MISS HIM IN BOTH 6102 03:53:39,788 --> 03:53:42,090 OF THESE ROLES AND NIDA IS IN 6103 03:53:42,090 --> 03:53:47,129 THE PROCESS OF GETTING APPROVAL 6104 03:53:47,129 --> 03:53:48,897 FOR NEW COUNCIL MEMBER THAT WILL 6105 03:53:48,897 --> 03:53:51,233 HAVE HIV EXPERTISE AND WE LOOK 6106 03:53:51,233 --> 03:53:53,302 FORWARD TO THAT PERSON JOINING 6107 03:53:53,302 --> 03:53:53,835 US SOON. 6108 03:53:53,835 --> 03:53:56,705 NEXT SLIDE. 6109 03:53:56,705 --> 03:54:00,242 I WANT THE START BY HIGHLIGHTING 6110 03:54:00,242 --> 03:54:01,009 PUBLICATION THAT WAS BROUGHT 6111 03:54:01,009 --> 03:54:02,844 ATTENTION OF ADVISORY COUNCIL. 6112 03:54:02,844 --> 03:54:05,347 THAT REALLY SPEAKS TO THE 6113 03:54:05,347 --> 03:54:07,115 IMPORTANCE OF CONSIDERING 6114 03:54:07,115 --> 03:54:08,317 INTERVENING SOCIAL DETERMINANTS 6115 03:54:08,317 --> 03:54:10,185 OF HEALTH WHEN TRYING TO ADDRESS 6116 03:54:10,185 --> 03:54:11,920 HIV AND OTHER INFECTIOUS 6117 03:54:11,920 --> 03:54:16,458 DISEASES LIKE HEPATITIS C. 6118 03:54:16,458 --> 03:54:17,926 THIS PARTICULAR STUDY LOOKED AT 6119 03:54:17,926 --> 03:54:21,029 THE ROLE OF HOUSING ON HIV AND 6120 03:54:21,029 --> 03:54:23,398 HEP C TRANSMISSION AMONG PEOPLE 6121 03:54:23,398 --> 03:54:24,933 WHO INJECT DRUGS GLOBALLY. 6122 03:54:24,933 --> 03:54:27,469 FROM AMONG PEOPLE WHO INJECT 6123 03:54:27,469 --> 03:54:30,372 DRUGS HIV AND HCD INFECTIONS ARE 6124 03:54:30,372 --> 03:54:32,974 COMMON AND MANY INDIVIDUALS ARE 6125 03:54:32,974 --> 03:54:34,409 UNSTABLY HOUSED AND AT RISK OF 6126 03:54:34,409 --> 03:54:35,577 INFECTION. 6127 03:54:35,577 --> 03:54:37,179 THIS STUDY USE MODELING ESTIMATE 6128 03:54:37,179 --> 03:54:40,816 THE PROPORTION OF HIV HCV 6129 03:54:40,816 --> 03:54:43,385 INFECTIONS PREDICTED TO OCCUR AS 6130 03:54:43,385 --> 03:54:45,554 A RESULT OF HOUSING INSTABILITY 6131 03:54:45,554 --> 03:54:48,156 AMONG PEOPLE WHO INJECT DRUGS 6132 03:54:48,156 --> 03:54:53,528 FROM 2020 THROUGH 2029 AND 58 6133 03:54:53,528 --> 03:54:54,262 COUNTRIES. 6134 03:54:54,262 --> 03:54:56,231 INVOLVED IN ANOTHER STUDY COUNTY 6135 03:54:56,231 --> 03:54:57,999 AND 58 COUNTRIES AROUND THE 6136 03:54:57,999 --> 03:54:58,967 WORLD WHERE DATA WERE AVAILABLE. 6137 03:54:58,967 --> 03:55:03,839 NEXT SLIDE. 6138 03:55:03,839 --> 03:55:05,741 THIS IS THE FIRST STUDY TO 6139 03:55:05,741 --> 03:55:06,708 ESTIMATE THE GLOBAL CONTRIBUTION 6140 03:55:06,708 --> 03:55:09,044 OF UNSTABLE HOUSING TO THE 6141 03:55:09,044 --> 03:55:11,279 TRANSMISSION OF ANY INFECTION 6142 03:55:11,279 --> 03:55:13,281 AND IT ADDS TO SMALL BUT GROWING 6143 03:55:13,281 --> 03:55:16,351 BODY OF EVIDENCE THAT LOOK AT 6144 03:55:16,351 --> 03:55:17,586 SOCIAL DETERMINANTS OF HEALTH, 6145 03:55:17,586 --> 03:55:20,255 HOUSING INSTABILITY, FOOD 6146 03:55:20,255 --> 03:55:22,224 INSECURITY TRANSPORTATION OR 6147 03:55:22,224 --> 03:55:23,492 INCARCERATION AND THE 6148 03:55:23,492 --> 03:55:24,659 CONTRIBUTION MADE ON INFECTIOUS 6149 03:55:24,659 --> 03:55:29,297 DISEASE INCLUDING HIV AND HCV. 6150 03:55:29,297 --> 03:55:30,432 AND FOCUSING ON HIGH RISK 6151 03:55:30,432 --> 03:55:31,333 POPULATIONS LIKE PEOPLE WHO 6152 03:55:31,333 --> 03:55:32,667 INJECT DRUGS. 6153 03:55:32,667 --> 03:55:33,702 YOU SEE IN THE RESULTS THIS 6154 03:55:33,702 --> 03:55:36,438 MODELS PREDICTS UNSTABLE HOUSING 6155 03:55:36,438 --> 03:55:38,840 WHETHER CONTRIBUTE 8% NEW HIV 6156 03:55:38,840 --> 03:55:43,979 INFECTION AND OVER 11% HCV 6157 03:55:43,979 --> 03:55:44,546 INFECTION WORLDS WIDE AMONG 6158 03:55:44,546 --> 03:55:46,181 PEOPLE WHO INJECT DRUGS ACROSS 6159 03:55:46,181 --> 03:55:46,782 THE 2020. 6160 03:55:46,782 --> 03:55:49,284 ACROSS REGIONS THE MAIN 6161 03:55:49,284 --> 03:55:51,787 TRANSMISSION POPULATION 6162 03:55:51,787 --> 03:55:54,990 ATTRIBUTABLE FRACTION RANKS AND 6163 03:55:54,990 --> 03:55:57,426 VARIES FROM 2.2 PERSON IN 6164 03:55:57,426 --> 03:56:00,028 EASTERN EUROPE TO 20% IN NORTH 6165 03:56:00,028 --> 03:56:00,796 AMERICA. 6166 03:56:00,796 --> 03:56:04,266 FOR HIV AND FOR HCB IT RANGES 6167 03:56:04,266 --> 03:56:07,836 FROM 2.8% IN EASTERN GROUP TO 6168 03:56:07,836 --> 03:56:10,038 26.2% IN NORTH AMERICA. 6169 03:56:10,038 --> 03:56:14,209 AND FOR BOTH HIV AND HCV AND 6170 03:56:14,209 --> 03:56:16,445 HIGH INCOME COUNTRIES WERE OVER 6171 03:56:16,445 --> 03:56:18,313 DOUBLE THOSE IN LOW AND MIDDLE 6172 03:56:18,313 --> 03:56:20,015 INCOME COUNTRIES. 6173 03:56:20,015 --> 03:56:21,650 SO AGAIN REALLY HIGHLIGHTS THE 6174 03:56:21,650 --> 03:56:23,652 IMPORTANCE OF FOCUSING ON THIS 6175 03:56:23,652 --> 03:56:25,420 TYPE OF RESEARCH AND IN TRYING 6176 03:56:25,420 --> 03:56:28,290 TO DEVELOP INTERVENTIONS THAT 6177 03:56:28,290 --> 03:56:31,460 WILL IMPACT ON THE SOCIAL 6178 03:56:31,460 --> 03:56:33,361 DETERMINANTS OF HEALTH 6179 03:56:33,361 --> 03:56:34,596 ASSOCIATED WITH HIGH RISK 6180 03:56:34,596 --> 03:56:35,931 BEHAVIOR AMONG GROUPS INCLUDING 6181 03:56:35,931 --> 03:56:39,000 PEOPLE WHO INJECT DRUGS. 6182 03:56:39,000 --> 03:56:42,537 SO NEXT SLIDE. 6183 03:56:42,537 --> 03:56:44,206 THIS SLIDE INCLUDES CONCEPTS 6184 03:56:44,206 --> 03:56:46,741 THAT WERE APPROVED BY OUR 6185 03:56:46,741 --> 03:56:50,345 NATIONAL ADVISORY COUNCIL IN 6186 03:56:50,345 --> 03:56:51,146 MAY. 6187 03:56:51,146 --> 03:56:54,216 YOU WILL SEE RANGE OF DIFFERENT 6188 03:56:54,216 --> 03:56:56,885 TOPICS THAT INCLUDES EVERYTHING 6189 03:56:56,885 --> 03:56:58,420 FROM MECHANISTIC AND BASIC 6190 03:56:58,420 --> 03:57:00,956 SCIENCE STUDIES TO A FOCUS ON 6191 03:57:00,956 --> 03:57:04,793 THE CRIMINAL JUSTICE POPULATION 6192 03:57:04,793 --> 03:57:07,128 IN ORDER TO END HIV EPIDEMIC. 6193 03:57:07,128 --> 03:57:10,265 NEXT SLIDE. 6194 03:57:10,265 --> 03:57:13,101 THIS LAST SLIDE HAS SOME 6195 03:57:13,101 --> 03:57:13,802 CURRENTLY OPEN FUNDING 6196 03:57:13,802 --> 03:57:15,370 OPPORTUNITIES ANNOUNCEMENTS, THE 6197 03:57:15,370 --> 03:57:17,138 RFA AGAIN ON RANGE OF TOPICS 6198 03:57:17,138 --> 03:57:19,374 FROM ADDRESSING THE INTERSECTION 6199 03:57:19,374 --> 03:57:21,676 OF STIMULANT USE IN HIV TO 6200 03:57:21,676 --> 03:57:24,346 IMPLEMENTING COMPREHENSIVE HIV 6201 03:57:24,346 --> 03:57:26,982 SERVICES AND HARM REDUCTION 6202 03:57:26,982 --> 03:57:28,083 PROGRAMS LIKE SERVICE PROGRAMS, 6203 03:57:28,083 --> 03:57:29,951 INCREASING ENGAGEMENT AND 6204 03:57:29,951 --> 03:57:30,952 RETENTION IN HIV TREATMENT WITH 6205 03:57:30,952 --> 03:57:33,288 PEOPLE WHO ARE USING SUBSTANCES, 6206 03:57:33,288 --> 03:57:36,057 AND THEN PATHOGENIC MECHANISMS 6207 03:57:36,057 --> 03:57:37,592 THAT INFLUENCE BLOOD BRAIN 6208 03:57:37,592 --> 03:57:40,529 BARRIER FUNCTION IN HIV AND 6209 03:57:40,529 --> 03:57:41,897 SUBSTANCE USE DISORDERS. 6210 03:57:41,897 --> 03:57:44,399 THAT'S MY LAST SLIDE. 6211 03:57:44,399 --> 03:57:46,501 >> THANK YOU, DR. CHANDLER. 6212 03:57:46,501 --> 03:57:49,037 ARE THERE ANY QUESTIONS? 6213 03:57:49,037 --> 03:57:54,309 ON THE COMMITTEE. 6214 03:57:54,309 --> 03:57:55,010 MOVING ON. 6215 03:57:55,010 --> 03:57:59,814 NEXT WE WILL HEAR FROM DR. 6216 03:57:59,814 --> 03:58:00,415 YARCHOAN. 6217 03:58:00,415 --> 03:58:01,683 OVER TO YOU. 6218 03:58:01,683 --> 03:58:03,285 >> THANK YOU. 6219 03:58:03,285 --> 03:58:06,922 I WANT TO THANK DR. FRANCIS 6220 03:58:06,922 --> 03:58:08,590 ALI-'SMAN FOR HIS SERVING NCAB 6221 03:58:08,590 --> 03:58:11,826 AND REPRESENTING THE THE NCI ON 6222 03:58:11,826 --> 03:58:12,193 OARAC. 6223 03:58:12,193 --> 03:58:14,596 HE ASKED IF I CAN GIVE UPDATE 6224 03:58:14,596 --> 03:58:16,498 TODAY AND SO I WILL GIVE A SHORT 6225 03:58:16,498 --> 03:58:18,133 UPDATE ON THREE TOPICS. 6226 03:58:18,133 --> 03:58:19,634 NEXT SLIDE. 6227 03:58:19,634 --> 03:58:22,170 THE FIRST IS AN RFA THAT WAS 6228 03:58:22,170 --> 03:58:26,041 APPROVED BY OUR COUNSEL BY THE 6229 03:58:26,041 --> 03:58:26,474 BSA. 6230 03:58:26,474 --> 03:58:27,943 BASIC TRANSLATIONAL RESEARCH ON 6231 03:58:27,943 --> 03:58:30,712 HEALTH DISPARITIES AND HIV AIDS 6232 03:58:30,712 --> 03:58:31,212 AND CANCER. 6233 03:58:31,212 --> 03:58:33,181 THIS RFA WILL FOCUS ON 6234 03:58:33,181 --> 03:58:35,517 BIOLOGICAL INTERACTION OF CANCER 6235 03:58:35,517 --> 03:58:36,952 HEALTH DISPARITIES IN 6236 03:58:36,952 --> 03:58:39,788 MARGINALIZED POPULATIONS WITH AN 6237 03:58:39,788 --> 03:58:40,922 UNDERLYING HIV INFECTION THROUGH 6238 03:58:40,922 --> 03:58:44,426 BASIC MECHANISMS TRANSLATIONAL 6239 03:58:44,426 --> 03:58:45,093 STUDIES. 6240 03:58:45,093 --> 03:58:47,662 IT WILL INVESTIGATE HOW HIV 6241 03:58:47,662 --> 03:58:50,065 INTERACTS WITH THE DISPARITIES 6242 03:58:50,065 --> 03:58:51,032 TO PROMOTE CANCER. 6243 03:58:51,032 --> 03:58:56,104 NEXT SLIDE. 6244 03:58:56,104 --> 03:58:57,205 SOME OF THE POSSIBLE SUBJECTS 6245 03:58:57,205 --> 03:58:59,274 TOPICS THAT WILL BE FUNDED WITH 6246 03:58:59,274 --> 03:59:01,943 THIS INCLUDES STUDIES HEALTH 6247 03:59:01,943 --> 03:59:04,245 DISPARITIES INTERACT WITH HIV TO 6248 03:59:04,245 --> 03:59:11,386 CAUSE CANCER TO INVESTIGATIONS 6249 03:59:11,386 --> 03:59:15,090 CAUSAL ONSET OF CANCER, GENETIC 6250 03:59:15,090 --> 03:59:17,425 OR SUSCEPTIBILITY RESPONSES, 6251 03:59:17,425 --> 03:59:18,994 HOST TO CANCER MICROBIOME 6252 03:59:18,994 --> 03:59:21,196 MAILSIS AND STUDIES OF VARIOUS 6253 03:59:21,196 --> 03:59:25,533 ONCOGENIC VIRAL CO-INFECTION. 6254 03:59:25,533 --> 03:59:26,701 THESE ARE SOME OF THE SPECIFICS 6255 03:59:26,701 --> 03:59:31,806 FOR THE RFA, IT INCLUDES RO1 AND 6256 03:59:31,806 --> 03:59:33,808 R21 ANTICIPATED RECEIPT DATES 6257 03:59:33,808 --> 03:59:36,711 DECEMBER OF 22 AND DECEMBER OF 6258 03:59:36,711 --> 03:59:37,812 23. 6259 03:59:37,812 --> 03:59:39,948 ANTICIPATED FUNDING IS 7 TO 8 6260 03:59:39,948 --> 03:59:43,551 RO1s AND 5 TO 6 R21 6261 03:59:43,551 --> 03:59:44,786 APPLICATIONS PER YEAR FOR TWO 6262 03:59:44,786 --> 03:59:49,491 YEARS AND TOTAL OF 59 A YEAR FOR 6263 03:59:49,491 --> 03:59:54,496 TOTAL OF 25 MILLION TOTAL COSTS. 6264 03:59:54,496 --> 03:59:55,964 ANOTHER THING I WANT TO SHARE 6265 03:59:55,964 --> 03:59:58,600 WITH YOU, LAST OCTOBER THE NCI 6266 03:59:58,600 --> 04:00:03,505 SPONSORED A MEETING TO EXPLORE 6267 04:00:03,505 --> 04:00:06,908 POSSIBILITY OF KSHV OR CAP SEIZE 6268 04:00:06,908 --> 04:00:09,010 SARCOMA ASSOCIATED HERPES VIRUS 6269 04:00:09,010 --> 04:00:12,147 VACCINE DEVELOPMENT AND THIS WAS 6270 04:00:12,147 --> 04:00:13,048 DISCUSSED THE POSSIBILITY THE 6271 04:00:13,048 --> 04:00:15,817 APPROACHES AND PRACTICALITY OF 6272 04:00:15,817 --> 04:00:18,553 DEVELOPING A VACCINE AGAINST 6273 04:00:18,553 --> 04:00:19,187 KHSV. 6274 04:00:19,187 --> 04:00:21,389 IT INCLUDED 65 INVITED 6275 04:00:21,389 --> 04:00:22,490 PARTICIPANTS AND ALSO OPEN TO 6276 04:00:22,490 --> 04:00:24,626 THE RESEARCH COMMUNITY. 6277 04:00:24,626 --> 04:00:27,896 SOME OF THE AREAS COVERED 6278 04:00:27,896 --> 04:00:31,099 INCLUDE KSHV TRANSMISSION AND 6279 04:00:31,099 --> 04:00:33,535 EPIDEMIOLOGY, IMMUNITY TO HERPES 6280 04:00:33,535 --> 04:00:34,869 VIRUSES, LESSONS LEARNED FROM 6281 04:00:34,869 --> 04:00:36,004 VACCINE DEVELOPMENT TO OTHER 6282 04:00:36,004 --> 04:00:36,671 VIRUSES. 6283 04:00:36,671 --> 04:00:38,473 AND THEN PRACTICAL ISSUES 6284 04:00:38,473 --> 04:00:41,609 RELATED TO DEVELOPING 6285 04:00:41,609 --> 04:00:44,045 IMPLEMENTING KSHV VACCINE. 6286 04:00:44,045 --> 04:00:45,046 NEXT SLIDE. 6287 04:00:45,046 --> 04:00:47,582 A LITTLE BIT ON THE RECENT 6288 04:00:47,582 --> 04:00:51,219 DEVELOPMENTS IN KS AN KSHV 6289 04:00:51,219 --> 04:00:54,723 EPIDEMIOLOGY, RIGHT NOW IN THE 6290 04:00:54,723 --> 04:00:57,625 UNITED STATES CAP SEIZE SARCOMA 6291 04:00:57,625 --> 04:00:59,861 DISPROPORTIONATELY AFFECTS AFTER 6292 04:00:59,861 --> 04:01:00,862 CAN AMERICAN MEN IN THE SOUTH 6293 04:01:00,862 --> 04:01:02,530 PARTICULARLY YOUNG MEN, THEY 6294 04:01:02,530 --> 04:01:04,332 HAVE WORST PROGNOSIS WHEN THEY 6295 04:01:04,332 --> 04:01:06,234 DEVELOP KS SEEN BY THE GRAPH IN 6296 04:01:06,234 --> 04:01:10,438 THE LOWER LEFT AND ALSO WHILE 6297 04:01:10,438 --> 04:01:12,440 INCIDENCE OF KS IS DECREASING 6298 04:01:12,440 --> 04:01:13,975 SLOWLY IN OTHER PARTS OF THE 6299 04:01:13,975 --> 04:01:17,378 COUNTRY IT IS INCREASING IN 6300 04:01:17,378 --> 04:01:19,447 YOUNG BLACK MEN IN THE SOUTH. 6301 04:01:19,447 --> 04:01:21,316 PERHAPS MOST IMPORTANT IN 6302 04:01:21,316 --> 04:01:23,852 SUB-SAHARAN AFRICA, KS CONTINUES 6303 04:01:23,852 --> 04:01:26,921 TO BE AN IMPORTANT CAUSE OF 6304 04:01:26,921 --> 04:01:28,723 MORBIDITY MORTALITY AND IN THREE 6305 04:01:28,723 --> 04:01:30,258 COUNTRIES IN SUB -SAHARAN AFRICA 6306 04:01:30,258 --> 04:01:32,961 IT IS THE MOST COMMON TUMOR 6307 04:01:32,961 --> 04:01:37,932 OVERALL IN MEN. 6308 04:01:37,932 --> 04:01:40,702 AND ALSO AGAIN KS REALLY 6309 04:01:40,702 --> 04:01:41,703 DISPROPORTIONATELY AFFECTS 6310 04:01:41,703 --> 04:01:42,637 PEOPLE WITH HIV. 6311 04:01:42,637 --> 04:01:46,007 THIS IS A STUDY FROM SOUTH 6312 04:01:46,007 --> 04:01:50,011 AFRICA AND IT SHOWS THE HIV 6313 04:01:50,011 --> 04:01:51,613 PREVALENCE IN CANCER PATIENTS 6314 04:01:51,613 --> 04:01:54,749 AND BLACK MALES, WITH KS AND 6315 04:01:54,749 --> 04:01:56,317 OTHER CANCERS COMPARED TO THE 6316 04:01:56,317 --> 04:01:57,786 BLACK MALES IN TOTAL. 6317 04:01:57,786 --> 04:02:02,190 AND THIS CAN BE SEEN IN THE 6318 04:02:02,190 --> 04:02:06,394 DIAGONAL STRIPED BARS BETWEEN 96 6319 04:02:06,394 --> 04:02:09,497 AND 100% KS PATIENTS WERE 6320 04:02:09,497 --> 04:02:10,965 INFECTED WITH HIV COMPARED TO 6321 04:02:10,965 --> 04:02:18,606 MUCH LOWER PERCENTAGE OF OTHER 6322 04:02:18,606 --> 04:02:19,841 CANCERS IN TOTAL. 6323 04:02:19,841 --> 04:02:22,644 THIS VACCINE MEETING, IT WAS 6324 04:02:22,644 --> 04:02:25,380 DISCUSSED A KSHV VACCINE 6325 04:02:25,380 --> 04:02:29,484 PREVENTS SARCOMA IN OTHER KSHV 6326 04:02:29,484 --> 04:02:31,052 RELATED DISEASES. 6327 04:02:31,052 --> 04:02:33,021 IT WAS ACKNOWLEDGED THAT 6328 04:02:33,021 --> 04:02:33,755 SCIENTIFIC PRACTICAL 6329 04:02:33,755 --> 04:02:35,723 IMPLEMENTATION CHALLENGES BUT 6330 04:02:35,723 --> 04:02:36,925 THE PARTICIPANT CONSENSUS AT THE 6331 04:02:36,925 --> 04:02:38,393 MEETING WAS QUITE OPTIMISTIC 6332 04:02:38,393 --> 04:02:40,595 ABOUT THE FEASIBILITY OF 6333 04:02:40,595 --> 04:02:41,529 DEVELOPING SUCH A VACCINE AND 6334 04:02:41,529 --> 04:02:44,632 THERE WAS A LOT OF ENTHUSIASM 6335 04:02:44,632 --> 04:02:46,568 AND THIS WAS IN PART BECAUSE 6336 04:02:46,568 --> 04:02:48,136 BASED ON THE OBSERVATION THE 6337 04:02:48,136 --> 04:02:51,439 VIRUS IS MUCH LESS TRANSMISSIBLE 6338 04:02:51,439 --> 04:02:53,675 HAHN OTHER HERPES VIRUS AND 6339 04:02:53,675 --> 04:02:54,909 CONSIDERATION WAS GIVEN TO 6340 04:02:54,909 --> 04:02:56,978 STERILIZING VACCINE OR ONE 6341 04:02:56,978 --> 04:02:57,912 PREVENTING DEVELOPMENT OF 6342 04:02:57,912 --> 04:02:58,246 DISEASE. 6343 04:02:58,246 --> 04:03:00,315 GIVEN THE KS SUSCEPTIBLE TO 6344 04:03:00,315 --> 04:03:02,984 IMMUNE CONTROL, EITHER APPROACH 6345 04:03:02,984 --> 04:03:05,186 MARKEDLY REDUCE DEVELOPMENT OF 6346 04:03:05,186 --> 04:03:06,988 KS. 6347 04:03:06,988 --> 04:03:08,756 AND THE MAJOR SPEAKERS AT THE 6348 04:03:08,756 --> 04:03:11,960 MEETING ARE IN THE PROCESS OF 6349 04:03:11,960 --> 04:03:13,828 PREPARING AND READYING FOR 6350 04:03:13,828 --> 04:03:14,796 PUBLICATION MANUSCRIPT 6351 04:03:14,796 --> 04:03:18,366 DESCRIBING THE MEETING. 6352 04:03:18,366 --> 04:03:21,636 THEN FINALLY I WANT TO MENTION 6353 04:03:21,636 --> 04:03:22,937 THE ANCHOR TRIAL WHICH WAS A 6354 04:03:22,937 --> 04:03:28,343 STUDY TO SHOW THE TREATMENT OF H 6355 04:03:28,343 --> 04:03:30,545 CELL, ANAL CANCER PRECURSOR CAN 6356 04:03:30,545 --> 04:03:32,947 PREVENT ANAL CANCER. 6357 04:03:32,947 --> 04:03:34,415 SOME OF THE IMPETUS FOR THIS 6358 04:03:34,415 --> 04:03:37,986 TRIAL IS SEEN HERE. 6359 04:03:37,986 --> 04:03:41,389 BETWEEN 91 AND PARTICULARLY 6360 04:03:41,389 --> 04:03:44,359 AFTER 96 UNTIL 2005 OR SO THERE 6361 04:03:44,359 --> 04:03:46,027 WAS DRAMATIC INCREASE IN THE 6362 04:03:46,027 --> 04:03:48,696 INCIDENCE AND THE NUMBER OF 6363 04:03:48,696 --> 04:03:50,698 CASES OF ANAL CANCER IN PEOPLE 6364 04:03:50,698 --> 04:03:52,300 WITH AIDS IN THE UNITED STATES. 6365 04:03:52,300 --> 04:03:54,602 IT IS SORT OF LEVELED OFF SINCE 6366 04:03:54,602 --> 04:03:59,173 THEN, BUT REMAINED HIGH LEVEL. 6367 04:03:59,173 --> 04:04:00,775 NEXT SLIDE. 6368 04:04:00,775 --> 04:04:03,978 THE ANCHOR TRIAL WAS DEVELOPED 6369 04:04:03,978 --> 04:04:07,749 TO SEE IF TREATMENT OF H CELL OR 6370 04:04:07,749 --> 04:04:09,617 HIGH GRADE SQUAMOUS 6371 04:04:09,617 --> 04:04:12,253 INTEREPITHELIAL LESIONS OF THE 6372 04:04:12,253 --> 04:04:15,623 ANUS WOULD PREVENT ANAL CANCER. 6373 04:04:15,623 --> 04:04:17,692 AND THERE WERE 4,000 PEOPLE 6374 04:04:17,692 --> 04:04:20,561 ENTERED IN THIS RANDOMIZE STUDY, 6375 04:04:20,561 --> 04:04:22,230 THEY WERE RANDOMIZED BETWEEN 6376 04:04:22,230 --> 04:04:23,898 OBSERVATION AND TREATMENT OF THE 6377 04:04:23,898 --> 04:04:26,567 LESION AND AS CAN BE SEEN HERE 6378 04:04:26,567 --> 04:04:29,404 STATISTICALLY SIGNIFICANT THAT 6379 04:04:29,404 --> 04:04:31,172 THE TREATMENT PREVENTEDDED ANAL 6380 04:04:31,172 --> 04:04:31,606 CANCER. 6381 04:04:31,606 --> 04:04:34,676 THIS WAS PUBLISHED ON JUNE 16 IN 6382 04:04:34,676 --> 04:04:37,545 THE NEW ENGLAND JOURNAL OF 6383 04:04:37,545 --> 04:04:38,446 MEDICINE WITH (INAUDIBLE) AS 6384 04:04:38,446 --> 04:04:39,380 LEAD AUTHOR. 6385 04:04:39,380 --> 04:04:43,584 IT IS VERY LIKELY THAT THIS 6386 04:04:43,584 --> 04:04:45,653 AFFECTS GUIDELINES FOR SCREENING 6387 04:04:45,653 --> 04:04:47,522 FOR H CELL, NO REASON TO SCREEN 6388 04:04:47,522 --> 04:04:50,191 IF IT WASN'T SHOWING THE 6389 04:04:50,191 --> 04:04:53,161 TREATING IT PREVENT ANAL CANCER 6390 04:04:53,161 --> 04:04:54,262 BECAUSE H CELL BY ITSELF IS NOT 6391 04:04:54,262 --> 04:04:55,897 A PROBLEM IN PATIENTS SO I THINK 6392 04:04:55,897 --> 04:05:00,835 IT WILL CERTAINLY AFFECT THE 6393 04:05:00,835 --> 04:05:01,769 GUIDELINES FOR SCREENING IN 6394 04:05:01,769 --> 04:05:03,304 PEOPLE WITH HIV WHICH HIGHEST 6395 04:05:03,304 --> 04:05:05,373 RISK OF DEVELOPING ANAL CANCER 6396 04:05:05,373 --> 04:05:06,975 AND HAVING H CELL AND POSSIBLY 6397 04:05:06,975 --> 04:05:10,011 OTHER GROUPS AS WELCH SO I WILL 6398 04:05:10,011 --> 04:05:16,284 END AT THIS POINT. 6399 04:05:16,284 --> 04:05:17,585 THE NCI THANKS THE OFFICE OF 6400 04:05:17,585 --> 04:05:21,823 AIDS RESEARCH FOR THEIR SUPPORT 6401 04:05:21,823 --> 04:05:23,224 OF THIS STUDY, IT WAS IMPORTANT 6402 04:05:23,224 --> 04:05:24,359 GETTING THIS STUDY OFF THE 6403 04:05:24,359 --> 04:05:25,560 GROUNDS IN THE NCI. 6404 04:05:25,560 --> 04:05:28,463 AND IT WAS THE LARGEST CANCER 6405 04:05:28,463 --> 04:05:29,998 TRIAL TO DATE IN PEOPLE WITH HIV 6406 04:05:29,998 --> 04:05:33,501 AND WE ALSO WANT TO THANK THE 6407 04:05:33,501 --> 04:05:35,670 PARTICIPANTS IN THE TRIAL. 6408 04:05:35,670 --> 04:05:37,338 WHILE TRIAL STUDIED TREATMENT OF 6409 04:05:37,338 --> 04:05:39,307 ANAL H CELL IT PROVIDES 6410 04:05:39,307 --> 04:05:46,247 RATIONALE FOR SCREENING. 6411 04:05:46,247 --> 04:05:47,148 NEXT STEPS INDICATE CORRELATIVE 6412 04:05:47,148 --> 04:05:49,017 STUDIES BASED ON SAMPLES 6413 04:05:49,017 --> 04:05:51,019 COLLECTED, RESEARCH AND IMPROVED 6414 04:05:51,019 --> 04:05:52,553 TREATMENT WHICH IS NOW IS AN 6415 04:05:52,553 --> 04:05:54,555 IMPORTANT AREA, AND RESEARCH 6416 04:05:54,555 --> 04:05:56,657 SHOULD DETERMINE THE BEST 6417 04:05:56,657 --> 04:06:01,129 ALGORITHM TO PRIORITIZE HIGH 6418 04:06:01,129 --> 04:06:03,631 RESOLUTION TO DIAGNOSE H CELLOR 6419 04:06:03,631 --> 04:06:04,899 CELL AND IT WILL BE IMPORTANT TO 6420 04:06:04,899 --> 04:06:07,468 TRAIN MORE PRACTITIONERS TO DO 6421 04:06:07,468 --> 04:06:08,836 HIGH RESOLUTION SO LIKE ANY GOOD 6422 04:06:08,836 --> 04:06:10,271 STUDY OPEN IT IS DOOR FOR MORE 6423 04:06:10,271 --> 04:06:11,706 RESEARCH AND MORE IMPROVEMENT. 6424 04:06:11,706 --> 04:06:16,878 NEXT SLIDE. 6425 04:06:16,878 --> 04:06:18,413 NOW I WILL END AND TURN IT OVER 6426 04:06:18,413 --> 04:06:21,349 TO QUESTION. 6427 04:06:21,349 --> 04:06:25,219 >> THANK YOU FOR THE UPDATE DR. 6428 04:06:25,219 --> 04:06:26,988 YARCHOAN. 6429 04:06:26,988 --> 04:06:32,226 YOUR DATA THE RESULTS YOU SHOWED 6430 04:06:32,226 --> 04:06:36,097 ON KARPASES SARCOMA AND ONE 6431 04:06:36,097 --> 04:06:37,331 COULD ASK ABOUT SOME OF THE 6432 04:06:37,331 --> 04:06:38,166 DRIVERS BEHIND THAT. 6433 04:06:38,166 --> 04:06:39,934 BUT OUT OF CURIOSITY DO YOU SEE 6434 04:06:39,934 --> 04:06:42,804 ANY CORRELATIONS BETWEEN KS AND 6435 04:06:42,804 --> 04:06:45,273 BLACK MEN AND PROSTATE CANCER 6436 04:06:45,273 --> 04:06:47,141 AND ARE THERE EPIDEMIOLOGICAL 6437 04:06:47,141 --> 04:06:49,444 MODELS THAT CAN ACCOUNT FOR 6438 04:06:49,444 --> 04:06:51,646 MAYBE SCREENING RATES AND LEVELS 6439 04:06:51,646 --> 04:06:54,582 OF DIAGNOSIS? 6440 04:06:54,582 --> 04:06:59,987 >> I'M NOT AWARE OF -- BOTH 6441 04:06:59,987 --> 04:07:03,724 DISEASES ARE NOW OCCURRING 6442 04:07:03,724 --> 04:07:04,826 DISPROPORTIONATELY IN BLACK 6443 04:07:04,826 --> 04:07:05,493 MALES. 6444 04:07:05,493 --> 04:07:08,629 REASON FOR PROSTATE CANCER NOT 6445 04:07:08,629 --> 04:07:09,931 SURE I DON'T PERSONALLY KNOW THE 6446 04:07:09,931 --> 04:07:11,833 REASONS FOR THIS AND I'M NOT 6447 04:07:11,833 --> 04:07:14,902 SURE COMPLETELY HOW WELL THIS IS 6448 04:07:14,902 --> 04:07:15,536 UNDERSTOOD. 6449 04:07:15,536 --> 04:07:21,008 WITH KS, IT IS -- KS IS LARGELY 6450 04:07:21,008 --> 04:07:30,685 DUE TO ACQUISITION DURING LIFE. 6451 04:07:30,685 --> 04:07:32,787 WE DON'T HAVE A SENSE IT IS ALL 6452 04:07:32,787 --> 04:07:33,387 IMPORTANT. 6453 04:07:33,387 --> 04:07:34,522 MY GUESS IS WHAT IS HAPPENING 6454 04:07:34,522 --> 04:07:37,258 THOUGH NOT INVESTIGATED IS THAT 6455 04:07:37,258 --> 04:07:39,460 THIS IS THE AREA HIGHEST 6456 04:07:39,460 --> 04:07:43,631 PREVALENCE OF HIV ACQUISITION WE 6457 04:07:43,631 --> 04:07:46,200 HAVE SEEN HIV ACQUIRED IN THIS 6458 04:07:46,200 --> 04:07:49,504 AREA, SEEN HIV ACQUIRED IN P 6459 04:07:49,504 --> 04:07:52,607 BLACK MALE, FOR VARIETY OF 6460 04:07:52,607 --> 04:07:54,408 REASONS NOT GETTING TREATED 6461 04:07:54,408 --> 04:07:58,746 ADEQUATELY FOR HIV. 6462 04:07:58,746 --> 04:08:00,882 THERE IS PROBABLY MANYOR MEN WHO 6463 04:08:00,882 --> 04:08:03,084 HAVE SEX WITH MEN IN THAT GROUP 6464 04:08:03,084 --> 04:08:08,122 ARE OFTEN STILL STIGMATIZED AND 6465 04:08:08,122 --> 04:08:08,990 DON'T SEEK HELP AND THEREFORE 6466 04:08:08,990 --> 04:08:12,927 YOU SEE THIS EXPLOSION OF 6467 04:08:12,927 --> 04:08:13,761 CAPASES SARCOMA. 6468 04:08:13,761 --> 04:08:15,196 THAT IS MY BEST UNDERSTANDING, 6469 04:08:15,196 --> 04:08:17,331 AGAIN THERE IS A FAIR AMOUNT OF 6470 04:08:17,331 --> 04:08:20,301 CONJECTURE BECAUSE PEOPLE 6471 04:08:20,301 --> 04:08:22,069 HAVEN'T PROBED IF SOCIO LOGICAL 6472 04:08:22,069 --> 04:08:26,874 REASONS FOR IT. 6473 04:08:26,874 --> 04:08:28,142 >> THANK YOU. 6474 04:08:28,142 --> 04:08:29,710 TOTALLY UNDERSTAND. 6475 04:08:29,710 --> 04:08:31,913 >> LIZ (INAUDIBLE) MD ANDERSON 6476 04:08:31,913 --> 04:08:33,181 IS SPEARHEADING A LOT OF THIS 6477 04:08:33,181 --> 04:08:36,884 RESEARCH. 6478 04:08:36,884 --> 04:08:38,653 >> ANY OTHER QUESTIONS FOR DR. 6479 04:08:38,653 --> 04:08:42,390 YARCHOAN? 6480 04:08:42,390 --> 04:08:46,460 WE WILL MOVE ON WITH THE NEXT 6481 04:08:46,460 --> 04:08:49,864 UPDATE FROM DR. JULIO ALBERTI, 6482 04:08:49,864 --> 04:08:52,767 HE IS NEW TO US. 6483 04:08:52,767 --> 04:08:56,704 SO JUST AS BY WAY OF BRIEF 6484 04:08:56,704 --> 04:08:57,405 INTRODUCTION SENIOR SCIENCE 6485 04:08:57,405 --> 04:08:59,941 ADVISOR AT THE OAR. 6486 04:08:59,941 --> 04:09:03,344 DR. ALBERTI IS IMMUNOLOGIST WITH 6487 04:09:03,344 --> 04:09:05,513 EXPERIENCE IN A RANGE OF 6488 04:09:05,513 --> 04:09:07,281 INFECTIOUS DISEASES AND 6489 04:09:07,281 --> 04:09:08,082 INCLUDING HIV. 6490 04:09:08,082 --> 04:09:10,918 HE SPENT TIME IN ACADEMIA AS 6491 04:09:10,918 --> 04:09:14,322 WELL AS NIAID -- NIAID BEFORE 6492 04:09:14,322 --> 04:09:15,723 COMING TO THE OAR. 6493 04:09:15,723 --> 04:09:17,158 SO IT IS A PLEASURE TO ARE YOU 6494 04:09:17,158 --> 04:09:20,194 WITH US. 6495 04:09:20,194 --> 04:09:24,365 >> THANK YOU VERY MUCH. 6496 04:09:24,365 --> 04:09:26,167 HAVE THE NEXT SLIDE PLEASE. 6497 04:09:26,167 --> 04:09:30,738 I WILL GIVE BRIEF OVERVIEW AND 6498 04:09:30,738 --> 04:09:34,709 THANK YOU TO DR. LIGHT FOOD, DR. 6499 04:09:34,709 --> 04:09:39,013 GANDHI AND DR. YARCHOAN AND 6500 04:09:39,013 --> 04:09:41,782 CHANDLER MADE MY JOB SIMPLE 6501 04:09:41,782 --> 04:09:46,887 HERE. 6502 04:09:46,887 --> 04:09:48,823 WITH CONCEPTS CLEARED. 6503 04:09:48,823 --> 04:09:55,930 NIAID HAD FOUR NEW CONSENTS 6504 04:09:55,930 --> 04:09:57,732 CLEAR AND FOUR REISSUED. 6505 04:09:57,732 --> 04:10:02,069 NIDA HAS THREE NEW CONCEPTS NIMH 6506 04:10:02,069 --> 04:10:02,837 HAS FLOWEROR FOUR. 6507 04:10:02,837 --> 04:10:06,173 NCI ONE NEW CONCEPT. 6508 04:10:06,173 --> 04:10:09,377 AND OFFICE OF RESEARCH 6509 04:10:09,377 --> 04:10:11,145 INFRASTRUCTURE PROGRAM HAS THREE 6510 04:10:11,145 --> 04:10:12,546 NEW REISSUED PROGRAMS. 6511 04:10:12,546 --> 04:10:19,053 NEXT SLIDE. 6512 04:10:19,053 --> 04:10:22,256 THESE CONCEPTS CLEARED AT THE 6513 04:10:22,256 --> 04:10:24,659 COUNCIL AT NIAID HAVE BEEN 6514 04:10:24,659 --> 04:10:32,133 ALREADY PRESENTED BY DR. GANDHI. 6515 04:10:32,133 --> 04:10:35,903 THESE NEW CONCEPTS BY NIMH, 6516 04:10:35,903 --> 04:10:37,605 THERE IS THE FIRST ONE IS 6517 04:10:37,605 --> 04:10:39,774 EPIGENETIC MECHANISM REGULATING 6518 04:10:39,774 --> 04:10:41,876 HIV IN THE CENTRAL NERVOUS 6519 04:10:41,876 --> 04:10:43,744 SYSTEM LATENCY AND 6520 04:10:43,744 --> 04:10:44,645 NEUROPATHOGENESIS USING NOVEL 6521 04:10:44,645 --> 04:10:47,048 SINGLE CELL TECHNOLOGIES. 6522 04:10:47,048 --> 04:10:49,784 THE SECOND CONCEPT IS 6523 04:10:49,784 --> 04:10:52,620 UNDERSTANDING GUT IMMUNE AT THIS 6524 04:10:52,620 --> 04:10:54,722 FUNCTION AND MICROBIOME IN 6525 04:10:54,722 --> 04:10:57,158 PATHOYENSIS IN MENTAL HEALTH 6526 04:10:57,158 --> 04:10:58,959 OUTCOMES OF PEOPLE LIVING WITH 6527 04:10:58,959 --> 04:10:59,126 HIV. 6528 04:10:59,126 --> 04:11:02,563 THIRD IS EXPANDING COLLABORATIVE 6529 04:11:02,563 --> 04:11:03,731 IMPLEMENTATION SCIENCE FOR THE 6530 04:11:03,731 --> 04:11:06,067 END OF HIV EPIDEMIC PLAN FOR 6531 04:11:06,067 --> 04:11:06,467 AMERICA. 6532 04:11:06,467 --> 04:11:09,870 AND THE LAST CONCEPT IS 6533 04:11:09,870 --> 04:11:13,174 IMPROVING UPTAKE OF PERSISTENCE 6534 04:11:13,174 --> 04:11:16,477 ON NOVEL TREATMENT AND 6535 04:11:16,477 --> 04:11:18,012 PREVENTION OPTIONS. 6536 04:11:18,012 --> 04:11:22,917 NEW CONCEPT BY NIDA. 6537 04:11:22,917 --> 04:11:25,152 DR. CHANDLER PRESENTED AND DR. 6538 04:11:25,152 --> 04:11:26,921 (INAUDIBLE) PRESENTED NATIONAL 6539 04:11:26,921 --> 04:11:27,455 CANCER INSTITUTE. 6540 04:11:27,455 --> 04:11:31,025 NEXT SLIDE. 6541 04:11:31,025 --> 04:11:33,961 CONCEPTS REISSUED OF THOSE HAVE 6542 04:11:33,961 --> 04:11:38,065 BEEN PRESENTED BY DR. GANDHI FOR 6543 04:11:38,065 --> 04:11:38,599 NIAID. 6544 04:11:38,599 --> 04:11:41,902 AND FOR OARAC THESE THREE NEW -- 6545 04:11:41,902 --> 04:11:45,906 REISSUED CONCEPTS HAVE BEEN 6546 04:11:45,906 --> 04:11:46,540 APPROVED. 6547 04:11:46,540 --> 04:11:49,176 THE FIRST ONE IS HIV AIDS 6548 04:11:49,176 --> 04:11:52,913 SCHOLARS USING NON-HUMAN PRIMATE 6549 04:11:52,913 --> 04:11:53,814 MODELS. 6550 04:11:53,814 --> 04:11:55,282 SECOND EARLY STAGE INVESTIGATOR 6551 04:11:55,282 --> 04:11:57,051 HIV AIDS RESEARCH USING 6552 04:11:57,051 --> 04:12:03,624 NON-HUMAN PRIMATE MODELS R21. 6553 04:12:03,624 --> 04:12:04,525 DEVELOPMENT OF APPROXIMATE MALL 6554 04:12:04,525 --> 04:12:06,861 MODELS AND RELATED MATERIALS FOR 6555 04:12:06,861 --> 04:12:10,698 HIV RESEARCH AIDS AS AN NOVEL 6556 04:12:10,698 --> 04:12:11,065 THERAPEUTIC. 6557 04:12:11,065 --> 04:12:13,300 THERE WAS A RECENTLY PUBLISHED 6558 04:12:13,300 --> 04:12:18,139 FUNDING OPPORTUNITY, THIS PAR 6559 04:12:18,139 --> 04:12:21,642 22-181 THESE ARE SPONSORED BY 6560 04:12:21,642 --> 04:12:25,045 NIDA NIMH AND NINDS. 6561 04:12:25,045 --> 04:12:26,814 AND PROVIDES RESEARCH 6562 04:12:26,814 --> 04:12:28,582 OPPORTUNITIES FOR NEW AND AT 6563 04:12:28,582 --> 04:12:31,051 RISK INVESTIGATORS TO PROMOTE 6564 04:12:31,051 --> 04:12:31,952 WORK FORCE DIVERSITY. 6565 04:12:31,952 --> 04:12:33,220 IT IS AN RO1. 6566 04:12:33,220 --> 04:12:40,027 THERE IS A RECENT ARTICLE IN 6567 04:12:40,027 --> 04:12:42,997 SCIENCE ADDRESSING THIS NEW 6568 04:12:42,997 --> 04:12:46,066 OPPORTUNITY AND PUTTING IT ON 6569 04:12:46,066 --> 04:12:48,436 THE CHAT. 6570 04:12:48,436 --> 04:12:50,104 BASICALLY THESE ARE IT IS A VERY 6571 04:12:50,104 --> 04:12:51,172 SIMILAR INITIATIVE COMPARED TO 6572 04:12:51,172 --> 04:12:54,542 THE ONE PRESENTED BY DR. GANDHI 6573 04:12:54,542 --> 04:12:58,512 APPROVED BY NIAID. 6574 04:12:58,512 --> 04:13:00,748 HERE WE HAVE THREE OTHER 6575 04:13:00,748 --> 04:13:01,382 INSTITUTES DOING EXACTLY THE 6576 04:13:01,382 --> 04:13:05,119 SAME. 6577 04:13:05,119 --> 04:13:06,454 NEXT SLIDE. 6578 04:13:06,454 --> 04:13:11,325 FINALLY I WILL CLOSE BY 6579 04:13:11,325 --> 04:13:13,594 REMINDING EVERYBODY ON THIS 6580 04:13:13,594 --> 04:13:17,565 CHALLENGE BY THE OFFICE OF DATA 6581 04:13:17,565 --> 04:13:19,233 SCIENCE STRATEGY IN 6582 04:13:19,233 --> 04:13:22,636 COLLABORATION WITH FASEB 6583 04:13:22,636 --> 04:13:24,104 HIGHLIGHTING THE -- OUR UPDATE 6584 04:13:24,104 --> 04:13:26,006 SHARING AND ER USE IN BIOLOGICAL 6585 04:13:26,006 --> 04:13:32,847 BIOMEDICAL SCIENCE. 6586 04:13:32,847 --> 04:13:33,714 THAT IS ALL I HAVE. 6587 04:13:33,714 --> 04:13:34,381 THANK YOU VERY MUCH. 6588 04:13:34,381 --> 04:13:37,251 >> THANK YOU, DR. ALBERTI. 6589 04:13:37,251 --> 04:13:45,025 SO WE HAVE SOME TIME FOR SOME 6590 04:13:45,025 --> 04:13:46,794 QUESTIONS. 6591 04:13:46,794 --> 04:13:49,597 HEARING NONE WE WILL MOVE ON. 6592 04:13:49,597 --> 04:13:51,699 AGAIN I WOULD LIKE TO THANK ALL 6593 04:13:51,699 --> 04:13:54,602 THE PRESENTERS IN THIS LAST 6594 04:13:54,602 --> 04:13:55,236 SESSION. 6595 04:13:55,236 --> 04:13:57,605 AS WE BEGIN TO CLOSE JUST WANT 6596 04:13:57,605 --> 04:13:59,940 TO REMIND EVERYONE THAT WE HAVE 6597 04:13:59,940 --> 04:14:01,375 ALLOTTED TIME FOR PUBLIC 6598 04:14:01,375 --> 04:14:02,042 COMMENTS. 6599 04:14:02,042 --> 04:14:04,211 DR. GLENSHAW HAVE YOU RECEIVED 6600 04:14:04,211 --> 04:14:05,946 COMMENTS FOR TODAY? 6601 04:14:05,946 --> 04:14:07,448 >> NOT FOR TODAY. 6602 04:14:07,448 --> 04:14:10,217 I WILL THOUGH PUT THE SURVEY IN 6603 04:14:10,217 --> 04:14:12,786 THE CHAT AGAIN FOR THOSE THAT 6604 04:14:12,786 --> 04:14:14,855 HAVEN'T HAD A CHANCE TO FILL IN 6605 04:14:14,855 --> 04:14:16,290 JUST PREFERENCES FOR THE FORMAT 6606 04:14:16,290 --> 04:14:21,662 FOR THE OCTOBER. 6607 04:14:21,662 --> 04:14:22,363 >> THANK YOU. 6608 04:14:22,363 --> 04:14:24,431 WE WILL PASS IT BACK OVER TO DR. 6609 04:14:24,431 --> 04:14:31,005 GOODENOW FOR CLOSING REMARKS. 6610 04:14:31,005 --> 04:14:34,375 >> THANK YOU SO MUCH. 6611 04:14:34,375 --> 04:14:37,111 HUGE THANK YOU TO EVERYONE THAT 6612 04:14:37,111 --> 04:14:38,145 PARTICIPATED IN THIS MEETING 6613 04:14:38,145 --> 04:14:38,646 TODAY. 6614 04:14:38,646 --> 04:14:46,587 THE PRESENTATIONS ARE REALLY 6615 04:14:46,587 --> 04:14:47,821 OOZE WE THINK ABOUT THIS GOING 6616 04:14:47,821 --> 04:14:50,324 FORWARD HOW TO CONTINUE TO 6617 04:14:50,324 --> 04:14:57,131 SYNERGIZE AND LOOK AT THE IMPACT 6618 04:14:57,131 --> 04:14:58,899 EACH SEPARATELY WHEN WE COMBINE 6619 04:14:58,899 --> 04:15:00,467 IN WAYS TALK ABOUT TODAY WITHIN 6620 04:15:00,467 --> 04:15:03,871 THE NIH AND ACROSS THE AGENCIES. 6621 04:15:03,871 --> 04:15:06,473 AND ACROSS THE DEPARTMENTS. 6622 04:15:06,473 --> 04:15:11,178 I WANT TO ADD ONE OTHER PIECE OF 6623 04:15:11,178 --> 04:15:13,113 INFORMATION ANNOUNCED TODAY WHEN 6624 04:15:13,113 --> 04:15:16,984 I TALKED EARLIER SHOWED YOU THE 6625 04:15:16,984 --> 04:15:19,920 ORGANIZATION NIH AND HOW THE 6626 04:15:19,920 --> 04:15:22,756 OFFICE OAR AND OTHERS ARE 6627 04:15:22,756 --> 04:15:25,726 EMBEDDED IN OFFICE OF THE NIH 6628 04:15:25,726 --> 04:15:26,827 DIRECTOR. 6629 04:15:26,827 --> 04:15:28,596 I DIDN'T FOCUS ON THE FACT THAT 6630 04:15:28,596 --> 04:15:32,132 THE ORGANIZATION OF THE OFFICES 6631 04:15:32,132 --> 04:15:35,703 IS IN THE DIVISION THAT IS 6632 04:15:35,703 --> 04:15:37,871 CALLED DIVISION OF PROGRAM 6633 04:15:37,871 --> 04:15:38,672 COORDINATION PLANNING AND 6634 04:15:38,672 --> 04:15:44,545 STRATEGIC INITIATIVES OR DPKPSI. 6635 04:15:44,545 --> 04:15:48,415 THE PERSON HEADING DPKPSI IN THE 6636 04:15:48,415 --> 04:15:52,820 ROLE AS DIRECTOR OF THE DIVISION 6637 04:15:52,820 --> 04:15:56,924 BUT DEPUTY DIRECTORS OF THE NIH, 6638 04:15:56,924 --> 04:16:00,628 REPORTING TO PRINCIPLE DEPUTY 6639 04:16:00,628 --> 04:16:02,830 NIH DIRECTOR IS DR. JAMES 6640 04:16:02,830 --> 04:16:04,832 ANDERSON. 6641 04:16:04,832 --> 04:16:06,934 AND TODAY WE BEFORE THIS MEETING 6642 04:16:06,934 --> 04:16:11,205 JIN HAD A MEETING WITH OFFICE 6643 04:16:11,205 --> 04:16:13,073 DIRECTORS TO ANNOUNCE THAT HE IS 6644 04:16:13,073 --> 04:16:16,176 RETIRING. 6645 04:16:16,176 --> 04:16:20,781 HE IS SERVING AS DPKPSI DIVISION 6646 04:16:20,781 --> 04:16:23,784 DIRECTOR FOR 12 YEARS AND I WANT 6647 04:16:23,784 --> 04:16:26,754 TO GIVE BACKGROUND IN THE COUPLE 6648 04:16:26,754 --> 04:16:28,956 OF COMMENTS IF YOU CAN INDULGE 6649 04:16:28,956 --> 04:16:30,824 BEFORE WE FINISH UP. 6650 04:16:30,824 --> 04:16:34,294 AS A NON-ACTING DIRECTOR OF 6651 04:16:34,294 --> 04:16:37,264 DPKPSI JIN FORMED DIVISION 6652 04:16:37,264 --> 04:16:41,869 OFFICES TO BECOME CENTRAL NIH 6653 04:16:41,869 --> 04:16:44,538 COORDINATORS FROM THEMATIC AREAS 6654 04:16:44,538 --> 04:16:46,640 INCLUDING LARGE NUMBER OF IMPACT 6655 04:16:46,640 --> 04:16:47,574 NIH COMMON FUND PROGRAMS. 6656 04:16:47,574 --> 04:16:49,376 IT WAS UNDER JIM'S LEADERSHIP 6657 04:16:49,376 --> 04:16:53,981 THE NUMBER OF OFFICES WITHIN 6658 04:16:53,981 --> 04:16:57,651 DPKPSI GREW FROM 7 TO 14 AND IT 6659 04:16:57,651 --> 04:17:00,387 WAS NOT BY CHOICE JIM'S TRYING 6660 04:17:00,387 --> 04:17:05,159 TO ESTABLISH LARGE EMPIRE BUT IN 6661 04:17:05,159 --> 04:17:09,630 FACT CONGRESS PASSING 6662 04:17:09,630 --> 04:17:11,865 LEGISLATION THESE OFFICES ARE 6663 04:17:11,865 --> 04:17:14,702 FORMED WITHIN THE NIH AND JIM 6664 04:17:14,702 --> 04:17:18,806 CARRY OUT THOSE MANDATES. 6665 04:17:18,806 --> 04:17:20,040 HE HAS BEEN INSTRUMENTAL IN 6666 04:17:20,040 --> 04:17:21,909 DEVELOPMENT OF FORT COMING NIH 6667 04:17:21,909 --> 04:17:22,810 WIDE STRATEGIC PLAN FOR 6668 04:17:22,810 --> 04:17:24,611 DIVERSITY EQUITY INCLUSION AND 6669 04:17:24,611 --> 04:17:25,646 ACCESSIBILITY. 6670 04:17:25,646 --> 04:17:27,514 AND IN THE CREATION OF 6671 04:17:27,514 --> 04:17:31,051 INNOVATIVE PROGRAMS THAT ADVANCE 6672 04:17:31,051 --> 04:17:37,324 TRAINING AND FACULTY RECRUITMENT 6673 04:17:37,324 --> 04:17:38,692 RETENTION AND INSTITUTIONAL 6674 04:17:38,692 --> 04:17:39,393 CULTURAL CHANGE. 6675 04:17:39,393 --> 04:17:42,629 JIM RECRUITED ME. 6676 04:17:42,629 --> 04:17:48,235 TO THE NIH AND HAS BEEN AMAZING 6677 04:17:48,235 --> 04:17:51,839 MENTOR AND ADVISOR OVER SIX 6678 04:17:51,839 --> 04:17:56,877 YEARS. 6679 04:17:56,877 --> 04:18:00,380 IT WILL BE A BIG CHANGE FOR ALL 6680 04:18:00,380 --> 04:18:02,449 OF US TO MOVE DIFFERENT 6681 04:18:02,449 --> 04:18:04,918 DIRECTION. 6682 04:18:04,918 --> 04:18:08,055 GOOD NEWS IS WHILE THERE IS A 6683 04:18:08,055 --> 04:18:10,491 SEARCH FOR DPKPSI DIRECTOR 6684 04:18:10,491 --> 04:18:17,698 ACTING DIRECTOR IS BOB ISINGER 6685 04:18:17,698 --> 04:18:18,866 MANY OF YOU KNOW AS MEMBER OF 6686 04:18:18,866 --> 04:18:23,604 THE OAR A LONG TIME AND IS -- 6687 04:18:23,604 --> 04:18:28,776 WAS ACTING OAR DIRECTOR DURING 6688 04:18:28,776 --> 04:18:31,011 THE INJURY BETWEEN JACK WHAT 6689 04:18:31,011 --> 04:18:31,812 IT'S CAR PREVIOUS DIRECT TORE 6690 04:18:31,812 --> 04:18:32,913 AND MY RECRUITMENT INTO THE 6691 04:18:32,913 --> 04:18:35,482 POSITION. 6692 04:18:35,482 --> 04:18:39,586 SO WE ARE VERY EXCITED BOB IS 6693 04:18:39,586 --> 04:18:41,688 STACK, MAY NOT HAVE KNOWN ME HE 6694 04:18:41,688 --> 04:18:43,023 LEFT THE NIH EARLIER THIS YEAR 6695 04:18:43,023 --> 04:18:49,062 TO TAKE A POSITION AT THE MILKEN 6696 04:18:49,062 --> 04:18:49,463 FOUNDATION. 6697 04:18:49,463 --> 04:18:53,767 BUT HE HAS AGREED TO COME BACK 6698 04:18:53,767 --> 04:18:55,335 AND HE IS KEEPING THINGS IN 6699 04:18:55,335 --> 04:18:56,537 ORDER UNTIL WE HAVE A NEW 6700 04:18:56,537 --> 04:18:59,740 DIRECTOR SO WE ARE VERY -- SINCE 6701 04:18:59,740 --> 04:19:01,175 MANY OF YOU KNOW THESE DIFFERENT 6702 04:19:01,175 --> 04:19:02,910 FOLKS I WANT TO GET THAT -- LET 6703 04:19:02,910 --> 04:19:05,445 YOU KNOW WHAT WAS GOING ON AS 6704 04:19:05,445 --> 04:19:07,681 HOT OFF THE PRESS TODAY. 6705 04:19:07,681 --> 04:19:10,317 WITH THAT BEING SAID, THANK YOU 6706 04:19:10,317 --> 04:19:10,784 AGAIN. 6707 04:19:10,784 --> 04:19:13,287 I'M ANXIOUS TO SEE THE RESULTS 6708 04:19:13,287 --> 04:19:15,355 OF THE POLL TO DETERMINE WHAT WE 6709 04:19:15,355 --> 04:19:16,824 ARE GOING TO DO IN OCTOBER. 6710 04:19:16,824 --> 04:19:21,094 IT WOULD BE LOVERLY TO SEE MANY 6711 04:19:21,094 --> 04:19:22,863 OF YOU -- LOVELY TO SEE MANY OF 6712 04:19:22,863 --> 04:19:24,598 YOU. 6713 04:19:24,598 --> 04:19:26,934 SO FINGERS CROSSED THAT WE CAN 6714 04:19:26,934 --> 04:19:29,102 AT LEAST DO SOME HYBRID MEETING. 6715 04:19:29,102 --> 04:19:29,903 BUT THANK YOU AGAIN. 6716 04:19:29,903 --> 04:19:31,805 I DON'T HAVE TO SAY SAFE TRAVELS 6717 04:19:31,805 --> 04:19:34,041 THIS TIME BECAUSE YOU ARE ALL 6718 04:19:34,041 --> 04:19:36,376 WHERE YOU SHOULD BE. 6719 04:19:36,376 --> 04:19:37,945 THANKS A LOT. 6720 04:19:37,945 --> 04:19:41,148 AND TO THE OAR STAFF, TO THE 6721 04:19:41,148 --> 04:19:44,651 NIH, AND TO ALL OF YOU WHO ARE 6722 04:19:44,651 --> 04:19:46,987 ACROSS THE GOVERNMENT AND ALL 6723 04:19:46,987 --> 04:19:51,625 THE OTHER AREAS YOU SO WELL 6724 04:19:51,625 --> 04:19:52,626 REPRESENT TO US DURING THE THESE 6725 04:19:52,626 --> 04:19:53,260 SESSIONS. 6726 04:19:53,260 --> 04:19:54,661 THANK YOU. 6727 04:19:54,661 --> 04:20:00,100 HAVE A GREAT SUMMER. 6728 04:20:00,100 --> 04:20:02,002 >> THANK YOU, DR. GOODENOW. 6729 04:20:02,002 --> 04:20:03,437 JUST AS REMINDER TO EVERYONE 6730 04:20:03,437 --> 04:20:05,439 BEFORE WE LEAVE THE NEXT OARAC 6731 04:20:05,439 --> 04:20:11,245 MEETING IS THURSDAY OCTOBER 27, 6732 04:20:11,245 --> 04:20:12,246 2022, HOPE THAT COULD BE A 6733 04:20:12,246 --> 04:20:15,916 HYBRID MEETING FOR US. 6734 04:20:15,916 --> 04:20:18,085 BUT NEVERTHELESS TODAY'S MEETING 6735 04:20:18,085 --> 04:20:18,819 IS ADJOURNED. 6736 04:20:18,819 --> 04:20:20,721 THANK YOU, EVERYONE. 6737 04:20:20,721 --> 04:20:30,898 THANKS.